e10vq

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PwWa6kgfEt2a4camC3twMw4Jfa/erRP3d+MnSmEFEbbqAZXbjpEvLdUQDtRBOpkE sa8TbG0Pktmo3pMAxOTNqw== 0000950137-07-011494.txt : 20070807 0000950137-07-011494.hdr.sgml : 20070807 20070807102411 ACCESSION NUMBER: 0000950137-07-011494 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20070630 FILED AS OF DATE: 20070807 DATE AS OF CHANGE: 20070807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZIMMER HOLDINGS INC CENTRAL INDEX KEY: 0001136869 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 134151777 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-16407 FILM NUMBER: 071030260 BUSINESS ADDRESS: STREET 1: 345 EAST MAIN STREET CITY: WARSAW STATE: IN ZIP: 46580 BUSINESS PHONE: 5742676131 MAIL ADDRESS: STREET 1: 345 EAST MAIN STREET CITY: WARSAW STATE: IN ZIP: 46580 10-Q 1 c17407e10vq.htm QUARTERLY REPORT e10vq

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2007

Commission File Number 001-16407

ZIMMER HOLDINGS, INC.

(Exact name of registrant as specified in its charter)


Delaware		13-4151777
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

345 East Main Street, Warsaw, IN 46580
(Address of principal executive offices)
Telephone: (574) 267-6131

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.

Large accelerated filer þ Accelerated filer o Non-accelerated filer o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ

As of July 26, 2007, 236,179,506 shares of the registrant’s $.01 par value common stock were outstanding.

ZIMMER HOLDINGS, INC.

INDEX TO FORM 10-Q

June 30, 2007


		Page

Part I — Financial Information
Item 1.	Financial Statements
	Consolidated Statements of Earnings for the Three and Six Months Ended June 30, 2007 and 2006		3
	Consolidated Balance Sheets as of June 30, 2007 and December 31, 2006		4
	Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2007 and 2006		5
	Notes to Interim Consolidated Financial Statements		6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		15
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		29
Item 4.	Controls and Procedures		29



Part II — Other Information
	There is no information required to be reported under any items except those indicated below.
Item 1.	Legal Proceedings		29
Item 1A.	Risk Factors		29
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		30
Item 4.	Submission of Matters to a Vote of Security Holders		30
Item 5.	Other Information		31
Item 6.	Exhibits		31
Signatures			32
Restated Certificate of Incorporation
Form of Performance-Based Restricted Stock Unit Award Letter
302 Certification of Chief Executive Officer
302 Certification of Chief Financial Officer
Section 906 Certification

Part I — Financial Information


Item 1.	*Financial Statements*

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EARNINGS
(In millions, except per share amounts, unaudited)


							Six Months
	Three Months Ended						Ended
	June 30,						June 30,
	2007			2006			2007			2006

Net Sales	$	970.6		$	881.6		$	1,920.8		$	1,742.0
Cost of products sold		216.4			200.0			422.8			389.4

Gross Profit		754.2			681.6			1,498.0			1,352.6

Research and development		53.5			48.6			105.8			96.0
Selling, general and administrative		374.3			344.8			735.9			679.7
Acquisition, integration and other expense		3.9			6.3			6.6			4.5

Operating expenses		431.7			399.7			848.3			780.2

Operating Profit		322.5			281.9			649.7			572.4
Interest income, net		1.3			1.2			1.1			1.7

Earnings before income taxes and minority interest		323.8			283.1			650.8			574.1
Provision for income taxes		92.2			82.0			185.5			167.1
Minority interest		(0.1	)		(0.2	)		(0.4	)		(0.5	)

Net Earnings	$	231.5		$	200.9		$	464.9		$	406.5

Earnings Per Common Share
Basic	$	0.98		$	0.82		$	1.96		$	1.65
Diluted	$	0.97		$	0.81		$	1.94		$	1.63
Weighted Average Common Shares Outstanding
Basic		236.9			245.5			236.9			246.6
Diluted		239.2			247.7			239.2			248.9

The accompanying notes are an integral part of these consolidated financial statements.

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS
(In millions, except share amounts)


	June 30,			December 31,
	2007			2006
	(Unaudited)

ASSETS
Current Assets:
Cash and equivalents	$	358.7		$	265.7
Restricted cash		2.3			2.4
Accounts receivable, less allowance for doubtful accounts		689.7			625.5
Inventories, net		682.9			638.3
Prepaid expenses		67.3			55.1
Deferred income taxes		148.4			159.2

Total current assets		1,949.3			1,746.2
Property, plant and equipment, net		865.9			807.1
Goodwill		2,507.3			2,515.6
Intangible assets, net		748.9			712.6
Other assets		249.4			192.9

Total Assets	$	6,320.8		$	5,974.4


LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	141.3		$	158.0
Income taxes payable		68.6			106.5
Other current liabilities		433.0			363.7

Total current liabilities		642.9			628.2
Other long-term liabilities		296.8			323.4
Long-term debt		95.2			99.6

Total Liabilities		1,034.9			1,051.2

Commitments and Contingencies (Note 13)
Minority interest		2.6			2.7
Stockholders’ Equity:
Common stock, $0.01 par value, one billion shares authorized, 251.8 million shares in 2007 (248.9 million in 2006) issued		2.5			2.5
Paid-in capital		2,947.1			2,743.2
Retained earnings		3,228.6			2,768.5
Accumulated other comprehensive income		213.2			209.2
Treasury stock, 15.8 million shares in 2007 (12.1 million in 2006)		(1,108.1	)		(802.9	)

Total Stockholders’ Equity		5,283.3			4,920.5

Total Liabilities and Stockholders’ Equity	$	6,320.8		$	5,974.4

The accompanying notes are an integral part of these consolidated financial statements.

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions, unaudited)


	For the Six
	Months
	Ended June 30,
	2007			2006

Cash flows provided by (used in) operating activities:
Net earnings	$	464.9		$	406.5
Adjustments to reconcile net earnings to cash provided by operating activities:
Depreciation and amortization		109.4			93.5
Share-based compensation		41.1			39.0
Income tax benefit from stock option exercises		37.9			3.3
Excess income tax benefit from stock option exercises		(25.6	)		(2.5	)
Changes in operating assets and liabilities:
Income taxes		4.1			72.3
Receivables		(54.2	)		(100.5	)
Inventories		(36.8	)		(11.0	)
Accounts payable and accrued expenses		2.4			(16.0	)
Other assets and liabilities		(47.5	)		23.3

Net cash provided by operating activities		495.7			507.9

Cash flows provided by (used in) investing activities:
Additions to instruments		(72.9	)		(62.5	)
Additions to other property, plant and equipment		(70.3	)		(52.3	)
Proceeds from sale of property, plant and equipment		—			16.2
Acquisitions, net of acquired cash		(112.1	)		(13.5	)

Net cash used in investing activities		(255.3	)		(112.1	)

Cash flows provided by (used in) financing activities:
Proceeds from employee stock compensation plans		132.1			16.2
Excess income tax benefit from stock option exercises		25.6			2.5
Repurchase of common stock		(305.2	)		(316.4	)

Net cash used in financing activities		(147.5	)		(297.7	)

Effect of exchange rates on cash and equivalents		0.1			4.5

Increase in cash and equivalents		93.0			102.6
Cash and equivalents, beginning of year		265.7			233.2

Cash and equivalents, end of period	$	358.7		$	335.8

The accompanying notes are an integral part of these consolidated financial statements.

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS


1.	Basis of Presentation

The financial data presented herein is unaudited and should be read in conjunction with the consolidated financial statements and accompanying notes included in the 2006 Annual Report on Form 10-K filed by Zimmer Holdings, Inc. In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods presented. The December 31, 2006 condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. Results for interim periods should not be considered indicative of results for the full year. Certain amounts in the three and six month periods ended June 30, 2006 have been reclassified to conform to the current year presentation.

Consolidated cash flows for the six months ended June 30, 2007 include the correction of an error in presentation of $20.2 million, which had previously been reported in the three month period ended March 31, 2007, as a component of the change in receivables in operating cash flows and is now appropriately reported as proceeds from employee stock compensation in financing cash flows for the six month period ended June 30, 2007. Management does not consider this error in presentation to be material to the Consolidated Statement of Cash Flows for the three months ended March 31, 2007.

The words “we”, “us”, “our” and similar words refer to Zimmer Holdings, Inc. and its subsidiaries. Zimmer Holdings refers to the parent company only.


2.	Acquisitions

We have made acquisitions that took place during the six month period ended June 30, 2007 which are described below. These acquisitions were accounted for under the purchase method of accounting pursuant to Statement of Financial Accountings Standards (SFAS) No. 141, “Business Combinations,” (SFAS No. 141). Accordingly, the results of operations of the acquired companies have been included in our consolidated results of operations subsequent to the transaction dates, and the respective assets and liabilities of the acquired companies have been recorded at their estimated fair values in our consolidated statement of financial position as of the transaction dates, with any excess purchase price being allocated to goodwill. Pro forma financial information has not been included as the acquisitions did not have a material impact upon our financial position or results of operations.

Endius, Inc.

On April 20, 2007, we acquired Endius, Inc. (Endius), a privately held spinal products company based in Massachusetts, for an initial aggregate value of approximately $80 million in cash, before adjustments for debt repayment and other items. Endius develops and manufactures minimally invasive spine surgery products, implants and techniques to treat spine disease. The acquisition of Endius will expand our spine product portfolio to include innovative minimally invasive instruments and implants.

Diadent, Srl.

On April 27, 2007, we acquired Diadent, Srl. (Diadent), a privately held distributor of our dental products in Italy, in a cash transaction. The acquisition of Diadent will provide us with direct sales of dental implants in Italy.

U.S. Distributor Network

During the quarter, we made investments in our U.S. based distribution network, including the acquisition of certain orthopaedic implant distribution businesses. These investments and acquisitions are expected to increase future revenues by enhancing our U.S. sales and distribution infrastructure.

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

3. Comprehensive Income

The reconciliation of net earnings to comprehensive income is as follows:


	Three Months						Six Months
	Ended						Ended
	June 30,						June 30,
	2007			2006			2007			2006
	(In millions)						(In millions)

Net Earnings	$	231.5		$	200.9		$	464.9		$	406.5
Other Comprehensive Income (Loss):
Foreign currency cumulative translation adjustments		(10.3	)		76.6			5.6			86.5
Unrealized foreign currency hedge losses, net of tax		(4.9	)		(29.2	)		(12.4	)		(34.7	)
Reclassification adjustments on foreign currency hedges, net of tax		4.6			1.6			6.8			3.7
Unrealized gains (losses) on securities, net of tax		(0.3	)		(0.9	)		(0.3	)		(0.7	)
Change in amortization of prior service cost, net of tax		0.8			—			4.3			—
Minimum pension liability, net of tax		—			0.5			—			(2.0	)

Total Other Comprehensive Income		(10.1	)		48.6			4.0			52.8

Comprehensive Income	$	221.4		$	249.5		$	468.9		$	459.3


4.	Inventories


	June 30,		December 31,
	2007		2006
	(In millions)

Finished goods	$	523.9	$	489.1
Work in progress		54.6		46.4
Raw materials		104.4		102.8

Inventories, net	$	682.9	$	638.3


5.	Property, Plant and Equipment


	June 30,			December 31,
	2007			2006
	(In millions)

Land	$	17.5		$	17.6
Buildings and equipment		903.3			783.7
Instruments		833.7			768.5
Construction in progress		43.0			105.3

		1,797.5			1,675.1
Accumulated depreciation		(931.6	)		(868.0	)

Property, plant and equipment, net	$	865.9		$	807.1


6.	Income Taxes

In June 2006, the Financial Accounting Standards Board (FASB) issued Interpretation No. 48, Accounting for Uncertainty in Income Taxes — an interpretation of FASB Statement No. 109, Accounting for Income Taxes (FIN 48). FIN 48 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

return should be recorded in the financial statements. Under FIN 48, we may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. FIN 48 also provides guidance on derecognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

We adopted FIN 48 on January 1, 2007. Prior to the adoption of FIN 48 we had a long term tax liability for expected settlement of various federal, state and foreign income tax liabilities that was reflected net of the corollary tax impact of these expected settlements of $102.1 million, as well as a separate accrued interest liability of $1.7 million. As a result of the adoption of FIN 48, we are required to present the different components of such liability on a gross basis versus the historical net presentation. The adoption resulted in the financial statement liability for unrecognized tax benefits decreasing by $6.4 million as of January 1, 2007. The adoption resulted in this decrease in the liability as well as a reduction to retained earnings of $4.7 million, a reduction in goodwill of $61.4 million, the establishment of a tax receivable of $58.2 million, and an increase in an interest/penalty payable of $7.9 million, all as of January 1, 2007. Therefore, after the adoption of FIN 48, the amount of unrecognized tax benefits is $95.7 million as of January 1, 2007, of which $28.6 million would impact our effective tax rate, if recognized. The amount of unrecognized tax benefits is $103.9 million as of June 30, 2007. Of this amount, $30.8 million would impact our effective tax rate, if recognized.

We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense in the Consolidated Statements of Earnings, which is consistent with the recognition of these items in prior reporting periods. As of January 1, 2007, we recorded a liability of $9.6 million for accrued interest and penalties, of which $7.5 million would impact our effective tax rate, if recognized. The amount of this liability is $11.5 million as of June 30, 2007. Of this amount, $8.6 million would impact our effective tax rate, if recognized.

We expect that the amount of tax liability for unrecognized tax benefits will change in the next twelve months; however, we do not expect these changes will have a significant impact on our results of operations or financial position.

The U.S. federal statute of limitations remains open for the year 2003 and onward with years 2003 and 2004 currently under examination by the IRS. It is reasonably possible that a resolution with the IRS for the years 2003 through 2004 will be reached within the next twelve months, but we do not anticipate this would result in any material impact on our financial position. In addition, for the 1999 tax year of Centerpulse, which we acquired in October 2003, one issue remains in dispute at the IRS appeals level. The resolution of this issue would not impact our effective tax rate as it would be recorded as an adjustment to goodwill.

State income tax returns are generally subject to examination for a period of 3 to 5 years after filing of the respective return. The state impact of any federal changes remains subject to examination by various states for a period of up to one year after formal notification to the states. We have various state income tax returns in the process of examination, administrative appeals or litigation. It is reasonably possible that such matters will be resolved in the next twelve months, but we do not anticipate that the resolution of these matters would result in any material impact on our results of operations or financial position.

Foreign jurisdictions have statutes of limitations generally ranging from 3 to 5 years. Years still open to examination by foreign tax authorities in major jurisdictions include Australia (2001 onward), Canada (1998 onward), France (2004 onward), Germany (2000 onward), Italy (2003 onward), Japan (2000 onward), Puerto Rico (2005 onward), Singapore (2002 onward), Switzerland (2004 onward), and the United Kingdom (2004 onward).

Our tax returns are currently under examination in various foreign jurisdictions, including Germany, Italy and Switzerland. It is reasonably possible that such audits will be resolved in the next twelve months, but we do not anticipate that the resolution of these audits would result in any material impact on our results of operations or financial position.

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

7. Retirement and Postretirement Benefit Plans

We have defined benefit pension plans covering certain U.S. and Puerto Rico employees who were hired before September 2, 2002. Employees hired after September 2, 2002 are not part of the U.S. and Puerto Rico defined benefit plans, but do receive additional benefits under our defined contribution plans. Plan benefits are primarily based on years of credited service and the participant’s compensation. In addition to the U.S. and Puerto Rico defined benefit pension plans, we sponsor various non-U.S. pension arrangements, including retirement and termination benefit plans required by local law or coordinated with government sponsored plans.

We also provide comprehensive medical and group life insurance benefits to certain U.S. and Puerto Rico retirees who elect to participate in our comprehensive medical and group life plans. The medical plan is contributory, and the life insurance plan is non-contributory. Employees hired after September 2, 2002 are not eligible for retiree medical and life insurance benefits. No similar plans exist for employees outside the U.S. and Puerto Rico.

The components of net pension expense for the three and six month periods ended June 30, 2007 and 2006, for our U.S. and non-U.S. defined benefit retirement plans are as follows (in millions):


	Three Months						Six Months
	Ended						Ended
	June 30,						June 30,
	2007			2006			2007			2006

Service cost	$	6.7		$	5.7		$	13.6		$	11.7
Interest cost		3.4			3.1			7.0			6.1
Expected return on plan assets		(4.4	)		(3.6	)		(8.9	)		(7.2	)
Amortization of unrecognized actuarial loss		0.8			0.8			1.5			1.9

Net periodic benefit cost	$	6.5		$	6.0		$	13.2		$	12.5

The components of net periodic benefit expense for the three and six month periods ended June 30, 2007 and 2006, for our U.S. and Puerto Rico postretirement benefit plans are as follows (in millions):


	Three Months						Six Months
	Ended						Ended
	June 30,						June 30,
	2007			2006			2007			2006

Service cost	$	0.4		$	0.4		$	0.8		$	0.9
Interest cost		0.6			0.5			1.2			1.1
Amortization of unrecognized prior service cost		(0.1	)		(0.1	)		(0.2	)		(0.1	)
Amortization of unrecognized actuarial loss		0.2			0.2			0.4			0.4

Net periodic benefit cost	$	1.1		$	1.0		$	2.2		$	2.3

We contributed $26.6 million during the six month period ended June 30, 2007, to our U.S. and Puerto Rico defined benefit plans and may make additional contributions of $1.4 million during 2007. We contributed $4.4 million to our foreign-based defined benefit plans in the six month period ended June 30, 2007, and expect to contribute an additional $3.8 million to these foreign-based plans during 2007. Contributions for the U.S. and Puerto Rico postretirement benefit plans are not expected to be significant.


8.	Share-Based Compensation

Share-based compensation expense for the three and six month periods ended June 30, 2007 was $20.2 million and $41.1 million, or $13.7 million and $28.0 million net of the related tax benefits, respectively. Share-based

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

compensation expense for the three and six month periods ended June 30, 2006 was $20.8 million and $39.0 million, or $15.1 million and $28.0 million net of the related tax benefits, respectively.

A summary of stock option activity for the six month period ended June 30, 2007 is as follows (options in thousands):


	Stock			Weighted Average
	Options			Exercise Price

Outstanding at January 1, 2007		14,184		$	59.75
Options granted		2,270			84.05
Options exercised		(2,768	)		45.19
Options cancelled		(291	)		73.61

Outstanding at June 30, 2007		13,395			66.53

The weighted-average fair value of the options granted in the six month period ended June 30, 2007 was $24.71 per option. As of June 30, 2007, there was $113.1 million of unrecognized share-based compensation expense related to nonvested stock options granted under our plans. That expense is expected to be recognized over a weighted average period of 3.3 years.

At June 30, 2007 there were 827,700 nonvested equity share units, with a grant date fair value of $67.86. The unrecognized share-based payment expense as of June 30, 2007 was $13 million, and is expected to be recognized over a period of 1.5 years.


9.	Stock Repurchase Program

During the three and six months ended June 30, 2007, respectively, we purchased 1,520,456 shares of our common stock at an average price of $86.69 per share for a total cash outlay of $131.8 million, including commissions, and 3,604,256 shares of our common stock at an average price of $84.66 per share for a total cash outlay of $305.2 million, including commissions, under stock repurchase plans authorized by our Board of Directors in December 2005 and 2006. Purchases totaling an additional $892.2 million may be made through December 31, 2008 under the plan authorized in 2006.


10.	Earnings Per Share

The following is a reconciliation of weighted average shares for the basic and diluted shares computations (in millions):


	Three Months				Six Months
	Ended				Ended
	June 30,				June 30,
	2007		2006		2007		2006

Weighted average shares outstanding for basic net earnings per share		236.9		245.5		236.9		246.6
Effect of dilutive stock options		2.3		2.2		2.3		2.3

Weighted average shares outstanding for diluted net earnings per share		239.2		247.7		239.2		248.9

During the three and six month periods ended June 30, 2007, an average of 0.1 million options and 0.6 million options, respectively, to purchase shares of common stock were not included in the computation of diluted earnings per share as the exercise prices of these options were greater than the average market price of the common stock. During the three and six month periods ended June 30, 2006, an average of 8.6 million options and 8.7 million options, respectively, were not included.

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

11. Segment Information

We design, develop, manufacture and market reconstructive orthopaedic implants, including joint and dental, spinal implants, trauma products and related orthopaedic surgical products which include surgical supplies and instruments designed to aid in orthopaedic surgical procedures and post-operation rehabilitation. We also provide hospital-focused consulting services to help member institutions design, implement and manage successful orthopaedic programs. We manage operations through three major geographic segments — the Americas, which is comprised principally of the United States and includes other North, Central and South American markets; Europe, which is comprised principally of Europe and includes the Middle East and Africa; and Asia Pacific, which is comprised primarily of Japan and includes other Asian and Pacific markets. This structure is the basis for our reportable segment information discussed below. Management evaluates operating segment performance based upon segment operating profit exclusive of operating expenses pertaining to global operations and corporate expenses, share-based compensation, acquisition, integration and other expenses, inventory step-up, in-process research and development write-offs and intangible asset amortization expense. Global operations include research, development engineering, medical education, brand management, corporate legal, finance, and human resource functions, and U.S. and Puerto Rico based manufacturing operations and logistics. Intercompany transactions have been eliminated from segment operating profit.

Net sales and segment operating profit are as follows (in millions):


					Operating Profit
	Net Sales				Three Months
	Three Months Ended				Ended
	June 30,				June 30,
	2007		2006		2007			2006

Americas	$	568.1	$	520.9	$	296.8		$	276.9
Europe		267.2		238.4		108.1			97.8
Asia Pacific		135.3		122.3		65.1			58.5

Total	$	970.6	$	881.6

Share-based compensation						(20.2	)		(19.6	)
Inventory step-up						(0.3	)		—
Acquisition, integration and other						(3.9	)		(6.3	)
Global operations and corporate functions						(123.1	)		(125.4	)

Operating profit					$	322.5		$	281.9

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Net Sales Operating Profit

Six Months
Six Months

Ended
Ended

June 30, June 30,

2007 2006 2007 2006

Americas
$ 1,135.9 $ 1,036.9 $ 593.8 $ 545.7

Europe
526.0 467.1 220.3 197.1

Asia Pacific
258.9 238.0 123.6 114.5

Total
$ 1,920.8 $ 1,742.0

Share-based compensation
(41.1 ) (37.8 )

Inventory step-up
(0.3 ) —

Acquisition and integration
(6.6 ) (4.5 )

Global operations and corporate functions
(240.0 ) (242.6 )

Operating profit
$ 649.7 $ 572.4

Product category net sales are as follows (in millions):


					Six Months
	Three Months Ended				Ended
	June 30,				June 30,
	2007		2006		2007		2006

Reconstructive implants	$	813.6	$	733.6	$	1,611.1	$	1,451.1
Trauma		50.3		49.1		100.4		95.8
Spine		49.0		46.0		95.7		89.1
Orthopaedic surgical products		57.7		52.9		113.6		106.0

Total	$	970.6	$	881.6	$	1,920.8	$	1,742.0


12.	Recent Accounting Pronouncements

In September 2006, the FASB issued Statement of Financial Accountings Standards (SFAS) No. 157, “Fair Value Measurements,” (SFAS No. 157) which defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. This Statement does not require any new fair value measurements, but provides guidance on how to measure fair value by providing a fair value hierarchy used to classify the source of the information. SFAS No. 157 is effective for financial statements issued for fiscal years beginning after November 15, 2007. The adoption of SFAS No. 157 is not expected to have a material impact on our financial position or results of operations.

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities — Including an amendment of FASB Statement No. 115” (SFAS No. 159). SFAS No. 159 creates a “fair value option” under which an entity may elect to record certain financial assets or liabilities at fair value upon their initial recognition. Subsequent changes in fair value would be recognized in earnings as those changes occur. The election of the fair value option would be made on a contract-by-contract basis and would need to be supported by concurrent documentation or a preexisting documented policy. SFAS No. 159 requires an entity to separately disclose the fair value of these items on the balance sheet or in the footnotes to the financial statements and to provide information that would allow the financial statement user to understand the impact on earnings from the changes in the fair value. SFAS No. 159 is effective for fiscal years beginning after November 15, 2007. The adoption of SFAS No. 159 is not expected to have a material impact on our financial position or results of operations.

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

13. Commitments and Contingencies

As a result of the Centerpulse acquisition, we acquired the entity involved in Centerpulse’s hip and knee implant litigation matter. The litigation was a result of a voluntary recall of certain hip and knee implants manufactured and sold by Centerpulse. On March 13, 2002, a U.S. Class Action Settlement Agreement (“Settlement Agreement”) was entered into by Centerpulse that resolved U.S. claims related to the affected products and a settlement trust (“Settlement Trust”) was established and funded for the most part by Centerpulse. The court approved the settlement arrangement on May 8, 2002. Under the terms of the Settlement Agreement, we will reimburse the Settlement Trust a specified amount for each revision surgery over 4,000 and revisions on reprocessed shells over 64. As of June 29, 2007, the claims administrator has received 4,133 likely valid claims for hips (cut-off date June 5, 2003) and knees (cut-off date November 17, 2003) and 200 claims for reprocessed shells (cut-off date September 8, 2004). We believe the litigation liability recorded as of June 30, 2007 is adequate to provide for any future claims regarding the hip and knee implant litigation.

On February 15, 2005, Howmedica Osteonics Corp. (“Howmedica”) filed an action against us and an unrelated party in the United States District Court for the District of New Jersey alleging infringement of U.S. Patent Nos. 6,174,934; 6,372,814; 6,664,308; and 6,818,020. On June 13, 2007, the Court granted our motion for summary judgment on the invalidity of the asserted claims of U.S. Patent Nos. 6,174,934; 6,372,814; and 6,664,308 by ruling that all of the asserted claims are invalid for indefiniteness. Our motion for summary judgment on the invalidity of certain asserted claims of U.S. Patent No. 6,818,020 remains pending before the Court. We continue to believe that our defenses are valid and meritorious, and we intend to defend the Howmedica lawsuit vigorously.

We are also subject to product liability and other claims and lawsuits arising in the ordinary course of business, for which we maintain insurance, subject to self-insured retention limits. We establish accruals for product liability and other claims in conjunction with outside counsel based on current information and historical settlement information for open claims, related fees and for claims incurred but not reported. While it is not possible to predict with certainty the outcome of these cases, it is the opinion of management that, upon ultimate resolution, these cases will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.

In July 2003, the Staff of the Securities and Exchange Commission informed Centerpulse that it was conducting an informal investigation of Centerpulse relating to certain accounting issues. We are continuing to fully cooperate with the Securities and Exchange Commission in this matter.

In March 2005, we received a subpoena and we have received supplemental requests since that time from the United States Department of Justice through the United States Attorney’s Office in Newark, New Jersey, requesting that we produce documents and related information for the period beginning January 1998 pertaining to consulting contracts, professional service agreements and other agreements by which we may provide remuneration to orthopaedic surgeons, including research and other grant agreements. We understand that similar inquiries were directed to at least four other companies in the orthopaedics industry.

We continue to cooperate fully with federal authorities with regard to this matter. We recently began discussions, which are still in preliminary stages, with respect to a potential resolution of this matter. Given that these discussions are still preliminary, there can be no assurance that we will enter into a consensual resolution of this matter with federal authorities or what the terms of any such resolution may be.

In June 2006, we received a subpoena from the United States Department of Justice, Antitrust Division, requesting that we produce documents for the period beginning January 2001 through June 2006, pertaining to an investigation of possible violations of federal criminal law, including possible violations of the antitrust laws, involving the manufacture and sale of orthopaedic implant devices. We are cooperating fully with federal authorities with regard to this matter. We understand that similar inquiries were directed to at least four other companies in the orthopaedics industry.

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Following the commencement of the Department of Justice, Antitrust Division’s investigation, we and several other major orthopaedic manufacturers were named as defendants in five putative class action lawsuits as of January 1, 2007. These lawsuits were brought by direct and indirect purchasers of orthopaedic products alleging violations of Federal and state antitrust laws and certain state consumer protection statutes. In each of these lawsuits, the plaintiffs allege that the defendants engaged in a conspiracy to fix prices of orthopaedic implant devices. The direct purchaser cases, South Central Surgical Center, LLC v. Zimmer Holdings, Inc. et al. and Chaiken DDS, P.C. v. Biomet, Inc. et al., were filed in the United States District Court for the Southern District of Indiana on July 13, 2006 and in the United States District Court for the Northern District of Indiana on July 26, 2006, respectively. The indirect purchaser cases, Thomas v. Biomet, Inc. et al., Kirschner v. Biomet, Inc. et al. and Williams v. Biomet, Inc. et al., were filed in the United States District Court for the Western District of Tennessee on July 18, 2006, July 24, 2006 and July 27, 2006, respectively.

On January 12, 2007, we and the other defendants in the five cases delivered a Motion for Transfer and Consolidation of Pretrial Proceedings under 28 U.S.C. § 1407 to the Judicial Panel on Multidistrict Litigation, requesting the court to transfer the cases to the United States District Court for the Southern District of Indiana for coordinated or consolidated pretrial proceedings. The motion was filed by the Panel on January 18, 2007. The plaintiffs did not oppose a stay of proceedings pending resolution of this motion. On January 15, 2007, the plaintiff in Thomas v. Biomet, Inc. et al. filed a Notice of Voluntary Dismissal Without Prejudice in the United States District Court for the Western District of Tennessee. On April 18, 2007, the Judicial Panel on Multidistrict Litigation issued a Transfer Order ordering that the three remaining actions pending outside the Southern District of Indiana be transferred to that district for coordinated or consolidated pretrial proceedings with the action already pending in that district. In each of these four remaining cases, the plaintiffs seek damages of unspecified amounts, in some cases to be trebled under applicable law, attorneys’ fees and injunctive or other unspecified relief. We believe these lawsuits are without merit and we intend to defend them vigorously.


Item 2.	*Management’s Discussion and Analysis of Financial Condition and Results of Operations*

Overview

We are a global leader in the design, development, manufacture and marketing of reconstructive orthopaedic implants, including joint and dental, spinal implants, trauma products and related orthopaedic surgical products (sometimes referred to in this report as “OSP”). We also provide hospital-focused consulting services to help member institutions design, implement and manage successful orthopaedic programs, which account for less than one percent of sales. Reconstructive orthopaedic implants restore joint function lost due to disease or trauma in joints such as knees, hips, shoulders and elbows. Dental reconstructive implants restore function and aesthetics in patients that have lost teeth due to trauma or disease. Spinal implants are utilized by orthopaedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities and trauma in all regions of the spine. Trauma products are devices used primarily to reattach or stabilize damaged bone and tissue to support the body’s natural healing process. OSP includes supplies and instruments designed to aid in orthopaedic surgical procedures and post-operation rehabilitation. Through our consulting services, we provide hospitals and other orthopaedic practices resource capabilities in the areas of business development, marketing, in/outpatient rehab practice, clinical pathways, care mapping and space design, community relations, customer service, delivery models, cost accounting, staff utilization and other areas. We have operations in more than 24 countries and market products in more than 100 countries. We manage operations through three reportable geographic segments — the Americas, Europe and Asia Pacific.

Certain percentages presented in Management’s Discussion and Analysis are calculated from the underlying whole-dollar amounts and therefore may not recalculate from the rounded numbers used for disclosure purposes.

We believe the following developments or trends are important in understanding our financial condition, results of operations and cash flows for the three and six month periods ended June 30, 2007.

Demand (Volume and Mix) Trends

Increased volume and changes in the mix of product sales contributed 8 percentage points of sales growth during the three month period ended June 30, 2007, compared to 5 percentage points in the same 2006 period. We believe the market for orthopaedic procedure volume on a global basis continues to rise at mid single digit rates with the potential for high single digit growth driven by an aging global population, obesity, proven clinical benefits, new material technologies, advances in surgical techniques (such as our Zimmer^® Minimally Invasive Solutions^tm (MIS) Procedures and Technologies), introduction of gender based devices and more active lifestyles, among other factors. In addition, the ongoing shift in demand to premium products, such as Longevity^® and Durasul^® Highly Crosslinked Polyethylenes, Trabecular Metal^tm Technology products, high-flex knees, knee revision products and porous hip stems, continues to positively affect sales growth. For example, during the three month period ended June 30, 2007, sales of products incorporating Trabecular Metal Technology were approximately $53 million, an increase of over 25 percent compared to the same 2006 period.

We believe innovative products will continue to affect the orthopaedics industry. In the second half of 2006, we launched the Zimmer Gender Solutions^tm High-Flex Knee Femoral Implant, which was the result of five years of intensive research based on an analysis of 800 femurs and patella. High Flex Knees now make up over 40 percent of our knee revenue on a global basis, having grown from approximately 28 percent prior to the launch of the Zimmer Gender Solutions Knee.

Pricing Trends

Selling prices remained flat during the three month period ended June 30, 2007, which is similar to the same 2006 period. The Americas experienced a 1 percent increase in selling prices during the three month period ended June 30, 2007, which is similar to the same 2006 period. In Europe, selling prices for the three month period ended June 30, 2007 decreased 1 percent, which is similar to the same 2006 period. Within Europe, both Germany and Italy experienced 3 percent decreases in selling prices in the three month period ended June 30, 2007, as a result of reductions in government implant reimbursement rates and group purchasing arrangements while other European markets were flat or slightly positive. Germany and Italy combined currently represent approximately 11 percent of

our sales. Asia Pacific selling prices decreased 1 percent for the three month period ended June 30, 2007, compared to a 3 percent decrease in the same 2006 period. As anticipated, Japan reported a 5 percent decrease in average selling prices as a result of scheduled reductions in government controlled reimbursement prices, while other Asia Pacific markets were flat to positive. Japan currently represents approximately 7 percent of our sales. With the effect of governmental healthcare cost containment efforts and pressure from group purchasing organizations, we expect global selling prices will remain flat in 2007.

Foreign Currency Exchange Rates

For the three month period ended June 30, 2007, foreign currency exchange rates had a positive 2 percent effect on sales. The positive effect of foreign currency exchange rates is expected to continue in the second half of the year. We estimate that an overall weaker U.S. Dollar will have a positive effect of approximately 2 percent on sales for the year ending December 31, 2007. We address currency risk through regular operating and financing activities, and under appropriate circumstances and subject to proper authorization, through the use of forward contracts solely for managing foreign currency volatility and risk. Changes to foreign currency exchange rates affect sales growth, but due to offsetting gains/losses on hedge contracts, which are recorded in cost of products sold, the effect on net earnings in the near term is expected to be minimal.

New Product Sales

New products, which management defines as products or stock keeping units (SKU’s) introduced within the prior 36-month period to a particular market, accounted for 24 percent, or $238 million, of our sales during the three month period ended June 30, 2007. Adoption rates for new technologies are a key indicator of industry performance. Our sales have grown with the introduction of new products, such as Trabecular Metal Modular Acetabular Cups, certain SKU’s of the NexGen^® Complete Knee Solution including the Gender Solutions Knee Femoral Implant for the LPS-Flex, and CR-Flex Knees, the Dynesys^®¹ Dynamic Stabilization System, the Zimmer M/L Taper Stem and PALACOS^®² Bone Cement.

We believe new products in our current pipeline should continue to favorably affect our operating performance. Products we expect to contribute to new product sales in 2007 include the Gender Solutions Knee Femoral Implant; products incorporating Trabecular Metal Technology, including the Trabecular Metal Primary Hip Prosthesis, Trabecular Metal Acetabular Revision System and Trabecular Metal Spine Components; Durom^® Acetabular Cups with Metasul^® LDH^® Large Diameter Heads; Versys^® Epoch^® Composite Hip Prosthesis; Zimmer^® Reverse Shoulder System, Anatomical Shoulder^tm Inverse/Reverse System; Zimmer MIS Femoral Nailing Solutions; NCB^® Locking Plate System; and CopiOs^® Bone Void Filler.³

New Accounting Pronouncements

On January 1, 2007, we adopted FIN 48, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under FIN 48, the tax benefits from an uncertain tax position may be recognized only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. FIN 48 also provides guidance on derecognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

Prior to the adoption of FIN 48, we had a long term tax liability for expected settlement of various federal, state and foreign income tax liabilities that was reflected net of the corollary tax impacts of these expected settlements of $102.1 million, as well as a separate accrued interest liability of $1.7 million. As a result of the adoption of FIN 48, we are required to present the different components of such liability gross versus the historical net presentation. The adoption resulted in the tax liability for unrecognized tax benefits decreasing by $6.4 million as of January 1, 2007.

¹ The Dynesys Dynamic Stabilization Spinal System is indicated for use as an adjunct to fusion in the U.S.

² PALACOS^® is a trademark of Heraeus Kulzer GmbH. Under license from Heraeus Kulzer GmbH, Hanau, Germany.

³ Manufactured by Kensey Nash Corporation.

This decrease in the liability resulted in a reduction to retained earnings of $4.7 million, a reduction in goodwill of $61.4 million, the establishment of a tax receivable of $58.2 million, and the addition of an interest/penalty payable of $7.9 million, all as of January 1, 2007.

Acquisitions

We completed the acquisition of Endius on April 20, 2007. The acquisition did not have a material impact on our results of operations for the three and six month periods ended June 30, 2007. However, the acquisition costs of approximately $73.0 million did have a significant impact on our cash flows for the six month period ended June 30, 2007.

Additionally during the three month period ended June 30, 2007, we completed acquisitions of Diadent Srl., a privately held distributor of our dental products in Italy, and certain U.S. based orthopaedic implant distribution businesses. These acquisitions did not have a material impact on our results of operations, balance sheet or cash flows for the three and six month periods ended June 30, 2007.

Second Quarter Results of Operations

Net Sales by Operating Segment

The following table presents net sales by operating segment and the components of the percentage changes (dollars in millions):


	Three Months Ended
	June 30,							Volume/						Foreign
	2007		2006		% Inc (Dec)			Mix			Price			Exchange

Americas	$	568.1	$	520.9		9	%		8	%		1	%		—	%
Europe		267.2		238.4		12			6			(1	)		7
Asia Pacific		135.3		122.3		11			11			(1	)		1

	$	970.6	$	881.6		10			8			—			2

“Foreign Exchange” as used in the tables in this report represents the effect of changes in foreign exchange rates on sales growth.

Net Sales by Product Category

The following table presents net sales by product category and the components of the percentage changes (dollars in millions):


	Three Months
	Ended
	June 30,							Volume/						Foreign
	2007		2006		% Inc (Dec)			Mix			Price			Exchange

Reconstructive
Knees	$	406.7	$	367.9		11	%		8	%		—	%		3	%
Hips		324.1		299.8		8			7			(1	)		2
Extremities		26.3		19.5		35			31			2			2
Dental		56.5		46.4		22			15			4			3

Total		813.6		733.6		11			9			—			2

Trauma		50.3		49.1		3			—			1			2
Spine		49.0		46.0		7			6			(1	)		2
OSP and other		57.7		52.9		9			9			(1	)		1

Total	$	970.6	$	881.6		10			8			—			2

The NexGen Complete Knee Solution product line including Gender Solutions Knee Femoral Implants, the NexGen LPS-Flex Knee, NexGen Trabecular Metal Tibial Components, the NexGen CR-Flex Knee, the NexGen Rotating Hinge Knee and the NexGen LCCK Revision Knee led knee sales. In addition, strong growth in the Zimmer Unicompartmental High-Flex Knee and the Innex^® Total Knee System were offset by declining sales of the Natural Knee^® II System.

Growth in porous stems, including the Zimmer M/L Taper Stem, the CLS^® Spotorno^® Stem from the CLS Hip System, and the Alloclassic^® Zweymüller^® Hip Stem led hip stem sales, but was partially offset by weaker sales of cemented stems. Bone cement sales improved significantly, led by PALACOS Bone Cement. Trabecular Metal Acetabular Cups, Durom Hip Resurfacing System products internationally and Longevity and Durasul Highly Crosslinked Polyethylene Liners also had strong growth.

The Bigliani/Flatow^® Complete Shoulder Solution and the Trabecular Metal Humeral Stem led extremities sales. Orthobiologicals and prosthetic implants, including strong growth of the Tapered Screw-Vent^® Implant System, led dental sales. Zimmer Periarticular Locking Plates and Zimmer Plates and Screws led trauma sales, but were partially offset by declining sales of intramedullary nails and compression hip screws. The Dynesys Dynamic Stabilization System, the Trinica^® Select cervical plate system, the Optima^tm⁴ ZS Spinal Fixation System and Spinal Trabecular Metal Spacers led spine sales as well as products acquired from Endius making a modest contribution to spine sales in the quarter. Extremity surgical products led OSP sales.

Americas Net Sales

The following table presents Americas net sales (dollars in millions):


	Three Months Ended
	June 30,
	2007		2006		% Inc (Dec)

Reconstructive
Knees	$	256.0	$	235.4		9	%
Hips		157.8		146.4		8
Extremities		18.5		13.5		38
Dental		31.3		27.0		16

Total		463.6		422.3		10

Trauma		30.1		29.1		3
Spine		40.2		38.0		6
OSP and other		34.2		31.5		9

Total	$	568.1	$	520.9		9

The NexGen Complete Knee Solution product line, including the Gender Solutions Knee Femoral Implants, NexGen LPS-Flex Knee, NexGen Trabecular Metal Tibial Components, the NexGen LCCK Revision Knee and the NexGen CR-Flex Knee led knee sales. The Zimmer Unicompartmental High-Flex Knee also made a strong contribution but was offset by declining sales of the Natural Knee II System.

Growth in porous stems, including growth of the Zimmer M/L Taper Stem and Alloclassic Zweymüller Hip Stem led hip stem sales, but were partially offset by weaker sales of cemented stems. PALACOS Bone Cement, and Trabecular Metal Acetabular Cups also exhibited strong growth.

The Bigliani/Flatow Shoulder Solution and the Trabecular Metal Humeral Stem led extremities sales. The Tapered Screw-Vent Implant System led dental sales. Zimmer Periarticular Plates, Zimmer Plates and Screws and the I.T.S.T. ^tm Intertrochanteric/Subtrochanteric Fixation System led trauma sales. The Dynesys Dynamic Stabilization

⁴ Trademark of U&I Corporation.

System, Trinica Select Cervical Plate System, the Optima ZS Spinal Fixation System and Spinal Trabecular Metal Spacers led spine sales. Wound management products led OSP sales.

Europe Net Sales

The following table presents Europe net sales (dollars in millions):


	Three Months Ended
	June 30,
	2007		2006		% Inc (Dec)

Reconstructive
Knees	$	100.9	$	90.2		12	%
Hips		115.6		106.0		9
Extremities		6.1		4.6		29
Dental		18.1		12.3		48

Total		240.7		213.1		13

Trauma		9.9		10.6		(6	)
Spine		7.4		6.2		21
OSP and other		9.2		8.5		6

Total	$	267.2	$	238.4		12

Changes in foreign exchange rates positively affected knee and hip sales both by 7 percent. Excluding these foreign exchange rate effects, the following product categories experienced positive sales growth in our Europe region: the NexGen Complete Knee Solution product line, including the NexGen LPS-Flex Knee, NexGen Trabecular Metal Tibial Components and the NexGen CR-Flex Knee, and the Innex Total Knee System. Growth in porous stems, including the CLS Spotorno Stem led hip stem sales. Longevity and Durasul Highly Crosslinked Polyethylene Liners, the Durom Hip Resurfacing System, Trabecular Metal Acetabular Cups and the Allofit^tm Hip Acetabular System also contributed to hip sales.

The Anatomical Shoulder System, the Anatomical Shoulder Inverse/Reverse System and the Coonrad/Morrey Total Elbow led extremities sales. The addition of a direct sales force in Italy as a result of the Diadent acquisition contributed to growth in dental sales and the Tapered Screw-Vent Implant System led dental sales. The Cable-Ready^® Cable Grip System, Zimmer Periarticular Plates and the NCB Plating System led trauma sales, which were offset by weaker sales of our intramedullary fixation systems. The Dynesys Dynamic Stabilization System, the Optima ZS Spinal Fixation System and Trabecular Metal Spacers led spine sales. Wound management products led OSP sales.

Asia Pacific Net Sales

The following table presents Asia Pacific net sales (dollars in millions):


	Three Months Ended
	June 30,
	2007		2006		% Inc (Dec)

Reconstructive
Knees	$	49.8	$	42.3		18	%
Hips		50.7		47.4		7
Extremities		1.7		1.4		23
Dental		7.1		7.1		0

Total		109.3		98.2		11

Trauma		10.3		9.4		10
Spine		1.4		1.8		(24	)
OSP and other		14.3		12.9		11

Total	$	135.3	$	122.3		11

Changes in foreign exchange rates positively affected knee sales by 3 percent and had no effect on hip sales. Reported decreases in average selling prices negatively affected hip sales by 2 percent. The NexGen Complete Knee Solution product line, including NexGen Trabecular Metal Tibial Components, the NexGen CR-Flex Knee and the NexGen LPS-Flex Knee led knee sales. Launch of the Gender Solutions Knee Femoral Implant in Australia also contributed to strong knee sales for the period. The continued conversion to porous stems, including the Fiber Metal Taper Stem from the VerSys Hip System, the Alloclassic Zweymüller Hip System and the CLS Spotorno Stem led hip stem sales. Sales of Longevity Highly Crosslinked Polyethylene Liners, the Durom Hip Resurfacing System and Trabecular Metal Acetabular Cups also exhibited growth.

Extremities sales increased due to stronger sales of our shoulder products. The Tapered Screw-Vent Implant System led dental sales. Trauma sales were affected by a reported 5 percent decrease in average selling prices during the three months ended June 30, 2007. A temporary registration issue with the ST360°^® Spinal Fixation System in Japan resulted in a decrease in sales of this device, contributing to the negative growth in Spine sales for the period. Powered surgical instruments led OSP sales.

Gross Profit

Gross profit as a percentage of net sales was 77.7 percent in the three month period ended June 30, 2007, compared to 77.3 percent in the same 2006 period and 78.3 percent in the three month period ended March 31, 2007. The improvement in gross profit margin over the same 2006 period reflects favorable changes in product and geographic sales mix while the decline from the period ended March 31, 2007 is driven principally by the effects of changes in foreign exchange rates combined with our hedging program. Under our hedging program, for derivatives which qualify as hedges of future cash flows, the effective portion of changes in fair value is temporarily recorded in other comprehensive income, and then recognized in cost of products sold when the hedged item affects earnings.

Operating Expenses

R&D as a percentage of net sales was 5.5 percent for the three month period ended June 30, 2007, consistent with the same 2006 period. R&D increased to $53.5 million for the three month period ended June 30, 2007, from $48.6 million in the same 2006 period, reflecting increased spending on projects focused on areas of strategic significance, including orthobiologics. We target R&D spending to the high end of what management believes to be an average of 4-6 percent for our industry.

SG&A as a percentage of net sales was 38.6 percent for the three month period ended June 30, 2007, compared to 39.1 percent in the same 2006 period. SG&A increased to $374.3 million for the three month period ended

June 30, 2007, from $344.8 million in the same 2006 period. The improvement in SG&A as a percent of net sales from the prior year is due primarily to controlled spending.

Acquisition, integration and other expenses for the three month period ended June 30, 2007 were $3.9 million compared to $6.3 million in the same 2006 period. The expenses for the period reflect in-process research and development write-offs related to acquisitions, integration consulting fees and costs for integrating information technology systems.

Operating Profit, Income Taxes and Net Earnings

Operating profit for the three month period ended June 30, 2007 increased 14 percent to $322.5 million, from $281.9 million in the same 2006 period. Increased sales, improved gross profit margins and controlled operating expenses drove operating profit.

The effective tax rate on earnings before income taxes and minority interest decreased to 28.5 percent for the three month period ended June 30, 2007, from 28.9 percent in the same 2006 period. The decrease in the effective tax rate is primarily due to increased profitability in lower tax jurisdictions.

Net earnings increased 15 percent to $231.5 million for the three month period ended June 30, 2007, compared to $200.9 million in the same 2006 period. The increase was primarily due to higher operating profit and a lower effective tax rate. Basic and diluted earnings per share both increased 20 percent to $0.98 and $0.97, respectively, from $0.82 and $0.81, respectively, in the same 2006 period. The higher growth rate in earnings per share as compared with net earnings is attributed to the effect of 2006 and 2007 share repurchases.

Operating Profit by Segment

Management evaluates operating segment performance based upon segment operating profit exclusive of operating expenses pertaining to global operations and corporate expenses, share-based payment expense, acquisition, integration and other expenses, inventory step-up, in-process research and development write-offs and intangible asset amortization expense. Global operations include research, development engineering, medical education, brand management, corporate legal, finance, and human resource functions, and U.S. and Puerto Rico based operations and logistics. Intercompany transactions have been eliminated from segment operating profit. For more information regarding our segments, see Note 11 to the consolidated financial statements included elsewhere in this Form 10-Q.

The following table sets forth operating profit as a percentage of sales by segment for the three month periods ended June 30, 2007 and 2006:

Percent of net sales


	Three Months
	Ended
	June 30,
	2007			2006

Americas		52.2	%		53.2	%
Europe		40.5			41.0
Asia Pacific		48.2			47.9

In the Americas, operating profit as a percentage of sales decreased due to increases in spending for direct to patient advertising in the second quarter of this year.

European operating profit as a percentage of net sales decreased from prior year, reflecting lower gross margins as a result of decreases in average selling prices.

Asia Pacific operating profit as a percentage of net sales increased primarily due to increases in gross margins as compared to the prior year. Gross margins increased throughout most of the Asia Pacific markets, including Japan, despite decreases in average selling prices in Japan as a result of reductions in government controlled reimbursement prices.

Six Months Results of Operations

Net Sales by Operating Segment

The following table presents net sales by operating segment and the components of the percentage changes (dollars in millions):


	Six Months
	Ended
	June 30,							Volume/						Foreign
	2007		2006		% Inc (Dec)			Mix			Price			Exchange

Americas	$	1,135.9	$	1,036.9		10	%		9	%		1	%		—	%
Europe		526.0		467.1		13			6			(1	)		8
Asia Pacific		258.9		238.0		9			10			(2	)		1

	$	1,920.8	$	1,742.0		10			8			—			2

“Foreign Exchange” as used in the tables in this report represents the effect of changes in foreign exchange rates on sales growth.

Net Sales by Product Category

The following table presents net sales by product category and the components of the percentage changes (dollars in millions):


	Six Months
	Ended
	June 30,							Volume/						Foreign
	2007		2006		% Inc (Dec)			Mix			Price			Exchange

Reconstructive
Knees	$	814.2	$	734.2		11	%		9	%		—	%		2	%
Hips		640.9		592.5		8			6			(1	)		3
Extremities		50.5		37.9		33			30			1			2
Dental		105.5		86.5		22			16			4			2

Total		1,611.1		1,451.1		11			9			—			2

Trauma		100.4		95.8		5			3			1			1
Spine		95.7		89.1		7			6			—			1
OSP and other		113.6		106.0		7			6			—			1

Total	$	1,920.8	$	1,742.0		10			8			—			2

The NexGen Complete Knee Solution product line including Gender Solutions Knee Femoral Implants, the NexGen LPS-Flex Knee, NexGen Trabecular Metal Tibial Components, the NexGen CR-Flex Knee, the NexGen Rotating Hinge Knee and the NexGen LCCK Revision Knee led knee sales. In addition, the Zimmer Unicompartmental High-Flex Knee and the Innex Total Knee System exhibited strong growth.

Growth in porous stems, including the Zimmer M/L Taper Stem, the CLS Spotorno Stem from the CLS Hip System, and the Alloclassic Zweymüller Hip Stem led hip stem sales, but was partially offset by weaker sales of cemented stems. Sales of bone cement improved significantly, led by PALACOS Bone Cement, Trabecular Metal Acetabular Cups, Durom Hip Resurfacing System products internationally, and Longevity and Durasul Highly Crosslinked Polyethylene Liners also had strong growth.

The Bigliani/Flatow Complete Shoulder Solution and the Trabecular Metal Humeral Stem led extremities sales. Orthobiologicals and prosthetic implants, including strong growth of the Tapered Screw-Vent Implant System, led dental sales. Zimmer Periarticular Locking Plates and Zimmer Plates and Screws led trauma sales. The Dynesys Dynamic Stabilization System, the Trinica Select, the Optima ZS Spinal Fixation System and Spinal Trabecular Metal Spacers led spine sales. Extremity Surgical Products led OSP sales.

Americas Net Sales

The following table presents Americas net sales (dollars in millions):


	Six Months
	Ended
	June 30,
	2007		2006		% Inc (Dec)

Reconstructive
Knees	$	518.7	$	475.3		9	%
Hips		314.1		288.3		9
Extremities		36.2		26.4		37
Dental		59.5		50.7		17

Total		928.5		840.7		10

Trauma		61.3		57.7		6
Spine		78.5		74.1		6
OSP and other		67.6		64.4		5

Total	$	1,135.9	$	1,036.9		10

Growth in porous stems, including growth of the Zimmer M/L Taper Stem and Alloclassic Zweymüller Hip Stem led hip stem sales, but was partially offset by weaker sales of cemented stems. PALACOS Bone Cement and Trabecular Metal Acetabular Cups also exhibited strong growth.

The Bigliani/Flatow Shoulder Solution and the Trabecular Metal Humeral Stem led extremities sales. The Tapered Screw-Vent Implant System led dental sales. Zimmer Periarticular Plates, Zimmer Plates and Screws and the I.T.S.T. Intertrochanteric/Subtrochanteric Fixation System led trauma sales. The Dynesys Dynamic Stabilization System, the Optima ZS Spinal Fixation System and Spinal Trabecular Metal Spacers led spine sales. Extremity surgical products led OSP sales.

Europe Net Sales

The following table presents Europe net sales (dollars in millions):


	Six Months
	Ended
	June 30,
	2007		2006		% Inc

Reconstructive
Knees	$	202.9	$	178.7		14	%
Hips		229.0		209.3		9
Extremities		11.1		8.8		26
Dental		31.5		23.6		34

Total		474.5		420.4		13

Trauma		19.0		18.5		3
Spine		14.4		11.7		23
OSP and other		18.1		16.5		9

Total	$	526.0	$	467.1		13

Changes in foreign exchange rates positively affected knee and hip sales both by 8 percent. Excluding these foreign exchange rate effects, these product categories experienced positive sales growth in our Europe region; the NexGen Complete Knee Solution product line, including the NexGen LPS-Flex Knee, NexGen Trabecular Metal Tibial Components and the NexGen CR-Flex Knee, and the Innex Total Knee System. Growth in porous stems, including the CLS Spotorno Stem led hip stem sales. Longevity and Durasul Highly Crosslinked Polyethylene Liners, the Durom Hip Resurfacing System, Trabecular Metal Acetabular Cups and the Allofit Hip Acetabular System also contributed to hip sales.

The Anatomical Shoulder System, the Anatomical Shoulder Inverse/Reverse System and the Coonrad/Morrey Total Elbow led extremities sales. The addition of a direct sales force in Italy as a result of the Diadent acquisition contributed to growth in dental sales and the Tapered Screw-Vent Implant System led dental sales. The Cable-Ready Cable Grip System, Zimmer Periarticular Plates and the NCB Plating System led trauma sales, which were offset by weaker sales of our intramedullary fixation systems. The Dynesys Dynamic Stabilization System, the Optima ZS Spinal Fixation System and Trabecular Metal Spacers led spine sales. Wound management products led OSP sales.

Asia Pacific Net Sales

The following table presents Asia Pacific net sales (dollars in millions):


	Six Months
	Ended
	June 30,
	2007		2006		% Inc (Dec)

Reconstructive
Knees	$	92.6	$	80.2		15	%
Hips		97.8		94.9		3
Extremities		3.2		2.7		18
Dental		14.5		12.2		19

Total		208.1		190.0		10

Trauma		20.1		19.6		2
Spine		2.8		3.3		(15	)
OSP and other		27.9		25.1		12

Total	$	258.9	$	238.0		9

Changes in foreign exchange rates positively affected knee sales by 3 percent and had no effect on hip sales. Reported decreases in average selling prices negatively affected hip sales by 4 percent. The NexGen Complete Knee Solution product line, including NexGen Trabecular Metal Tibial Components, the NexGen CR-Flex Knee and the NexGen LPS-Flex Knee led knee sales. Launch of the Gender Solutions Knee Femoral Implant in Australia also contributed to strong knee sales for the period. The continued conversion to porous stems, including the Fiber Metal Taper Stem from the VerSys Hip System, the Alloclassic Zweymüller Hip System and the CLS Spotorno Stem led hip stem sales. Sales of Longevity Highly Crosslinked Polyethylene Liners, the Durom Hip Resurfacing System and Trabecular Metal Acetabular Cups also exhibited growth.

Extremities sales increased due to stronger sales of our shoulder and elbow products. The Tapered Screw-Vent Implant System led dental sales. Trauma sales were affected by a reported 5 percent decrease in average selling prices during the six months ended June 30, 2007. A temporary registration issue with the ST360° Spinal Fixation System in Japan resulted in a decrease in sales of this device, contributing to the negative growth in Spine sales for the period. Powered surgical instruments led OSP sales.

Gross Profit

Gross profit as a percentage of net sales was 78.0 percent in the six month period ended June 30, 2007, compared to 77.6 percent in the same 2006 period. Primary contributors to the improvement in gross profit margin were reductions in unit manufacturing cost for various products and the effects of changes in foreign exchange rates

combined with our hedging program. Under our hedging program, we temporarily record the effective portion of changes in fair value of derivatives which qualify as hedges of future cash flows in other comprehensive income, and then recognize the hedged item in cost of products sold when it affects earnings.

Operating Expenses

R&D as a percentage of net sales was 5.5 percent for the six month period ended June 30, 2007, consistent with the same 2006 period. R&D increased to $105.8 million for the six month period ended June 30, 2007, from $96.0 million in the same 2006 period, reflecting increased spending on projects focused on areas of strategic significance, including orthobiologics.

SG&A as a percentage of net sales was 38.3 percent for the six month period ended June 30, 2007, compared to 39.0 percent in the same 2006 period. SG&A increased to $735.9 million for the six month period ended June 30, 2007, from $679.7 million in the same 2006 period. SG&A expenses in the first quarter of 2007 were positively affected by the favorable settlement of a legal claim made against a third party for interference in a contractual relationship with a former distributor of our products.

Acquisition, integration and other expenses for the six month period ended June 30, 2007 were $6.6 million compared to $4.5 million in the same 2006 period. The expenses for the current period reflect in-process research and development write-offs related to acquisitions, estimated settlements for certain pre-acquisition product liability claims, integration consulting fees and costs for integrating information technology systems. The expenses in the prior year period were offset by a gain on the sale of our Austin, Texas facility and land and a favorable adjustment to acquired Centerpulse reserves related to product liabilities.

Operating Profit, Income Taxes and Net Earnings

Operating profit for the six month period ended June 30, 2007 increased 14 percent to $649.7 million, from $572.4 million in the same 2006 period. Increased sales, improved gross profit margins and controlled operating expenses drove operating profit.

The effective tax rate on earnings before income taxes and minority interest decreased to 28.5 percent for the six month period ended June 30, 2007, from 29.1 percent in the same 2006 period. The decrease in the effective tax rate is primarily due to increased profitability in lower tax jurisdictions.

Net earnings increased 14 percent to $464.9 million for the six month period ended June 30, 2007, compared to $406.5 million in the same 2006 period. The increase was primarily due to higher operating profit and a lower effective tax rate. Basic and diluted earnings per share each increased 19 percent, respectively, to $1.96 and $1.94, respectively, from $1.65 and $1.63, respectively, in the same 2006 period. The higher growth rate in earnings per share as compared with net earnings is attributed to the effect of 2006 and 2007 share repurchases.

Operating Profit by Segment

The following table sets forth operating profit as a percentage of sales by segment for the six month periods ended June 30, 2007 and 2006:

Percent of net sales


	Six Months Ended
	June 30,
	2007			2006

Americas		52.3	%		52.6	%
Europe		41.9			42.2
Asia Pacific		47.8			48.1

In the Americas, operating profit as a percentage of sales decreased due to increased spending for direct to patient advertising that occurred in the first half of this year.

European operating profit as a percentage of net sales decreased from the prior year, reflecting lower gross margins as a result of decreases in average selling prices.

Asia Pacific operating profit as a percentage of net sales decreased primarily due to increases in operating expenses as a percent of sales as compared to the prior year. Operating expenses grew at a faster rate than sales in Japan where average selling prices decreased by 5 percent as a result of reductions in government controlled reimbursement prices.

Liquidity and Capital Resources

Cash flows provided by operating activities were $495.7 million for the six month period ended June 30, 2007, compared to $507.9 million in the same 2006 period. The principal source of cash was net earnings of $464.9 million. The positive cash flow associated with the tax benefit from stock option exercises was $12.3 million in the six month period ended June 30, 2007. Operating cash flows from working capital changes for the six month period ended June 30, 2007 decreased compared to the same 2006 period primarily due to increased pension funding and tax payments made during 2007.

We continue to focus on working capital management. At June 30, 2007, we had 58 days of sales outstanding in trade accounts receivable, which is favorable to June 30, 2006 and March 31, 2007 by 1 day. At June 30, 2007, we had 284 days of inventory on hand, unfavorable to June 30, 2006 by 11 days and favorable to March 31, 2007 by 3 days. Our inventory levels increased in 2007 due to preparation for new product launches and increased production.

Cash flows used in investing activities were $255.3 million for the six month period ended June 30, 2007, compared to $112.1 million used in investing in the same 2006 period. The biggest contributor to the increase in cash flows used in investing activities was the acquisition costs related to the acquisitions of Endius, Diadent and the additions to our U.S. distributor network. Cash payments related to acquisitions during the six month period ended June 30, 2007 were $112.1 million compared to $13.5 million in the same 2006 period. Additions to instruments increased during the six month period ended June 30, 2007 due to an increase in instrument deployments related to new product launches. Additions to other property, plant and equipment increased during the six month period ended June 30, 2007 as we continue to expand our manufacturing and research and development facilities.

Cash flows used in financing activities were $147.5 million for the six month period ended June 30, 2007, compared to $297.7 million used in financing activities in the same 2006 period. Proceeds from our stock compensation plans have increased in the six month period ended June 30, 2007, compared to the same 2006 period due to an increase in employee stock option exercises. For the six months ended June 30, 2007, we purchased 3.6 million common shares for a total of $305.2 million under our stock repurchase programs, compared to $316.4 million in the same 2006 period.

We have a five year $1,350 million revolving, multi-currency, senior unsecured credit facility maturing March 31, 2010 (the “Senior Credit Facility”). We had $95.2 million outstanding under the Senior Credit Facility at June 30, 2007, and therefore, our available borrowings were $1,254.8 million. The $95.2 million is owed by our Japan subsidiary and carries a low interest rate, which is why we have not repaid the debt. The Senior Credit Facility contains a provision whereby borrowings may be increased to $1,750 million.

We and certain of our wholly owned foreign and domestic subsidiaries are the borrowers, and our wholly owned domestic subsidiaries are the guarantors, of the Senior Credit Facility. Borrowings under the Senior Credit Facility are used for general corporate purposes and bear interest at a LIBOR-based rate plus an applicable margin determined by reference to our senior unsecured long-term credit rating and the amounts drawn under the Senior Credit Facility, at an alternate base rate, or at a fixed rate determined through a competitive bid process. The Senior Credit Facility contains customary affirmative and negative covenants and events of default for an unsecured financing arrangement, including, among other things, limitations on consolidations, mergers and sales of assets. Financial covenants include a maximum leverage ratio of 3.0 to 1.0 and a minimum interest coverage ratio of 3.5 to 1.0. If we fall below an investment grade credit rating, additional restrictions would result, including restrictions on investments, payment of dividends and stock repurchases. We were in compliance with all covenants under the

Senior Credit Facility as of June 30, 2007. Commitments under the Senior Credit Facility are subject to certain fees, including a facility and a utilization fee. The Senior Credit Facility was upgraded to A- in April 2007 by Standard & Poor’s Ratings Services. The Senior Credit Facility is not rated by Moody’s Investors’ Service, Inc.

We also have available uncommitted credit facilities totaling $67.0 million.

In December 2005, our Board of Directors authorized a stock repurchase program of up to $1 billion through December 31, 2007. In December 2006, our Board of Directors authorized an additional $1 billion program through December 31, 2008. As of June 30, 2007, we had purchased shares of common stock with an aggregate purchase price of $1.1 billion, including commissions, under these programs. We may use excess cash to purchase additional common stock under the program authorized in 2006.

Management believes that cash flows from operations, together with available borrowings under the Senior Credit Facility, are sufficient to meet our working capital, capital expenditure and debt service needs. Should investment opportunities arise, we believe that our earnings, balance sheet and cash flows will allow us to obtain additional capital, if necessary.

Contractual Obligations

We have entered into contracts with various third parties in the normal course of business which will require future payments. The following table illustrates our contractual obligations as of June 30, 2007, including the adoption of FIN 48 (in millions):


					2008		2010		2012
					and		and		and
	Total		2007		2009		2011		Thereafter

Long-term debt	$	95.2	$	—	$	—	$	95.2	$	—
Operating leases		92.2		12.1		34.4		20.6		25.1
Purchase obligations		30.8		29.2		1.6		—		—
Other current tax reserves		11.5		11.5		—		—		—
Other long-term liabilities		296.8		—		99.8		46.2		150.8

Total contractual obligations	$	526.5	$	52.8	$	135.8	$	162.0	$	175.9

Recent Accounting Pronouncements

Critical Accounting Policies

Our financial results are affected by the selection and application of accounting policies and methods. On January 1, 2007 we adopted FIN 48. FIN 48 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under FIN 48, the tax benefits from an uncertain tax position may be recognized only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. FIN 48 also provides guidance on derecognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. FIN 48 requires significant judgment in determining what constitutes an individual tax position as well as assessing the outcome of each tax position.

There were no other changes in the six month period ended June 30, 2007 to the application of critical accounting estimates as described in our Annual Report on Form 10-K for the year ended December 31, 2006.

Forward Looking Statements

This quarterly report contains certain statements that are forward-looking statements within the meaning of federal securities laws. When used in this report, the words “may,” “will,” “should,” “anticipate,” “estimate,” “expect,” “plan,” “believe,” “predict,” “potential,” “project,” “target,” “forecast,” “intend” and similar expressions are intended to identify forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These risks and uncertainties include, but are not limited to:


	•	competition;

	•	pricing pressures;

	•	dependence on new product development, technological advances and innovation;

	•	reductions in reimbursement levels by third-party payors and cost containment efforts of health care purchasing organizations;

	•	the outcome of the pending U.S. Department of Justice investigations announced in March 2005 and June 2006;

	•	challenges relating to changes in and compliance with Federal, state and foreign governmental laws and regulations affecting our U.S. and international businesses, including tax obligations and risks;

	•	retention of our independent agents and distributors;

	•	changes in customer demand for our products and services caused by demographic changes or other factors;

	•	changes in general domestic and international economic conditions, including interest rate and currency exchange rate fluctuations;

	•	our ability to protect proprietary technology and other intellectual property and claims for infringement of the intellectual property rights of third parties;

	•	product liability claims;

	•	the possible disruptive effect of additional strategic acquisitions and our ability to successfully integrate acquired companies;

	•	our ability to form strategic alliances with other orthopaedic and biotechnology companies;

	•	changes in prices of raw materials and products and our ability to control costs and expenses;

	•	changes in general industry and market conditions, including domestic and international growth rates;

	•	our dependence on a limited number of suppliers for key raw materials and outsourced activities; and

	•	shifts in our product category sales mix or our regional sales mix away from products or geographic regions that generate higher operating margins.

We discuss these and other important risks and uncertainties that may affect our future operations in Part I, Item 1A — Risk Factors in our most recent Annual Report on Form 10-K and may update that discussion in Part II, Item 1A — Risk Factors in this or another Quarterly Report on Form 10-Q we file hereafter. Readers of this report are cautioned not to place undue reliance on these forward-looking statements. While we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this report.


Item 3.	*Quantitative and Qualitative Disclosures About Market Risk*

There have been no material changes from the information provided in our Annual Report on Form 10-K for the year ended December 31, 2006.


Item 4.	*Controls and Procedures*

We have established disclosure controls and procedures and internal controls over financial reporting to provide reasonable assurance that material information relating to us, including our consolidated subsidiaries, is made known on a timely basis to management and the Board of Directors. However, no control system, no matter how well designed and operated, can provide absolute assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report are effective.

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) that occurred during the quarter ended June 30, 2007, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Part II — Other Information


Item 1.	*Legal Proceedings*

Information pertaining to legal proceedings can be found in Note 13 to the interim consolidated financial statements included in Part I of this report.


Item 1A.	*Risk Factors*

Except as reported in any previously filed Quarterly Report on Form 10-Q, there have been no material changes from the risk factors disclosed in Part I — Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2006.


Item 2.	*Unregistered Sales of Equity Securities and Use of Proceeds*

The following table summarizes repurchases of common stock settled during the three month period ended June 30, 2007:


					Total Number of		Approximate
					Shares Purchased		Dollar Value of
					as Part of		Shares that May
	Total Number				Publicly		Yet Be Purchased
	of Shares		Average Price		Announced Plans		Under Plans
	Purchased		Paid per Share		or Programs*		or Programs

April 2007		—	$	—		—	$	1,024,032,907
May 2007		272,356		88.24		14,502,000		1,000,000,077
June 2007		1,248,100		86.36		15,750,100		892,218,836

Total		1,520,456	$	86.69		15,750,100	$	892,218,836


*		In December 2005, our Board of Directors authorized the repurchase of up to $1 billion of common stock through December 31, 2007. In December 2006, our Board of Directors authorized the repurchase of an additional $1 billion of common stock through December 31, 2008.


Item 4.	*Submission of Matters to a Vote of Security Holders*

Our annual meeting of stockholders was held on May 7, 2007. The matters submitted to the stockholders for a vote included:


	•	the election of two directors to the Board of Directors;

	•	ratification of the selection of PricewaterhouseCoopers LLP (“PwC”) as our independent registered public accounting firm for 2007;

	•	approval of amendments to our Restated Certificate of Incorporation to require the annual election of all directors; and

	•	a stockholder proposal relating to “simple majority” voting.


	Number		Number		Number		Number of
	of Votes		of Votes		of		BROKER
Matter	FOR		AGAINST		ABSTENTIONS		NON-VOTES

Election of Larry C. Glasscock as director		200,870,734		6,610,772		1,661,372		—
Election of John L. McGoldrick as director		196,620,523		10,908,078		1,614,277		—
Ratification of PwC as our independent registered public accounting firm for 2007		207,286,489		434,177		1,422,212		—
Approval of amendments to Restated Certificate of Incorporation to require the annual election of all directors		206,091,230		1,654,442		1,397,206		—
Approval of stockholder proposal relating to “simple majority” voting		141,938,120		35,380,684		3,198,192		28,625,882

Following are the directors, other than the directors elected at the annual meeting, whose terms of office as directors continued after the annual meeting: J. Raymond Elliott, David C. Dvorak, Stuart M. Essig, Arthur J. Higgins and Augustus A. White, III, M.D., Ph.D.


Item 5.	*Other Information*

During the period covered by this report, the Audit Committee of our Board of Directors was not asked to and did not approve the engagement of PwC to perform any non-audit services. This disclosure is made pursuant to Section 10A(i)(2) of the Securities Exchange Act of 1934, as added by Section 202 of the Sarbanes-Oxley Act of 2002.


Item 6.	*Exhibits*

The following documents are filed as exhibits to this report:


3	.1	Restated Certificate of Incorporation of Zimmer Holdings, Inc. dated July 28, 2001, together with Certificate of Amendment of Restated Certificate of Incorporation of Zimmer Holdings, Inc. dated May 9, 2007
10	.1*	Form of Performance-Based Restricted Stock Unit Award Letter under the Zimmer Holdings, Inc. 2006 Stock Incentive Plan
31	.1	Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 of the Chief Executive Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31	.2	Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 of the Chief Financial Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32		Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


*		indicates management contracts or compensatory plans or arrangements

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ZIMMER HOLDINGS, INC.
(Registrant)


	By:	/s/ James T. Crines

James T. Crines

Executive Vice President, Finance and

Chief Financial Officer

Date: August 7, 2007


	By:	/s/ Derek M. Davis

Derek M. Davis

Vice President, Finance and Corporate

Controller and Chief Accounting Officer

Date: August 7, 2007

EX-3.1 2 c17407exv3w1.htm RESTATED CERTIFICATE OF INCORPORATION exv3w1

Exhibit 3.1

RESTATED
CERTIFICATE OF INCORPORATION
OF
ZIMMER HOLDINGS, INC.

The corporation was incorporated under the name “Zodiac Holdings, Inc.” by the filing of its original Certificate of Incorporation with the Secretary of State of Delaware on January 12, 2001. The present name of the corporation is Zimmer Holdings, Inc., as changed by the filing of a Certificate of Amendment of Certificate of Incorporation with the Secretary of State of Delaware on March 21, 2001. This Restated Certificate of Incorporation of the corporation, which both restates and further amends the provisions of the corporation’s Certificate of Incorporation, was duly adopted in accordance with the provisions of Sections 242 and 245 of the General Corporation Law of the State of Delaware (the “DGCL”) and by the written consent of its stockholders in accordance with Section 228 of the DGCL. The Certificate of Incorporation of the corporation is hereby amended and restated to read in its entirety as follows:

ARTICLE I

NAME

SECTION 1.01. The name of the Corporation (which is hereinafter referred to as the “CORPORATION”) is “Zimmer Holdings, Inc.”

ARTICLE II

REGISTERED AGENT

SECTION 2.01. The address, including street, number, city, and county, of the registered office of the Corporation in the State of Delaware is Corporation Trust Center, 1209 Orange Street, in the City of Wilmington, County of New Castle. The name of its registered agent at such address is the Corporation Trust Company.

ARTICLE III

PURPOSE

SECTION 3.01. The purpose of the Corporation shall be to engage in any lawful act or activity for which corporations may be organized and incorporated under the DGCL.

ARTICLE IV

CAPITAL STOCK

SECTION 4.01. The Corporation shall be authorized to issue 1.25 billion shares of capital stock, of which 1 billion shares shall be shares of common stock, $0.01 par value per share (“COMMON STOCK”), and 250 million shares shall be shares of preferred stock, $0.01 par value per share (“PREFERRED STOCK”).

SECTION 4.02. PREFERRED STOCK. The Preferred Stock may be issued from time to time in one or more series. The Board of Directors of the Corporation (the “BOARD OF DIRECTORS” and each member thereof, a “DIRECTOR”) is hereby authorized to provide for the issuance of shares of Preferred Stock in series and, by filing a certificate pursuant to the DGCL (a “PREFERRED STOCK DESIGNATION”), to establish from time to time the number of shares to be included in each such series, and to fix the designation, powers, privileges, preferences and rights of the shares of each such series and the qualifications, limitations and restrictions thereof. The authority of the Board of Directors with respect to each series shall include, but not be limited to, determination of the following:

(a) the designation of the series, which may be by distinguishing number, letter or title;

(b) the number of shares of the series, which number the Board of Directors may thereafter, except where otherwise provided in the applicable Preferred Stock Designation, increase or decrease, but not below the number of shares thereof then outstanding;

(c) whether dividends, if any, shall be cumulative or noncumulative, and, in the case of shares of any series having cumulative dividend rights, the date or dates or method of determining the date or dates from which dividends on the shares of such series shall be cumulative;

(d) the rate of any dividends, or method of determining such dividends, payable to the holders of the shares of such series, any conditions upon which such dividends shall be paid and the date or dates or the method for determining the date or dates upon which such dividends shall be payable;

(e) the price or prices, or method of determining such price or prices, at which, the form of payment of such price or prices (which may be cash, property or rights, including securities of the same or another corporation or other entity) for which, the period or periods within which and the terms and conditions upon which the shares of such series may be redeemed, in whole or in part, at the option of the Corporation or at the option of the holder or holders thereof or upon the happening of a specified event or events, if any;

(f) the obligation, if any, of the Corporation to purchase or redeem shares of such series pursuant to a sinking fund or otherwise and the price or prices at which, the form of payment of such price or prices (which may be cash, property or rights, including securities of the same or another corporation or other entity) for which, the period or periods within which and the terms and conditions upon which the shares of such series shall be redeemed or purchased, in whole or in part, pursuant to such obligation;

(g) the amounts payable out of the assets of the Corporation on and the preferences, if any, of shares of the series in the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation;

(h) provisions, if any, for the conversion or exchange of the shares of such series, at any time or times at the option of the holder or holders thereof or at the option of the Corporation or upon the happening of a specified event or events, into shares of any other class or classes or any other series of the same or any other class or classes of stock, or any other security, of the Corporation, or any other corporation or other entity, and the price or prices or rate or rates of conversion or exchange and any adjustments applicable thereto, the date or dates as of when such shares will be converted or exchanged and all other terms and conditions upon which such conversion or exchange may be made;

(i) restrictions on the issuance of shares of the same series or of any other class or series, if any; and

(j) the voting rights, if any, of the holders of shares of the series.

SECTION 4.03. COMMON STOCK.

(a) The Common Stock shall be subject to the express terms of the Preferred Stock and any series thereof. Each share of Common Stock shall be equal to every other share of Common Stock, except as otherwise provided herein or required by law.

(b) Shares of Common Stock authorized hereby shall not be subject to preemptive rights. The holders of shares of Common Stock now or hereafter outstanding shall have no preemptive right to purchase or have offered to them for purchase any of such authorized but unissued shares, or any shares of Preferred Stock, Common Stock or other equity securities issued or to be issued by the Corporation.

(c) The holders of shares of Common Stock shall be entitled to one vote for each such share upon all proposals presented to the stockholders on which the holders of Common Stock are entitled to vote. Except as otherwise provided by law or by the resolution or resolutions adopted by the Board of Directors designating the rights, powers and preferences of any series of Preferred Stock, the Common Stock shall have the exclusive right to vote for the election of Directors and for all other purposes, and holders of Preferred Stock shall not be entitled to receive notice of any meeting of stockholders at which they are not entitled to vote. The number of authorized shares of Preferred Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority of the outstanding Common Stock, without a vote of the holders of the Preferred Stock, or of any series thereof, unless a vote of any such holders is required pursuant to any Preferred Stock Designation.

(d) Subject to the rights of any class or series of stock having a preference over the Common Stock as to dividends, the holders of the shares of Common Stock shall be entitled to receive such dividends and other distributions in cash, stock or property of the Corporation as may be declared on the Common Stock by the Board of Directors at any time or from time to time out of any funds legally available therefor.

(e) In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, subject to the rights of

any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation, dissolution or winding up, the holders of shares of Common Stock shall be entitled to receive all of the remaining assets of the Corporation available for distribution to its stockholders, ratably in proportion to the number of shares of Common Stock held by them.

(f) The Corporation shall be entitled to treat the person in whose name any share of its stock is registered as the owner thereof for all purposes and shall not be bound to recognize any equitable or other claim to, or interest in, such share on the part of any other person, whether or not the Corporation shall have notice thereof, except as expressly provided by applicable law.

ARTICLE V

STOCKHOLDER ACTION

SECTION 5.01. Effective as of the time at which Bristol-Myers Squibb Company, a Delaware corporation, shall cease to be the beneficial owner of an aggregate of at least a majority of the then outstanding shares of Common Stock (the “TRIGGER DATE”), any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meeting of such holders and may not be effected by any consent in writing by such holders, except this provision shall not apply to any action taken by the stockholders of the Corporation after the Trigger Date in respect of a record date occurring prior to the Trigger Date. Effective as of the Trigger Date, except as otherwise required by law and subject to the rights of the holders of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation, dissolution or winding up, special meetings of stockholders of the Corporation for any purpose or purposes may be called only by the Board of Directors pursuant to a resolution stating the purpose or purposes thereof approved by a majority of the total number of Directors which the Corporation would have if there were no vacancies or unfilled newly-created directorships (the “WHOLE BOARD”) or by the Chairman of the Board of Directors and, effective as of the Trigger Date, any power of stockholders to call a special meeting is specifically denied. No business other than that stated in the notice shall be transacted at any special meeting of stockholders. Notwithstanding anything contained in this Restated Certificate of Incorporation to the contrary, the affirmative vote of the holders of at least 80% of the voting power of all shares of the Corporation entitled to vote generally in the election of Directors (the “VOTING STOCK”) then outstanding, voting together as a single class, shall be required to alter, amend, adopt any provision inconsistent with or repeal this Article V.

ARTICLE VI

ELECTION OF DIRECTORS

SECTION 6.01. Unless and except to the extent that the By-laws of the Corporation (the “BY-LAWS”) shall so require, the election of Directors of the Corporation need not be by written ballot.

ARTICLE VII

BOARD OF DIRECTORS

SECTION 7.01. NUMBER, ELECTION AND TERMS. Except as otherwise fixed by or pursuant to the provisions of Article IV hereof relating to the rights of the holders of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation, dissolution or winding up to elect additional Directors under specified circumstances, the number of the Directors shall be fixed from time to time exclusively pursuant to a resolution adopted by a majority of the Whole Board (but shall not be less than three). The Directors, other than those who may be elected by the holders of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation, dissolution or winding up, shall be classified, with respect to the time for which they severally hold office, into three classes, as nearly equal in number as possible, one class to be originally elected for a term expiring at the first annual meeting of stockholders following the effectiveness of this Restated Certificate of Incorporation, another class to be originally elected for a term expiring at the second annual meeting of stockholders following the effectiveness of this Restated Certificate of Incorporation, and another class to be originally elected for a term expiring at the third annual meeting of stockholders following the effectiveness of this Restated Certificate of Incorporation, with each Director to hold office until such person’s successor is duly elected and qualified. At each annual meeting of stockholders, Directors elected to succeed those Directors whose terms then expire shall be elected for a term of office to expire at the third succeeding annual meeting of stockholders after their election, with each Director to hold office until such person’s successor shall have been duly elected and qualified.

SECTION 7.02. STOCKHOLDER NOMINATION OF DIRECTOR CANDIDATES; STOCKHOLDER PROPOSAL OF BUSINESS. Advance notice of stockholder nominations for the election of Directors and of the proposal of business by stockholders shall be given in the manner provided in the By-laws, as amended and in effect from time to time.

SECTION 7.03. NEWLY CREATED DIRECTORSHIPS AND VACANCIES. Except as otherwise provided for or fixed by or pursuant to the provisions of Article IV hereof relating to the rights of the holders of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation, dissolution or winding up to elect Directors under specified circumstances, newly created directorships resulting from any increase in the number of Directors and any vacancies on the Board of Directors resulting from death, resignation, disqualification, removal or other cause shall only be filled by the affirmative vote of a majority of the remaining Directors then in office, even though less than a quorum of the Board of Directors, and not by the stockholders. Any Director elected in accordance with the preceding sentence shall serve for the remainder of the full term of the class of Directors in which the new directorship was created or the vacancy occurred and until such Director’s successor shall have been duly elected and qualified. No decrease in the number of Directors constituting the Board of Directors shall shorten the term of any incumbent Director.

SECTION 7.04. REMOVAL. Subject to the rights of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation, dissolution or winding up to elect Directors under specified circumstances, any Director may be removed from office only for cause and only by the affirmative vote of the holders of at least 80% of the voting power of all Voting Stock then outstanding, voting together as a single class.

SECTION 7.05. AMENDMENT, REPEAL, ETC. Notwithstanding anything contained in this Restated Certificate of Incorporation to the contrary, the affirmative vote of the holders of at least 80% of the voting power of all Voting Stock then outstanding, voting together as a single class, shall be required to alter, amend, adopt any provision inconsistent with or repeal this Article VII.

SECTION 7.06. OTHER PROVISIONS. Notwithstanding any other provision of this Article VII, and except as otherwise required by law, whenever the holders of one or more series of Preferred Stock shall have the right, voting separately as a class, to elect one or more Directors of the Corporation, the term of office, the filling of vacancies, the removal from office and other features of such directorships shall be governed by the terms of this Restated Certificate of Incorporation (including any Preferred Stock Designation). During any period when the holders of any series of Preferred Stock have the right to elect additional Directors as provided for or fixed pursuant to the provisions of Article IV hereof, then upon commencement and for the duration of the period during which such right continues: (i) the then otherwise total authorized number of Directors of the Corporation shall automatically be increased by such specified number of Directors, and the holders of such Preferred Stock shall be entitled to elect the additional Directors so provided for or fixed pursuant to said provisions, and (ii) each such additional Director shall serve until such Director’s successor shall have been duly elected and qualified, or until such Director’s right to hold such office terminates pursuant to said provisions, whichever occurs earlier, subject to his earlier death, disqualification, resignation or removal. Except as otherwise provided by the Whole Board in the resolution or resolutions establishing such series, whenever the holders of any series of Preferred Stock having such right to elect additional Directors are divested of such right pursuant to the provisions of such stock, the terms of office of all such additional Directors elected by the holders of such stock, or elected to fill any vacancies resulting from the death, resignation, disqualification or removal of such additional Directors, shall forthwith terminate and the total authorized number of Directors of the Corporation shall be reduced accordingly.

ARTICLE VIII

BY-LAWS

SECTION 8.01. The By-laws may be altered or repealed and new By-laws may be adopted (a) at any annual or special meeting of stockholders, by the affirmative vote of the holders of a majority of the voting power of the Voting Stock then outstanding, voting together as a single class; PROVIDED, HOWEVER, that any proposed alteration or repeal of, or the adoption of any By-law inconsistent with, Section

2.02, 2.07 or 8.01 of the By-laws, by the stockholders shall require the affirmative vote of the holders of at least 80% of the voting power of all Voting Stock then outstanding, voting together as a single class; PROVIDED, FURTHER, HOWEVER, that in the case of any such stockholder action at a special meeting of stockholders, notice of the proposed alteration, repeal or adoption of the new By-law or By-laws must be contained in the notice of such special meeting, or (b) by the affirmative vote of a majority of the Whole Board. Notwithstanding anything contained in this Restated Certificate of Incorporation to the contrary, the affirmative vote of the holders of at least 80% of the voting power of all Voting Stock then outstanding, voting together as a single class shall be required to alter, amend, adopt any provision inconsistent with or repeal this Article VIII.

ARTICLE IX

AMENDMENT OF CERTIFICATE OF INCORPORATION

SECTION 9.01. The Corporation reserves the right at any time from time to time to amend, alter, change or repeal any provision contained in this Restated Certificate of Incorporation, and any other provisions authorized by the laws of the State of Delaware at the time in force may be added or inserted, in the manner now or hereafter prescribed by law; and, except as set forth in Article X, all rights, preferences and privileges of whatsoever nature conferred upon stockholders, Directors or any other persons whomsoever by and pursuant to this Restated Certificate of Incorporation in its present form or as hereafter amended are granted subject to the right reserved in this Article. Notwithstanding anything contained in this Restated Certificate of Incorporation to the contrary, the affirmative vote of the holders of at least 80% of the Voting Stock then outstanding, voting together as a single class, shall be required to alter, amend, adopt any provision inconsistent with or repeal Article V, VII, VIII or this sentence.

ARTICLE X

LIMITED LIABILITY; INDEMNIFICATION

SECTION 10.01. LIMITED LIABILITY OF DIRECTORS. A Director shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a Director, except, if required by the DGCL, as amended from time to time, for liability (a) for any breach of the Director’s duty of loyalty to the Corporation or its stockholders, (b) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (c) under Section 174 of the DGCL, or (d) for any transaction from which the Director derived an improper personal benefit. Neither the amendment nor repeal of this Section 10.01 shall eliminate or reduce the effect of this Section 10.01 in respect of any matter occurring, or any cause of action, suit or claim that, but for this Section 10.01 would accrue or arise, prior to such amendment or repeal.

SECTION 10.02. INDEMNIFICATION AND INSURANCE.

(a) RIGHT TO INDEMNIFICATION. Each person who was or is made a party or is threatened to be made a party to or is involved in any

threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a “PROCEEDING”), by reason of the fact that such person, or a person of whom such person is the legal representative, is or was a Director or officer of the Corporation or, while a Director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans, whether the basis of such proceeding is alleged action in an official capacity as a Director, officer, employee or agent or in any other capacity while serving as a Director, officer, employee or agent, shall be indemnified and held harmless by the Corporation to the fullest extent authorized by the DGCL, as the same exists or may hereafter be amended, against all expense, liability and loss (including attorneys’ fees, judgments, fines, amounts paid or to be paid in settlement, and excise taxes or penalties arising under the Employee Retirement Income Security Act of 1974, as in effect from time to time) reasonably incurred or suffered by such person in connection therewith if such person acted in good faith and in a manner such person reasonably believed to be in compliance with the standard of conduct set forth in Section 145 (or any successor provision) of the DGCL and such indemnification shall continue as to a person who has ceased to be a Director, officer, employee or agent and shall inure to the benefit of such person’s heirs, executors and administrators; PROVIDED, HOWEVER, that, except as provided in paragraph (b) hereof, the Corporation shall indemnify any such person seeking indemnification in connection with a proceeding (or part thereof) initiated by such person only if such proceeding (or part thereof) was authorized by the Board of Directors. The Corporation shall pay the expenses incurred in defending any such proceeding in advance of its final disposition with any advance payments to be paid by the Corporation within 20 calendar days after the receipt by the Corporation of a statement or statements from the claimant requesting such advance or advances from time to time; PROVIDED, HOWEVER, that, if and to the extent the DGCL requires, the payment of such expenses incurred by a Director or officer in such person’s capacity as a Director or officer (and not in any other capacity in which service was or is rendered by such person while a Director or officer, including, without limitation, service to an employee benefit plan) in advance of the final disposition of a proceeding, shall be made only upon delivery to the Corporation of an undertaking, by or on behalf of such Director or officer, to repay all amounts so advanced if it shall ultimately be determined that such Director or officer is not entitled to be indemnified under this Section 10.02 or otherwise. The Corporation may, to the extent authorized from time to time by the Board of Directors, grant rights to indemnification, and rights to have the Corporation pay the expenses incurred in defending any proceeding in advance of its final disposition, to any employee or agent of the Corporation to the fullest extent of the provisions of this Article with respect to the indemnification and advancement of expenses of Directors and officers of the Corporation.

(b) RIGHT OF CLAIMANT TO BRING SUIT. If a claim under paragraph (a) of this Section 10.02 is not paid in full by the Corporation within 30 calendar days after a written claim has been received by the Corporation, the claimant may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim and, if

successful in whole or in part, the claimant shall be entitled to be paid also the expense of prosecuting such claim. It shall be a defense to any such action (other than an action brought to enforce a claim for expenses incurred in defending any proceeding in advance of its final disposition where the required undertaking, if any is required, has been tendered to the Corporation) that the claimant has not met the standard of conduct which makes it permissible under the DGCL for the Corporation to indemnify the claimant for the amount claimed, but the burden of proving such defense shall be on the Corporation. Neither the failure of the Corporation (including its Board of Directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such action that indemnification of the claimant is proper in the circumstances because the claimant has met the applicable standard of conduct set forth in the DGCL, nor an actual determination by the Corporation (including its Board of Directors, independent legal counsel, or its stockholders) that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that the claimant has not met the applicable standard of conduct.

(c) NON-EXCLUSIVITY OF RIGHTS. The right to indemnification and the payment of expenses incurred in defending a proceeding in advance of its final disposition conferred in this Section 10.02 shall not be exclusive of any other right which any person may have or hereafter acquire under any statute, provision of the Restated Certificate of Incorporation, By-law, agreement, vote of stockholders or disinterested Directors or otherwise. No repeal or modification of this Article shall in any way diminish or adversely affect the rights of any Director, officer, employee or agent of the Corporation hereunder in respect of any occurrence or matter arising prior to any such repeal or modification.

(d) INSURANCE. The Corporation may maintain insurance, at its expense, to protect itself and any person who is or was a Director, officer, employee or agent of the Corporation or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any such expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the DGCL.

(e) SEVERABILITY. If any provision or provisions of this Article X shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (i) the validity, legality and enforceability of the remaining provisions of this Article X (including, without limitation, each portion of any paragraph of this Article X containing any such provision held to be invalid, illegal or unenforceable, that is not itself held to be invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby; and (ii) to the fullest extent possible, the provisions of this Article X (including, without limitation, each such portion of any paragraph of this Article X containing any such provision held to be invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested by the provision held invalid, illegal or unenforceable.

IN WITNESS WHEREOF, the Corporation has caused this Restated Certificate of Incorporation to be signed by its duly authorized officer this 28^th day of July 2001.


				/S/ J. RAYMOND ELLIOTT

		Name: Title:		J. Raymond Elliott President and Chief Executive Officer

CERTIFICATE OF AMENDMENT
OF
RESTATED CERTIFICATE OF INCORPORATION
OF
ZIMMER HOLDINGS, INC.

Zimmer Holdings, Inc., a Delaware corporation (the “Corporation”), hereby certifies as follows:

FIRST. The Board of Directors of the Corporation duly adopted a resolution setting forth and declaring advisable an amendment of Section 7.01 of Article VII of the Restated Certificate of Incorporation of the Corporation so that, as amended, such Section 7.01 shall read in its entirety as follows:

“SECTION 7.01. NUMBER, ELECTION AND TERMS. Except as otherwise fixed by or pursuant to the provisions of Article IV hereof relating to the rights of the holders of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation, dissolution or winding up to elect additional Directors under specified circumstances, the number of the Directors shall be fixed from time to time exclusively pursuant to a resolution adopted by a majority of the Whole Board (but shall not be less than three). Beginning with the 2008 annual meeting of stockholders, the Directors whose terms are expiring, other than those who may be elected by the holders of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation, dissolution or winding up, shall be elected for one-year terms, with each Director to hold office until such person’s successor is duly elected and qualified.”

SECOND. The Board of Directors of the Corporation duly adopted a resolution setting forth and declaring advisable an amendment of Section 7.03 of Article VII of the Restated Certificate of Incorporation of the Corporation so that, as amended, such Section 7.03 shall read in its entirety as follows:

“SECTION 7.03. NEWLY CREATED DIRECTORSHIPS AND VACANCIES. Except as otherwise provided for or fixed by or pursuant to the provisions of Article IV hereof relating to the rights of the holders of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation, dissolution or winding up to elect Directors under specified circumstances, newly created directorships resulting from any increase in the number of Directors and any vacancies on the Board of Directors resulting from death, resignation, disqualification, removal or other cause shall only be filled by the affirmative vote of a majority of the remaining Directors then in office, even though less than a quorum of the Board of Directors, and not by the

stockholders. Any Director elected in accordance with the preceding sentence shall serve a term expiring at the next annual meeting of stockholders and until such Director’s successor shall have been duly elected and qualified. No decrease in the number of Directors constituting the Board of Directors shall shorten the term of any incumbent Director.”

THIRD. The Board of Directors of the Corporation duly adopted a resolution setting forth and declaring advisable an amendment of Section 7.04 of Article VII of the Restated Certificate of Incorporation of the Corporation so that, as amended, such Section 7.04 shall read in its entirety as follows:

“SECTION 7.04. REMOVAL. Subject to the rights of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation, dissolution or winding up to elect Directors under specified circumstances, any Director may be removed from office with or without cause and only by the affirmative vote of the holders of at least a majority of the voting power of all Voting Stock then outstanding, voting together as a single class.”

FOURTH. The Board of Directors of the Corporation duly adopted a resolution setting forth and declaring advisable an amendment of Section 7.05 of Article VII of the Restated Certificate of Incorporation of the Corporation so that, as amended, such Section 7.05 shall read in its entirety as follows:

“SECTION 7.05. AMENDMENT, REPEAL, ETC. Notwithstanding anything contained in this Restated Certificate of Incorporation to the contrary, the affirmative vote of the holders of at least a majority of the voting power of all Voting Stock then outstanding, voting together as a single class, shall be required to alter, amend, adopt any provision inconsistent with or repeal this Article VII.”

FIFTH. The Board of Directors of the Corporation duly adopted a resolution setting forth and declaring advisable an amendment of Section 9.01 of Article IX of the Restated Certificate of Incorporation of the Corporation so that, as amended, such Section 9.01 shall read in its entirety as follows:

“SECTION 9.01. The Corporation reserves the right at any time from time to time to amend, alter, change or repeal any provision contained in this Restated Certificate of Incorporation, and any other provisions authorized by the laws of the State of Delaware at the time in force may be added or inserted, in the manner now or hereafter prescribed by law; and, except as set forth in Article X, all rights, preferences and privileges of whatsoever nature conferred upon stockholders, Directors or any other persons whomsoever by and pursuant to this Restated Certificate of Incorporation in its present form or as hereafter amended are granted subject to the right reserved in this Article.

Notwithstanding anything contained in this Restated Certificate of Incorporation to the contrary, the affirmative vote of the holders of at least 80% of the Voting Stock then outstanding, voting together as a single class, shall be required to alter, amend, adopt any provision inconsistent with or repeal Article V, VIII or this sentence.”

SIXTH. That thereafter, pursuant to a resolution duly adopted by its Board of Directors, an annual meeting of the stockholders of the Corporation was duly called and held, upon notice in accordance with Section 222 of the General Corporation Law of the State of Delaware (the “DGCL”) at which meeting the necessary number of shares as required by the Restated Certificate of Incorporation of the Corporation were voted in favor of the amendments.

SEVENTH. That said amendments have been duly adopted in accordance with the provisions of Section 242 of the DGCL.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed on its behalf by its undersigned duly authorized officer as of May 9, 2007.


	ZIMMER HOLDINGS, INC.
	By		/s/ CHAD F. PHIPPS
			Chad F. Phipps
			Associate General Counsel and Corporate Secretary

EX-10.1 3 c17407exv10w1.htm FORM OF PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD LETTER exv10w1

Exhibit 10.1

Zimmer Holdings, Inc.

2006 STOCK INCENTIVE PLAN
PERFORMANCE-BASED RESTRICTED
STOCK UNIT AWARD GRANTED TO

AWARD RECIPIENT: [ ]

TARGET NUMBER OF RESTRICTED STOCK UNITS: [ ]

MAXIMUM NUMBER OF RESTRICTED STOCK UNITS: [ ]

AWARD DATE: [ ]

Compensation and Management Development Committee:

Gentlemen:

You have advised me that I have been granted the above performance-based restricted stock unit (“RSU”) award subject to the terms, restrictions and conditions set forth in this agreement. I understand that I may be expected to retain shares of the common stock of Zimmer Holdings, Inc. (the “Company”) issued to me on settlement of this award to comply with the Company’s stock retention guidelines in effect at the time the shares are issued.

My signature below indicates my agreement to all the terms, restrictions and conditions herein set forth.



Date		Signature

ZIMMER HOLDINGS, INC.
2006 STOCK INCENTIVE PLAN
PERFORMANCE-BASED
RESTRICTED STOCK UNIT AWARD

RSU AWARD

Under the terms of the Zimmer Holdings, Inc. 2006 Stock Incentive Plan (the “Plan”) the Compensation and Management Development Committee of the Board of Directors of Zimmer Holdings, Inc. (the “Committee”) has granted to the Award Recipient on the Award Date the award of RSUs set forth above (the “Award”). The purposes of such Award are to motivate and retain the Award Recipient as an employee of the Company or a subsidiary of the Company, to encourage the Award Recipient to continue to give best efforts for the Company’s future success, and to further the opportunity for stock ownership by the Award Recipient in order to increase the Award Recipient’s proprietary interest in the Company. Each RSU represents the conditional right to receive one share of the Company’s common stock, par value $0.01 per share (“Common Stock”). Upon settlement, the earned RSUs shall be settled by distribution to the Award Recipient of one share of Common Stock (subject to any tax withholding as described in Section 4) for each RSU then being settled. Except as may be required by law, the Award Recipient is not required to make any payment (other than payments for taxes pursuant to Section 4 hereof) or provide any consideration for the Award other than the rendering of future services to the Company or a subsidiary of the Company.

GENERAL

(a) No RSUs shall be earned unless and until the Committee shall have determined the extent to which the performance criteria set forth in Annex A hereto have been met with respect to the eighteen month period beginning July 1, 2007 and ending December 31, 2008 (the “Restriction Period”).

(b) The Award Recipient shall not have any of the rights of a stockholder of the Company, including the right to vote or receive dividends and other distributions with respect to the shares of Common Stock underlying this Award, until the conditions in Section 3 have been satisfied.

(c) Neither the RSUs nor any interest thereto may be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of, except by will or the laws of descent and distribution, and any such purported sale, assignment, transfer, pledge, hypothecation or other disposition shall be void and unenforceable against the Company.

(d) Notwithstanding anything to the contrary herein, the number of shares of Common Stock that may be issued in settlement of this Award shall be limited to the maximum number of shares of Common Stock that would not exceed the individual participant limitation contained in Section 3(b) of the Plan.

CONDITIONS

(a) Except as set forth in sub-sections (b) and (c) below, if during the Restriction Period, the Award Recipient’s employment with the Company or any Subsidiary or Affiliate terminates for any reason other than Retirement, death or Disability, the RSUs covered by the Award shall be canceled, forfeited and surrendered, unless determined otherwise by the Committee in its sole discretion. For the avoidance of doubt, it is expressly stated that, except as set forth in sub-sections (b) and (c) below or unless determined otherwise by the Committee, an Award Recipient whose employment with the Company or any Subsidiary or Affiliate terminates during the Restriction Period for any reason other than Retirement, death or Disability shall not be deemed to have earned a pro rata portion of the shares covered by this Award and instead shall forfeit the Award in its entirety. The terms “Subsidiary,” “Affiliate,” “Retirement” and “Disability” shall have the meanings specified in Section 2 of the Plan.

(b) In the event of an Award Recipient’s Retirement, death or Disability prior to the end of the Restriction Period, if such Retirement, death or Disability occurs after the Award Recipient has been continuously employed for one year or more from the Award Date and prior to a “change in control” of the Company, or as otherwise determined by the Committee, the Award Recipient or his estate shall be entitled to a portion of the RSUs covered by this Award at the end of the Restriction Period, subject to the attainment of the performance criteria described in Annex A as certified by the Committee. As soon as practicable following the availability of audited results of the Company for the year ended December 31, 2008, the Committee shall determine whether and the extent to which the performance criteria described in Annex A have been satisfied and the number of RSUs covered by the Award that would have been earned if the Award Recipient’s employment had not terminated prior to the end of the Award Period. The Award Recipient or his estate shall be entitled only to a pro rata portion (rounded down to the nearest whole share) of such RSUs based on the number of whole calendar months the Award Recipient was employed from the beginning of the Award Period to the date of termination divided by eighteen (18).

(c) If the Company undergoes a “change in control” during the Award Period, the number of RSUs earned under this sub-section (c) shall be the greater of: (i) the Target Number as specified above or (ii) the number of RSUs that would have been earned by applying the performance criteria specified in Annex A to the Company’s actual performance from the beginning of the Restriction Period to the date of the change in control. The Committee shall determine the “Fair Market Value” of the shares of Common Stock underlying the Award under this sub-section (c) as of the date of the change in control, the payment of which shall be deferred until the earlier of: (i) any termination of employment of the Award Recipient that is a “Qualifying Termination” or (ii) December 31, 2008. The Company shall pay the value of the earned Award (net of any Withholding Tax Obligation as defined in Section 4) in cash as soon as practicable thereafter. The terms “change in control,” “Fair Market Value” and “Qualifying Termination” shall have the meanings specified in Sections 2 and 14 of the Plan. Notwithstanding the foregoing or any other provision of this Award, to the extent any payment under this Award constitutes “nonqualified deferred compensation” within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (“Code”), and the payment is to be made upon the Award Recipient’s Qualifying Termination, if the Award Recipient is a “specified employee” of the Company within the meaning of Code Section 409A at the time the Qualifying Termination occurs, then the payment will be made on the date ending on the expiration of the sixth month following the date of the Award Recipient’s Qualifying Termination.

(d) In the event that the Award Recipient fails promptly to pay or make satisfactory arrangements as to the Withholding Tax Obligation as provided in Section 4, all RSUs covered by the Award shall be forfeited by the Award Recipient.

(e) The Award Recipient may, at any time prior to the expiration of the Award Period, waive all rights with respect to earning all or some of the RSUs covered by this Award by delivering to the Company a written notice of such waiver.

(f) (i) A transfer of an Award Recipient’s employment from the Company to a Subsidiary or Affiliate, or vice versa, or from one Subsidiary or Affiliate to another, (ii) a leave of absence, duly authorized in writing by the Company, for military service or sickness or for any other purpose approved by the Company if the period of such leave does not exceed ninety (90) days, and (iii) a leave of absence in excess of ninety (90) days, duly authorized in writing, by the Company, provided the Award Recipient’s right to reemployment is guaranteed either by a statute or by contract, shall not be deemed a termination of employment. However, any failure of the Award Recipient to return to the employ of the Company at the end of an approved leave of absence shall be deemed a termination. During a leave of absence as defined in (ii) or (iii), the Award Recipient will be considered to have been continuously employed by the Company.

(g) As a condition of receiving the Award, the Award Recipient has entered into or reaffirmed a non-solicitation and/or non-compete agreement with the Company. The Award Recipient understands and agrees that if he or she violates any provision of such agreement, the Committee may require the Award Recipient to forfeit any or all RSUs covered by this Award and to repay to the Company any portion or all of any gain or benefit received by the Award Recipient with respect to the Award.

ISSUANCE OF SHARES; DEFERRAL AND TAXES

(a) As soon as practicable following the availability of audited results of the Company for the year ended December 31, 2008, the Committee shall determine whether and the extent to which the performance criteria in Annex A have been satisfied and the number of RSUs earned.

(b) The Award Recipient may not request the Committee to approve, and the Committee will not approve or permit, the deferred payment of any part of the Award.

(c) The stock certificate(s), if any, evidencing the shares of Common Stock issued upon settlement of this Award shall be issued and registered on the Company’s books in the name of the Award Recipient after the lapse of the Restriction Period and no later than March 15, 2009.

(d) The Company shall not be required to issue or deliver any certificate or certificates for shares of the Common Stock underlying this Award prior to (i) the admission of such shares to listing on any stock exchange on which the stock may then be listed, (ii) the completion of any registration or other qualification of such shares under any state or federal law or rulings or regulations of any governmental regulatory body, (iii) the obtaining of any consent or approval or other clearance from any governmental agency, which the Company shall, in its sole discretion, determine to be necessary or advisable, and (iv) the payment to the Company, upon its demand, of any amount requested by the Company for the purpose of satisfying its withholding obligation, if any, with respect to federal, state or local income or FICA or earnings tax or any other applicable tax assessment (plus interest or penalties thereon, if any, caused by a delay in making such payment) incurred by reason of the issuance of the shares pursuant to this Award (the “Withholding Tax Obligation”). The Award Recipient may satisfy the Withholding Tax Obligation by authorizing the Company prior to the time of settlement to not issue the number of shares of Common Stock having a Fair Market Value equal to the value of the Company’s minimum required Withholding Tax Obligation.

CHANGES IN CAPITALIZATION

If prior to the issuance of the shares of Common Stock underlying this Award, any changes occur in the outstanding Common Stock by reason of stock dividends, recapitalization, mergers, consolidations, stock splits, combinations or exchanges of shares and the like, the number and class of shares of Common Stock underlying this Award shall be appropriately adjusted by the Committee, whose determination shall be conclusive. If as a result of any adjustment under this paragraph any Award Recipient should become entitled to a fractional share of stock, the Award Recipient shall have the right only to the adjusted number of full shares and no payment or other adjustment will be made with respect to the fractional share so disregarded.

NOTICE

Until the Award Recipient is advised otherwise by the Committee, all notices and other correspondence with respect to this Award will be effective upon receipt at the following address:

Compensation and Management Development Committee of the Board of Directors of Zimmer Holdings, Inc.

Zimmer Holdings, Inc.
345 East Main Street
Post Office Box 708
Warsaw, Indiana 46581-0708

NO ADDITIONAL RIGHTS

Except as explicitly provided in this agreement, this agreement will not confer any rights upon the Award Recipient, including any right with respect to continuation of employment by the Company or any of its Subsidiaries or Affiliates or any right to future awards under the Plan. In no event shall the value, at any time, of this agreement, the RSUs, the shares of Common Stock underlying the Award or any other benefit provided under this agreement be included as compensation or earnings for purposes of any other compensation, retirement, or benefit plan offered to employees of the Company or its Subsidiaries unless otherwise specifically provided for in the Plan.

BREACH OF RESTRICTIVE COVENANTS

The Award Recipient understands and agrees that if he or she violates the restrictive covenants referred to in Section 3(g) of this agreement or any other restrictive covenant in favor of the Company that he or she is a party to, the Committee may require the Award Recipient to forfeit his or her right to any unvested portion of the Award and, to the extent that any portion of the Award has previously vested, the Committee may require the Award Recipient to return to the Company the shares covered by the Award or any cash proceeds received by the Award Recipient upon the sale of such shares.

CONSENT TO ELECTRONIC DELIVERY

The Company may, in its sole discretion, decide to deliver any documents related to the Award granted under and participation in the Plan or future awards that may be granted under the Plan by electronic means or to request the Award Recipient’s consent to participate in the Plan by electronic means. The Award Recipient hereby consents to receive such documents by electronic delivery and, if requested, to agree to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

10.

CODE SECTION 409A COMPLIANCE

To the extent applicable, it is intended that the Plan and this agreement comply with the requirements of Code Section 409A and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service. Any provision of the Plan or this agreement that would cause this Award to fail to satisfy Code Section 409A shall have no force or effect until amended to comply with Code Section 409A, which amendment may be retroactive to the extent permitted by Code Section 409A.

11.

UNFUNDED OBLIGATIONS

Any provision for distribution in settlement of the RSUs and other obligations hereunder shall be by means of bookkeeping entries on the books of the Company and shall not create in the Award Recipient or any beneficiary any right to, or claim against any, specific assets of the Company, nor result in the creation of any trust or escrow account for the Award Recipient or any beneficiary. The Award Recipient and any of his or her beneficiaries entitled to any settlement or distribution hereunder shall be a general creditor of the Company.

12.

CONSTRUCTION AND INTERPRETATION

The Board of Directors of the Company (the “Board”) and the Committee shall have full authority and discretion, subject only to the express terms of the Plan, to decide all matters relating to the administration and interpretation of the Plan and this agreement and all such Board and Committee determinations shall be final, conclusive, and binding upon the Award Recipient and all interested parties. The terms and conditions set forth in this

agreement are subject in all respects to the terms and conditions of the Plan, as amended from time to time, which shall be controlling. This agreement contains the entire understanding of the parties and may not be modified or amended except in writing duly signed by the parties. The waiver of, or failure to enforce, any provision of this agreement or the Plan by the Company will not constitute a waiver by the Company of the same provision or right at any other time or a waiver of any other provision or right. The various provisions of this agreement are severable and any determination of invalidity or unenforceability of any provision shall have no effect on the remaining provisions. This agreement will be binding upon and inure to the benefit of the successors, assigns, and heirs of the respective parties. The validity and construction of this agreement shall be governed by the laws of the State of Indiana.


		ZIMMER HOLDINGS, INC.

		By

ANNEX A

PERFORMANCE CRITERIA

The number of RSUs that may be earned with respect to the Award shall be determined based upon the compound annual growth rate [CAGR] of earnings per share for the Restriction Period. The number of earned shares expressed as a percentage of the Maximum Award shall be determined by reference to the following payout matrix:


Actual	Compound
Performance as a	Annual Growth Rate
Percentage of	[CAGR] of			Percentage of
Targeted	Earnings per Share**			Maximum
Performance*	for the Restriction Period			Award Earned*

Less than 85%	Less than %		None
Minimum 85%		%			18.3	%
90%		%			23.3	%
Target 100%		%			33.3	%
110%		%			66.7	%
Maximum 120%		%			100.0	%


*		Linear interpolations between specified percentages.

**		Computed based on net earnings adjusted to exclude (i) the after-tax effect of inventory step-up costs associated with any acquisition; (ii) the after-tax effect of acquisition and integration costs; and (iii) any other major non-operational charges to earnings described in management’s discussion and analysis of financial condition and results of operations appearing in the Company’s annual report to stockholders for the applicable year.

EX-31.1 4 c17407exv31w1.htm 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER exv31w1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a) OF THE SECURITIES
EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

I, David C. Dvorak, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Zimmer Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ David C. Dvorak

David C. Dvorak

President and Chief Executive Officer

Date: August 7, 2007

EX-31.2 5 c17407exv31w2.htm 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER exv31w2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a) OF THE SECURITIES
EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

I, James T. Crines, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Zimmer Holdings, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ James T. Crines

James T. Crines

Executive Vice President, Finance

and Chief Financial Officer

Date: August 7, 2007

EX-32 6 c17407exv32.htm SECTION 906 CERTIFICATION exv32

Exhibit 32

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Zimmer Holdings, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ David C. Dvorak

David C. Dvorak

President and Chief Executive Officer

August 7, 2007

/s/ James T. Crines

James T. Crines

Executive Vice President, Finance

and Chief Financial Officer

August 7, 2007

10-Q 7 c17407e10vqwxpdfy.pdf QUARTERLY REPORT PDF begin 644 c17407e10vqwxpdfy.pdf M)5!$1BTQ+C(-)>+CS],-"C$S.2`P(&]B:B`\/"],:6YE87)I>F5D(#$O3"`S M,C@T,#0O3R`Q-#(O12`S-C@W-2].(#,R+U0@,S(U-3F4@,3DS+U!R978@,S(U-38T+U)O;W0@,30P(#`@4B]);F9O M(#$S."`P(%(O241;/$0S,3!%0D8R040U,44Y.$5!-SE#-T%"-C4U.#(S.4,U M/CQ!-C5$-T1%-D0W1$)!-#1&.44Y0S)&-C8V1C')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HQ.3(@,"!O8FH\/"],96YG=&@@ M-C$R+T4@.#DQ+T9I;'1E(FU(JG%DM-.%9KG,S`T/3G:UKLZ.N;=WUI?9MNIM9T;7MEN>1S19(N.A0 MQ!G;YB+3Y,:G<=&Q3++%L5FF*1#($$@XKC`E`"@E81(@TQ2>.)%=86*S*^N- M%!<@UXT728$KXPF5A.N)$]EX1=@5IMY(09@`-1RDX#%0BQ10RI7CD4J1NL7- M)8MFABXHXISS.&71S+18$)>S3_'$'*!I,UPLK@2H>6E.2VP&BLPM MDTH3Y#,5`;FA3U-C6>1TH%Z@^4X6[0J3>R=UIGV!S;AI"*;9O9 MXA(`-$$EX9PI-D,@#I`PO9$F"',_PH-([D]XW`D.'*#[0:$Q`Q0L0&-5(8*, M)]2*078!@Y39Q+6C`Q2V'0T,C()"&D"*@5$")"((8C)P`)F"8"9;!EP4HH`! MG2F6`=;"I&1L;&P!,95)24FI`VR$L`58C:"@L7%:!D124#`-QF103RXW"'1'4W1A=&4\/"]' M4S(@,34P(#`@4B]'4S,@,37!H96XO42],+UDO4"]T:')E92]P87)E;FQE9G0O M9"]P87)E;G)I9VAT+THO'EZ>WQ]?G^`@8*#A(6& MAXB)BHN,C8Z/D)&2DY25EI>8F9J;G)V>GZ"AHJ.DI::GJ*FJJZRMKJ^PL;*S MM+6VM[BYNKN\O;Z_P,'"P\3%QL?(R+CY.7FY^CIZNOL[>[O\/'R\_3U]O?X^?K[_/W^_P(,`*WV?X$*#0IE;F1S M=')E86T-96YD;V)J#3$T.2`P(&]B:CP\+TQE;F=T:"`U,C7!E(#`O1FEL=&5R+T9L871E1&5C;V1E+T5N8V]D95LP(#(U-5TO0FET'AX@(B(B)"8F)B@J*BHL+BXN,#(R,C0V-C8X.CHZ/ M#X^/D!"0D)$1D9&2$I*2DQ.3DY04E)25%965EA:6EI<7EY>8&)B8F1F9F9H: MFIJ;&YN;G!R'IZ>GQ^?GZ`@H*"A(:&AHB*BHJ,CHZ.D)*2DI26E MI:8FIJ:G)Z>GJ"BHJ*DIJ:FJ*JJJJRNKJZPLK*RM+:VMKBZNKJ\OKZ^P,+"P ML3&QL;(RLK*S,[.SM#2TM+4UM;6V-K:VMS>WM[@XN+BY.;FYNCJZNKL[N[N\ M/+R\O3V]O;X^OKZ_/[^_P$#`P,%!P<'"0L+"PT/#P\1$Q,3%1<7%QD;&QL=' MQ\?(2,C(R4G)R)BXN+C8^/CY&3DY.5EY>7F9N;FYV?GY^AHZ.CI M:>GIZFKJZNMKZ^OL;.SL[6WM[>YN[N[O;^_O\'#P\/%Q\?'R/CX^7GY^?IZ^OK[>_O[_'S\_/U]_?W^?O[^_W__ M_P(,`.>L/Q`*#0IE;F1S=')E86T-96YD;V)J#3$U,"`P(&]B:CP\+T)'(#$T M."`P(%(O5%(O261E;G1I='DO2%0O1&5F875L="]/4"!T=P2C*(2AG%S_4R4J*XPT'FR4PD<7"LKU MFEM#:F8]U[ELJ>G?\Y#+]*F4P+&^674]5UX$EC*5I+*LUOVPYDY3W*Q-)=*2 M&[.SRU&*!%&E4ZX<)1X(&W5Q!$9XQ]0#0WO#[F_X4;82T3D/$Q3H7(0T)WW= M(K^QQ),NFL+^=P>SV#_;ACD=;O.;FLNC9NE)E&1O6!BU.5(2EY-.P80Z$IPI MG(LL3T5-N9](+9G_4:E5TR^[>5%)H]3.RSAZ:S:G[LO#\]E MUCVC`9J@,R>2AC:L'B/4`VW94+>T.9?$]XWVT&D/+T#]C`:N8',KX3[OM\[[ MC;"%2GE:6:J0,48$M+"KX%6``0"$,N&X#0IE;F1S=')E86T-96YD;V)J#3$U M,B`P(&]B:CP\+TQE;F=T:"`T,3,O1FEL=&5R+T9L871E1&5C;V1E/CYS=')E M86T-"DB)7)--T2FWH(<*5JL1Q.%J5>K.Y7:>5U_[W2DZMC`KO4RI]+JI%A M-@ESIFCD,J"-@@,:WM7@B9WJLVD2G.!!QE8^D8M)#^$D'![2!#?Q)#\;?EX?%^--*K(KDNMP MM#X$^S!C1FGR%K!"B!:D39;F:$]B@8!^2(Z'Y@DES6WJ1.W M^$8J=`1NR.UY M#9NL/4_2\9%KR0;U?0_EV6:V&TJC[W(]+627VRKCMF_`\=LA7>_4^Y2A,:5H M''U?Y;\``P`S?H'WL6[_?`KX`D2D8RB/80$4?"F;#SNA\<86* MS\=K"\5`C9ZO-Z6@]9!6/3C3&4B5_IVQ!%:LT]>A2"WF;TH45WJ26>LP1RT8 MP80V9T8$GA'C1`'3=F58/&IDQ%0N_T<)O[U**3+](ZC[\J\5D&CY#S(>Q[0! ML8T6>'UC[3Z7D&T4Z=%+T0AY5K(@:]P1Y?#PC>4HPW>STXW_2O:/*&N$K9JW M$4#VS9FU=3_GA$;=T?&*^/R\_BHY444Z$1[=PW;G])B:Z76"P>N\:#T8G:!^ MLRF<@1P!*0,$:&Y-?KO-<7R^.,=:X^%P?1 MC1^O6"QPUNN`09T!/<'F^3:VL*]R*_DVN/\9AK->59V7X1*79ESF%^VW<92Q MV%LM,38Y("TR,3<@,3`Q,"`X.#-=+T%S8V5N="`V.3DO0V%P2&5I9VAT M(#8U,R]82&5I9VAT(#0T,2]4>7!E+T9O;G1$97-C7!H96XO=&AR964O,](>YJYKK2_7X>T3>96N^`0FTBI%.%G*T[F?+X/V1AV/Z4P M539@R^]@SN_7P=&)FR9Z)PJ51!Q&TFMJE-`O;#U;+Z(J:6O9?C.&EO-1`_0N MB;GW![]R3N;%S,F]#*:3X<]@A$2'*.;0,;]"A1_\BPJCGKIW!6[=/36TUO,/ M%4$N;554^".^:U3)VE6A5$RNJ^B&<5G.V6]FN;XQE6>/2)VN8Y9:Y'+]YQ!! M+4P;^',(.XRS*P7AH.KSW_AN+D\*.\X4'N))83&P'T8-7/+RT^0\S&./07!Y M_XI!&JY04Z/!RG<.S-66BA@,6ZJP4)S<^E81%-<#&ZXC%N,V*.E<#D21L>4*G'M.+1C8>Q,4L)Y0L M.VZ,.N.K(YFU"!M3Q;.']5J$+?A+"!W$9^ M#;GV!X\=0-*Y,'>%P9Y(A1Z,!W#^"S``L2G,%`T*96YD7!E+U1Y<&4Q+T9O;G1$97-C%LM,38X("TR,3@@,3`P,"`X.3A=+T%S M8V5N="`V.3DO0V%P2&5I9VAT(#8V,B]82&5I9VAT(#0U,"]4>7!E+T9O;G1$ M97-C7!H M96XO<75O=&5D8FQL969T+W%U;W1E9&)L.EPLC:3WX964-&",9%I8IJ2$),'^_3U2F()* MATBA`2=3>J>0&+S'*,%*R;+HGDG`N5`Q=J,#K=5]]AA3ATS`XK3"@4@0R)(JVZ9X[F#ZUC6GY7,\4U*`XN\_?5RLUH^;-Y1` MZN:K]0/$7[8?HOD[23W;0T2\0@Q"XU,B`H:E&4(,WI/,"]_QY4^?=31(.5[Y M%8-V= M\B:0T^GSK]^:HMT765?4X_XT-:;,%$@=X/FT5?%;Q]&C\X0J`KG.IVXXZOGS>"IX``0`(ENNA#0IE;F1S=')E86T-96YD;V)J M#3$V,"`P(&]B:CP\+U-U8G1Y<&4O5'EP93$O1F]N=$1E7!E+T9O;G0^/@UE;F1O8FH-,38Q(#`@;V)J/#PO3&5N M9W1H(#8V-R]&:6QT97(O1FQA=&5$96-O9&4^/G-T=7^"@-C2;JR_9N!=8!';!=&F"'I0?'5F)OB>W)RMK]^Y&6O667H1>:(OD> MWV.S^[AY^P$RR';'#4@AI729Q+\U5K(03I5EIK015AJZS%66I3L*08.2BCF?;RCI&-?N"U9%:;JA5N+Y7>IKV2/7++/ M]`'X89PM)'_>$3.5F!5$QL[$EE!I+50).E/*"JN,2;SV[+YI`MK5U]?8_?28,%(XK#UR,$*SKO;3GB]$_B<1MFD% M*E.@A95VH;+CA<8=_=F/[=#[=P1(Z^V9S0W.G:DYIER^=:!AP=$)9PNHCY8F MVX+(RQQS[S?;&0_#&J<_]DU75Q%9*ZG9X1??0F%P>MWZ^CM^E`XWN%2!XH+V M?&E];'V@)T!8C-.+8\&?>(Y,NRF&JH]4H=#7/0-B"46!W6TU42@Q?^S.OEFG M5N=S`E,X9AQ"G,MRE#SX']?!V[ MH5_I@EX?AI`0+`.[9\UBT%:A-@`DEY)0D%PR"4764[U95D8<1=.OH8N=GT@_ M8O'P6K=5?YKUE$CSOHYI=W@Z]],[^E4:#HB8[O M,O2QG5)/@0*G70J,CRG$FV;3M6Y30\ZF%B7UR\8Y&WWHAJ3HC%G%A.%N\9.= MZH^=),_NS;_7\T)V.I7/[J\^.4TVDE,._[G<;'2*5U+4H5>C]_R.7FG#JF]2 M2->MZ&JTH:VNAV^>]"5$?8-XBW+L.$AVGG5T.L?1"].+ M[^G*G"&VLVY.V=5>JK1LI)^DY^RW``,`3&XW+0T*96YDOK53-*XF3AKG:*H81/RIYE^0,B5% MTMMHQ]3MMN3&-BV]]G[,#1=M=9#!$#&[H,ASQ4*\&Y9=VQQ255N*THG[1ZS4 M3$;1;E+[%8'VTHB'9I?7#B4_-NFP23L."2'6)6/$+JTK+TET^\.N&0Z\;:1' MR"LEM6ARD^B;7<7UZU02031MF_JT`Y$EMJR")JL.&Q5Y9%\P)X^S&N@T/-M3 MY7/Z0B_@&EM>*>+ZHL=4U2*:U9#U(ZL!ZUPI;2YW%,JV@@!;=T!VZ+:@2$7AM5YQ6D.;7%2K#E)NB8,82#;RO M-;H@TSJ5(%ZS(93FOM]<$'$@?RUV/WSO4UF3T'1?$P<$DIF$LG)6GHQT$&]^ MMIMFR(>0@;ZOVH/,VN"=G3[W<5&&BC+O"S%#[I*6FWD] M.CJ/Q3.V7H#*.;"-H'W^NA?(\%Q4YK^FOP2]Q=M?,:8KVUQ15OX)X-HXB*-F M3XT3!0\1>)S(15AG'"<*^C1.Y"T2IW$B[X[CQ!GW[SA1,&CF<2+'OXV&*Q6V M]IO4]P7!BG;[\*T9^&"OQ6?1C.4TFA-X0_:0C]FH!<,??9,ACKYQ>8+8-\ZA MI'`+[..3<^ZF?P48`+`C//(-"F5N9'-TGQ4H`I"=%#*>Q5+L+)1*`?U5*VRRULK MF+K)+,1HC<`DDZVJ7A@R,Z0AV&@7Z*Z;L45&$"B$!?L^DQ4!K$>3\I2HPY)G M4(6./$QV&U481`ZU.AT^YYJD]GDB!/!2(X9\[D>IC<\IQ-RAGUM:#KNZ;R8[ M!^&?W;AK4EFR1=]L56#J?AC[NAV_E$F_GS0$1EX`4J)J'OQ6]ZFTK'I7VK!/ M?3@E(](L67?'8]:7X@)#YH]"$$N^R,00/P(,`#K#;FH-"F5N M9'-TUL;P<[VLG.=K&KW>QN#WO:R][VL:_][.\`!SK(P0YQ MJ,,<[@A'.LK1CG&LXQSO!"ZRM6N<:WK7.\&-[K)S6YQJ]O<[@YWNLO=[G&O^]SO`0]ZR,,>\:C' M/.X)3WK*TY[QK.<\[P4O>LG+7O&JU[SN#6]ZR]O>\:[WO.\#'_K(QS[QJ<]\ M[@M?^LK7OO&M[WSO!S_ZR<]^\:O?_.X/?_K+WW\$&`"]PG\""@T*96YD7!E+U1Y<&4Q0R],96YG=&@@ M-C4Q-"]&:6QT97(O1FQA=&5$96-O9&4^/G-T&HG+`G*:BH(((5!04%%44$!,1;H4*$B!%"(.$.I2@8P`1$\<)%"BHA MHB@%M("*%Q2MERJH%76]T'6=LMW2==H9WQ._M.ZA,SNS/_;'SO?-^^.9>;YY MGV>>9SZ,8\7E8!@F#@T+7K=JI7N,4J70SEVN3DV:0%T9"<8X6C'.=E.0/TK[ M4/AA"=]9C=E#WB0XX##@[+Q9S.%B6$WC"G5ZGD:9O"-3-BMQMLS;S]?'8V(N M^G/Z34P_+UE0DGJ;0K8^3YNI4&EE:](2U9ITM4:>J4CRE,F"4E-ET1,O:&71 M"JU"D\VB?RXC4VIEND`6MELG3DN:I-3(E MR]-F;=,JDY1RC5*A]?PO(1R,/1RJ99#.I8?+LR?LG M/W38Z-#E\$&\0WR%((A1QQ6.ATA[^'M%WU0WY=[&92=-1?$,!EPV-@^#-80TTZ,%!,]Q6;9CV3G M+5C_K']?5'[@*B0-WJCO;J*1=2NYLC_\)%U3-[V'US8.'BG2U=*VN89>* M"EJ+/)>DY#6?ID7H%3#P!OF`C_@YA*U^0$02S3\#0]IQKK8!_QZ(J2MIMY=_ MGJS:%-978**/5%=62VH/[/IR_>)H=:Z4I2-_\Z]8'_!Y<-,<2L9HD!Q-1KV4 MGPGMA$+D0)L$0@M%`S>[7EUG?X/!9:SG%;D3PZT@)SUKI=ZJ8:=J!`< M:+7@Y\C^E:B%0H-KXWW7TR*H84*0-N.M^F[:P3GCY\L.T@U9C?KHPY$K/.ERZIXN_YH:?J,E5?VB579V:K M-_3H]OK0I>7\+A_CXV62HM3B[0%/^\;BI'M+H^/33`GY3DF%>LV75$I;P='! MHEL#H_0!'7^NXE`,E7U$>?9,H]'8O>-@R1A]H/IL7F5Y=Y136M.)LL.2UF/- MK2.?)BSNE;+9V`,^&,Q[P+N!0LC_TT=8!D*L!\IXT`W=)"I#0BC#V:>*(``[ M!P&\Z.RXV*?HBHM-3MQ*BRQD9;;YLQQ,"\]Y,&!>37KCJ/CW MS_AO<5&1R>QDPD[`?'"&^3QX"!IRS>ZUNFPZ1U>ES+W\P6H&F'\#$'MF3-'ZB1=^GB-U$(*PLN3D-!`:QE;@4@/3DPX MX!AHX%D4HNO5N_>]8D$N>.P$#SY;'TP_J#][ M:TA"C#YNCX_T\M/$%DKS!<302`8XR)$3Y;TI+98.5XTODJ2H,G>&/4S[*RO0 M'D0@>Y+PR/^DE!CM:>UJ>4J-K3COCFR6>H>EL8JA!O&`QP3GB+\Z!PIP)7(9 M+Z@AF>`E@GG(CMTG8#YR$2(^&`1$+^O<#`&1"]/O`$^`MDU!"AP2X0*_$A>5 M?,N4`H$QUL]X,)OI(^$4_@T0?/0$GX/&'^E&=/=53EZ2XMW0-A(+KVKR8AS?DDKOJD9V@V/4.'!)M"!DH:?OW8@G M@A^5H?>:'ZKZ[A$MJLF&IMX,(_S1*C:"!^N+-W'I5!$);`]=(`9"*3;1TAO> M*$2!EFZ@B1V]J6^!P"Z&[>]!LS_/'-Q"QE84G-GZ'FF9X]/4.-)8>E6!7R@W ME#AI(+Y%H*R,K>JD&AK.F1[1D(77I9P.2J=VYNT-U]$:>"JPE$,Q^0\H>X?* M^*)]^A;-:;C;!L8V38OX-U@`7N"':`@DTN`H_)-LPXFL>^5O"I$K%5$T'W'E M>0V]-&.P.FXP&"]+B.P7QR*#9V3)$25%!HLU"4]P0@7)^X;'7U.`N_0OJJ,K M!<39\[7`-_Z;ZVJ/BN*^PNS!F1\V#;%,UN!L,^-)U%2IEE1%$[4HBE$@$$71 M1$DU*H&X+#`(NY$WLNPN^P)10'D)#(_P6/&!("B)H+$)F.*CGN0H1O!Q;+5H MJ.V=];[WW?M]]PZXL^"+M]G#.?R50)\VMIG6LBX="MUM M"-<3CKHNY^1FQ1D(E/Q$=^=,^*-RWN+ELFP@`-^85D@GPAA(5YOA"`FSE\@6;*!'3$8-9BD;Y15>7EBGPJ65^,87[QO?C">M"6[_`0_)F$C=+=`4\N8A'[@ M5PNTR&B9HZ5.7OD+T7?5QO5ZCM$*TB`Z`3LITCB?D)D)LU5!NN)V'G+12'4`!7"(*M.VP7F(A#8%7:%O%[%U1"0/MH3D*X9+**$FKU:(1`^!]\HD9&@66GR!.FLDQ3R<:Q/^Z06K,D5A^'P?`)!P(-IZ1AD%5W]+%`X,& M:VQ?[2=+'!%NYSJA453\ES#3@Y^[TRPJ(_9'VR^RD@[U=]A.V3@1/Q!0N_$T M(8IW8#WL0)=.6]OEW^\)J,UPRA0D"_#>[MR('"+`/1%%%$39_\;"7M#CO2@T MRA`A"_,`>>(ZL^BD1050!$BB1>4&^PY;GPST]RY+IY6\<%1`IXV=$XKN-&R4 M332*/'V:G1^*"AN\/BC_,9&D'GXJT.=-[7GOL*XOD-H<'A27G%%`QV`M)ZU!PTV6\_9QSF-%3);9'A256DN:-;4<7Y`\ MO6$I+.\Z\[3`0\1M`KIJ*-'O8779V?'Q'([%&@H^04,MUAX[*?2^7.C)7TRU M03_!?$PYV(SJ1`C"6JI45YB1SJ9\:@PUD0?NHO'Y=;J)7D_!CXEW>H%6J:$Q M%1F^&/NHUB05=O&2&MUIM%R6Y?U!0!UC($RK#!-K#,_AF'A!NHX\H66R#)=H.50M%0D[57KC$?D4V@QELE-84+!/I*;GG:)M85A]:E MIRZ3.Y4NHL7YG]9<9J5=5@0VUQ!51X-->D)9719ZK<88)I.ZC61+)R4[WR33 MWRZM;&"5J17%"977&6E&21R=-(ZUW&J7AJBNPJJKQX@T+L%=%-?_$D8 MBWM-"#^6_"G\L4"7E!I7]_),ATN#UL;EA.5P8V/O]&Y6.,C,_P\"W:5ISEE* MF-Z*5^%9"_0X`_MC?SUD#,.L5E@%T_GF27@C7HA?Q1H]R4(H`F]+MZ7OJ,>- MCJ(K#I)T..CP$HYL?>:F@+[(;30N8EVA*#PM/2.;R\DUY7VPSX-Y!'G2=\HJ M2TE)BVKPZ"Y,XRD?:O"+5IZ0P*M@O;:2$/&:(,+HF`ZG!D]6ZI.U^@05HPM9 MV7QO%P\^QW\@JSB`_;G:"38I^.5O\6Q8N(4CUTK`%=AL+E+UGSU0>YG'CYTG M?A:$9W3/:T*>G9!E?&F=;(*S^XRY*^FD."7$ MQB)=;F[J'LW6YB4JYEN\7HU_'QII7@C^;_'?[*;ZU9V):]CTW#_@W\K'`[,. MJ"=:7H/-#72I/;_\2&-'S+]4$-('+]X!A?^%F#(>OW&-8JXM:M-5G6/[>S[[ M''YS$:/`<*\@V3E/]*IX%D'N7XJYS0P\BY%?'230+29'WD=LLB'3 MF,5A=_R`,M'388C25^RK*69;&BQC8=\OH"Y3469)DL/'&T_&%\A#^`7XD3(4 M&8N*V-9ZZU'YJ4X2_?J#665;(-HUXEU/0Y`43>VG8:DK6HZ1K=)(<6M5C<,V M;6PV*Y.E*3)-?W?G*KD6FT"W&^OSU&R\V4R<]&=N#LRA,LJ-!25L0Z7Y2YGC M"`$PE0E'U/`!;O?&*W'"QY$QN3&YY.RRB2C:%FEWL!5%U;?`G3O6_03[40=3 MBA*RV/@XTR:CO&Y$%&=-L48,XB`XZDT^N(2*NON%'G(U8^G?**=_V$1;.XVM MIIUL_.X-.9FR+N^2SZM4:E]IBGB8K2\N&"#5W!%0M[%F6WXV!./;WO@-M#C1 MM%H.T<=DW^]/LMYB(01!./15-C78*PAKN]DAC3H4]=*HN],3],H$>A,YF=PL M.-$FO>2DO$M=1U`R_HBJI\N[ZP>O5SQ6O38?59NO<5.55"I_3'75?,?[ MO=][WWN_ER[>)X/4M:_NB([M\A98BBEP`7M@J2BJ0XR[1N?DV.ETNF*M0LTW M5G!0AUY\WDM@S]_IL]-KA*^Y5'_N-'L^SM#,G#(U==VM.[R7W8JH)+PX'%.1 MOV`\OXD=%&Z77[_.QE<8(FXK^KN%#@N'@\;H](RDA&B%4M-E??RZS53..2S, M:!>7C("78#,)'+C!,MN&=POIKOQ&[7YFYOL:-#5J%SHPF&55P(9;9#JEX*.M M;S':H3R4FL9!#0Y$$(@G:&-5??>`XG$%9OSPFB-[?0,R?V+P''J1L_U`0GCJ-HDSATE*`E7K@0E1PU1&M':2^\N*6IK9<1)?%2% M+FN;BP,9_!4RJZ*[?!4K7=?CK60C7OK,[>$]B^5<%^N-*,TW#55ZF%]O3Q9" MGM'9A_T.;.3!ZA)\NV&M!)P#!N;9PGHX2P/;:>P^6YNH MKF`-<7R0/M;^>[R&3DHY$N:G^%0]_1<=!^6R$5TF$;Y;%1BM7HE=L>?TEK=_ M&FM_/BZ-++P@?M('^ZPV=X`;`P=;HIFM@LR[),TPP<#-QWUKP0&UZH<':TZ3 M<4>C3D]@3C1$7^PQM9Z=V&SUP5\68Y?E[.ZP,?Q(%IBDB]82J`?;P>''.2>D MFAB8/<<"L5_G6N66O[J3QN,,/R/J47%XBGJYF?I'MI@L+J:_QDZ(>IE]*C*Z M0JG`GWBY;]PVN.=N`E>$J!>;P[.V1.UD@CHT_>DL^>/59O]"95PDXW_W",R' M!>#<2CZV&)T,T;/4=+:WWFZ+_KB^DSG3W=3XBN>KVMA)4\>E<>9J7%O.298< MWS032%^R:)3;L9R/3%M</0>#0$>5Y1FMC#A?NO=HE;C(/$= M&3'#VZ,'>CL[^GJCSX:'QB@CWH/^W`3^@LUM"?!),8+&,4FRP?SJHA-,7A91 MEBQVQ(YVXC;LJT*#_/YLCD!6Y2DCI9L%M*]26]5'1CMD$EYBQJY:4YN2S:3' MZS+(R-$26Z:I58IR.^\9U;Z.7Y,#;V[+-#!>M[:PD`9(M)`XGA7 M:+Q?*-NN2;R\6N$6YJO*X(IDU-`D]E>A-JU9%R11$Z(NC"D@=^<+**HLGU!' MSC8A0\]P[V5^[U&)]"0^=I_NO0^'2G.-[5)0#!>'+X[P0;'2NHJ/#2DBZ[GH MI[@3<'??`Z/ZQ2X2]Q+>*LS"NC\+:UTX@<(2*/VS4'H*:O-FH_0_T2?[_V_\ M,ZRBA_2JE\$:4NA@,Z32("M_?7>\P0]_AJF\=3LV\M_#'!8O<\).CTEOY>#C M)_`!*`ZJ\5BX#5==WZT_]MR M;./FK\,+-@2HQWGV`>ZA]Y?$5DTQL`C%=%H21A733Y_"!ECG.N&V,2XT)DTB M^;L;DF<#!0;-(6:F"!W,R3D@>69&DCT!-HZ(2]IM.F$IL4:"_O+O=$G:KD#% ME_&WP.EA#7SX<*`Y,I*#P)GSM+(RI720$9]ID(>_7;LRJB5(@9=OP@OP7.SY M9.N;MJ'J_@L.X5WJ=`9K5`8+`4E6*T] M*N5'HS009G2*ZSOD+2U);X#]6[B1>@+/88J&)6J4I]-FI:8<-.XGVG'5K_U^ MR>'/(+=B%1.7K`R6!*.MZH?6`BX>;VB1-9VL,%17W3HVK'A^[?[-48[/NP#_[I%9F"U?(6UP)'HDRK^6A88&A]@F7\'V4 MK"]S@SF*IUT3OS MEP[59Y\^S\`,/J!"G436!#!$QG>AE)3$Q$.*@.)>"P?/L)\*7<@W9$4R9"[; MWKEC^N;`A98VJ>FDC#76Z6%>K;U#9;(8),B;Q2B\`E9(PDU,E4K&"I6LI?@, M?Y3)U&KRT]AMV-L=PNQR37QI&6-JTG>4L@(N5:$6;3E?DU21=>8WQCWP(1YR M-LM@K;BP:;BN1)!DV.SM-N($*&S?!4GW*E0RBZZIZ"BCWHM_GN!)WD_J@PAP M:F::C27F$G)II@H)NFJ^*KD\J^+$R6@O[.D<#$ST'YL9LU!2)^U(5"%S87F^ MV1M<9^8Z"S)P@%&[HMR$^;A!I+F8N`W4D9U]44)S,9/+_E4U;3 MZ/^@@2B:,N&]NZU:0V[#<7#$P<[D\7GJBL,*[57@(:`T?0S?PC2-/V@TL=:0 MAN0JC7U-2D5Z`9.>I%472]6`)%[$F/AG07[J/ZA.^B^J-869!6FLU[_T.\3Y MNR]KT\*&I5.E%B_K`8<*9E#OEJ@,8RUM*?+/E*YOFSY!OK]OPA2IN0UKXOQ; M(VJSE\6>>;G@R'?)O7+?-7\HSML[IW=A'ZB9_MWS*6/WKQKF[XM9#'_5/&7G MJYCWTV+6[ZKI;-\73/I3VL=>._-'V-3O<3,Y?N?U_"B>_%V@FU-N@7.E^'\> MSN_RW#T\?#\Z1'YJBP($&`"7!E+U1Y<&4Q0R],96YG=&@@-S4S-R]&:6QT97(O1FQA M=&5$96-O9&4^/G-T4BWNB]4:L=%S9K M51`]1&73N$144%$)$B!(""014!81PF98%$46E8+L519!1(L#91A+95&4'^_YGN<\"PJVP\-]^6ZE M2J&UW:56R<,_GA>Q(@X[UY2=-],:N:#PW^)^L\;GJ3$+B+6$R[-;YXEO"S$3 M#N=<\29UQ'&-,CA$)_[;D:5B1Z>U7ZSXB&O^0*>/Z.0@E@2J`Q1B[^-:G4*E M%7N%'U%K(M0:N4X1:"<62\+"Q+L^*FC%NQ1:A2;*>/W#C5BI%H1!+/,3R\$![M4:L-/*TQP*TRD"E7*-4:.W^F@3C&!^& M\S`+2VRA->;,P3;.Q8(P3(EA.@R+QK`,#),9>\"X&([EZ/7#"5F$:;=N%V>!A^GV?+\^,]XV_B)_&?FGF8#7^R^I-",9\H M(=Y:N9"69!HY:KW9NG^.Y9PFFX4V(38OY^Z=VTPY4ZG4&Y&7:&3>P7F#\ZGY MH_0!.I$&QEPL$`L,5>QDI;"E2#_XOA9X(WY%Q+_9]6PZ"5S^X4:WW_.<;$(6O>B8.3P,QG(4QT-4*P1 M^1PO+(AEB`^)A;'Q!0=%R'P9FO_9DH&06T`.@_U[QJA?DIZ75DBG%.6G-8HZ MJHH*KC!9&>C=[R9X*\_(VP/H85?<4)L;'=S-F8[,03%#)=A\S7 M&:T[);3[/(*W)1!^5=C\ZL$(.'Y#M$$MVT'>:RB_<;->N6^MHU]$/!U]([J] ME6(WHCDD"HOB-:17IBJH[=N3]V/>(>BHKT&E"X_R/ MU)^JR#V3F9E-9^9D9V:)WNT#+E2 MB+ZVZ?<"\V5T? M,,\%GA^PW6-!SZ*%_?`!>1<3)PA]/TL8`R2>BZJX\H7+YN>EXY+TK&UI$Q9?RR[YU#7-N8Y+/X+_V M=LE[J"KMN9-!D1Y!6VA]&E[!;Z]LK:0*DBLB]2I#('VX/,&92N"WKWANHBGFOTA5:&G>`G9R%/!SR>7]II,.2+:@V14 M45HS-"8"\W)[7U=_QU5V#')',OPD2_$%\?7L6)<0'HTH!HA^L(6G9']6>6I] MC%E/:+Y$0[D&N-C1.Q6=!T6Q.KW:YWEJ&3C"S!>P$&Q6U\DO,\2SOIN5-SNH M&Q'_0J3GRC`TYPA=E(97%34_'A,-UN_UM7<]X!!N#`NQ6WM86;0POPGTCXD8 M-@QBR<6L[#`/W9^6X5NAED_<0NN&^40,K'O'1YX])-+S(`G&\2QCZ0WL/T.0\S.7W37E2J+49+0!;4&'*13T;@68@WL]?/X]4.N'%GA'G0S=31># MX`V(P+W*#`6@1G*RYK-/$7[01^KJ.0@N77EE>7E,67G]N5J1H""*'1_D?,E* MN.R>J67D-(\7>]C_TTO)>/NUR]6](E#QT/[I<;R7!R%3"W&CFRE!E;!SR&T0 MU/V[AXAQ"(%>DG@)?*=FE81R\Y-+G0_V#M/$^%AKX]4*&CD@9W)]GQ/,HHV? MG*^!:?O]J+N(>LT0PQW53YI?44/;^A#^Q9(]2YR;E#])C,25'@%AJ_['=K4& M17%E8<:V^VJEHM'>`>E)=1N-F%7+!\8@LN"+Q%+CBJCXP)3Q$14486$8>H!A M!&1@&(:7"@Z/YJF(/`09'%^H*5;7!;.NQ+=&HYM:S>JZCKJ>GMS)9F\S[II4 MK/[7U?><\]WS?=\YS;'7;\ECU">:SER]WKI\V=2EF[Z(YS?7^O_Q!C=$TD'F M$7E@@ZKQ`>Q\3)U+5$-Q.?A!.&SA(&@\T'@H]@["7M@W\!@>!%S7FE\LFZ=/EKS7B(,OO9-[<.[X&O!*\*(RH@,(0^H MX;>!8C^'=^'IF\3(5F,\\(TB[7<%>.8)8#S,QKU4O.%`<^G-"Y>XNV&ENAV1 M.+K( ML#T\;)M8)G55L7OL>55 M:]@C?<]%_);RF&.%";E*00:'_*Q#1>JC7%[R"G4&)-(Z)CHSVF)*7-#LK\&S MR/[Y-M9B*\P>#]/@TWLPS)HGZ"OIF&US0_%0#1Z.W[I/&/N^H_=PNV#O/%O5 MI8&A7P>-JO?Z4&5"QV\J]H8V!0 MR59,4K1#IQUVMY,L3YQ04=O\DY?/#B\V2?X>@M6QC-_:53%XF`;_UI)G%R`/ MP43SG=PR0VF0;RVD:IG0'>D)!.=$B&=:2BW5/&@8H/:E^)<)]4P.C*;=#0Q[ M2$0]IKJLWRFUA6@S%I+:DD2Y#0V!2,*<\Z^3[ZKM]"1_(B<0SR/QT:QT?5*@ M!H\A\1N+"^IY>/?7\>_\/_['*-"8.BN;-+]90J'Y2:57.8A%,,9\-;11OLTAIU9 M(H3T`17S1,/*,`!\S]H$^`SU[;,Z"GB/4$XZH$U2O71"MY.2O.&@Q`07IDM? M<;`>NO$*-"L[,4"I_Z"$/._E,-17NO=:$2_A@R*ZDF4C/<81N!LB?OV>X/>< M'Y)@D5P#)14@)U7I#5T2,]N:L.>&$NQ6??'E?'*H2T1W?J:8C\B\;#*TRS^1 M0Z%."@[*7>HKMI(;A>33#A'=-I4:0CGW!K0BU9#`?U%_=YYF>W*,:"A**=<+ MQI+ZM$[-?G@O'R(\M.W/_8Z3DJ<089XT2^8X+FI['-;AM3RL0_^+VR:BBZ:: MG<&O^A:LX&XEN`N,Y9C];5QBJ\_]4Z"OA,N2A\V'YJ4(F-@Z.D_&!6T7&0PZV[37]XD2Y%9V` M.70\@WW"%V;C<9KI^KP.08Y!-^N++RJ].O`*AIB1H7.-(J9&\DUUL$==*Y2$1I%PLB$3(P[? M-R,W*R?2>*;(=)2;5MD%]Z(W)>:(S8GRI^ZC=(58B4!65[^SK5H`[(\ M@$.LR667.5B`S'52;IWF16^E_8A04>ZPW^#8Q\#B=\Y@GL<5#/P^5-U49Q45"/@3"28<^#D,UQ(\53W)&MZXIBW9%G$ZHV(0>.V% MB<\ACOL%JL%83U#Q$Q_&\\>7T?XWP#L:.,W>*DN>3<`/76?5_>#T9.DGX/I! MQX)>`2WT#QVP'X)6!2BYA#0%J&NLI%YO3:A,W(_70]&(4WO`NPXX#B;BP&I_ M'A]@V-LBNK2S+..5)G4SE"8U2BBH(%WZ"P>K4+<5,O!Y&J8Q[&-WI'Q/?6!W M\1D[^.1@7X)[G#D@E[AS)&F:RZ[JNP>&IY2\E"S7.F:'V:2-C5_>LE@S9?)2 MS'S0N_9!A`!CIY5'A7/+-X0'8]$X)K.#KF7[AR/_L5%550Y03HJI_,UU>*:D#\HW2 M14[>]26"`0UZ/*!:J&.R((1VGV>R<`A=1R92S7X)!FB^=."R MXF8W%3;.A%1=GU70H5]BAB496[@BG7 M(B7\.I%I-[?FK.=TR>O,63P>ZZ;P>/@[K3VEMY=Q39*U6_$\243'S95&^V3( M=1\;4<9`O'RV\9K-=B*?3(:[GIB%/TRE?IBNQ"0*;\EIS=[(Z3)C,G4\'H8? MX!'P/9UZV%A3P1TZ]E^VJS0HJBL+#^-T7S(FF/#F!>CGO,=$9]2H&:5241.5 M1(B"48(;NXB*[$M0Z&ZZFX9F:;II&AK9FL>.0K-OB@NB"&ZH,XH+X"C:KN,D M%2G\_B<]N7M*YQ=<2>> M*[PMTIISJBHDC;5%QXS$0B]'9[45"6W+>^:]P-VG\&)[`OR1\-D1;'<71W3. M<>'%YV';'8@9!9^*WLJ*@6+[7WOH5=)ZMMC(),K%K3WZN+3L].P,CF2(%,^' MO:),8&N;YVO0TGQUU0T) MF1HP'Z2CK]H+NPI=;''O$>[UV)4(]V<(U\&37I,B7X^=&%PJ%CR%5R)^J@') ML+NH47S%7/YWF,-`DGC*>^J52"6,H`-DA7)XJ#D+6BFL/.#8_6CM/9@_20;E M(9A%Q^O2XU2L-C-.G<)$)+3V$_75478&%IYDB?8*I3,SU!HIDV!H;N;`'UTP M_(`7L-3WV#[$<[>R/+&UL::^CBO1\KRDM:>ZO:4_PX/U0=1+O.RKCZ/G2;P& M(X:&3Q]J[V8]3'UYU4QE:_Y`'^>@:1-F7H+E_%&9XZ@59(^H2;*CC=-G"R]7 MMS'_[)K[D;<2BS#:ZVGNY)8IZ8B7WYR$C>?![QM'4U\:8'(+-2G?"OYW1D5OB^G8RWQQE8`+.O#ISI M'XA=MY^C$F`A;J*]M(;:PQ+A,K)Q/67C&CC-M?@-5[P$-+,,). M.`SFR'K'NKN;B!+V$1?J1%3"Z9KCE2>J[,FU1B&A#5"7W<'1&<(B6$Y')(>M M@XN9S_"[/G@C_F!B!=E&YIZ#V:VE'+X#B^A'E;U- MP\SM4J_@_1P1'[PPKPUV6NQ^LLZ`BX(?C6>!O;C;-#C,]IL^[V-J&\S-'3N: MMF`O`_YR"[L.W.OLQ_8`^5.*W M;@=^BR466!QYJ)6CQL*&!$_Z2F]#UX-*+$E,T7ZQ;E72X]LL==<5KA^G>UQW21*#X_N*!!4GOH<*V1+>K2EC-G?NJ%WYS, MK-$T<`[D>9BAU_&^:04?*S4I*'DZL$1C(B,R&!W*@YEXUM=!L8%1K].QX'_I M&#H=XH(W(9Z*16LTV=NRR:/%\2C()#?=DD`..G&XEV]FANO#O3@O+=16$0$**+?`7QX@]U>XJ)#1 M;#96,)4U>;X<5J%5BIR-.I9ROBC\AZR`\HK8KI;Z^F9+2D-\E"J6S.:5.*%# M&"\?FC[ZZ?318!=*KS!L#F0C-1?"&+E4E1QQ7-X/].$?X2U.V(ZT!?XR_U1_ MI8L2&?DW6)2S`D[]7PC"?3D/'A7DT>Y:J5O[WP!-]!:+ M-XC*%269V1*U6I?%RE60P(N_,8;O#[B,%X.?]#Q@14VV+X_S*8&'MRGO>+UN_-(K/;R*"H_QC@@@4YD.CXT.E@5[LWB M>+0^61=J*Y%D'NW*CRN8D(`)==1WD,J[D>\;P.%(])52'YA#+!)YE&04[=B? MWU)/-@LTEO9BSDJ?K_=)V;Z,N+[US+9=L:&^W#C*)F0GMRM"5"%J>P4R%I>^ MCL.&Z1QU,FN&'>]8P=-*';OSA/95J4-LX%$\\B](JVR70`?J[FFM;6'.5T?Z M<'@/4!-CF,G.BQ7ZJUE%:"M M1A[*,B(VEJ+8=DO&(0:XZ^!*>K>+^UVWU=N#$J6^#Y<&*8)4M MA"6EAA*FLT"QFZ,FK3JZI^B,I8L!!Q/^)!FO62J/V1IRI,&&706;1X3W++DR MQP,/0&DENG9*6$77AR>;`QC\W@+\6\SBA>.>CT>N];54<2;L(PY,2_Y<1XAE M5*#0TM3"$Q+2"4@&%6;K1&OP/3HOUJ#TE]MGIRKT*L8M_+NG'#GSG:&;D]_E M>R;:=CP>?GCF79YYR7'"2HU,6.DM2MU6#0E`-H\"C-&%HQ+*#"FH[>C)`RPU M8$=54\E_*J_:GJ3.*M\'; MRYSK#![-R;3S;E$YS)?LK@QHT:R#'1QRE!\`1%YTU*D*W(+;6VAM[VE MI:6%>TNAM"!4`;%B1?$-'.(P;L,HRBVY)S\3%QM]E?X)?SZ9S? M.<^3<\[O=YI=3:T4WQO7CU`W?SS[8/)@;UZ4(:)(<1,[T&7MZR1[0K'Q7S%_KC$;K.C]49:ZK+J%S']1,,Q![C:M-$O2"])J3*G%9#Y&5VLJ#!54EOD;@8%[:(D!CW(G MN1P2N?%%/U0-!T==L1@=CV-K<">'$?H+[:>%,2%9[=%)7XC*#FEWDE29X#Z& M577;N\Q'R.(-:$7),GHQM&`VKU5L);N[FB).6D2Y+-YI[[2*%:JO&J*7?0]H/H536J%9_D.SK;NIWR_A[6'RXP6\90M@*M#,]'U*W`#%(]H9= MX43VS2S>S7GK.G<"A7Y++Q'<)@_5[/;WRH^>!Y9?D!$K%IP6+^5U^6(!!FCX M4QQR^T*>#!&7UP1$=3*5*=NE@B08OY/F:FBM9TF=N;$\LMF@TSF>(:"6+M]O#=AUIM)JSWZ?U?04W@F2HVQF4"RID\7Z^U3&< M_2MZ,QVIT-JR?`.GL66PL%C&TSF"'.,70LTM]#UX%9,%PNSJ)]*HF")(^X@A MZ7#BRRE6=9(/F/2DN:[,I*'7(2W"H1FS>2R!-O+X(!_FY30%!KR-ZVEHU8(* MV=.%\M'E+%E;B.@=-*&I*P]JJ'RNR,H00Y7ALDLSYVX!>9F6=?N[HLSI;*54;%<\5"HR))6@546HT+6U=K+5]$(5H%7=)23$1_X38T'PNJ MQCRN@3L4T"K4\6RI+*%?D=7-VR%PA\`4`EM:_15"RIR& MP;2\OJW?;Z>)?XVP!,T+U.XCOSQX*&^;/N*GVP9\`V0[&RFM/%Q3_/F-O?=^ M'YF:NE;9GW6-=LI#_7?FS\?.37U+7B\8VWF&1F\`AFE#YA.=9+CCPB1-_*,X MW\76,)82MHPTM!PZ/1B(1">R8Y^NWU2T>O/9@^/Y-"?WM)2YQK=CZRV)4WG M2(D"LS_V,&&(;43H:VFC'!'U_73K-GE_:]L1;2F[M_"4J7!E+U1Y<&4Q0R],96YG M=&@@-3DW-2]&:6QT97(O1FQA=&5$96-O9&4^/G-T)S0DZ.V"+X=QRH^>E5$Z@.?*%1`0`@:$0()$$,(`B$/$@D) M4D'"0[&@"/*H@T_4:GW"1;TMJ=V[GKQ(UW[@GV@W[HG)GU M8>]]UO__6WNMC6/>7AB.X_YKUD5MB(Z:'JO(DJMGKLY+W:M(\ZR'#PF.\\.\/$O-KLY.4ZIRE*K4/'GZ M+)9=OG*C5=GI6JRF25&>PZ1;8R3YLC M9Y='LZG9Z;.5*E;!_Z?.WZE6I"M250JY>M9[0!C.?]@8'!M/8/X8%HAADT78 M#`*;YX4MP+'%&+;"%]LBP@P8MIBO"B;`"&P55HJU8U>Q)]C_\&C\<_R-E]+K MD2!;<-M[CO=%8@G1)UPDW$^*R13R%U&"J&/,1V-ZQD:,M8Q]."YM7)M/N$^C MS[/Q9>._$\?[BGV;)P@GE$\D)\;ZB?S,?G^EME$7_"?Y&R6D)"O`+^![)FBZ-7]]]*@7FH4A)`OC:?KI+#S1`R&GP9J@C%R'D\M6+ET14 M2G$]@=:@V4O1'!1!K[6AT-_00H9/,%>#0\Y]P0GTJ03"8!QXPR+81$-`#OA' MPAAFGXEHC6T)8^EY.N2S$XF9'2APT_KD))&811(HQ+\9%#B01'+]^/#`7?J, MZH3"D&I*99+/615T1FR&IIB7@-@!O!_T`NB"@Q*D%.K7$9`C%+,E(,#;0"#X M1XG$!SO2U=!S,K_@#HJ!=^9MUE M/TF[ZGH]OG!H^]R_DG]"*NX00EUO[F^Z\*`M+=?_2G"D"QYJEYV0$=0 M/SZO_BD#L33RFZE0,%OVW$J29I1J"W930OFB&ZM(559B+9-3=(HO>I"\W5P8=NP1B6`HK M6T14%VI&M9('?0D1<[>B94@8;@/O5M?G4`:,3`S5-A=D='/3-'@\AP3<;9=D MD\-X:/_?9G(#0;E"=&;$$H'8,HN\+%@'&UQD4E6QHY4^ZJP[W,9M7^A$[?N.[8ZGPS8O M09,8:CA[3W6OC'H*D[D&27V5O>Z:].\]NZ+Y89EBF6[G\0>TY[B7W?@0>'.) MC0(WR\DE/9!`%`A+3<;]V7GKCT5*D19%H5RT%25":!2((/3I[V=[9(6'B<2$ MJ)6(D*)QL3]`($S]-Y@@$:;4(%I9*1-SN*V=^WF4]0D(J/M4#P2X)THNFUM- M"EICV&LI>1=$!TX2+L!\B($=,KXQ8F`^*F3022&LW2@Y7%55?UT*4:>0;^CZ M/>@VNI>H=G:ZZL[6=(Y>8"=<[(3:3H_4XR/4,[?8/4DR8N3+JB,]-M+=[K_L/)+ M(_70'>RQ8M()KYB_J,B@M>599OVH#^W:XHIX`X_M<)&*RM3*T_0A>ZWS*',' MU(2UZ71%O[2ATY)<8,JSZ&4-I@=0K'4DS:VPH266X+?B+=6'[`-2".LN7J>O MT%OUHP8X7-L#/2X8.F76^%T!+T[=2#WC7<2[ITFHYT55A+Y4KTG/C3GUL13M M05O09TB;<@)E0L/PKT=/#\KZ84/#8%O55U7!+M2D(Z^:CEFR:=TNM"([C\G+ M5I7$2]$GF3#A$2Q\`39(^N;E'A18(VNT>(1Y\H$^..K"#6Z7P'V0QT8VG?", MJ!7B&HV)]_K!ZB+CJK/M M=5\/@24(>H5K4(EV;88YRY'5M.O)=9^_H\@/Q-DNU.UG@SO!@ MJ'3":R:GI9!6_65M=`*#/@PU'K@,&QN'+CDZ_PQBW?Z*;1Z(`RYRFW-?92]] MV%%;T\'<`N5!*Y!H.U%;T)J@HO,+*K8:^??BN(O^&!&A1P4SUV6G7"/ZL9YR1O0+3&2:#0U8LL:+QT0*MY7&O3_]DL]ZBFKBR, M@WHOV&JT7./">Z?WUD=]C*_1^EP^IG9J1ZO%Y:N\%`41$!F$$$A(@(0D),1` MGBB/$`*((!#`I8@411%4JN-S5$1&*46MSS6N6KOV84Y&Y@9<\]?\?=8Z>W]G M?]_O;%D*K5+&*?>PD]V^L=A7H@G3\')"[#[[34+ZVKB@SDI9II'Q0IKO'\%WA"*0F\&(Y>2:[5%X=&&$_2MER']2C+8VP1WQ*5`%)W(^$@81HRU,%8<^&UPDF> M>+C0>Y=WYSNTYMW(@4UHA1!6XE%=>`S^*Y;B>!YR6X#>U@=B"`(-[&3=-5@K MA(EOH`M"7C:L_1,6S,:/\2X\T0!3R]GAO)\Z#G5#E#OXUI,UF,Y#[I3V&$_K M],P]&I[6'[E7_2_M>H^IY;EU=+'!D'^:;8/MA+:L,/LV`SLN@N`>1SV'V7A% MSBX6YY#P]69AOLEBKV9@1'7X&KP<3S)\E:'(-4J&?ZU![R5*KT&O*4HO*!IJ M0/*.ZD9_MPNWY\KK,^KG@=X?IE9>N-U#PS3\I2&:OY/_1[*.Z"-IA2KF`WY3 M>:<&>9R:S4?*FLX[U68PY3>S';#WFA;&X6X"9I+4!#HY9/G?!UIXGMAQSCHV5 MY!*4>Q].X@=88+(ZJ^K.1=]B8-+MWUY<3SDQ_QFWJ$]QI(6^<<[5SE*],-8X M94L.YXF*'?VKWAO=*1PY,-;#W6-D.)[GT!$P[E*K`28R>)J[(G7];EV8CA?< M9/?YTIR6TT@7FHIL52QP2$NTD_>:4J;(N>(AF/-[VE2[]WV$1@Y\[7%G@)PL MT9_6Q=,'=J]1R5DS\]K./P!*@\:O+-X:>BM MYZ5DY$X\O41+W*HK^P'F,O!GTIWD?D.DHUR?"[!2:B2FA43MQ\L8O)A$$O2& M$"C/AIY#@C*_XI\@Z*ZVF&JDI"@21@AWA4E$:8PZRV*M>08OC/FK,J./;J;X7?6N7@3GA%O7/B&HYH[VZI!T,OEZ@E**@_0)HMIF2'Q M5%-=P[U.EFIT?YPG?/H4$F#TL2IIZ*Q9.&YR0JRCC14HR]'XLQ!6[)#XE?\, MM7W4:^0/G<*EM6C&=KA)I#K#X M#VX]H?-)[HYK@[FP`M;`PKLA9]8NV#@O,);5YQ#4PSH@?H"`LD=:LS_U.C`S M2!.)?7D(SDJI;6C&$;<&7KR)G6,3BRF4VRB$ZYK+3>:6%YD,YI0[EW3#]+K(V$.F(5/ MCM_LOL!4')*FJ+4\+"/".4B:*8P(#M^WG0D/++_I-#O-I5R5B8`EY2\>]M"G MXXX$\6H7XI5XZL;:5>_>_/+,?I@5K,1[2E%/+4C+O/&,^VA1S\AZ])GP*?F% M>QFQ1YV(!1L8A<9FXP[G&8KIBL2"](-LM-ZP-YO>:6G,J&%@=`>_(`JJN#MP MEP!OTE)+8"_R7%XUK'W$%!S2J3EEIB&95EH2:LL=3J=3WOP7[!>,ER])9.>3 M`AQ1!H]+X?L3A65^MG;7`YC=&=M#]5+O41R:)0P@-:J\/!E']>:EBO(BF.78 M=S,>]4U34H.'1]'2XL4^2IVZ;;8Y"WTMK:MX`V?/OBQC^4IMD_>1A>4 M51:R!86Z`H;ZS^.7C^XYLYU9)5PK2?7B&>Y087!(V((T[&5Z7FZH;*QGC<:Z M2@MC>QVEXQRR2OG@B'4?1`^7 MP^,?@H@O>#E;N%HJFAK$J)0YA[C\`D,I72HIDD3I8G0AS6FN)Y>Z8%$C^QN: M_Z&#!?((3P=U.41=MEDCHXT*;7)&D"\U`3Z'J_^W>K_ROVQ6:5!;UQDM)1)* MJ7'#C5QXSWXOF4F<2=R&.-1-P'%LXG%B6I?QPF*6V)``9A,[6I`$0H`0:`&# M$-H08A-B![,;;`*D=4),3$T,Q"5QT]2.?\0SU-/F>^[U-+UJ)S\ZT[_WS;QS MWKGGG7/F)6+N%3MDV(G>5NX,*D9SW*O@(XS/K9"5T`72&3A\E`4&`D9[YPP" M._ZMW,_=HY/FX*?W12>S1'5_+MZK>G%<>=P/JD_H"JC:DI((]04RDB1!Z_Q9 M.#[13^*Q630:VE(L.-G;6MQ'3WE&UD99HO,D]W2!#G%=(* MG?6BN/G'SO%5%Y]YM3'EV8WKS)D^/S'1\'S2?9` M^&[SSH;A-LI"0X^.$?\DI15D2^ERK='!HBSK%K@&J;%B]X7(\%`L.$;\P[.. M=7QII2;$'6FO/8=#$D3D;`F2O-HFQ*IB*V(J".ZUIVF31Y4O?QG4%+Y&''N`YEF=%I8Q%GOX[OG"+^YT0[R4I M?@"_\/ITU#](9>R!2-BYDO,%%K!58N%L^_FX9XAG,3]>-/PA_.0>),(3;`!. ML<$[3HZ:U$D"'UK!=I=TU$Y8$6+__3@*!Q06FKLOC<'NKD^8&]V_G[E,7]>? MRF?QQEUAAY[7H7>6RRCQ\X\%^?@))KNR.C^6ED.*S:\@3=??U@,_-@VRY1UM MFBZ:V/!7$`XA:Z(_O!IV^JV,(N(_]WV>N;[&H*71%@XIX07TN\1P?_LWUU-; M`JJJS,KTMEP/$TPB&:_Z`@$G\]F M-KKM:'L8]@HE.)1GYYLOUC=;/6/27GKI?A?XL'_&`7]=IN;Z3>T,XJYWGCK= MP-KY;<#RE/Q*375%J4CB.$<_JSR80TS^)OCOBZ2RY(EGPN7?3%5Y$V@._MGO M,P(MOC#''1$>Y/<\-#35FJIJ@]6&&G6-)B\C\5Q6::DZKZI:K=7H-/IJP2W^ M4=S#JY%+HQ24J*>B;?[2%/DORAIYV84921):I6DR&74&O9'DUE>\._P`U0=G M+\._K*T2CR1PXG,X]#DRHE@NA=CO?$9>AI16U9D;;):IBVWL;9CG1?!3GRDY MD1`A0,:XS!._3*;%6I?%R-Z#[[VJ#<67QZO)>%#ZC3MUN6S^8=QPGCKO5`S? MO05/`>\&8^2CJ.(PR6LR2F%(G[[2W7UOF4204^9:9O=TZT M]@L,?`]>YH4[74$57:VLT6A:?P8MD'B)':P7LD6TS"Q5:0S6MCI)7GF9)&B]& M;\+B9V>6TD<"\[E<9.+V@J]0E"])%].2JBY[#5O=E0F[6RG=#=CA85!7>V-I M)]W9[&QED:FSI$4:EQ05%L>H%GE?RQ2Z$CH[LDB=SR)]O8+7U&\UFFAWO3+' MQ.HU@SA83>&?[R_(+*51M$SF+*%+RF5R\I8BNW2@K\7L=#"#(Q,+LRN]^*=! ML1:;TD-W>'3`OTE8XO<6H[_D.BV=DD!NUQBRH&D;]YS0V-*HM]$?6I)?<;.. MF`E\-(W*3TDHS&7>SRQ3RVET5E;6(Z+%I:5B%EE2)K5-X`\#7#KX#TNZTPM4 M8B7S[H+Y/2KV#4PG'V,D("A;/PGOE-4%RP[)*Q/9@/YPUZ:8$USS@7*4K;$JE)197)M M>854-U#`Q'U:ZHRTPB1\&V3&(WXYV(\74,0U/`C\[L'?'J`/8#_WD#2E1*3( MRFT7N]WM[>Z!'#L9""Y(VO5_S@-DK8^>=6"-!`R/BZN]U-:N=AF.&<5 MX%P]5]0$/],]N>'/:9^&1\)_"S``YC!G3@H-"F5N9'-TSGK5MV[9MV_H6L[9MV[9MV[:-_^&\'!$1!Q0XH<(%-ZE!A\5RBYD4^MZCY40`% M40B%401%40S%40(E-5%+H33*:.(JBW(HCPJHB$JHC"JHJHNK&JJC!FJB%FJC M#NKJXJZ'^FC@$7=#-$)C-$%3-$-SM$!+M$)K0]QMT-80K1W:HP,ZHA,ZHPNZ MHILI6G?T0$_T0F_T05_T,T7OCP$8:(D^"(,1@R$8BF$8CA$8B5$8[15]#,9B MG%<\XS$!$S$)DS$%4S'-%L]TS,!,S,)LS,%T#,'=B)7=B-/=B+?=@?$.L` M#N)0A%B'<01'<0S'<0(G<0JG<09G@V*=PWE<"(KW(B[A,J[@*J[A.FZ$Q'L3 MMW`;=W`7]W`?#_`P)/8C/(X4^PF>XAF>XP5>XA5>XPW>XEU8[/?X@(]A\7W" M9WS!5WS#=_S`3_R*$M]O_,%?_,-_`08`?<&2#PH-"F5N9'-TL_?<=&=9[/P^RRC+8AO+R?A?E_RXC\%U1 M?'NSV, M\_?^>+.7^6>*V,^`OT#(_E-NK^B?-S^`D`VBYOX>QO5[?SP`JLD0^^GXU^6O M(_M/_@.B?V[\N/7C!IN#@^BL9/;?57\D6[HTOYNP!E6S?1?_G<^ZB8VO<>H/ MN^W?5_7V'6.36R`V96+P?Q[.^5R+N0$"#``:\&\S"@T*96YD%LM-"`M,S(X(#$U,#(@.#$S72]!7!E+T9O;G1$97-CDQPN#(,LY^88-PP=$1U`U89^+F M%6LF'4`FN%_GB%-'@X>V%?(C)>?(*^R>'^ZK.Y!O;)$=C;`[UY]?*=`O(?S@ MA!2A`J7`XB#D\46'5STAR(S]Q65N72]4>7!E+T5N8V]D:6YG/CX-96YD M;V)J#3$W,R`P(&]B:CP\+T)'(#$T."`P(%(O5%(O261E;G1I='DO2%0O1&5F M875L="]/4"!F86QS92]50U(@,30Y(#`@4B]4>7!E+T5X=$=3=&%T92]302!T M'0@ M,3'0@,3'0@,3@Q(#`@4B]$97-T*$,Q-S0P-S`R M.3`P,#`P,#$P*2]0'0@,3@T(#`@4B]$97-T*$,Q-S0P M-S`R.3`P,#`P,#'0@,3@U(#`@4B]$97-T*$,Q-S0P-S`Q-3`P,#`P,#8I+U!R978@,3@W M(#`@4B]4:71L92A)=&5M(#(N($UA;F%G96UE;G207-I'0@,3@V(#`@4B]$97-T*$,Q-S0P-S`P-C`P,#`P,#4I+U!R M978@,3@X(#`@4B]4:71L92A.3U1%4R!43R!)3E1%4DE-($-/3E-/3$E$051% M1"!&24Y!3D-)04P@4U1!5$5-14Y44RD^/@UE;F1O8FH-,3@X(#`@;V)J/#PO M4&%R96YT(#$W-"`P(%(O3F5X="`Q.#<@,"!2+T1E'0@,3@X M(#`@4B]$97-T*$,Q-S0P-S`P-#`P,#`P,#,I+U!R978@,3DP(#`@4B]4:71L M92A#3TY33TQ)1$%4140@0D%,04Y#12!32$5%5%,@7"A);B!M:6QL:6]N'0@,3DP(#`@4B]$97-T*$,Q-S0P-S`P,S`P M,#`P,#$I+U!R978@,3%LP(#`@-C$R M(#7!E+U!A M9V4^/@UE;F1O8FH-,B`P(&]B:CP\+T-O;&]R4W!A8V4\/"]#2DM M,S(R*&ET96US*2TS,C&-E<'0I+3,R-BXT*'1H;W-E*2TS,C8N-2AI M;F1I8V%T960I751*"C`@+3$N,#DY."!41`I;*&)E;&\I,3`N,2AW*32DM,S(Y*$AO M;&1E%LP(#`@-C$R(#'!E;G-E'!E;G-E&5S*2TS,C`N,BAP87EA8FQE*5U42@HY+C,T,C0@,"!41`HP+C(Y.3D@ M5&,**"XN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN M+BXN*51J"C(W+C$R-3D@,"!41`HP(%1C"ELH-C@N-BDM,S4Q,"XW*#$P-BXU M*5U42@HM,S8N-#8X,R`M,2XT,#`R(%1$"ELH3W1H97(I+3,R-"XY*&-U'1'4W1A=&4\/"]'4S(@,34P(#`@4CX^/CX-96YD;V)J#3$R(#`@ M;V)J/#PO3&5N9W1H(#2DM,S$U+C@H7"AUF%T:6]N*5U42@HQ M,BXV.#$T(#`@5$0*,"XR.3DY(%1C"ELH+BXN+BXN+BXN+BXN+BXN+BXN+BXN M+BXN+BXI+34N-R@N+BXN+BXN+BXN+BXN+BXI751*"C(T+C`X,38@,"!41`HP M(%1C"ELH,3`Y+C0I+3(X,S0N.2@Y,RXU*5U42@HM,S8N-S8S("TQ+C0P,#(@ M5$0*6RA3:&%R92UB87-E9"DM,S(X+C(H8V]M<&5N&-E"DQ,BXT*&5R M8VES97,I751*"C(R+C4W.30@,"!41`HP+C(Y.3D@5&,*6R@N+BXN+BXN+BDM M-2XW*"XN+BXN+BXN+BXN+BXN+BE=5$H*,30N,S4S-R`P(%1$"C`@5&,*6RA< M*#(U+C9<*2DM,C8V,RXR*%PH,BXU7"DI751*"BTS-BXY,S,Q("TQ+C0P,#(@ M5$0*6RA#:&%N9V5S*2TS,C4N-RAI;BDM,S(Q+C@H;W!E&5S*5U42@HU+C8R M.3,@,"!41`HP+C(Y.3D@5&,*6R@N+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN M+BXN+BXN+BXN+BXN*2TU+C'!E;G-E2DU-"XX*"PI+3,Q-BXY*'!L86YT*2TS,CDN."AA M;F0I+3,R-"XW*&5Q=6EP;65N="E=5$H*,C$N.3(W-"`P(%1$"C`N,CDY.2!4 M8PI;*"XN+BXN+BXN+BXN*2TU+C"DM,S(U+C8H8F5N969I="DM,S(Y+C0H9G)O;2DM,S(S+C4H"DQ,BXU*&5R8VES97,I M751*"C(R+C0W-S,@,"!41`HP+C(Y.3D@5&,*6R@N+BXN+BXN+BXN*2TU+C6EN9RDM,S(U*&YO=&5S*2TS,C`N."AA'1=+T5X=$=3=&%T93P\+T=3,B`Q-3`@ M,"!2/CX^/@UE;F1O8FH-,34@,"!O8FH\/"],96YG=&@@.#@Q,3X^6EN9RDM,C4W+C$H;F]T97,I+3(U,BXX*&EN8VQU M9&5D*2TR-C,N,RAI;BDM,C4S+C2DM,C0W+C$H6FEM;65R M*5U42@HP("TQ+C(P,3@@5$0*6RA(;VQD:6YG2DM,C0U+C4H9F]R*2TR,S0N,BAA*2TR,S8N,RAF86ER*2TR-#0N M-BAS=&%T96UE;G0I+3(U-"XQ*&]F*2TR,S(N-RAT:&4I+3(T,"XU*&9I*3$P M+C$H;F%N8VEA;"DM,C4R+C0H<&]S:71I;VXL*2TR-#`H2DM,3@T+C@H86-C M;W5N=&EN9RDM,C`Y+C,H<')I;F-I<&QE"DM,C8W+C(H M;6]N=&@I+3(W,BXW*'!E"DM,SDQ+CDH;6]N=&@I+30P,RXQ*'!E2DM,S8S+C(H:&5L9"DM,S4X+C0H2DM M,S4V+C4H)#@P*2TS,S$H;6EL;&EO;BDM,S0V+C@H:6XI+3,S,RXQ*&-A6UE;G0I+3(R,RXR M*&%N9"DM,3DY+CDH;W1H97(I+3(P-BXX*&ET96US+BDM,C$S+C,H16YD:75S M*2TQ.3@H9&4I,30N,RAV*3$R+C4H96QO<',I+3(P-RXU*&%N9"DM,3DY+CDH M;6%N=69A8W1U2DM,C`R+C4H<')O9'5C=',L*2TR,#8H:6UP;&%N=',I M751*"E0J"ELH86YD*2TR-38N-BAT96-H;FEQ=65S*2TR-C,N-BAT;RDM,C0X M+C$H=')E870I+3(V,RXW*'-P:6YE*2TR-3(N."AD:7-E87-E+BDM,C4W+C4H M5&AE*2TR-3DH86-Q=6ES:71I;VXI+3(V-2AO9BDM,C0Y+C'!A;F0I+3(U-"XS*&]U'1'4W1A=&4\/"]'4S(@,34P(#`@4CX^/CX-96YD;V)J#3$X(#`@ M;V)J/#PO3&5N9W1H(#@P,3$^/G-T"DM,38V+C@H+BDM,CDY+CDH+BDM,CDY+CDH M+BDM,C0Y.2XT*#`N."DM,S(U,2XQ*)2DS.2XV*"PI+3,R,BXV*&YE="DM,S(U+C8H;V8I+3,R,RXT*'1A>"E= M5$H*,34N-3DU,B`P(%1$"C`N,CDY.2!48PI;*"XN+BXN+BXN+BXN+BXN+BXI M+3(T-#DHERDM,C2DT,RXQ*"PI+3,R,BXV*%!L86YT*2TS,C,N.2AA;F0I+3,P.2XW M*$5Q=6EP;65N="E=5$H*."XP,#`U(#`@,"`X+C`P,#4@-#$P+C&5S*5U42@HP("TQ M+C(P,3@@5$0*6RA<*$9)3BDM,C8V+C@H-#A<*2XI+3(W-BXS*$9)3BDM,C8U M+C0H-#@I+3(W-2XU*&%D9')E%LP(#`@-C$R M(#7!E+U!A9V4^/@UE;F1O8FH-,C`@ M,"!O8FH\/"]#;VQO'1=+T5X=$=3 M=&%T93P\+T=3,B`Q-3`@,"!2/CX^/@UE;F1O8FH-,C$@,"!O8FH\/"],96YG M=&@@,3$V,3@^/G-T2DM,C,T+C0H:68I+3(R,BXS*&ET*2TR,S(H:7,I+3(R M."XW*&UO2DM,C0T+C8H=&AA;BDM,C,S+C"DM,C,T+CDH<&]S M:71I;VXI+3(S-"XY*'=I;&PI+3(S-2XS*&)E*2TR,S4N,2AS=7-T86EN960I M+3(S-"XW*&]N*2TR,C0N-2AE*32DM M,C,P+C$H=&AE*5U42@HP("TQ+C(P,3@@5$0*6RAT87AI;F"DM M-#$V+C,H8F5N969I=',I+30P.2XX*')E8V]G;FEZ960I+30R-2XW*&EN*2TT M,3(N-2AT:&4I+30Q,"XV*&9I;F%N8VEA;"E=5$H*5"H*6RAS=&%T96UE;G1S M*2TR,C2DM,C$U+C4H<&5R8V5N="E=5$H*,"`M,2XQ.38Q(%1$"ELH;&EK96QI M:&]O9"DM,S&5S+"DM M,C8X+C8H86-C;W5N=&EN9RDM,CDT+C,H:6XI+3(W-BXT*&EN=&5R:6TI+3(Y M,2XQ*'!E2DM,CDQ+C(H,2PI M+3(X,2XW*#(P,#"DM,C@U+CDH;&EA8FEL:71Y*2TS,#8N,BAF M;W(I751*"BTR+C`P,3$@+3$N,3DV,2!41`I;*&5X<&5C=&5D*2TR,34N-RAS M971T;&5M96YT*2TR,C4N-2AO9BDM,C`T+C0H=BDQ."XQ*&%R:6]U2DM,S8R+CDH;VXI+3,S-RXX*&$I+3,S."XS*&=R;W-S*2TS M,S(N,BAB87-I2DM,S"DM,C,T+CDH2DM,C8R+C(H M<&%Y86)L92E=5$H*,"`M,2XR,#$X(%1$"ELH;V8I+3(T-"XQ*"0W+CDI+3(T M-2XT*&UI;&QI;VXL*2TR-C$N,BAA;&PI+3(U,BXX*&%S*2TR-#0N,2AO9BDM M,C0T+C$H2F%N=6%R>2DM,C4Q+C4H,2PI+3(T,B@R,#`W+BDM,C0T+C(H5&AE MF5D*2TR M-C0N-BAT87@I751*"E0J"ELH8F5N969I=',I+3,U.2XY*&ES*2TS-3,N-"@D M.34N-RDM,S4Q+CDH;6EL;&EO;BDM,S"DM,S4Y+C8H"DM,C0P+C8H8F5N969I=',I+3(S.2XY*&EN*2TR,S8N."AI;F-O M;64I+3(T-RXV*'1A>"DM,C,U*&4I-RXT*'AP96YS92DM,C,X+C@H:6XI+3(S M-BXX*'1H92E=5$H*+3(N,#`Q,2`M,2XQ.38Q(%1$"C`@5&,*6RA#;VYS;VQI M9&%T960I+3,U,2A3=&%T96UE;G1S*2TS-34N-RAO9BDM,S0P+C0H16%R;FEN M9W,L*2TS-#0N-"AW:&EC:"DM,S,Y+C,H:7,I+3,T,BXQ*&-O;G-I2DM,C2DM,C(V+C@H9F]R*2TR,#4N."AU;G)E8V]G;FEZ960I M+3(R-2AT87@I+3(Q,BXR*&)E;F5F:71S*2TR,#8N."AW:6QL*2TR,3(N-BAC M:&%N9V4I+3(Q-RXW*&EN*2TR,30H=&AE*2TR,3(N,BAN92DX+C'0I+3(P M."XT*'1W96QV92DM,C`X*&UO;G1H65A&%M:6YA=&EO;BDM,C2DM,C4Y M+C8H<&]S'0I+3,S-2XW*'1W96QV92DM,S,X+C0H;6]N=&AS M+"DM,S0R+C(H8G5T*2TS,S$N.2AW92DM,S0Q+CDH9&\I+3,S-RXX*&YO="DM M,S0S+C,H86YT:6-I<&%T92DM,S8S+C4H=&AI&%M M:6YA=&EO;BDM,S(R+C,H9F]R*2TS,#@H82DM,S`T+C0H<&5R:6]D*2TS,3,N M-2AO9BDM,S`V+C4H,RDM,S`U+C$H="DM,"XQ*&\I+3,P-"XY*#4I+3,P-2XQ M*'EE87)S*2TS,3`N-BAA9G1E&%M:6YA M=&EO;BDM,S$R+C"DM,S,V+CDH'0I+3(R,BXT*'1W96QV*34N-BAE*2TR M,C0N.2AM;VYT:',L*2TR,C,N,BAB=70I+3(Q."XU*'=E*2TR,C(N."AD;RDM M,C$X+C@H;F]T*2TR,C0N,BAA;G1I8VEP871E*2TR-3`N,2AT:&%T*2TR,S0N M-BAT:&4I+3(R.2XR*')E&%M:6YA=&EO;BDM-#(T+C(H8GDI+30P-2XY*&9O"DM-#$V+C,H875T:&]R:71I97,I+30R,"XV*&EN*2TT,3(N-2AM86IO M"DM,C,T+CDH M&%M:6YA=&EO;BDM,C0T+C2DM,C,V+C$H86YD*5U42@HM,BXP,#$Q("TQ+C(P,3@@5$0* M6RA3=VET>F5R;&%N9"XI+3,Q."XU*$ET*2TS,#$N-RAI2DM,S$P+C8H<&]S'0I+3,P-"XW*'1W96QV92DM,S`T+C0H;6]N=&AS+"DM,S`R+C8H8BDQ,BXU M*'4I,"AT*2TS,#0N-RAW*3`H92DM,CDV+C4H9"DP*&\I+3,P,RXX*&YO="E= M5$H*,"`M,2XQ.38Q(%1$"ELH86YT:6-I<&%T92DM,S4W+C@H=&AA="DM,S,V M+C2DM,S(R*&UA=&5R:6%L*2TS-3`N.2AI M;7!A8W0I+3,T-"XW*&]N*2TS,C8N-2AO=7(I+3,R,BXS*')E'1'4W1A M=&4\/"]'4S(@,34P(#`@4CX^/CX-96YD;V)J#3(T(#`@;V)J/#PO3&5N9W1H M(#$P,C,P/CYS=')E86T-"B]#2DU-RXV*"PI+3,U-BXV*&%N9"DM,S4X+C&ES="DM,C@T*&9O"DM,C`T+C@H;6]N=&@I+3(Q-BAP97)I;V1S*2TR,#'!E8W1E9"DM,S,W+C@HF%T:6]N*2TS-#$N,RAO9BDM M,S(S+C0H=6YR96-O9VYI>F5D*2TS,S@N,RAP"DM,C8W+C(H M;6]N=&@I+3(W."XS*'!E'!E8W0I751*"E0J"ELH=&\I+3(Y.2XQ*&-O;G1R:6)U=&4I+3(Y."XV M*&$I,"AN*2TR.3%LP(#`@ M-C$R(#7!E+U!A9V4^/@UE;F1O8FH- M,C8@,"!O8FH\/"]#;VQO'1=+T5X M=$=3=&%T93P\+T=3,B`Q-3`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`M,BXU M,C@S(%1$"ELH.2XI+3$P,#$N-RA3=&]C:RDM,S$U*%)E<'5R8VAA2DU-"XR*"PI+3,S,RXY*'2DM-#4S+C0H;V8I+30T M,BXU*"0Q,S$N."DM-#0Q+C4H;6EL;&EO;BDM,3@H+"DM-#0Q+C8H:6YC;'5D M:6YG*5U42@HP("TQ+C(P,3@@5$0*6RAC;VUM:7-S:6]N2DM,S"DM,C$V+C(H;6]N=&@I+3(R M,2XW*'!E2DU-"XR*"PI+3(P.2XR*'0I,"AO*2TR,30H M<'5R8VAA'1'4W1A=&4\ M/"]'4S(@,34P(#`@4CX^/CX-96YD;V)J#3,P(#`@;V)J/#PO3&5N9W1H(#8W M,3`^/G-T2DM,C(T+C8H;V8I+3$Y."XW*$5U2DM,S$Y+C@H;V8I+3(Y-2XQ*$IA M<&%N*2TS,#(N,RAA;F0I+3,P-RXV*&EN8VQU9&5S*2TS,#8N,RAO=&AE'!E;G-E'1'4W1A=&4\/"]'4S(@ M,34P(#`@4CX^/CX-96YD;V)J#3,S(#`@;V)J/#PO3&5N9W1H(#DW-#(^/G-T M2DM,3DP+C0H<')O=FED:6YG*5U42@HP M("TQ+C(P,3@@5$0*6RAA*2TT,#8N,RAF86ER*2TT,#,N,RAV*3(S+C@H86QU M92DM-#`X+C@H:&EE'!E8W1E9"DM,S(Y*'1O*2TS,C2DM,SDW+C8H=&\I+3,X.2XX*'-E<&%R M871E;'DI751*"C`@+3$N,3DV,2!41`I;*&1I%LP(#`@-C$R M(#7!E+U!A9V4^/@UE;F1O8FH-,S4@ M,"!O8FH\/"]#;VQO'1=+T5X=$=3 M=&%T93P\+T=3,B`Q-3`@,"!2/CX^/@UE;F1O8FH-,S8@,"!O8FH\/"],96YG M=&@@,3`Y,C<^/G-T2DM-#8U*')E8V%L;"DM-#2DM,3@U+C4H;W8I,3DN,RAE2DM M,C2E=5$H*5"H*6RAF=71U2DM,CDW+C4H:6XI+3(X-RXW*'1H92DM,CDQ+C8H M56YI=&5D*2TR.3,N-RA3=&%T97,I+3(Y,BXS*$1I2E= M5$H*5"H*6RAJ=61G;65N="DM,C(T+C$H;VXI+3(P,2XX*'1H92DM,C$R+C(H M:6XI,C0H=BDR,RXX*&%L:61I='DI+3(R,2XW*&]F*2TR,#0N-"AT:&4I+3(Q M-RXY*&%S2DM,C`Q+C@H2DV M,"XU*"XI751*"C(N,#`Q,2`M,BXR,3`Y(%1$"ELH5RDV-2XS*&4I+3$Y-BXV M*&%R92DM,C`W+C4H86QS;RDM,3DW+C,H2DM,C`U+CDH8V]U2E=5$H*,"`M,2XR,#$X(%1$"ELH M86YD*2TT,S@H;W1H97(I+30S,RXV*&-L86EM&-H86YG92DM-#@Y+CDH0V]M M;6ES2DM,C(X+C@H,3DY."DM,C(R+C$H<&5R M=&%I;FEN9RDM,C,V+C(H=&\I+3(R-2XT*&-O;G-U;'1I;F2DM,S$V+C2DM,S,P+C$H8F4N*5U42@HR+C`P,3$@+3(N,C$P.2!41`HM,"XP,#`Q M(%1C"ELH26XI+3,Y,2XV*$IU;F4I+3,X,RXV*#(P,#8L*2TS.3$N-RAW92DM M,S@W+C,H%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH-,S@@,"!O8FH\/"]#;VQO2DM,CDR+C4H9&ER96-T*2TS,#2DM M-#`W+C@H,C8L*2TT,3`N.2@R,#`V+"E=5$H*,"`M,2XQ.38Q(%1$"BTP+C`P M,#$@5&,*6RAR97-P96-T:78I,3(N-"AE;'DI-30N,2@N*2TT,#(H5&AE*2TT M,3(N,BAI;F1I2DM,S(R+C@H M,3@L*2TS,C`N,R@R,#`V+"DM,S$X*$IU;'DI+3,R,BXX*#(T+"DM,S(P+C,H M,C`P-BDM,S$X+C8H86YD*2TS,C0N."A*=6QY*2TS,32DM,S4S+C8H,3@L*2TS-#(N.2@R,#`W+BDM,S0V+C,H M5&AE*5U42@I4*@HM,"XP,#`Q(%1C"ELH<&QA:6YT:69F2DM,C(S+C,H,34L*2TR M,C0H,C`P-RPI+3(Q-BAT:&4I+3(R.2XS*'!L86EN=&EF9BE=5$H*,"`M,2XQ M.38Q(%1$"C`@5&,**&EN*51J"B]&,B`Q(%1F"C`N.3@P-R`P(%1$"ELH5&AO M;6%S*2TQ.#@N."AV*38Y+C@H+BDM,3DW+C@H0FEO;65T+"DM,C$P+C4H26YC M+BDM,C`Q+CDH970I+3(P-RXW*&%L+BE=5$H*+T8S(#$@5&8*,3$N,S8P-2`P M(%1$"ELH9FDI,3`N,2AL960I+3(P-BXU*&$I+3(P,BXS*$YO=&EC92DM,C$S M+C2DV,"XU*"XI751*"C(R+C,P,38@+3,T+C`W,#,@ M5$0**#$T*51J"B]&,2`Q(%1F"BTQ,"XW-#@S(#8U+C,S-#4@5$0*6RA:24U- M15(I+3,R,2A(3TQ$24Y'4RPI+3,Q,BXQ*$E.0RXI+3,P.2XR*$%.1"DM,S$Q M+C(H4U5"4TE$24%22453*5U42@HM-RXV-#F5D*2TS-34N.2AB>2DM M,S,W+C@H;W)T:&]P865D:6,I+3,U,BXT*'-U2DM,C@P+C$H=&\I+3(V-2XQ M*')E871T86-H*2TR.#$N-BAO6EN9RE=5$H*+3(N M,#`Q,2`M,2XQ.38Q(%1$"ELH=VAO;&4M9&]L;&%R*2TR.3(N,BAA;6]U;G1S M*2TR.#0N,RAA;F0I+3(W.2XS*'1H97)E9F]R92DM,CDQ*&UA>2DM,C"DM,S$X+C(H;6]N=&@I+3,R.2XT*'!E"DM,S,Q+C2E=5$H*+T8V(#$@5&8*,RXY M-#4V(#`@5$0**+LI5&H*+T8S(#$@5&8*,"XX,C65T:'EL96YE&EM871E;'DI+3(Y-"XQ*"0U,RDM,C8X+C8H;6EL;&EO;BPI M+3(X.2XU*&%N*5U42@HM,C8N,32DU."XR*"XI+3$X M-BXU*$DI,"AN*2TQ.3,N,2AT:&4I+3$Y-2XR*'-E8V]N9"DM,3DS+C0H:&%L M9BDM,3DV+C8H;V8I+3$Y,R@R,#`V+"DM,3@W+C4H=V4I751*"BTR+C`P,3$@ M+3$N,3DV,2!41`I;*&QA=6YC:&5D*2TS,#$N-"AT:&4I751*"B]&,B`Q(%1F M"C4N-#$Y-2`P(%1$"ELH6FEM;65R*2TR-S@N.2A'96YD97(I+3(X,RXR*%-O M;'5T:6]N65A7-I2DM,C0X M+C@H,C@I+3(R-"XU*'!E'!E2DM,C0Q+C@H92DW+C4H>'!E'1'4W1A=&4\/"]' M4S(@,34P(#`@4B]'4S0@,3`P(#`@4CX^/CX-96YD;V)J#30U(#`@;V)J/#PO M3&5N9W1H(#$R,S$U/CYS=')E86T-"B]'4S(@9W,*0E0*+T8S(#$@5&8*,3`N M,#`P-B`P(#`@,3`N,#`P-B`V."XY.34R(#2DM M,3DY+C,H2DM,C`Y+C$H M-RDM,3@P+C,H<&5R8V5N="DM,3DW+C0H;V8I+3$X,2XW*&]U'!E8W0I751*"E0J"ELH9VQO8F%L*2TS M,S0N,RAS96QL:6YG*2TS,C8N,2AP&-H86YG92DM,S(R+C8H4F%T97,I751*"B]&,R`Q(%1F"C`N M.3DW-R`M,2XX-#@Q(%1$"ELH1F]R*2TQ-CDN.2AT:&4I+3$X.2XU*'1H65A2DM,C`Y+C$H,BDM,3@U+CDH<&5R8V5N="DM,C`S+C$H;VXI+3$X-"XX M*'-A;&5S*2TQ.#65A2DM,C8V*')IF%T:6]N+"DM,C(Q*'1H'!E8W1E9"DM,S,V+C8H=&\I+3,R,2XX*&)E*2TS M,C`N,2AM:6YI;6%L+BE=5$H*150*+T=3-"!G$=E;BE4:@HO M1C8@,2!49@HS+C(R(#`@5$0**+LI5&H*+T8S(#$@5&8*,"XW-C4S(#`@5$0* M6RA#;VUP;&5T92DM,C0Y+C$H2VYE92DM,C,Q+C(H4V]L=71I;VXI+3(S-RXY M*&EN8VQU9&EN9RDM,C0V+C7,I5&H*+T8V(#$@5&8*,RXS,S,S(#`@5$0**+LI5&H* M+T8R(#$@5&8*-RXU,#`U(#`@,"`V+C8V-C(@,C8R+CDY.#0@-#(S+C@Y,C@@ M5&T**#$I5&H*+T8S(#$@5&8*,3`N,#`P-B`P(#`@,3`N,#`P-B`R-CDN,#8T M-2`T,3DN-#2DM M,S4S*&%F*3$Q+C7-T96TI+30Q,"XY*&%N9"E=5$H*+T8R(#$@ M5&8*,3,N.34V.2`P(%1$"ELH5"DU-RXQ*'(I,"AA*3$V*&)E8W5L87(I+30Q M-"XR*$UE=&%L*5U42@HO1C,@,2!49@HW+C4Y,#<@,"!41`I;*%-P:6YE*2TT M,#DH0V]M<&]N96YT7,I751*"B]&-B`Q(%1F"C(N-38R-"`P(%1$"BB[*51J"B]&,B`Q M(%1F"C$N,#(P-"`P(%1$"BA%<&]C:"E4:@HO1C8@,2!49@HR+C4U,2`P(%1$ M"BB[*51J"B]&,R`Q(%1F"C$N,#(P-"`P(%1$"ELH0V]M<&]S:71E*2TT.34N M-RA(:7`I+30X.2XW*%!R;W-T:&5S:7,[*5U42@HO1C(@,2!49@HM,S0N-#0T M-"`M,2XQ.38Q(%1$"BA::6UM97(I5&H*+T8V(#$@5&8*,RXQ,#8V(#`@5$0* M*+LI5&H*+T8S(#$@5&8*,"XW,C4V(#`@5$0*6RA292DQ-BXY*'8I,3(N-2AE M2DM,C$Q+C@H M,2PI+3(P."@R,#`W+"DM,C`T+C4H=V4I+3(P-2XX*&%D;W!T960I+3(Q."XR M*$9)3BDM,3DW+C,H-#@L*2TR,#$N,BAW:&EC:"DM,C$T+C8H861D"DM,C`P+CDH8F5N969I=',I751*"C`@+3$N,C`Q."!41`I; M*&9R;VTI+3,R.2XR*&%N*2TS,C`N,2AU;F-E"DM M,S(U+C8H<&]S:71I;VXI+3,R-2XV*&UA>2DM,S,P+C$H8F4I+3,R,"XQ*')E M8V]G;FEZ960I+3,T,"XW*&]N;'DI+3,R-2XQ*&EF*2TS,3,H:70I+3,R."XS M*&ES*2TS,3DN-"AM;W)E*2TS,C4N.2AL:6ME;'DI+3,S-2XS*'1H86XI+3,S M,"XQ*&YO="DM,S(P+C8H=&AA="DM,S,Q*'1H92DM,S,Q+C(H=&%X*2TS,C4N M-BAP;W-I=&EO;BDM,S(U+C8H=VEL;"DM,S(V*&)E*5U42@I4*@I;*'-U&%M:6YA=&EO;BDM,S,U M+C0H8GDI+3,P.2XU*'1H92DM,S$T+C(H=&%X:6YG*2TS,3&5S M+"DM,CDQ+C(H86-C;W5N=&EN9RDM,S(R+C'!E8W1E9"DM,C`V+C(H"DM,C$R+C(H:6UP86-T2DM,C,X+C(H;V8I+3(Q-2XW*"0Q M+C2DM,C$U+C4H9W)O"DM M,C(S+C4H;&EA8FEL:71Y*2TR,S(N-2AF;W(I+3(Q-RXR*'5N2DM,C$W+C4H,2PI+3(Q,RXW M*#(P,#F5R*2TS,#`N M-"A';6)(+"DM,CDS+C$H2&%N874L*5U42@HM-RXV,S8Q("TQ+C(P,3@@5$0* M6RA'97)M86YY*38T+C2DM,S(P+C@H M2RDR-"XW*&5N%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH--#<@,"!O8FH\/"]#;VQO'1'4W1A=&4\/"]'4S(@ M,34P(#`@4B]'4S0@,3`P(#`@4CX^/CX-96YD;V)J#30X(#`@;V)J/#PO3&5N M9W1H(#2DM,C`Y+C@H"DM,S0X+C,H2DM,C$T+C@H)#"DM,3@W+C@H;6]N=&@I+3$Y,RXS*'!E2DM,CDX+C(H;W!E M&-H86YG92E4:@HM,C8N,#$S,R`S M+C,W,R!41`I;*%1H&-H86YG92E=5$H*+3(N,#`Q,2`M,2XQ.38Q(%1$"ELH2DM,S(U+C@H4')O9'5C="DM,S(Q+C8H0V%T96=O'1R96UI=&EE M%LP(#`@ M-C$R(#7!E+U!A9V4^/@UE;F1O8FH- M-3`@,"!O8FH\/"]#;VQO'1'4W1A=&4\/"]'4S(@ M,34P(#`@4B]'4S0@,3`P(#`@4CX^/CX-96YD;V)J#34Q(#`@;V)J/#PO3&5N M9W1H(#$Q-#"DM,CDS+C2DM,3DV+C$H9&5C;&EN:6YG M*2TR,37-T96TI M5&H*+T8R(#$@5&8*,BXY-#2DM,C4U+C,H;V8I,C(N-"AF2DM,C,U+C@H=V5A:V5R*2TR-#(N,2AS86QE2E=5$H*+T8R(#$@5&8*,C2DM-#$Y+C4H86YD*5U42@HO1C(@,2!49@HR M,BXS-C,Y(#`@5$0*6RA,;VYG92DQ,2XU*'9I='DI751*"B]&,R`Q(%1F"C0N M,S,Q,2`P(%1$"BAA;F0I5&H*+T8R(#$@5&8*,2XX,S8W(#`@5$0*6RA$=7)A M*3$Y+C,H65T:'EL96YE*2TS,S@N.2A,:6YE'1R96UI M=&EE6YE6YA;6EC M*51J"BTT,2XY,C$X("TQ+C(P,3@@5$0*6RA3=&%B:6QI>F%T:6]N*2TT,#(N M.2A3>7-T96TL*2TS-S8N,RAT:&4I751*"B]&,B`Q(%1F"C$P+C8S-#D@,"!4 M1`I;*%0I-3&%T:6]N M*2TS-SDH4WES=&5M*2TS-S8N.2AA;F0I751*"BTS,BXV,S8Q("TQ+C(P,3@@ M5$0**%-P:6YA;"E4:@HO1C(@,2!49@HR+CDW,#4@,"!41`I;*%0I-32DM,S0R M+C(H"DM,C(P*$MN964L*5U4 M2@HO1C(@,2!49@HV+C8R,3,@,"!41`I;*$YE>$=E;BDM,C$T+C(H5"DU,2XU M*'(I,"AA*3$V*&)E8W5L87(I+3(R-RXR*$UE=&%L*5U42@HO1C,@,2!49@HQ M,"XV-3 EX-3.1 8 c17407exv3w1xpdfy.pdf RESTATED CERTIFICATION OF INCORPORATION PDF begin 644 c17407exv3w1xpdfy.pdf M)5!$1BTQ+C(-)>+CS],-"C4U(#`@;V)J(#P\+TQI;F5A-IB8&!@9F!@>L/`PL#`^8J!GP$!^(%BK$#, M<0'"CX\ZG#J_6%KM,^^SFP\/M!7*,3`Z9;TRTF5(`X&9$T!JDA1]/G:T&A]3 M$CDOT1%L@Y5KLN!'3\!$KO0C28J^G'8*#`P<>!$#1P.0Z&!@8)1HP.D$(%!E M8#H7#J0%@%@8[.!@!EZ@WYA[)!O6=E8P''1'4W1A=&4\/"]'4S$@-C,@,"!2 M/CX^/@UE;F1O8FH--3D@,"!O8FH\/"]3=6)T>7!E+U1Y<&4Q+T9O;G1$97-C M"]H M+VDO8B]T+W1H2]F+THO='=O+WIE7!E(#`O1FEL M=&5R+T9L871E1&5C;V1E+T5N8V]D95LP(#(U-5TO0FETF5;,C4V72]286YG95LP(#%=+T1E8V]D95LP(#%= M/CYS=')E86T-"DB)```!__X``0(#!`4&!P@)"@L,#0X/$!$2$Q05%A<8&1H; M'!T>'R`A(B,D)28G*"DJ*RPM+B\P,3(S-#4V-S@Y.CL\/3X_0$%"0T1%1D=( M24I+3$U.3U!14E-455976%E:6UQ=7E]@86)C9&5F9VAI:FML;6YO<'%R7I[?'U^?X"!@H.$A8:'B(F*BXR-CH^0D9*3E)66EYB9FINHJ:JKK*VNK["QLK.TM;:WN+FZN[R]OK_`P<+#Q,7&Q\C)RLO,S<[/ MT-'2T]35UM?8V=K;W-W>W^#AXN/DY>;GZ.GJZ^SM[N_P\?+S]/7V]_CY^OO\ M_?[_`@P`K?9_@0H-"F5N9'-T("(B(B0F)B8H*BHJ+ M"XN+C`R,C(T-C8V.#HZ.CP^/CY`0D)"1$9&1DA*2DI,3DY.4%)24E165E986 MEI:7%Y>7F!B8F)D9F9F:&IJ:FQN;FYPGI\?GY^@(*"@H2&A MH:(BHJ*C(Z.CI"2DI*4EI:6F)J:FIR>GIZ@HJ*BI*:FIJBJJJJLKJZNL+*RL MK2VMK:XNKJZO+Z^OL#"PL+$QL;&R,K*RLS.SL[0TM+2U-;6UMC:VMKX M.+BXN3FYN;HZNKJ[.[N[O#R\O+T]O;V^/KZ^OS^_O\!`P,#!0<'!PD+"PL-# MP\/$1,3$Q47%Q<9&QL;'1\?'R$C(R,E)RWM[?7]_?X&#@X.%AX>'B8N+BXV/CX^1DY.3E M9>7EYF;FYN=GY^?H:.CHZ6GIZ>IJZNKK:^OK[&SL[.UM[>WN;N[N[V_O[_!P M\/#QOKZ^WO[ M^_Q\_/S]??W]_G[^_O]___\"#`#GK#\0"@T*96YD2](5"]$969A=6QT+T]0 M(&9A;'-E+U5#4B`V,B`P(%(O5'EP92]%>'1'4W1A=&4O4T$@9F%LMS:I/6P M-D/JIQ9[:'-KAC8>T@[=OF/[X)(FG5XV8+`!R11Y#GE("PW2LUMGAR<7:-8/ M&=:&WE@7KJA-%4NS6V:K[&.;'4[8LUUEB"XE+$U!#WKVKLK@O&GOLZ(W$AI% M8T&F.9G:I\P:`^VW++DZA-C[T'9DXBBYTE0AN23A%.7K/LH51:PX],J.`8,K M[<_;#7CO@KW9/,K&!/`C5UD'>:0%#7QM/V6YKUR(*9K:F%7QXE7/`_2*QJ<*"E7`:N!GW?" M7];"KSC#,JQ4OW?1W@+I7MLE;J& MO+8/I"7W6$^W$OT_+.5!W*=)1TJ]5;1[$HV' M>"CA-_M<2G7=0E/JT]2$S&EW)U:EWFR%>JUU'$!>NCU/L]4X)^8_KW*XD37-W4U*EGG=C*5%3@+#7MI1>GHYRX M;HOX]*WNN@^S7.4)H'Y4.\+-[A/'/V'T35GWH).2""B7IMKEL34X-]1D31'W MG`U@EQG1I[:I)R6(F@3(XT6-0#Y3#H`;/P`8]'D< M6VF#0`_:WA M;QVK;O`O7LE6%7%D-_C^)`"L[,E1RU%:EH+GJ3)'3_&G)T):^*<@,;M!@E;R MJ";+0C9VE';LIH[D<['Z<=8;(@<<[P3:2TI$\")TXG+!;.;^GT@\CG)$PR2# MYHMDV3H^'_`GE*OK@%0O'2`$R>G,/W,9A@)]]C./_Y`"0;FXW=>3;HSXS@$K MKZ78TLORTP+]!.0KFN?5^E!4_0X,0+''?LY*X$W\M1[]ZO2;6S^_X?^D"OM# M]T]ZMSQ4/V&F)!>QJS-%99W8E7U65]YGL!CM6+-$!YU9/_9-_15@`)?<)E8- M"F5N9'-T-U%NX[PT%B(3 MFZQ(H;G;)'&"AF:_B6A7UM`LFZ]JJVVB#CHJXU)-L[8FSM70#;S9LWVG38'+ MK",;UPCV)\!3%F?*==J6%^>'<<\`IS%0KJ:3TS9%OTFG<8IX] M-*P/#02Y_:$CDR/X$,`W),&/ZQ-O.$WN0U(7/!;'ACHT,F%&N,78E>]*5%`,NCW0'A/55"]1 M1X&;U&A-O:HQ72-4EB,\:%NID0JQK+Z,R[*8)=ZJ97881A"&/>'6V)YB:N5NY+/<'@@9 MZ)>!>5%4$1A!FO_;[*`)U2#\6K#6WZ'J8@U M1/4B2^,DK].SR.I59#87D<$S62VIFL0.+PJ;[F-B8?Y!L_T7X^[NMT_:D+A_L^%%,QZ$ M$'NN^1OS*9MYY5@FQ@ZSEU[-$TA9YE1*>,2$EHG>@L03O#C(:6"#Y"L^(*N@ MW9XYOOL9X!2/K>0T!0>AN4Y%FB,9"8EC"#T%KIC/`I)LA6`9)(->>%'%'G1) M*!#Z!;"7M97L4#>W33Q/(*8O#H9J^"@AKA/8ACIG*;##QU?Z/P*9=R_@C MP`"P')O4#0IE;F1S=')E86T-96YD;V)J#38W(#`@;V)J/#PO3&5N9W1H(#4W M,2]&:6QT97(O1FQA=&5$96-O9&4^/G-T*?$I MW=VL\J9LFZ"LZC[,K+'8!M6M9P4M756K[CS[IC=JA&"@ M0>U'<"5%!S5N8T)- MX-`T>L?@#5-5!)7_*;1GA1.@I8_:;6+^*$H_&/7*$BIQGZ'`RJ!.P*%/GYY3 M0R^ECREZ(J0WM98F5ZPI.ZG0BS3S)FE+L<#J7YC](!CI?(+"49%\`&Z+&9-` M6&UZ%061S0P.;L?#@='C63+O65GQ,%UMFK)N%<7:"M,PX_RM;62:V'J>YIS. MC?HAN:$CC2B_@*(UE;ZA5`Q_NE42$74;19MHE.`Q9*=@E9T26'HY_WP+Z(S/ MO,(%$]KF+Z;UV:"83::(PLU<%H\D1M:,;=7TZ7BWN%^F/!5!`UA3OS8O,E.@ MNWA%R7AMU!W(!E5R2&"'5!<"3=;QZXA7*L$)L&7[7JM(-R-'CR_,C-9->2'M MH2A)2E`#@[+PDS[O]HQ;,TMJ**&=H!&[IRR]CCK7%][`!"G*?4OI3$HVK?0V M[WG;TZN\;DV)A)24Y.7,5W?TBX$W@`U=_OT#W\.7O)B#34.*K\J3HV)']\O? M3'J">(2L)&>0DF_EO_+HY"*>R:9>?B_G^C@>.-OSM0IV^,F"[]YZ83&LDQ58`L?0J6PK*5] MZ45A=?`VH!(*-9&%3*Q):*-LK:-<`6FI@WQ>;UL5X9(-&U4$X%XEXQ,8M9?B M\9F^7UJ.NA58:N^]G2 M/9&\D?%ZR-Y3#F>2B>PCB[+2I/"!YPJ]@BAJ??D<)L,9A!AVN?89EP'`4TYFB<\=R%2>N]E9CTKW+D",/ ME`20'1FSOVM$3F,X*A?^^>9D9B^V',9WRF@8N1X.O`R]N'!M_^=(8U@9'4H3 MA+DM6.UX[ET9:`"WN&!:]P^&LXN[344;[M^/+) MCAUN!PP#PW(GSA0;!6)):(T M'+*[2R#3<"*],JA(W9K.F6;)[NF+73!ZJ270G0!_"7HF\5>``0#581ZL#0IE M;F1S=')E86T-96YD;V)J#38Y(#`@;V)J/#PO3&5N9W1H(#8Q,"]&:6QT97(O M1FQA=&5$96-O9&4^/G-T=7\"@"DR#)W\?!RZ'# MT!:MAQV"'K(T7T!J!ZZS(/]^I$2Y:$^FJ*?WR$?)*_7G>'K#QM3JV*//3:7V MT]!_0U=3")S)53M<^@F]-YFZ26K8P?T6764*=85V':-W=(XP$VIOG#K%$UO4 MI6F4$<8.769*=4#[L2>U)@AN;8,TE.2XQL*#]#6T61'T0/`0)77A#I)J.><\RQ!VB31!T MM8LRY$RH]77#@*'=AC/PR@TP;LJH8>>AJ+) MQIR#C[R?4-=VV1_1$\O"\1%X)B_:5L659?N%QOO@841Z)`.9F M4_`K@CGF$N8JKAUC$4<"'I"9K=H]-X7^`3Z5^MB98`O$OU*0J;[,9^`+_!1@`.EDC MK`T*96YDLLKD6@WCMRFX2F]6O^A/S',%]]W9)"N\ M\;XI5.:,R\M`?+<:\:5I]&:N5AOPN7%Z1E&%'@!3!#UN!S:/$-`Z9><>O#.2 MH-!SAJJGS;QGNE'ME_*I(,/X7!]_:B_`!6T@*PG,HGQI\MHV*O.F*9PG3529 MM345234V@6O\")ES^@M4QNM..$\A:S!_BRXR7YPHL7R-8,D1ZZT_!6/>)6\<9Q)M0.G$,#A]-D(6B- M5:)SS5CUT+-9B?LI8O=+IAC&.(D\*I1BSG8EJ8:(5BL^[9`:YT!+VB=1S?RL M&BO+"K3Z0H@>)':]3N(W`GTE/J:7DD6,()34NX""6*9"WE,N-;W7]C&*.PBGH2JLJ>O*'S:#+YJT&8*K M99YV2QJ!'&F"Q4E9(S7^A"(.&;^B!XC#WD-)4XT!\3B-QQ'BR^HY>I>FDP,' MIEXP)FT9446OSKLF3;JK#UNKJEC;C!:$+)I*/T*-61^QG[COT.@#&C?L2PFQ M,;1HL.D!-Y)@XKYJJ/4R*(S]P%[+#(8;9]GH$F@[90VC^C%EFC5MMH"S%\-Z M-JIMGW`OE2P9EEB`9*68._V;OUIP#99V#?14+R^1H:1M<86OFJ(ZVE7D;\__ M<,`=@*>]>B0/5NAQ1_O"*F[4:BU*X]B$MTWZCS1!*'IOM-J73'#H0.RNT-,# MYWI>\T9KXHU)$F\:CX7:CN):/,\_*%&U%^ST/5:JE2GX/6!@^_Q8W"!/8<`4*4&_L-#7-&!#'?1: MUC!'%F+P6VN4D:U'-OOW5LI$X=>D>\34`F'2+5XOS)3K57UQ_B?``,HM.X<- M"F5N9'-T7!E+U1Y<&4Q0R], M96YG=&@@-CDV-2]&:6QT97(O1FQA=&5$96-O9&4^/G-T=W_?AF!4/PW&<6OKYYU\L]7,-4R4IM=.7JY,4R>_:$SD)SCE;<2XV MCL@')?^2_HLC6>ZBQD20;@=5]ITN[$HQQL/QG;4+U2EI&M6&.)WLC]%39#,] MY\V9]J[.?5\]WU5/=YD\1AVEE(6F:77*)*UL27*T6I.BUBATRI@9,ID\,5&V M_-T&K6RY4JO4Z"W=]^?(5%J90J;3*&*420I-@DP=*PM2):MU:2E*F7R13)$< MXZ;6R%06G'93E%85HU)H5$KMC-]3P7#+PT@<$_(P6SML@ATV6X@M<,94&):* M84$6"3`"([%R?!E>AE_!W_*\>,MXR;Q"WFU"2(03YXFW5A%6YZS^26XD[_(I MOIK?+U`)K@JG"AO'2,9461/6\ZRW6)L_\ONHS8:RB;'YWC;$ME,T1A0O.F<7 M:/=@K-_8?'M[>YW]=^)`<8WX)776899#L<._:"-]UO%+QYYQU+@R)]PITNF% M\TSG:N?73)Y$*,F27';YD\M)F4@F,C5P;PZ+3]7D]O[<#/R!=374/[CY7"$- MA""BS7_GNAW"+E60@!I`5$ZXW(^9\G358#B+6@34\/2P\S]NDJ8C1_[FPU=5 M/T@\FI\*7E<_.PT"!K#`%D3WLK#-@CR7UZNO0SPA6C*#_J(]LND"LW_']>'= M;`L:IJGAKIAS"7[,)*_T^#Q6Q*68&J&R>7<3Q!TZV"C^K@\TA[K[8&,]=2K+ M[,H):,3[`W(8']"X:`AL!V`J$#\M*-\@K4J@VQLWK/G4'TD]`DV7]G5T#'\I(0HY5S)JK3J*J.4^D]6M3&C:KT$64]%'W\R^4[<::#[P>UGJ65_ M76%%036;5U-9T":YV%!3=4!:4H1&WO+(3KX%MQJ>TS&ZVK\\N@?3>FJW&(U= MTAV&TJS-#++R1M;>K$C+^4,!P@`3#X`TIHT*INK>#^WQOYQ8N=L)?0:X"=0C#)2_NM=[A?T-!FN?$,>1/PUN M+U]:9/%E@(V_L^8.J[RTY%;(UYE&)_@,X2:DGL2@#.YM M5.0C-)ZFZO[_H53D[T^%E5UX&VPCVJ""#H)M70*1+`L(_!80!-AG65C7M>PY M]O7&^J0DC29!V6RLDXI\RO7F@%0\&[XAH-W"<#$?I;T-(&_P11GU9G$]?O`5 M5+TBH-3,TN!0@LH6^12A7.2`'(H@^\&-$B@#!VF]%0I2H%1DC6P[D`Z"(*@# M=&`+U@I(14%2D:G&/,4BALHBHK4C'*GA^Z;NZI1RPX*<$K38GG$8?$)P:OB8WK*=#(HQ%,9*4`X??,"//'7V M\>`;!JQFWG"?/7TM4-ZA;L)T>$3?+#F4WVH07HNOE&L8WRB?&6RP\M)ZB5&7JU[U-/\@ MS`2;9S`!G#YM4>R54G_K.7GXY$7F1,K?$;UX5B(:%\W6%)`--1WW!B6]K2O# MW7S7NB=;R((Q\!H7DBJN;(?<>Y2!2P0C/8D+B>"CZZ,A9"`T"ZC3R+M?0!G` M>T2`%E^C42X?LF&(++&(?HS[=@`'[A8!2[C[-(3S=WUE^JI4>OQY=CF9GI6= MM5&"E'R$HZUD;F%IW@X)8`7@OPYY,$@D#UW*KDCY:Z`DVI2\=<-9[0#,`MX; M<'Z>=23RO#3XSO0]WM5"448#9W4&*AU9[-$5*7GAGKQ?9R,)8UC+D=12LSE_77T;,*RG5?_'(_8Z73-^R'D3. MF;QBLE>[ZK'<`IRU*"K1@Z'Z[W.3Z,ZF"]_WMZP(FQT:J]2P&P[,^O8>(ZK5 M0\Y)SJH!;WP)N,WP1C^AX>&'H,SB:T*MCB,HL- MH1@(\0,@J$AP@1\_9$:J#B&K#YKT?2K`3[\MR&RC4O[]+AN.'*TM+0R+;=S2]#_9$/??;*#9.G:55F^ODIZ!,234 M\$^XDCLRJN*-3&S\MEC6`#L%HULL,00":``A:B!%T&6J-1R#CG:H/&:H%0,Y M`ODC7B"@6O:8Q]$/"ZHSY MWO5L/Q`,N*&%U1XL.LJ'->@Y_:HI?^NO;%=Y5%3G%7<8V'/2\_Y[YWWW][O?_=W?O:]%JXH_E7QB M1Q"''+Z4N>BMQ,)V7K(-L5MMU7RI+=^A41T>>"S@,/DQQ6I?-H>#;Q\.7A,G?=>A7;IKISK8Y?$@D(5 M53$*VEDX>Q/6@1_H<"8H,%N+M:RJ4B#7<\HRGEW`ZX;DN;F\*@I62GWJ:HMX M#$;VQOWY.']QJ7-V`(?=:+8LWF`H:>&'0PF%Z(!#7;"G@Z(\Z,R9(W,+U64NIMP2!*F=#(<- M5#GG7H#OKCWD!7\D[:*>1^.3>1F)"4$:'$?C-Y04UO'PZY_'O_-3_-=)D"%E M7BXM?K-(P@H2RC_E();`.-.G9F=&68`?O=/43CA?!:V=(YN`E48_W%JODMSK MX5LU[DYD^XW5YD`.7R/OOJ%[$W_G#PPL@F*8,UN!U'83`MM$_#BM-O:4,'0!G]2*.28##XG;%IX1TR4&_M M+N2]C7*B&]I%Q;-]+*\A` M^=YKQ;R(C0*YFF.C-<:UV`MK?_Z>YN\]/WR7170/$15`7,JJ4=`CLO.MNTIO MR,%NU95<*:"'>@1RYW\ZYC4Z+YM2.Z0?Z*$PEQ(:I1[U55O9C2+Z::=`;AO+ M4\,XSQ82D9*ZB_]+W6=O:F*2HH74XN2*1*VAK"[MD&8?_*8`UGIE^PS[%9=2 MFDX;\X1)-,5QD3%QJ,>-/&PB/\9M%TB_L28[Y'G=0N2\6VG>A8:*2QPL)_6. MIV.8EL@OQT9Q\4GFM7)/GQ')2M/VCO#+F`H%OM1@5PQ<`@?SSX0"0D80`U MV$#Z!.!03,)(&(\^L$C;-@25X_X)<2"`\K;+!F1W M^LH%R=2='JIN5]!Z7\DN,X3)-5UHT07D>!,.M2;9KW`03DQ.T>S4/.FKZCJL MK:SH[KK!J1Z""E\YC3R/E2PL"U,WE^4W=,-X$_KCJ\A9MND3\JT"_\S]H:L- M6F5$RB9-1G1/$-6;K;NJXO?A9BCV/5D*HYS`<3`5@QPS>#S`JFX+Y%*V/?-Y M<^AGR[?5()+@P@SQ$P[6DUXK9.(Y!F:QJH>>#=(]]8$]):>[P"0&_/W:48N`>I7RNE573+U;/I)J,N=N>:EN6:Z=-6(3NQ;^/G:[4P859% MY$INS9:5P:A9!Z..";R.;<#M3`U;45KIX!M.1%[3@'__EW>UL`GO5\-D[J\G M&WN>]$T/JN3KV&<*EOY]2%'M@$@71#I^%2BM$]4!!0:QGY-V?T!@\/Y$'.S0 M.MD<"&4\Y]@<#&6<=#34[!-AL.8#3QX[/T\W39;9$2)7O5MRBXK'+OB^6^F6 MURE,$=A+N&*;"LW95NAMGW-:$NG M=O,WLIQN(73]*+?`BEL\V,B32OOUW;*L2F75*BK<(4KW4CG\)H'M,+7F;>;T M29M,.3Q.\"AQ"OR+T9U,[+)S3:*U5S8?42#'3%6&KFE@]ASUM;.P4SK3<,UF M.UY`+?HS;\RB[V8JOPN48])6:\EKS=W*Z;.BL_0\CL#/T1>^8%(.&FHJN;:C MUD8:LEH@I\WVG.;`YB#?T=B*8Z5?,L:].94VKKZZ^(B5?F$2R$=&6TQ38,>$ MQ]A^$G\[E`)/E8(/H^+ON*W5W\_.GH4UMV#'15AF.UAA.[%[Z$]F5NH.5[J7 MR&0R*1ESFSF*$Y(2=#$\,LAO.LO\X4%BGXYHYD]/35N?Z"9`JDJW6;05-G-AXT%'/PS"8^`!',Q6ZUC6)7%2<97T> MK5V/2"**$FQ;/\35L,^7MFGXI?OU!:<+_5ZX:S\UI54RH5B!;>PP1:5F&[+3 MM52R>IP(.YG,O5EB&;>_+O^HG'JS0([DVO-D0CZXVA<7D+EYNDFRH9X5R?3\ MM,K+')TG,!'T%Y\V%[91'"K$#NE.AV*/=%D&\$(X^&BQEI3#I*6/W MU)($G,O4LY_L+;\`_AIXG_4L\CQE4J1SQ$E_KH;?S_@(C'J8XQS9_H\W[L#$ MVW2$=L++ZN@\0U0*;\R,2HO7;(MI/$;WLI:R7IC2P].M[$_JS/2T#+TFQG+@ M@!8BR,>6KW`2KWJ(0]\.VY)<'MM8+]8XM'N,=CO7V%'5W'`L?2&_C*B>X'_9 MKO*HIJXT7H9)+AU;;'E]HN\Y[]&Z'4=ME=.IVG%IE2I81=S8051V#(J0A20$ MPA(20B#LR6,-8,(B@A%0$66QKLQ1L0)6L2E6QFD[SFC;XWUSKG/.W.",\\^< M\_YYYWS?_?WNM]SO]ZW^\N.$)93O0.S0\.#I$UW,9F-/02U=W5;8W\.ZJ]OY M63?@&NZ,U..V`TJ_)R;Q]C9.?E4\4MM._Z5SX8=^"IQ'<,S'=))=K2!C?SUZ M`>ZX`KVG7^R&`+V],7!76AZC@\-"C4%`O`R3AV:$J=P4H+"D0E]"G]%+1"R^ M[=>\H,6E^9XK_P%<208GQ$9MIE=OF<#J=#EP<[[`WB^V/9C\V5\2M4U#J M($["OSXGXW*B4P_0?ILOP:5P_JW^2WW]25M+62(9+D-6TE>CK^^F^!'@Y'K1 MR35DAFO9:ZYH)6A)%)FC:/3;Y0@@3Q0%%TCM8UU=5JR1_87%6@&1/%AWKOI\ MC1N^UFV8W`Y!ITOS;5=^.5Q#QJ9%;?6F_3[MAE]DLG!$"#VS?`96T']"[_BC M'>B#B;5X3UEX&,#F\K/#%5[G M`TDT&[H)NXP#PTR?\;,>NK[1U-*QW[H'^>K1%WO8M4D/T4WA!GFVGY910A,' M/C(4'+]&P9O0';BCY*_@XHD#$KBL&2;:C38/VVCRM^NNPN![5ALQYD7T>CU= M1;;6-K1U,?BW3VW1_Z!U&]/UZR*IP*W[T9L,MD#"N--M+#$6-<3[D#?MC9U3 MU8@Z(M9\OG5]RN/[#/'0"]XY1]HW`$6ZH4R"#;VX0^*R>'KCLC`T:U='Q)44 MEKC;X+U.KY)31XYG6E4,,>X5'!=^$&.,[W\^#3^]!`6VC#$O(T-,?H?($H&H M,*RHD:H_W5UO8$HZ-57TI9_M$T+V77J1M8=AX<>>I7ONP[H[R`F>05'AI2K MC7AXAH'3!7`6FKTS-"DD_E4Y%OVG'"-G4EST.L4OD\`F=>Z^7!RTPQP(-M@2[B'E1B#M@NJY.79N91*ILIRL[)PL909[*"%@;]QAG6$N_S'(QQW%!\H# M,T)?=51YH8FVER@BV9<2L"]'YYO%S`3RA9/)4P?1U3`'9G'"747RLLL4_\., M^S.G>^",>]7_W%/`WG15`);M_%KL[VG*'?"8DKTAWJ`#G MZA@'X@L3#?T4/`F,YX9N#]1$^S%(!+:E:2.=+9+&@8.%AXLF*&@$'98.W'E? M%P8$LR@.?*G0A>1ABR,<2#$(]I<6MEKPS@'&,GY9L,Y_9ZJ$ZYF.QDA#Q<&:YRDP-#6<6K/&R?J5%/DWK8XX$#^CB(LP^FR0"E*MP) M'L^!H**,ZA,4[`!=I]KJ6^DKM7'^+(H!&U,TL4Z+:%R,Q9E<'P73`9SM8XT( MB(F/"&7NS\#=<$%SL`55[Z&4]MX;YM+RS0T3[M"'1]%(FHMBL-;A_[97C@QI.+V.P=M,`W)IAU1Z):N*N==^.R MKWJ,.Z!XBI@<1YYD5+[$3\/(H:86;%948O6S"B2=L&6=IB%[!WKAMWO>QH?> M&R)"CTA8G4%P%^1AFG\+DX7)PY3.%)97Z,OIDT7R0RPQZ="2ITHNV3IIZ&Y$ MGZ2A3:MDB7O#>QN=V#5P]S7^75N^U*-I"BH<6/&^Y->3EN@T4S"-WEV*?H,8 MM&S5?<-CPD%Q3: MO6J<@%P.!!L2BF]3A`F*0?N9"TT,<:VI(OXDW62N:SXA;4B(29#ZA+.ZQS.S MKB54&I(>JL!W-917_K<3W=O5%J.$W]&8+?6X>-W?!!-&PTS$<7@+WB2)BGSX M>T&6D&C-UVIRL^6'Z_?3?XCRV_/Y<.SU>):P7DX4M*?7IR91N\,5"4MECP8S M&860B$$K38"PEI<4%U71A;9>V5EZ9++GT=5X6V@K2[2B-T8$L9:\EGKJ>(-] M^,Q9R2(+[C3U`/]6N\LHGB-E>(XLQF.D3&_,96(#E>*8:#>Q6)R726D-6D,! M,XB&A$NZCUX\UW>BMXE150I46>GB)#I8?Z6-A?9GP%U].=/,SS%[W''`+;BD M\?Z4>H'+ M,T"KKEVWDT)&\/XWJ=VUYXOM=J:W5[`&&'0"0M97<\H\9'9S+Y7P^SB7.C[2 ME4]QSCY6*6PNL&2G47$^:&7",F81+!=HR_*X*JK94M1D8#@4K`3U!?5YG*C3 MYR>D;-KA%E5MR"^G2\L;K94L?`^.-5TIK>YPJF:74@D8DBCN(C-C-E9N(H[,[`+$$=C,`HL"2\ M1()>I"`JD+7\A:1;K1K;EK/;[C+[:W;676?==6?6M6U9TR&SQGP^[[W#Y_-Y%V``AV9_*LO.%<;FXQC_ID`O M!5)B$9&G48?)"K67@5E@9_.Q?(F]5:`+X83[20=PZ)?IMAKW*MQX/#6+ESX` MX@_D(?O5J)C@$K'D8L8"//S6BO%D3C%K-)8)T!W8RLJFC.YR^+A>%PM,/A98 MAR]H*PF95:,?R7:Y;Q75P@W3!E0FTKJ^+)LU=$:@IZ2\Y&`]?E_[6=XYU_TY MR^8*T2P>J$>@Y^7)R%+[3W3TALP`G,)XCD@U;4FIN?(+_!D=) M'!`VS_TU5K0:U>ABBL:]TLDY@7HN9[Q.UN<>]-KY9C2,:!@G0XJ82;//%N2\ MC&FZ770Z/!.8'`8*22;5MM(@L*,]B+_.,W:W+6OGK.$^OX4I#N4'WWU]LP;L M>QX_$J`I-[];C"'V$KMHR6H!`!`0C#VJ6%WO!LETJS!+3 M"@WX_ZPD[GB;VBZQYU?=^<*\MORJ/SDD!B0IQ$O!D!3F1#$^,9UYN_;:PER$ MD>E]]/]G#F)FHD8'2^_B=JDP5YG<)Z,%P^C)[VM?V(TKZ?O#`\*MGI?>&24N MRV.\'!N3HYRB!'S.T9A(U0+.W7_!!@`&2'<5PH-"F5N9'-T7!E+U!A9V4^/@UE;F1O8FH-,B`P(&]B M:CP\+T9O;G0\/"]&,2`U.2`P(%(^/B]02!O9B!T:&4I,38N,R@@*2TR M-"XT*$(I,3DN-BAO*2TP+CDH82DM."XQ*'(I,BXY*&0I,C,N-2@@*2TR-"XT M*&]F("E=5$H*+30Y+C@V,C$@+3$N,3(Q.2!41`HP+C`Q,C4@5&,*+3`N,#$X M-"!4=PI;*$1I*3(R*')E*2TW+C(H8RDQ-RXR*'0I+3(N-"AO*3(T+C0H2`I+3(T+C0H8F4I,3"DM,"XX*&,I M,38N-"AE*2TX*'`I,C,N-BAT*2TS+C(H("DR-"XT*'2`I,C0N-"AS*2TQ,RXT*&4I,32!D*3(T+C$H:2DM,BXW*'9I*3(Q+C6$I+3,Q+C8H8BDM,C0N-"AL*2TR+C0H92DM,S$N-B@[*2TR+C0H("DM M,C0N-"@@*5U42@HP("TQ+C2!B92DM-RXQ*"!R92DQ-RXS*&1E*2TW+C$H92DQ-RXS*&TI M+3$T+C@H92DQ-RXS*&0I,"XQ*"PI,3@N-2@@*2TR-"XT*&DI,C(N,2AN*3`N M,2@@*2TR-"XT*'=H;RDR-"XU*&PI+3(N,RAE*2TW+C$H(&]R(&EN('!A*3$W M+C,H2!B92DM-RXW*"!C*3$V+C2DM,"XU*"!O2DU+CDH+"DM,C0N-2@@;RDM,3@N-2AF*2TQ-"XW*"!S*2TS M,2XY*&@I-2XY*&$I+3(U+C'1=+T5X=$=3=&%T93P\+T=3,2`V,R`P(%(^/CX^#65N9&]B:@TV M(#`@;V)J/#PO3&5N9W1H(#$U-32!T:2DR,2XX*&TI+3$U+C$H92DQ-R@@*2TR-"XT M*&]R*3(X*"`I+3(T+C0H="DR,2XX*&DI+3(N-BAM*3DN,RAE*2TW+C0H2DM,3$H("E=5$H* M+34P+C0Y-C<@+3$N,3(R(%1$"C`N,#$Q-B!48PHM,"XP,32!O*3(S+C@H="DM,RAH M92DQ-BXV*'(@8RDQ-BXV*&\I+3`N-BAR<&]R*5U42@HR-"XY.3(Q(#`@5$0* M,"XP,3$W(%1C"BTP+C`Q-S8@5'<*6RAA*2TX*'0I+3,N,BAI*3(Q+C(H;VX@ M;W(@;W1H92DQ-BXT*'(@92DM."AN*2TP+C@H="DR,2XR*&DI+3,N,BAT*3(Q M+C(H>2DM,"XX*"PI+38N."@@*5U42@HM-#DN.3$P.2`M,2XQ,C$Y(%1$"ELH M82DQ-BXT*&YD('1H*3(S+C8H92DM."@@<')I8RDQ-BXT*&4I+3@H(&]R('!R M:6,I,38N-"AE*2TX*',I,3`N,B@@;W(@"DM,"XX*&,I+3@H:"DM,"XX*&$I751*"C(T+C"DM,"XQ*&,I+32!O=&AE M*3$V+C8H3LI,C$N-"@@*2TR-"XT*&$I,38N-BAN9"`I+3(T+C0H("E= M5$H*5"H*,"XP,3(Q(%1C"BTP+C`Q."!4=PI;*"`@("DM,C0N-"@@("DM,C0N M-"A<*"DR-RXX*&HI+3(N."A<*2!T:&4I,38N."@@*2TR-"XT*'9O*3(T*'1I M*3(Q+C8H;F<@*2TR-"XT*'(I,C2`I+3(T+C0H2DR,RXY*"!O="DR,2XU*&AE*2TW+C2!S*3$P+C2DR-"XX*"`I751*"BTU M,BXQ-38S("TQ+C$R,3D@5$0*,"XP,3(R(%1C"BTP+C`Q.#$@5'<*6RAT*3(Q M+C2DP M+C$H(&$I+32DR-"XT*"!B92DQ-RXR*"`I751*"BTU,2XU-#8Q("TQ+C$R,B!41`HP M+C`Q,3<@5&,*,"XP,#8X(%1W"ELH:2DR,2XR*&XI+3`N."AC*3$V+C0H2DM,"XX M*"!T*3(Q+C(H:"DM,"XX*&4I+3@H("DR-"XT*&$I,38N-"AF9FER;2DX+C2`I+3(T+C0H%LP(#`@-C$R(#%LP(#`@ M-C$R(#'1'4W1A=&4\/"]'4S$@-C,@,"!2/CX^/@UE;F1O8FH-.2`P(&]B:CP\ M+TQE;F=T:"`Q-3`P,3X^2!C*2TW M*&PI,C(N,BAA*2TW*',I,3$N,BAS*3$Q+C(H("DM,C0N-"AO*3(T+C8H2`I,C0N-"AS M*3$P+CDH:"DM,"XQ*&$I+32!E*3$W+C$H M<75I*3(Q+CDH=&$I,32!O9B!T:&4I,38N,B@@*2TR M-"XT*'0I,C$H:"DM,2AE*2TX+C(H;BDR,RXT*"`I+3(T+C0H;W5T*3(Q*',I M,3`H="E=5$H*,C0N-3`S.2`P(%1$"C`N,#$R-2!48PHM,"XP,3@T(%1W"ELH M82DQ-RXR*&YD:6XI,C0N-"AG*3`H("DM,C0N-"AS*3$Q*&@I,"AA*3$W+C(H M2DP+C8H(&$I,32`I,C0N-"AC*2TV+C8H;RDP+C8H;BDR-2AS*2TQ M,BXX*&4I,32`I,C0N-"AT;R`I,C0N-"AA*2TV+C8H;BDP+C8H>2DR M-2@@82DQ-RXX*&,I+38N-BAT*3(R+C8H:2DM,2XX*&]N("DR-"XT*'1A*3$W M+C@H:V4I+38N-BAN*3(U*"!B>2DR-2@@="DR,BXV*&@I,"XV*&4I751*"C4Q M+C(R.#D@,"!41`HP+C`Q,38@5&,*+3`N,#$W-2!4=PI;*"!S*3$P+C$H="DM M,RXS*&]C*3$V+C,H:VAO;"DR,2XQ*&1E*2TX+C$H2`I+3(T+C0H8RDQ-BXU*&PI+3,N,2AA*3$V+C4H M2!O9B!T:&4I,38N-B@@*5U42@HM M-3(N,#`Y.2`M,2XQ,C(@5$0*,"XP,3(T(%1C"BTP+C`Q.#,@5'<*6RAT*3(Q M+CDH;RDM,"XQ*'0I,C$N.2AA*2TW+C,H;"!N=6TI.2XT*&)E*3$W+C$H2DR-RXT*"`I+3(T M+C0H9&4I,C`N,BAN:64I,C`N,BAD*3,H+BDR,2XT*"`I+3(T+C0H3F\@8G5S M*3$T*&EN*3(W+C0H97,I,30H70I,C(N-BAH:6YG(&,I,32DR-"XY*"!P"DM,"XU*&,I,38N-RAE*2TW M+C"DM,"XU*'0I,C$N-2AE*2TW+C2UL*3(Q+C4H82DM-RXW*''1'4W1A=&4\/"]'4S$@-C,@,"!2/CX^/@UE;F1O8FH- M,3(@,"!O8FH\/"],96YG=&@@,38U,#8^/G-T"DM M,"XY*&,I,38N,RAE*2TX+C$H<'0I,C$N,2@@*2TR-"XT*&$I,38N,RAS*3$P M+C$H("DM,C0N-"AO="DR,2XQ*&AE*3$V+C,H"DP+C4H8RDM M-BXW*&PI,C(N-2AU'!I*2TT*'(I,C8N-BAI*2TT*&YG("E=5$H*+34P+C`U-S0@+3$N,3(Q M.2!41`HP+C`Q,CD@5&,*+3`N,#$X."!4=PI;*&$I,3'!I"DM,2AP*5U42@HU M,"XY-C`T(#`@5$0*,"XP,32!E*3$W+CDH;"DM,2XW*&4I+38N-2AC*3$W+CDH M=&4I,32!O2!I M;F,I,38N-"AR*3,H92DM."AA*3$V+C0H2!V M82DQ-BXT*&,I+3@H82DQ-BXT*&YC*2TX*&DI,C$N,BAE*2TX*',I,3`N,B@@ M;VX@=&AE*3$V+C0H("DM,C0N-"A";RDR,RXV*&$I+3@H2!T:&4I,32DR,RXX*"!T*3(Q+C0H:"DM,"XV*&4I+32!O8RDM-RXV M*&,I,38N."AU*2TP+C0H%LP(#`@-C$R(#'1' M4W1A=&4\/"]'4S$@-C,@,"!2/CX^/@UE;F1O8FH-,34@,"!O8FH\/"],96YG M=&@@,38U,#D^/G-T2!F*3(W M+C8H;RDM,"XV*'(@8RDQ-BXV*&$I+32!B*3(S+C@H>2DM,"XV*"!T M*3(Q+C0H:"DM,"XV*&4I+32!O=&@I,C0N,BAE*2TW+C0H"DM,"XY*&,I,38N,RAE M*2TX+C$H<"DR,RXU*'0I+3,N,R@@82DM."XQ*',I,3`N,2@@*2TR-"XT*&\I M,C,N-2AT*2TS+C,H:&4I,38N,RAR=VES*3$P+C$H92DM."XQ*"!R92DQ-BXS M*'%U:7(I,C"DR M,RXW*&4I+3BDM."XU*&4I,34N.2AD(&YU*3(S+C$H;2DM,38N,BAB M*2TQ+C,H92DQ-2XY*'(I,BXU*"`I751*"BTU,BXS-3$V("TQ+C$R,3D@5$0* M,"XP,3(@5&,*,"XP,#8U(%1W"ELH;RDR,RXY*&8I,RXS*"!$:2DR,2XU*')E M*2TW+C2!E*2TW+C8H;"DR,2XV*&4I+3"DU+C8H8V4I,C(N."AP*34N-BAT*3,N,B@@87,I,38N M-B@@;RDU+C8H="DS+C(H:"DS,"AE*2TQ+C8H2!S*2TQ,RXQ*&4I,3BDM-RXW*&4I,38N-RAD*2TP+C4H M("DR-"XT*&YU;2DM,34N-"AB*3(S+CDH92DM-RXW*'(@*3(T+C0H;V8@*3(T M+C0H1&ER92DQ-BXW*&,I+32!B92DM-RXT*"!A*2TW+C0H;"DR,2XX*'1E M*3$W*')E*2TW+C0H9"!O2!O9B!T:&4I,38N."@@*2TR-"XT*'9O*3(T*'1I;BDR-"AG M("DM,C0N-"AP*3(T*&\I+3`N-"AW92DM-RXV*'(@;V8@=&AE*3$V+C@H("DM M,C0N-"A6;W0I,C$N-BAI*2TR+C@H;F%LP(#`@-C$R(#'1'4W1A=&4\/"]'4S$@ M-C,@,"!2/CX^/@UE;F1O8FH-,3@@,"!O8FH\/"],96YG=&@@,34U,C4^/G-T M2DM,C4N M,2@M;"DR,2XS*&$I+32DR,RXW M*"!T*3(Q+C,H:"DM,"XW*&4I+32`I+3(T M+C0H2UL*3(R*&$I751*"C4P+CDQ,38@,"!4 M1`HP+C`Q,#0@5&,*+3`N,#$V,R!4=PI;*'<@;W(@0BDM-BAY*2TR-BXU*"TI M,C8N,2AL*3$Y+CDH82DM.2XS*'2DR-"XQ*"!T*3(Q+C2PI,3@N-"@@ M*2TR-"XT*'0I,C(H:"DP*&4I+32!O="DR,2XY*&AE*2TW M+C,HBDM,C"DM,"XU*&,I,38N-RAE*2TW+C2DR,RXW M*"`I+3(T+C0H82DQ-BXU*&YD('!U2PI,3@N-"@@*2TR-"XT*'0I,C(H M:"DP*&4I+32!P2!D=70I,C$N,RAY(&$I+3"DR,RXW*&,I+36$I+3@N,2AL*3(Q+C$H="DM,RXS*'D@="DR M,2XQ*&\I+3`N.2@@*2TR-"XT*'0I,C$N,2AH*2TP+CDH92DM."XQ*"!#;W)P M*3(S+C4H;W)A*2TX+C$H="DR,2XQ*&EO;BDR,RXU*"`I+3(T+C0H;W(@:70I M,C$N,2AS*3$P+C$H("DM,C0N-"AS*3$P+C$H="DM,RXS*&\I,C,N-2AC*2TX M+C$H:VAO*3(S+C4H;&1E*3$V+C,H2`I+3(T+C0H;2DY+C(H82DM M-RXU*'0I,C$N-RAT*2TR+C2!T;RDR,RXR*"`I+3(T+C0H;W(@:7,I.2XX M*"!I;G8I,C,N,BAO*2TQ+C(H;'9E*3$V*&0I751*"C4T+C@T,2`P(%1$"C`N M,#$T.2!48PHM,"XP,C`X(%1W"ELH(&EN(&%N>2DR-BXX*"`I+3(T+C0H("E= M5$H*150*#0IE;F1S=')E86T-96YD;V)J#3$Y(#`@;V)J/#PO0W)O<$)O>%LP M(#`@-C$R(#'1'4W1A=&4\/"]'4S$@-C,@,"!2 M/CX^/@UE;F1O8FH-,C$@,"!O8FH\/"],96YG=&@@,3@W.3(^/G-T2DM,"XV M*"`I+3(T+C0H2DR,RXX M*&4I+32DR-"XS*&4I+32!O="DR,2XT M*&AE*2TW+C@H2!W:&EL*3(Q+C0H92DM-RXX*"!S*2TQ-"AE*3$V+C8H2`I,C0N-"AT:"DR-"XU*&4I+3"DR-"XU*&ES*3$Q+C$H=',I,3$N,2@@*3(T+C0H;W(@;2DY+C8H M82DQ-RXS*'D@:&4I,3'!E*3$W+C,H;G,I,3$N,2AE*2TW+C$H+"DQ."XU M*"!L*3(R+C$H:2DM,BXS*&$I,32!A*3$W+C,H;F0@*3(T+C0H;"E=5$H*-3$N,3`V."`P(%1$"C`N,#`U."!4 M=PI;*&]S*3$Q+C(H"DM,"XW*&4I+32!S*3$P+CDH M=2DM,"XQ*&,I+3BDM."XQ*&4I,38N,RAD*2TP M+CDH("DM,C0N-"AB*3(S+C4H>2DM,"XY*"`I+3(T+C0H="DR,2XQ*&@I+3`N M.2AE*2TX+C$H($)O82DQ-BXS*'(I,BXY*&0@;V8@*5U42@HU,2XP,#DR(#`@ M5$0*+3`N,#`T.2!48PHM,"XP,#$@5'<*6RA$*2TS.2XU*&DI-"XV*'(I+3$S M+C8H92DM,C0N-BAC="DM,3DN."AO*32!A*2TW+C(H9"DR-"XT*'9A*2TW+C(H;BE=5$H*-3(N,3`W-2`P(%1$ M"C`N,#$R.2!48PHM,"XP,3@X(%1W"ELH8RDQ-RXV*&4I+38N."@@<&$I,3"DM M,"XT*'1E*3$V+C@H;G0@=&AE*3$V+C@H($0I+3(R+C4H1RDQ+CDH0RDR,"XQ M*$PI+3$Q+C4H(')E*2TW+C8H<74I,C0H:7)E*3$V+C@H2E=5$H*-34N,S"DM,2XQ*'`I,C,N,RAE*2TX+C,H;G,I.2XY*&4I+3@N,RAS M*3DN.2@@:6YC*3$V+C$H=2DM,2XQ*')R92DQ-BXQ*&0@8GD@*2TR-"XT*&$I M,38N,2@@1"DM,C,N,BAI*3(P+CDH2DM,2XQ*"!A*2TX+C,H2`I,C0N-"AO2!B92DQ-RXS*"`I+3(T+C0H9&4I,3BDQ-RXS*&4I+32DR M-"XX*"`I+3(T+C0H92DQ-RXV*&TI+3$T+C4H<&PI,C(N-"AO>64I,32`I+3(T+C0H="DR,2XY*&DI+3(N-2AM*3DN-"AE*2TW M+C,H('1H*3(T+C,H92DM-RXS*'(I,RXW*&4I,3%LP(#`@-C$R(#'1'4W1A=&4\/"]'4S$@-C,@,"!2/CX^/@UE;F1O8FH-,C0@,"!O8FH\/"], M96YG=&@@,38W-3,^/G-T2`I751*"BTT.2XV,3@@+3$N,30V,R!41`HP+C`Q,C$@5&,*,"XP M,#8T(%1W"ELH'!E*3$V M+C@H;G,I,3`N-BAE*2TW+C8H2`I,C0N-"AT:&4I,38N-B@@8RDQ-BXV*&PI+3,H82DQ-BXV M*&DI+3,H;2DX+CDH82DM-RXX*&YT*3(Q+C0H(&8I,C"DR-"XQ*&,I+32E=5$H* M-3$N,#4X(#`@5$0*,"XP,3`V(%1C"BTP+C`Q-C4@5'<*6R@@:&$I+3DN,2AV M*3(R+C4H92DM.2XQ*"!O2!D:6TI."XY*&DI+3,H;BDR,RXX*&DI+3,H2`I+3(T+C0H82DQ-BXV M*&9F92DQ-BXV*&,I+32!$:2DM M-"XW*')E*3$T+CDH8RDM.2XU*'0I,3DN-RAO2DR-"@@*2TR-"XT*&]C*3$V+C@H8RDM-RXV*'4I+3`N-"AR M*3(W+C@H"DR-"XT*'!E*2TW M+C(H;G,I,3$H92DQ-RXR*"PI+38H('1O('!R;W0I,C(H92DM-RXR*&,I,3'!E*3$W+C$H;G,I,3`N.2AE*2TW+C,H M+"DQ."XS*"!L*3(Q+CDH:2DM,BXU*&$I,32DR,BXX*"`I+3(T+C0H2DR-RXQ*#LI,"XS*"!A;F0@7"@I M-BXU*&DI,C0N-RAI7"DI-BXU*"!T;R!T:&4I,3DN.2@@9BDV+C4H=2DR+C2!A*2TW+C@H=2DM,"XV*'0I,C$N-"AH;W)I*5U42@HR M-2XY-C@S(#`@5$0*,"XP,3$T(%1C"C`N,#`W,2!4=PI;*'HI+3@N,RAE*3$V M+C$H9"!O9BDR-RXQ*&9I8RDQ-BXQ*&4I+3@N,RAR("E=5$H*+34S+C0W-#(@ M+3$N,30V,R!41`HM,"XP,#@X(%1C"C`N,#`R.2!4=PI;*'1H*2TR,2XS*&ES M*2TS-"XW*"`R*2TR,2XS*#@I751*"C8N.34U,B`P(#`@-BXY-B`T-"XX."`W M,S2!O*3(T+C0H9BDS+C@H($HI,3$H=2DP*&PI,C(H>2DP*"`R M*3(T+C0H,#`Q+BDQ."XT*"`I+3(T+C0H("E=5$H*+3,N,CDT.2`M,2XQ,C(@ M5$0*,"!48PHP(%1W"B@@*51J"E0J"BTP+C`P-3D@5&,*6R@@("DM,C0N-"@@ M*5U42@I%5`IQ"C$@:2`*-#$R+C`X(#6TI,3`N-"AO;F0@*3(T+C0H12DQ-"XR*&QL:2DR M,BXY*&]T="DR,BXY*"`I751*"C`@+3$N,3(Q.2!41`HP+C`Q-#8@5&,*,"XP M,#,Y(%1W"ELH4"DY+C,H'1=+T5X=$=3=&%T93P\ M+T=3,2`V,R`P(%(^/CX^#65N9&]B:@TS,"`P(&]B:CP\+TQE;F=T:"`Q,C4X M,3X^2!C*2TX+C$H92DQ-BXS*')T M:2DR,2XQ*&8I,BXY*&EE*3$V+C,H2`I,C0N-"AA*2TW M+C(H9"DP*&\I,C0N-"AP*3`H=&4I,3&4I,32DP M+C4H(&\I,C0N.2AF*30N,R@@="DR,BXU*&@I,"XU*&4I+38N-R@@*3(T+C0H M5VAO;&4I,32!C*2TW*&PI,C(N,BAA*2TW*',I,3$N,BAS*3$Q+C(H("DM,C0N-"AO M*3(T+C8H2DR,RXX*&4I+32`I,C0N-"AA*2TW+C(H9"DP*&\I,C0N-"AP*3`H=&4I,32DM,C`N,R@@87,I+3,S+C"DM,"XX*&,I,38N-"AE*2TX*'!T*3(Q+C(H(&$I,38N-"AS*3$P M+C(H(&]T*3(Q+C(H:&4I,38N-"AR=VES*3$P+C(H92DM."@@*3(T+C0H<')O M=FDI,C$N,BAD92DQ-BXT*&0@9F\I,C,N-BAR(&]R*3(W+C0H(&9I*3(Q+C(H M>&4I+3@H9"DR,RXV*"!B>2`I,C0N-"AO2!I;F,I,38N-"AR*3,H92DM."AA*3$V+C0H2!V82DQ-BXT*&,I+3@H82DQ-BXT*&YC*2TX*&DI,C$N,BAE*2TX M*',I,3`N,B@@;VX@=&AE*3$V+C0H("DM,C0N-"A";RDR,RXV*&$I+3@H2!B92DM-RXS*"!F:2DR,2XY*&QL92DQ-RXQ*&0@8GD@=&AE M*3$W+C$H("DM,C0N-"AA*3$W+C$H9F9I2!O M9B!T:&4I,3'1=+T5X=$=3=&%T93P\+T=3,2`V,R`P(%(^/CX^ M#65N9&]B:@TS,R`P(&]B:CP\+TQE;F=T:"`Q-#(P,SX^2`I+3(T+C0H1&DI,C$N-"AR M92DM-RXX*&,I,38N-BAT*2TS*&]R(&TI."XY*&$I+32DM,"XT*"!O9B`I+3(T+C0H="DR M,2XV*&@I+3`N-"AE*2TW+C8H('9O="DR,2XV*&EN9RDR-"@@*2TR-"XT*'!O M=V4I,38N."AR*3,N-"@@;V8I751*"C4P+C2`I,C0N-"AA M*2TW+C(H9"DP*&\I,C0N-"AP*3`H=&4I,32DM,C`N,R@@87,I+3,S+C70I,C(N,2AH:6XI,C0N-2AG*3`N M,2@@8RDQ-RXS*&]N="DR,BXQ*&$I+32`I,C0N-"AA*2TW+C(H9"DP*&\I,C0N-"AP*3`H=&4I,32`I+3(T+C0H;"DR,2XV*&$I+32`I+3(T+C0H;RDR,RXW*'0I+3,N,2AH92DQ M-BXU*'(@*2TR-"XT*'`I,C,N-RAE*2TW+CDH%LP(#`@-C$R(#70I,C(N-BAH:6YG(&,I,32!A*3$W M*&1O<'1E*3$W*&0I+3`N,B@@8GD@:71S*3$P+C@H($)O82DQ-RAR*3,N-BAD M(&]F("DM,C0N-"A$:2DR,2XX*')E*2TW+C0H8RDQ-RAT*2TR+C8H;W(I,C@H M2DM,3@H('0I M+3(P+C0H:"DM,3@H92`I+3(T+C0H4BDM,C$N.2AE*2TP+C@H2`I751*"BTU,RXU-#,2-Z?' M.U5N-_K#VKI5]\>M.N<[W_F^OG)Q\+35NB2MR2O$J(^3 M7B<)*E)XQTV8,&H$Z8S M&%.W)&LUP1]K8@QQ,XV<1B?&F=(^-^GB=#&<3FN:\083@A0/,9H@QA#$1(*8 M1!%>;L1L-\*?(`((PE-L`#&"D!%SB$BBF1Q))I!W1@2-:).]+XN2\6YCW1+= MSLEGRH]1,ZA5VDM5%;MS@4\*&#'*/<[[,&,Y M^)1'.OM&QTFFLK*U[B8+:=3^Q,;@9.:++86?Y+,<_(!<5MBN_`T*GN$"N:+$ MW.TA5#!EYA,54D/J&YP>&*-R#C:]4]*H1%UN/@& MH!0$U>9R`4#@/WO$\+3@+X+02/^:H:P6- MMN7,1/39MJ39>)4%[#<@Z#1,A\DL_?RU/NK_UT>/6>R+_XY#P`V'@D--"X.@ MJCO>K08:#=0Z+N]F%7TBLPM=T,"3_Q5Y6EPG'&P M/'[$H79KIT@3QV(+Q**KG?9VZ?U7#K45G+$MD^BO3,Q?FR?2_Y5':W?%E_R# M@:U@P5M1>'S!6JDMCY`"#Q3Q3HHG02X""12O7%T2Z^B7@+[O+NZRBPF'.-1I M[7K=S[B"-9)SA]`KS9T$[_$.72/6F..XP0 MCNXWVGM+Q/!2A*-<>APEZ.5X%T?=R*_*6L>XC&A5=N8"B5\VC_Q*M]1>9P2M M'8'#=5]^E`*'\$QN=Q532PW6%1+9GY$T!FGISEFB8]J%A>UT1^4XR."IX++T MZIN,,,F.:+.PRG5*7B?@WWP>]B`XV$JG@PQXID*DR$>#-@'WL-KU,,6;VB&WF;1 MXK^+5I@'0?03L>1!GEJ\QVR_RT`X`L_B<\7]+>YW.LIO-(O+`2\[$,#BVQ1] MET-?YS=8YS*N**BN.J@18MIO#8308\ MVCZ\):"U$;Z29@HH$7$Y!-)WQ8!ZX8FRH=1>WJ.ZT_K9%#QN71I^MU`M+,>W ME#F9Q559:AP-)^47#@XUP!B&O@OS<4)9J%@&1UTL:+#Y2#7,R[!^O%-4X2&/ M7LD+ZX\BB,57Y1!#*;"OV#ZFP:.Y/@-(T?-_67F,?B"8!:,2DI*0.3\_,]40 MU12@HG_`$7H\(3RZR`<"_=7?)[UE`VB MY:XGE!5'R^NI0S!GJ/1ZB;NK%LTUV4(DPSE%PYG/.DF>_#?,AMOM,N^4K=U['_P#0,WT=6:\IXR\5-R2*XF*YW!KS%T8N>M]05Q M3,;VE!VI+*;Q`'X7KLES^8RV:N9D3=&WTE@]X-"9O`/6(RM@C^NQIS@R9N&G MP[T5U3V[QP][X5"Z,%;*&BAS+I*R.CBJW5I7J&>2BXI$VWS$?@@?RG.JK+LJ MF/I#1=](*9^*V\=VD/M2#QMPNR=>B%,V1^OR=?GB;^C@48(CNJ29J2ZON04HNDVRTK;-*"XE'1OLV^]H!O`Q:/.$CX*J//BQS%Z5I%H:: MR3IA2.94@$690JT3OSJB&/\/7P"@_W..^`_Y!1B;_*`'=OMB!:<&G;ZGW=:B MK)6+B_<]D/P2_048>_C8!PYXGODXFOMZEP;WH)+\=8X'?9GX5I7W7ID(^VZ, M^'.3]Q"+"1Z@0WD7_PP)]Q\+C`P.]XX4^6(5`@P`"A"51`H-"F5N9'-T7!E+U1Y<&4Q+T9O;G1$97-C7!E+T9O;G0^ M/@UE;F1O8FH--#`@,"!O8FH\/"]#;W5N="`Q,R]4>7!E+U!A9V5S+TMI9'-; M-#$@,"!2(#0R(#`@4ET^/@UE;F1O8FH--#$@,"!O8FH\/"]087)E;G0@-#`@ M,"!2+T-O=6YT(#$P+U1Y<&4O4&%G97,O2VED7!E+UA-3"],96YG=&@@,S,R,"]4>7!E M+TUE=&%D871A/CYS=')E86T-"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB M5S5-,$UP0V5H:4AZDY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z M>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](C,N,2TW,#$B/@H@("`\&UL;G,Z>&%P/2)H='1P.B\O M;G,N861O8F4N8V]M+WAA<"\Q+C`O(CX*("`@("`@("`@/'AA<#I#&%P.DUO9&EF>41A=&4^,C`P-RTP."TP-U0Q,#HQ.#HQ M-2TP-#HP,#PO>&%P.DUO9&EF>41A=&4^"B`@("`@(#PO&UP;65T83X*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@(`H\/WAP86-K970@ M96YD/2)W(C\^#0IE;F1S=')E86T-96YD;V)J#30T(#`@;V)J/#PO05LU,R`P M(%)=+U8@,2XQ+T-N6S0U(#`@4ET^/@UE;F1O8FH--#4@,"!O8FH\/"]$6S0X M(#`@4ETO5'EP92]*;V)4:6-K971#;VYT96YT')E9@T*,"`U-0T*,#`P,#`P,#`P,"`V-34S-2!F#0HP,#`P,#$U-S4S M(#`P,#`P(&X-"C`P,#`P,34X-SD@,#`P,#`@;@T*,#`P,#`Q-3DV,2`P,#`P M,"!N#0HP,#`P,#,P-SDV(#`P,#`P(&X-"C`P,#`P,S`Y,C(@,#`P,#`@;@T* M,#`P,#`S,3`P-"`P,#`P,"!N#0HP,#`P,#0V-C(X(#`P,#`P(&X-"C`P,#`P M-#8W-30@,#`P,#`@;@T*,#`P,#`T-C@S-B`P,#`P,"!N#0HP,#`P,#8Q.#@X M(#`P,#`P(&X-"C`P,#`P-C(P,3<@,#`P,#`@;@T*,#`P,#`V,C$P,"`P,#`P M,"!N#0HP,#`P,#')E9@T*,3$V#0HE)45/1@T* ` end EX-10.1 9 c17407exv10w1xpdfy.pdf FORM OF PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD LETTER PDF begin 644 c17407exv10w1xpdfy.pdf M)5!$1BTQ+C(-)>+CS],-"C(Y(#`@;V)J(#P\+TQI;F5A-IB8&!@!B(-!E8& M!E$/!GX&!.!G8`&*LC!P-``Y&>R^9HZ+MQ4P,',>F):6"5;`R!(LIR+H4S'! MU?"1H\CQ3I;&*<=[0(I!.I`10P>R=B0KA*&8@2&6@9=I`P-SAZ#!3587KP8> MMA5+C_*I+TSH9HEEVLLI+GO1#Z)#AH%QI1O(;B">"1!@``]?(3(-"F5N9'-T M7!E+T-A=&%L;V<^/@UE;F1O8FH-,S$@,"!O M8FH\/"]#'1=+T5X=$=3=&%T93P\+T=3,2`S."`P(%(^/CX^#65N9&]B:@TS,R`P M(&]B:CP\+U-U8G1Y<&4O5'EP93$O1F]N=$1E7!E+T9O;G0^ M/@UE;F1O8FH-,S4@,"!O8FH\/"]3=&5M5B`X-"]&;VYT3F%M92]*3T%&3T,K M5&EM97,M4F]M86XO1F]N=$9I;&4S(#0X(#`@4B]&;&%G"]H M+VDO8B]T+V]N92]Z97)O+W!E7!H96XO0B]$+U4O5R]'+U@O8V]L;VXO;R]M+W`O M92]N+W,O82]D+V7!E(#`O1FEL=&5R+T9L871E M1&5C;V1E+T5N8V]D95LP(#(U-5TO0FETF5;,C4V72]286YG95LP(#%=+T1E8V]D95LP(#%=/CYS=')E86T- M"DB)```!__X``0(#!`4&!P@)"@L,#0X/$!$2$Q05%A<8&1H;'!T>'R`A(B,D M)28G*"DJ*RPM+B\P,3(S-#4V-S@Y.CL\/3X_0$%"0T1%1D=(24I+3$U.3U!1 M4E-455976%E:6UQ=7E]@86)C9&5F9VAI:FML;6YO<'%R7I[?'U^ M?X"!@H.$A8:'B(F*BXR-CH^0D9*3E)66EYB9FINHJ:JK MK*VNK["QLK.TM;:WN+FZN[R]OK_`P<+#Q,7&Q\C)RLO,S<[/T-'2T]35UM?8 MV=K;W-W>W^#AXN/DY>;GZ.GJZ^SM[N_P\?+S]/7V]_CY^OO\_?[_`@P`K?9_ M@0H-"F5N9'-T("(B(B0F)B8H*BHJ+"XN+C`R,C(T- MC8V.#HZ.CP^/CY`0D)"1$9&1DA*2DI,3DY.4%)24E165E986EI:7%Y>7F!B8 MF)D9F9F:&IJ:FQN;FYPGI\?GY^@(*"@H2&AH:(BHJ*C(Z.C MI"2DI*4EI:6F)J:FIR>GIZ@HJ*BI*:FIJBJJJJLKJZNL+*RLK2VMK:XNKJZO M+Z^OL#"PL+$QL;&R,K*RLS.SL[0TM+2U-;6UMC:VMKX.+BXN3FYN;HZ MNKJ[.[N[O#R\O+T]O;V^/KZ^OS^_O\!`P,#!0<'!PD+"PL-#P\/$1,3$Q47% MQ<9&QL;'1\?'R$C(R,E)RWM[?7]_?X&#@X.%AX>'B8N+BXV/CX^1DY.3E9>7EYF;FYN=G MY^?H:.CHZ6GIZ>IJZNKK:^OK[&SL[.UM[>WN;N[N[V_O[_!P\/#QOKZ^WO[^_Q\_/S]??W] M_G[^_O]___\"#`#GK#\0"@T*96YD2](5"]$969A=6QT+T]0(&9A;'-E+U5# M4B`S-R`P(%(O5'EP92]%>'1'4W1A=&4O4T$@9F%L>.8Y"$B?Q_OFZ&R+<_"56$BT*HJ?GW;2&.7%A]WWO`&4QJDDM-1D M*=EZ6G`T0%X/KZEHDXMN35(&G8.6LL^;EM.'PF,JS_N=;`W=3CS0&I7AE8EO MR>Q4$(^T*BO@E6Q1BV_TFXCI2PGZ2#8?[[Z6S7T!/%$60X`7P-4ZL2QVQ=VH M4FMI,/5")^#"J-Y:K$^'W>1@[;L`+:I@,3"4VX>>D1R$P>6+&6DL$6O=P59V M=+%AI$:Q.CF'97^R*&8_R+&BY=OJ@?6(?U/,69_[RI2:)D@K&DR%6L=41Y>Z MS+Q>R$2=V\@V4"=.I56=6!7K8M:?Y!VS.8*U-#HCCB5VU)X9.:F6+;57DYD3 MS6&33VO(=M@G6(X)2M9\4H%SRN-IS1?0RB;M#^M/?JH_ET_9D:#4)]DRZSE< M]LOB@]F[V2:[YV6R9\6>]L M%I-U0(/(UF(\RK/H!/27%Y+_"!Q+K"JCJS&P.@4ZYCEN]H^WPX0C+_?89H6Y M*7/FF6=2R(J-I;!5P9[7Y*."^&3[?"[\1*W&_SP8Y_!?!L,%1+\_%WI$WJ3# M/QT]8N"7``,`/[E)C`T*96YD>S=B-GPQW2VF,'E8B8CDZM"?):ZKZR8R$@G2HMK&5G4 MPM4%H$.JTJ"92*U5(N9EZ^CBIE*KOAAYGV!CW[&,\0MSU!;X4WKM%3M_"PD6 MEU,VS:551@Q`WI5?>Y\N#&@H[WO&*MW/$XB0B$F1R+@70[FFS[$G;F3YB+[: M^V+"5.?PSU.`MYM@-UG?GD*)NW,`C;E.4F'W,`+S"7!8D/<4SR]2)J@V/I.')SME0:> MBZ74M(/-OO(^A[`3;#AL8+;D.%8];+T,Z'P\-##F#.^L>JHX\[FKJZ"!4?5, M,S"M?2^-(8NDR:)P)P;EV(&WA3+]X&*W"K@WH3/&[0LU,O-]^>+"#5;YA*B$ MF;N\14!&TP`\6OG!8[00UF.`Y)1>!/FS>I,FH2N[PPYE6!SQ)PE\WKSO7XFH M2^44@)G#`1J:F14[&9'+DDISY$D)4TYS@NWLK%[QD;$.'H.-#_6RHV[:]-V4 M74B.654MC1?^J>^KF@KG$@^>]CI4X$0D$WQ'5M[$CBUY=]IPMVI&92L.W:"Z MWOO2UITVM*&G]+J!U=K#_0(>!Y/>AT[>BM\>Y5J:&%\ZM>QC470K8KP]F,]B&1^)EJ&-A[\"#``)1UJ?#0IE;F1S=')E86T- M96YD;V)J#30R(#`@;V)J/#PO3&5N9W1H(#8U."]&:6QT97(O1FQA=&5$96-O M9&4^/G-T' MS,GTN7Z-M@]<@`"5*ETD_'\?0)";IT75.M.XSD)EC75V#9O/B]K4UK6PV9%4 MKV!S6WQ3HW;>.+7758>_B[96)5TYLU3CH)U3.W8DDH<8M%NBZZ(KV^`?6-UR MC#A[V&E+>@Q]+I'R-X9<'/)WSQ%)"ASBF$XL0@X.NE:0,4\H#9PY`SNB?A8D==2-\;/FMY+=2T8ZB47\8BX%"Z@$W>'' MK#[,M)](Z6UFV;Q*P0>;.DZ5YB8.[^O=DA4<\O,]6QC2= M&9I*,Z]Z;5H\-RB'_CZ>J+]OGA9M;;SO'-2T714M5;.4]\%J+5:# MJ#V6.Z#J#%+Y.J#D34-P*QYA4Q/?L41DC*J`?%QD3T@$:GW'4%\B$>W4.:\= M5@Y'XHS")UVUZ(#'D-MLE1'#L^*]ZVA,*V*)_5&SOSGN03OB%'DD*SZVCG:0 M@L/]#PO/FDZFG;(%7]#YMEAUG2'UND8?I`@T9S\1P'F7A#V32(G+G44O9$0- M">A`3W/00F7+03?M,$-XCWJ)U7O$9D8E5H83,[,/+9_O\ZSZE=F4>C*/^^755&HO!20D0G&> MQ<=U@\SLPOO;&-?4LK^TOK1)_#JN/>\4/D?6YV>DHLL$F$\/W^$@`CZ/^5;D M(-BR,1&TFQ984/("N^FJK%S!JAO&PE6D&X$;,HV6:&,:'<::;[[+=RF)_;^, M"]WV;K)OQ^DUY$SQ(U/6)S\4*(F0W[4`2'PONBF`V"3\%6``4W!J9@T*96YD MMNP-8^9$F:&,OLP?-:]#NV#QXE4KD,ZY--BCSG\&*YNAS$$&F56YU#-1[$ M*M8F@VHYB-QKD4+U,O@B`$!&)E&)V+],7R4^4Q'LGU)KI46-IK)BT]#I0D8Y M>GMI##Y^=6NRX>M:ZASC=NT+U,VJIO,EG2[HK.<81@Y$WV6I,O$JXR,?9VR\ ML^,\YJ)X-EA6#WT+K&U'W#OHMYP84%DUIW8$Q&K.9)2J4D"W%QEIZT133E!DW2%(=*Z^:_(UF?S"`&, MF+5*M36>.,DL,\>E_S)BXKS!(F,DQ2(S58CW,D'@.5O3H:O(O3FB1$38YE*\ M<]/.Q%"B^$Q@(TR,W(PSYIJ-RHHD/ZTY+OS<%)RUTTD MLV)$!IV$P#$^D1+N*G;,.>P*[F>H)Z4A)CB:$`'#3WB`BR"&C#\^79+(X)BT M+2#"&60VV=\CR>$>L6_>(_?-RO'Q$EO1A>\09],'G]M5]R5'.G5;[7H)[=/1 M=ZK1LW5MU0$'<"6=:'\AI?X62!B!X3MI_082R$6[(Y@5P=1D-1OF.W/C1$V3 M9DGIBAV&MHX^,<_50]3<^PST$K%ZM5)WBCEB9!7?IQ$L,RN!G,PFC%5JN:WD]2F+LO5O)K`\6WRH+N= M<:G-]&<2 M-[,S^!80K`?CG9WJ865<@%MHD]M"*^.G$&W7\F/8RKWZ-@);<'IO,NOUTO@, M:T]5MW5O?'Y&K1AC,$FFVWZ/Q*87K7X;YX%IC=<\'?^5ZEXRO[W`@GN]_&JSY19J'4UB.*T8(X&+GE[4WV%TAU`9]UW[6E&PH@$P/][L"+N MA1(KOA8L)L^ZE M/:)CB7F@C\M90>,+ZL.6$RCR'#Z*`I@A('D8#$F(I$W!4GN".\UZ@U)"D)5U MNN.8T1]7VS!%H\/("+0\RGHDTZ,-/E;P1L/\C;IH4ONAB?$IK(_!S+T*2 MPN8(;UP!9UST2F)<4"%6>^AIJLTG+*X)\L1BJ:EL%?(K/LO$]([DL/3YR<[,H\[1P9:$RM?FVR-(L6U5JTRP2^&O+I=J\+WYJ]7@8C5VE M3A],XM):#SN3V$PK<[^Y6201(K&I+9:Y`%E;(A!"5@SS:J`&$*QNC%T"6F.2 M&CX[7M$V_5R9I`)P5Z2%WG*.Q[+6.&BEU6BY@\-@$`-$E]`(+VPI&0A7RU,9= M!08OZ"QGE8I$P>RX?1UPMDJ_D(9+F!'SMISDCZFQ=5I-V=\-M%BBE;%SPUE[ MAE[_,+BZC;F15W])4)8R"PALSYDUC!Y\R]2Z468(7G@]JZ'[M>?=48U!#;LS M1K*2LC=J)#$5_(4"0F`_'WPPQ8EH3`R/0)*;1K#K\&)6X,>H&D7]\2,.%4<,'Z]8S.6Q3CP+;,T]Q5-=N2O(.&XF=+7C]@ M7>%]^"((F7Q3L'^&:RN!V**'BMP"XP$"&7Q/[R3U(M^ZR;;ER;;%]%#B`Y:Q MKGA[<[J]M(A=[O1O)G9MH$D):F4BU8JD*E$J-)?#]\SA232,\/2'"^\,2N-P M$.!XV\N3XN=''+N.*+9^EE7L(TL_7J'A3PI0,@X0M9/$+2\'+^L64O@&.'W+ MQPH@L_$I_9E:JX<()KP2'LU-\U&>Q%L%SV_;42KE#-W#@?YTP9NSXZ(HJOWP)F7A[7KJ6.1K>QIL#SV%4Q60,-;L)P5^W-BX3,K(VSA/JNC5KFCQ:F-7R6:6)D74:\S8 M7^O;11QH8Y>X+`.WRW+F9I4B4^I[6T:CS1QE^AV++*-GFRV3+#(/T9MU*06. MV]^*>%3`SCI*,@Q;1J/'QX9W^\F`;:/8#Y"=.NRWK7_1KZ;K-?ADJ5O""`,T M3?-XL4)E0Z>96Q320#H0&>Y&\I`PVCBCT2#-]\`O'RR^]G[`%R@W%]DMZE+` M'9/_".TA)F(]<%M9S5T9%"^[X_CR:8:-YB26CG"6^$XGZI*,8I!H8[83)B>N6;FD+IR;O>C2V2\5_/)B M7:VG6Q/?Z8MU!:>/NMUR>3P5B4+\ZPGHH0GFA(Z8T]5!S56S.TM5NU-:J;[F M>13)BDZ3C.ZB@[22AZ`<`KR<1P9!&0TM>[HD>7)V[8`L#"27@3!Y8\#@E8^& M6DF_$GU&VN7\9^E))G>,@;$.]4!I#O?.ORV*#N,W._G MZSC?QL/@WW$RS?7,M9[)P`Z^1\>=>I@,N,KK"P]7\WL:;,64%5=`9"NBH%O% M'7?\D.;\3/"S@$TZ")?(J\+(8&"(?'Y=VGB("/`0'K/LF\'3]D_%[LS\B[ZAYZFYZ$60R>-OHTK^SC:JH MVVDZM@&Z*L&CL+GH$+_QRL)_/SR2@P)#/Y.AV6UF??(2524)6PAU3:<20`T3 M]W#6N?%G:DD$KI_HM11:5$*'8?X*,`#QKY\'#0IE;F1S=')E86T-96YD;V)J M#30W(#`@;V)J/#PO3&5N9W1H(#,Q-"]&:6QT97(O1FQA=&5$96-O9&4^/G-T M+\G/@[=ELY`F'DFAC:T@[MI2]GYR&T@[MMC@MH8V* MC%*1]!_8/Q\F])RI8HDQ32K;*K!:H0(Z"E+I,D+BJ%/)2-0[<#:SR^?`!=E_ M[>;8S4OA4C'Z3>@W^R""U;]__BJ_3T%Q]+NIO($%DYB=H2"-4:;ZD*+FF51* MKC,).&C&Y#$,M:AM(*22+-$ZJ&`VFG3H`X0J(ZI?!%$+CT$R%K^XJ)83U=HV MM0/6=XYA!0P'ZXTHG($)[F'[1/!J+WMPR?QEB)51%8Z.S:^YO)P_W,;!CP`# M`#A1;&P-"F5N9'-T7!E+U1Y M<&4Q0R],96YG=&@@-S(Y-2]&:6QT97(O1FQA=&5$96-O9&4^/G-TC'0WB-[[6.FE%D<8NR:-%1$)64;.X::*"!9FOH MA@9D%9K-!M169%$)LHJR*`0U(2,R)IHHN(8!,7&+(C-23C1QOM=>4TYK?B13 M94W=JN_'K7N^^L[Y[CDXQC?#S.`G. M.?`Y1TL[Y(427V6]LB,,CBI,!%G64&W3Y\C>%&-F.+Z_;J4J*4.MC(Y)D?XU M8JYT@?NR)?/?UJ7OJOO;ZNXFE46JPA72X`Q-BB)!(UV3&*%2)ZG4\A1%I(M4 M*HN/EP:][:"1!BDT"K76=/MN'*E2(Y5+4]3R2$6"7!TG545)_96)JI2,)(54 MMEHJ3XQT5:FE2A-.DQJN448JY6JE0N/R9RH8;CH8@6/F/,S*&IM)8RLP[&,' M3(EA:1@68)(`XV$$9L`_P??@%_'?S(Z;/3%[Q9/PEO!R>;U\@A_//TY8$G%$ MK8`1[!*<%SH*"\WMS%/,1Z9LG/*MA8_%28O'4YVFMDQ];AEJ>=[*QJK`ZI4H M573/VMFZPOKA!RH;S";&YKC-39M7XD+Q!.E%]MN*;+=1+E2+'6878??O:2[3 M;MK+[(L=>`ZI#M_36^AFB94D1F)TS'+\=;K[]!YFGE0D%>E;N9WG"NA@"<,[?;9OWV?^66EOY`<0V3!9MDJ>N[#3>.;&=0I)">= M0_I_3F6SD)U@9\LEY3/)XHZ'PE]K?CH+0AJP=9V(&F9@MPEYKG!86X_,S-$: M%VI]3]B)\_31?5OT%S[K'8#@258.CZE(04)D7>3AKQ/9&%)R/2<#Y0C##`Q&/`1G:3`63]2\Z' MLL3:*G\\"#/N,R"KFZNJ)YR)M&3/O*KU8RIX*'?+Z)KSIDCU8`K@?5J6;3R."T M7!;`B.`(Y_J:UMY_@P5S06\POQE^;["0\:C[:>+K\`8%UY$[2=UUCC01R-NO M;6[8N^]D.]/4JM>?ZRC3V1]8'[TAGE8?R3[<5--0Q[2IJI_1!J&AA$C^KF'% M&4G=X:K&B][Q'N?8@KW$B\%+\BMTJV9_;E3RZJBUC*Z8:!;VM_2UT-4%S!GOAMV\;JBD_&'W9:%(F@<\_`;P>&"39V)8WWGX MY/'DYH0$M3I.T9%9SXJ\#%JC;QJ>#U_QH,>T#C\!ROC-E[@F$&4W&\7->.-3 MJ'[*@PHC0X%M.=JSVJL4Z9`MLBV%_!^NE<,>L&6;^P@V.U`N^T@WTL-RDL*$=^;D2V\.@%O;Y* MTJ%/UK*OMPAE4:6!I8Q(/\(U#.,P_H#'J6`ZE;.7\(],+XF2H`(!>,$JXLR7 M]\9?TL!?<,UMD?,VY)3`U!<1`T?;1L8E8-'DNMD[;,%B%Q;YHD`BEZ.%HNPN M;OR2&&Z.*6Z1U\$9[E+7RYN*NM+-K\16R=2T=[B7"Q.@N+!#DIFB4VUZ6-0( M"\#R)Y@)]A]URH^PY/VATRVG!^C/D_Z)*+^%\6A:!%-;3+36]MX>EPQW;=SL MZKW-+=%$%C+77>$"T\15/:"[3:9S\9!)S>8"0P7HZNM`8AUT",FSR'-42*:# MYW,A\KM"(9T`\F&"*#>)?I+[>@P'[@8/UG!W*-@L.'A`?Z""/?4HWT!DY>7G M)4N00H!PM(O0E504[I,`5@P^V]%B&HEDP6N9#4G?K9-$Z!-W17^I&8.%8/82 M'![E'0OK9P-N.1_VK#$79;=R_"]`=PCOF(`]CWE@01\6\U1..JF7K9].`L1.S;Y>_L-@]>E MRL;*2K:QJ6M_AT14K>4FAO'/.!F/VV"<1[T6"#)#PV8=+B#ZVX\<&Y1`@@!M M?3U!#`H@QCB3,$UC%+6*+XSX#(/J>L@(.0$Q,$B1CT#HWIL@HWVVR_T]=@R. M,N3$>%_WB68&N2$/:OF0.WS`F!YYM`.__ZKV&T0_9I_0(Y\,(6+) MG`US/'J4]V0FX,+5X?&+:7+T#C>;ZCMQ_A^CG1M"%@5'*=1,=,/"KV_3HCHM M%)SF^*UXVQ/03?(NIE)@.`1S(`AB:/!T`@)9(SM/A"$']R^0.=!_.W_DY!FF MO+10'6+Z]$41#G`1C%1&26[.+F:G5IX1*YF1"E-&?FR8N`<.>K0IP.0RDPVA M#'CB'X!'AH$C_/P^,Y+U"/'?:])WJ0`O?F^0VTTF_>=M-AQKKQH;O$'?"ZC2 MYFTK"8EJRSGQ/]D0\TY\>&Q.=#LN;GO>LN!6MNP$DN))8MZA$<,VQ&FL$02@,\`8<1T`&9H9AE658 M'JL+.PB(&VI"M1:3&HW&-2;:G"91:S/!YK[)G33]'F.3]*3G_??.^^[O_K[[ MN[][WU*5,US2;,TQ%.^^CC;Y/>\D%G>XC.+6J,6Z.!^]F&Q.L0P789-$$K=8 MNXMS['FEPDD8P4`9VS6%R3>41J9P.R,M.WD1"HEK'[4A('`$AN,19A3T6R6Q M';H[H:1=E,8`XP"38QX0=6N%TTOS<:;=N(ASK2$AQF1_,SW_D*A;(*X*^(YG M0:?G5`HV^N&)XK_5@(J#Z;C$/H?'9A8VX6>:QTVFU!9!G7`NY4QD((<7:U5'[\V(.)(Y3''"%,M2D*&'OGK3@^:G\HY1%ZO M28,$)I&-3(^TFA*6-\_2XD*ZMKV`.K3!HBDP%U8^@-&V;$%?R41'+0G!%[4X M!D<^I(H=WW/Y6(?0U7VAJE<++WX8-*[>?:]BN_RIPG7`(;/@H8XJ]X1V%B[> M@0W@`SJ<#1YX0,!:5ETADEL9Q:F#%_"J,65!)J^.@E#YLJ;**IV",7VQOS_- M?["J;IX_ASUHL:[8;"QHH9.M@$)T0'<7'.R@*$\=4%';_/T0K_U#U$GREQ"L MB6$G;MT8C:.U^!MK=I<`V02FF>];R@PE03ZUL%?'ANQ/C:<\IT$9! MRX+J4,JL,J&>S0)?QG6$5;>)I-]4E_&*DMM\7=H*FEN2*+>34;"9*N?2C^"% MM=UN\*=R//4\&I\L3-4G!6IQ`HW?4)!;S\.O?A[__@_Q7R6!QKT+,VGQFR42 MDI-4\A$',00FF#^RU*46^_O0.S5T0G\EM':.:0)6'OMDQR&U[-P(WVBP4,]> M,559`CA\F;S]FFXI3O<%!I9!/DSJ?\2KG\'8F[ MWVR>J,5=Z(E!M-!>#6O.KQ7F7P-5]%.M6H:AX'/!+L";Y-HA6T\N[VZ4,SW0 M+GE\XX`^ATKRA$:)#_;13)/=,)880SO466;_7 M$,__H?Z3I=H]R=&B(3^E7"\8B^OW=6L/PZ]S(-PMVT'LEQPJ>29MS#-FR1S+ M1>R)Q4310];_&,2T1C\=' M<0G)EG"EIR]()-2\JV/YAVB`'&]JL&NN7:W.^7.>CX1EQ"WG8_)7BIC4L7"* MC@]L%5FW.-3M/\HO5I1;R6E8S,2QZ!6Z(A/]M`'Z[$Y!CB9WZ@NN*+4Z^IR% M1X]R.S.ITF[T=P2.+>!2::GE$BBW,2:[[F M9%\;`9OK.&-GH4!^G[&YPMC`?6Z*5)HK?EWFP?];Y'G`ZN"[PP:JNV)X`41D(S^U&`#Z../PS$9 M(V`B>L$RH6T8JB9\!K$@@NJ>PP&J>2AB[(19J!+E\_4&P,46JZQ*KSSW`3GF]++KO.P7)BKI,L==IGERN[C@L5Y3U=MSGU M$U#C2^>1Y[&"A==#-,W%V0T],-&,OC@5.>O.Q*1LFZA0P-[(]_%Q:Q7`84@K3!B"6^Q]6(U!/6?'3OHCC3ZUC9MT&STC@M*55 MUFR[@%\X+V@&R>GITD_)#9*.`;U"6A@<.M#5!JT*47H)^Q2BSDF29KLMOC+A M,&Z'?.^S1>!9!QP'TS"P>A:/1UGU/9%U!V#X2B6_ M09?K1':_V:2+B0MK6:V=.>,-9"=?WOIYN`"3YI9'A')A;X4&H78#>)X2>1W; M@+N8&K:\J**:;S@3<5,+OE<>?RK`-GQ8!7[<7\XV]CZ[/#.P@J]G!QM'_D>W M1U4U1#@@HOJ7`?(&2>.?8Y2N<'+A.P2&'M'CT&JACLV`^8SK$IN!\YDZ.I%J M#DLP5/N.*XM=E*6;H:C[!%'$UB,[)8\!!WS7HW(J6QSN%=FKF77)8SFL)?-2 M(_64V7'[KUE%AAS5T> M[.191=FM0D4*14JS>)0[@U7.54KX;2+;86[-VLXE)F\S9_`XR:7"*?!W1G=6 MWU7&-4FV/L7S))&<,E<:NV:`Q772NXR%./E"PTV[_70.G0R?N&/F?3M;]6V` M$I-V>$M6:^8.+C$].CV1Q]'X.7K#E\S>8\::"J[MI*V1AJP2R7E+649S0'.@ M]UALQ?'R+QA3:4:%G3M4E7_"1K\PB^1/)ON>IH".20/8?A9_.YP"3Y.#CJ/' MQ[BSU=>GC+T(87Z9NKN(:Z['/9%.E=D5PP59L=Z$?7@CG>.!/#7O';OV]=IH\( M!HGLL.W,:>*DQF/5AW@8"9,?X5BF7-<:IN>B8JT;LVCM>B6R/B_)ON-=7`?_ M8;O*HZ*ZSG@IG;FD-AAY?4'GV?=HM%6KMLJQ45.71(F"48(;.XB"++(%A)EA M9A@8Q&%P9F`0D.&Q"0+#*KL+HBPJ;JT[8!4=4:E-3FQBHG[/<_&*&MNR8U,RT MS'2.E*P4SX5$489Y7_DAB:7:<-(6>I,&@OW`0W>DVR?`-V9G"A6'`3 M7HKXB2HDPZM%->*KYJ)_P"P&$L03'A,O12KA(CI"=CK'O7A1]>N":KO'(_;0 M^WH:78TCW@Q"1/5?D;^^HXA[O005Z^M/L._L8.6(?3-VIA,AXO4@CD@<0SWZ MT#3NS1*4JH\-9AT?:Y@JT/"]I:"MKJN].7\MZ(NH%7OK%DJ@Y$O?>\/Z!OHZF5G:MJ>M`&5/2 M8.CIXAPUC<*4R[",/RYSNFX%V6-JE"RAP_2YW"MEC$A:YFEZT:(")_SM*&USY02F\_E)>W=R7BL/0OS8.:UGK/=/='K#W)4',S'M;2[5E_1 M*1&N(!O7,S:N?I-<\]]QQ8M0W9[8XA`&_VH!1M@9A\`L6?M0:VLMD?J>XER= MB(KK*S]9(:`;7855^W%Q;`,CH\*62]*^/Q22=\GL;!%3$XI[OU M+F3^AC_PQ)OP1R/+R;HU^SS,;"CD\#U80#\N::\=8.X6N@<#U1XN"=XTG@H.XE93[P#;;?JTBZFH,M)4B MPT/'JL#,H[\8#]1=I/%R7(C[L&*"^![I]9" M#;E0QUR>+:;KRPXWM++DMUM3J?]:YS"4W9,=+/%>OP._QQ(++([H:."HH9!^ MP8V^VE[5,E:")?')VL_6KTQXE[KO`S9-T^RJD3#'F2XFA"Q^:G!_)K)X? M@*=L;@X:3."HVX==5^C5"DE\35JMFJ6&77PC`G<1C.$=S\?AD[,@LJ0.N9A8 M:O0AIO-$L8:`G"I)14=GA9'-:]$6,6=_:(=?G,XHUU1QCN1ZF/ZW^;YM!4\K M-2HH>=JO0&,B&B``=1R`*7CJE_[1?I%ORS'GIW(,GDQQSKL43T2C-9K,[9GD MTF)XY&^2F^Y(8#\ZU=G.US$#E6'N'/9'J^1:?RVQB$2.*PCPU$,#,OC]#73"]7+_% MCXW07`AAY%)54OA)>3?0G=_#>YP0A+0Y/C*?%!_E#"4R\N^PJ.D*./-_(0CW M93RL+2:7=M]*W3GX(:AYL*"I2%&1D2M1JW3Y6KH(X M7OR5,>R@[Q6\$+RGU]6*P`D8B[Z/X7%(*NK*WY>>L2]=ELT9H6-MN^W,ZF> ML8>T>VQVZ`&2JT0>11KV&'LD2U0D-I?XX:X7GEWNE M;%=Z3-<&9ONNZ&`O;AAE$K*C08I`5:#:08&,^85O\[!QLD:=S9H!IWM6<+-2 M)^Z-TUXJ=:`-/))'/CFI)4T2:$:M;0T5]CU0G:<)M%&"G&W#2^ M6P(I"*:ZU09Y[8X,\F?O3L+=L<$%3\+E'GH'I[$(KA:[NG$H'K>';"&$QI+E MV`Y/Q(FIJ,8INLJ1W,,#= M!!LON^Z*L@_7LIE&T6WT7Y"\]L`>8`B0&5+84&AOH`YFJ,(Y:A1JXYN MRSMK:6'`T80_3L)K%LOW;`L\5F7#+H4M%X5IEBR9TY$Q4%J)<)\05M*584EF M7P9/FX=_B5D\?]CMR<4;7?6EG`E[BOU2DS[5$6+IQ2BX,"7WE(1,`E)!N9DZ MT1K\@#X0K5?ZR!TR4Q39*L8U[)NG'#GS_?[;H]\8W.)M2RP/WSWS*,JX[#1B MI2Z.6.FM2MTV#4E`)H]\C5&YUR64&9)1X_'31UCJXI'"R*/,D>+RZB;9X:C= M43*W0"[[R>1;5^)CHV:2I-4V%25(7,Z<\G3#%$W`LQ4 M#5R#JS15F`6_$Z6+J?HLG38S0Q%3L8/Y4XC'UL\&PB]%Y-[@V)PZ`D($:$&/Q@AF$?!$T4%\DF[(7)7K1K:2WL]M7>]M[V=NUN7]9[ MNZZO8RL;;-92)@O(B$,-60P$323*DGTP*(DOG\Y=#@F>^A_PY??IE^PDSEN-D-.9\LW+B]96W/HI[F_41OFM+>1 MCD21CFQ',A(-1KSTR:.LI:^WWF*Q<$Z2#_&A`'T=KNA>K!BO?7UEOEJ@'0G, MX3IC&:0Z@C?/,Z#\#ZYWKSIE]7FY\!N--(J!YJO-1P0AOT""AW#/6?RV M$+;VD,02=.(#7K?G"]IB'+8/4^V>'V0&W(/;[7A)F!..D#"";_O%7$DOA\ME MNEK%]N$A`2-L5R:_E%?D>KUD53]0M%-J5YTZ4M,^AM45`SG/:;*_#>X^]3+= M"F(8'^64";*8&RN$:`5VL'@FD.&4X86VAY`MO%-_/!7RQR@IEC^78$`3^*EP M4TI=J+EPK60%UZW@346;W7RM3OT1X;-XP9?QFTDG9W29Z%>@Z0TP@$PXETB3 ML\6Q^0C"_YC%*[Z$=Q%BN^$Q0R=H>A<0%\F9?#A?8S_$XD4AZL@<`Q3\TW!* MCK@E:CR2F$&7?@IX?X:-4-!POIQA`@[^4Q4@\*[4H.%H3H&1%4J:= M5+OKP(V[S6'?A),EK1[_4&V1=2KX6=$H]JW")M!AN`\:HLE2J2JV*'`/BT\& M\@$KZ>(\AU^E;;/=WZ?);#&41@?J8?%Y<2)8.?P'?,$`=7#_8*==,/(M+&A% M>-9@6F`2,F;2I+G+HIY$=%TV_&D,.V;,`$=#!CDH>5=+#G:`^D/:<+H&$H; MJ4ZACV.(Q9'\X-6?+Z\!\AJ-@LE.!6EZ,M2BWPB65+*D?:S9Z](\UFQU:>K4 MO8!J/A/&#HQR0]LH2.M`3MV!*?!OG(=;L+1N10I?N$L!6@>G'NU`EOQ97+^A M'@0:J`'^X.>-U7(O8![4"E$A#H%=*,\V:(;=^]O;R'VKCGQQ7JE^U1\?\?H" M`9X.^/F`0'F]D=A4:FGM$D.\!)](ONM>A#! ME.*_K=TA[[^7/&T:8(_W++BGI8@HCM%B>$P,49+D\]A&N]I/,`0/.-L3].OM M\N9+,K3&@3FH`TKT$2OB=ED]&@==7!E+U1Y M<&4Q0R],96YG=&@@,C(R,R]&:6QT97(O1FQA=&5$96-O9&4^/G-TQR7)K9Z'Q[QF MDIS\R'FG7IWSW7N_[[OWO?-H:I@+1=.T*B#0?U'@PDFK#$DZ\Y3Y)F.<$_U4 M4M/2R&'2Z`_=\5R<_'/VSS[R':--M!*R7,$^XM+H#_Q4E`M-5^]?8$K9)!CT M&]*T$V(G:J?-GC5CLG.?.;3/=NZSO;3^<:;U.FW()G.:+LFL79H<:Q)23$), MFBYNJE;K;S1J@YT,9FVPSJP3,@@ZY$9K,&MCM&E"3)PN*49(U)KBMMV27 M\1+VPF&07P<5=S[YF_E1^J2P9;V;F_G=5>55ZMH=6[>$S`DV96J4VESPI4^` MK^S$;?9#:DU'_.E31SM.]^J.K8G4QT;S2C.)PWCP53T$7Z;^X?]-8M;!M\.< MN([@G00_2O`X4BS:P.^8%+&1KG',E3E^9V,C2S>W1_\3FZ5&#Y,""X,]27XY MAM4%HP18:T.&\LB*HUQ=W8GF`1[2%7L2[?XI7,*F;0'NH4$+Y+$_0,DK M7")7PE71)K3"N7:PMPLVU5OP!N\F4-B8C4Q'G4/#]EI.EB[E!C/1GDO"(W9KFN!9JB(;NWV9.JEL.&2C MKOV5ET!]6\!C&GD;1`W>42BEV:2?BZ>@U4;_@^@5@;?,(=K8T!T;*J]P4B:Z MWE/15<';\',!=5MZB3R.Q440BV[TEG<[\:<".EG251K@M!646!Q:2-IZ:D.A MV^,K^SG(@B*H9C&IE)M[2@F^FI--H5_=<:!`4[ZM!PQ MF=+*P6/R9NFQXO3VQH$:0I0HH`=%NQ,".=Q7BO!/TCPYU@N*VCK+HCX-TS.8 MC)::"@,+AX[S8(;D9J/K'/-DCH6.62RN$!3=EN9M1BY%%+$"3^<_@\_D6_9; MMM=R+0?%KRL)^TO2=ND^H=X($;C;`R_`J?HH0[&AF!QZA0UMJ(BJ/,(=V-7X M"&3\T7.OL+=\Y^9=J5NY%%-IF,4Y"1LRE6\N#WV(`Z##`Z:#<.#0L^KASAMP M1'ISA&Z6WL@<2BAB4Q5A.!Y39=A<(;DZY!YU@_4H`Z^7-ROVGVM^>+>Q;:#]5F;'$UG(==S"N0E7%7V[\H(T[U0H0=P8SOLHE-_EW)1&M=(V M^!A4X":3O(!F4\RIR<%JWQ4/0-NS`US_M+NCS^&D?=O'+_>JU%"9$Y?>J/TJSY8;%798`+,!`USALF66KO8X/+2ED.< M-(`3S>A22?VV4`[_'C69#1V!ZBD39N'Y)!&/^W[FH[O-S4<[^`#$9'^SKZ8, MW/8.)X&([]F\^*`H'Q'@`".^%SIW$-<.`J@UEPA`6^ MO:'S2*V0OIVO3A+#RHS#W^)I;%KFAK5!ZLGIK_]BT4"5XJ(E%^;C^6J,O*;@ M"7C>:_]7?[YL?]Y/FO@$K[>#\CVU,8]Z3X7F40%E;L_4+L4J,S1I3?JVAIK:I M7D/T&^$]>[7J5O\-<49TL&7!LJ#"*W_@E7-%JS3->A<\55?`$X\C!_(%59G2T<&]A-(=/H<@LBSZ?-T,!8KQPF.0@;^8ZNZ&WJ[VMN\MP M9%UT@CYFB-`QW$K?!(ULB&AK:XM&>H*#S>A,^9H\S>`.9,[3QPZQ**44HJZZ MJ;>J;I,3XG_Y1HYFSC@N6=GP,K'5QD$E8AZ`R]S652NC34'1O#U;N.2EGKDV MT)RC*54P9P9PB!FUE#19PIP.(]*+$XH(=Z$5Q546D@Y([4%4??QLUR7QRT0> M%Z,TT1AI(1FY5J2KR&^P<\[XR;,G+XIA1F?<+!HC2DD\'Y'K^A]W=WYQQO1( M'58VHEQLM0[YNC?DRWL=\<(3+SU#7HX7U18,32LBJT1?2)B*K"BJRM+2R)'\ M@ZBFZ\SQBV6K3$ZM^)RL!*>7+43KDYQ6R==Y4\?#-!@O`S_8Q(*BZN6=_GU! M>"IF"KP7^8AO@>+Q>'?L_AV6$TNCGX`+C`+-E+_CWV#-YQAAEMQZT0J78>R, MQ\3W(^*Y%DY;V1456_;V7)#K'>8"\VCGMTJPVE2H-]J\%3(W^[))67HP_\%;`"3_QX3Z/L#<_2F MA1]O^SFD!I^5D9.6E,]NO1OHR\;J'Q/8]SC[?G3Q&JJGI:\>$^3$N6!$H!\. M>)[Y.)K[>I<&]Z"2_'6.!WV9^%:5]UZ9"/MNC/ASD_<0BPD>H$-Y%_\,"?'1=+T5X=$=3=&%T93P\+T=3 M,2`S."`P(%(^/CX^#65N9&]B:@TS(#`@;V)J/#PO3&5N9W1H(#(V-3$T/CYS M=')E86T-"C$@,2`Q(')G"B]'4S$@9W,*,3@@,3@@-3@P+C`X(#"DR+C@H=&4I,C`H;G0@=&\@=VAI*3(T+C@H8RDM-"XT*&@@=&AE*3(P*"`I M+3(T+C0H<"DR-RXR*&4I+30N-"AR*38N-BAF*38N-BAO*3(W+C(H"!!("DM,C0N-"AH M*3(T+C(H92DM-RXT*')E*3$W*'1O(&AA*3$W*'9E*2TW+C0H(&)E*3$W*&4I M+32!O9B!T:&4I,38N.2@@*2TR-"XT*')I*3(Q+C2DR-"XQ M*"PI+38N,R@@:6YC*3$V+CDH;"DM,BXW*'5D*3(T+C$H:6YG('1H*3(T+C$H M92DM-RXU*"!R:6=H="DR,2XW*"!T;R!V;W1E*3$V+CDH(&]R("DM,C0N-"AR M*5U42@HU,"XV,3@W(#`@5$0*,"XP,3(X(%1C"BTP+C`Q.#<@5'<*6RAE*2TV M+CDH8RDQ-RXU*&4I+38N.2AI*2TR+C$H=BDR-"XW*&4I+38N.2@@9&EV:2DR M,BXS*&1E*3$W+C4H;F1S*3$Q+C,H("E=5$H*+34P+C8Q.#<@+3$N,3(R(%1$ M"C`N,#$R-2!48PHM,"XP,3@T(%1W"ELH82DQ-RXR*&YD(&]T*3(R*&AE*2TW M+C(H6DI,C(H;F<@*2TR-"XT*'0I,C(H:"DP*&ES M*3$Q*"!!=V$I+3"DM M,"XR*&,I+37!O="DR,BAH92DM-RXR*&,I,32XI M,3@N-R@@("E=5$H*,"`M,2XW,S$W(%1$"C`N,#$R-B!48PHM,"XP,3@U(%1W M"ELH("`@*2TR-"XT*"`@*2TR-"XT*%PH*3(X+C,H9"DP+C$H7"D@*2TR-"XT M*$YO="DR,BXQ*'2!H92DM-RXQ*')E*3$W+C,H:6XL M*3$X+C4H('1H92DQ-RXS*"`I+3(T+C0H;G4I,C0N-2AM*2TQ-"XX*&(I,"XQ M*&4I,3"DP+C4H8RDM-BXW*&4I M,36TI751*"C4P+C"DM,"XV M*&,I,38N-BAE*2TW+C@H<'0I,C$N-"@@82DQ-BXV*',I,3`N-"@@2!O*3(T M+C(H2`I,C0N-"AO2`I,C0N-"AT:"DR-"XT*&ES*3$Q*"!! M=V$I,32`I,C0N-"AO8RDM-RXX M*&,I,38N-BAU*2TP+C8H2DM M,"XV*"`I,C0N-"AE*2TW+C@H;2DX+CDH<&QO*3(S+C@H>2DM,"XV*&4I+364I,38N-BAA M*2TW+C@H2PI,3@N."@@*2TR-"XT*&]R(&$I,3"DR-"XU*"`I+3(T+C0H02!A*2TW M+C$H2!F*5U42@HU,2XX,SD@,"!41`HM M,"XP,#0Y(%1C"BTP+C`P,2!4=PI;*&\I+3$W+C0H"!!("DR-"XT*&AA*2TW+C@H=BDR,RXX*&4I+36TI+3$U+C,H92DQ M-BXX*&XI+3`N-"AT*3(Q+C8H(&AA*3$V+C@H9"`I751*"C4T+C4Y-CD@,"!4 M1`HP+C`Q,S,@5&,*,"!4=PHH;F]T("E4:@HM-30N-3DV.2`M,2XQ,C(@5$0* M,"XP,3(S(%1C"BTP+C`Q.#(@5'<*6RAT*3(Q+C@H92DM-RXT*'(I,C@H;2DM M,34N,2AI*3(Q+C@H;BDM,"XR*&$I+32!T;R!A*2TW+C0H('!R;R!R82DM-RXT M*'0I,C$N."AA*2TW+C0H('!O2`I,C0N-"AU;F1E*3$V+C4H6DI,C$N-BAN9R`I,C0N-"AT:&4I751*"C4R+C(U M,SD@,"!41`HP+C`Q,#,@5&,*,"XP,#@R(%1W"ELH('!E*3$U*')F;W)M*3"`I,C0N-"A!('0I,C(H;RDP*"`I,C0N-"AT:&4I,36TI."XY*&4I M+36DI,C$N.2AN M9R!4*2TQ,2XR*&4I,32`I+3(T+C0H="DR,2XY*&@I+3`N,2AE*2TW+C,H('9A*3$W M+C$H;'5E*3$W+C$H("DM,C0N-"AO*3(T+C,H9BDS+C2!7:71H*3(T+C8H:&]L9"DR-"XV*&DI+3(N M,BAN9R!4*2TQ,"XY*&$I,36DI,C(N,2AN9R!4*2TQ,2AE M*3$W+C,H2`I751* M"BTU,BXW-#(Q("TQ+C$R,B!41`HP+C`Q,C,@5&,*+3`N,#$X,B!4=PI;*&\I M,C0N,BAT*2TR+C8H:&4I,3"DM,"XR*'0I,C$N."AE*2TW+C0H;G0I,C$N."@@*2TR-"XT*&$I,36TI.2XV*&4I M,32DR-"XV*&DI+3(N,BAN9R!4*2TQ,"XY M*&4I,36DI,C(N,2AN M9R`I,C0N-"A4*2TQ,2AE*3$W+C,H6TI+3$T+C@H92DQ M-RXS*&XI,"XQ*'0I,C(N,2@@=VEL*3(R+C$H;"DM,BXS*"`I,C0N-"AB92DQ M-RXS*"!M*3DN-BAA*2TW+C$H9&4I,3'!I%LP(#`@-C$R(#%LP(#`@-C$R(#'1'4W1A=&4\/"]'4S$@ M,S@@,"!2/CX^/@UE;F1O8FH--B`P(&]B:CP\+TQE;F=T:"`R,S8W,SX^2DR-"@@82DQ-BXX*')R82DM-RXV*&YG*3(T*&4I M+32!T:&4I M,32!D92DM-RXR*&PI,C(H:2DM,BXT*'9E*3$W+C(H2!A*2TW+C(H('=R:70I,C(H=&4I+32DR+C2!I9B!T:"DR-"XT*&4I+32DM,"XY M*"`I+3(T+C0H7"@Y*3(S+C4H,%PI("DM,C0N-"AD*3(S+C4H82DM."XQ*'ES M*3$P+C$H+"DQ-RXU*"`I+3(T+C0H82DQ-BXS*&YD(%PH:6DI,C$N,2AI*2TS M+C,H7"D@82DM."XQ*"!L92DQ-BXS*&$I+3@N,2AV*2TP+CDH92DQ-BXS*"!O M9B`I+3(T+C0H82DQ-BXS*&(I+3`N.2AS*3$P+C$H92DM."XQ*&XI,C,N-2AC M*2TX+C$H92DQ-BXS*"`I+3(T+C0H:2DR,2XQ*&XI+3`N.2@@*2TR-"XT*&4I M751*"C(S+C$Q,C@@,"!41`HP+C`Q,B!48PHP+C`P-C4@5'<*6RAX8RDM-RXW M*&4I,38N-RAS*3$P+C4H2!A*2TV+CDH=2DR M-"XW*'1H;W)I*3(R+C,H>BDM-BXY*&4I,32DR-"XW*&TI+3$T+C8H92DQ-RXU*&YT(&ES*3$Q M+C,H(&=U82DM-BXY*'(I,C@N-2AA*2TV+CDH;G0I,C(N,RAE*2TV+CDH92DQ M-RXU*&0@*2TR-"XT*&4I,32DM,"XW*"!C*3$V M+C4H;VYT*3(Q+C,H6TI."XX*&4I+32!O M9B!T:"DR-"XX*&4I+38N."@@*5U42@HM-3(N,C`U,2`M,2XQ,C(@5$0*,"XP M,3(R(%1C"BTP+C`Q.#$@5'<*6RA#*3(P+C(H;RDM,"XS*&TI+3$U+C(H<"DR M-"XQ*&$I+32!A*3$V+CDH="DM,BXW*"!T:&4I,38N.2@@*2TR-"XT M*&4I,38N.2AN9"!O9B!A*2TW+C4H;BDM,"XS*"!A*2TW+C4H<"DM,"XS*'`I M,C0N,2AR*3,N-2AO=F4I,38N.2AD("DM,C0N-"AL*3(Q+C64I+38N-RAD*3(T+CDH("DM,C0N-"AB>2DR-"XY*"`I+3(T+C0H="DR M,BXU*&@I,"XU*&4I+38N-R@@0V]M*3$P*'`I,"XU*&$I+38N-RAN*3(T+CDH M>2XI+34N-2@@*2TR-"XT*"`I751*"C`@+3$N-S,Q-R!41`HP+C`Q,3<@5&,* M+3`N,#$W-B!4=PI;*"`@("DM,C0N-"@@("DM,C0N-"A<*"DR-RXT*&2DR-"@@*2TR-"XT*&]R(&$I,38N."AL;"!24RDV M+C@H57,I,3`N-B@@*2TR-"XT*&,I,38N."AO=F4I,38N."AR92DM-RXV*&0@ M8GD@=&AI*3(Q+C8H2!T;RDR-"@@*2TR-"XT M*'0I,C$N-BAH*2TP+C0H92DM-RXV*"!#;VTI.2XQ*'`I+3`N-"AA*3$V+C@H M;GD@*2TR-"XT*&$I,38N."AN>2!P;W)T*5U42@HU-"XP,3$R(#`@5$0*,"XP M,3(Y(%1C"BTP+C`Q.#@@5'<*6RAI;VX@;W(@82DM-BXX*&PI,C(N-"AL("E= M5$H*+34T+C`Q,3(@+3$N,3(R(%1$"C`N,#$R-"!48PHM,"XP,3@S(%1W"ELH M;RDR-"XS*&8I,RXW*"`I+3(T+C0H82DQ-RXQ*&YY(&=A*2TW+C,H:2DR,2XY M*&XI+3`N,2@@;W(@*2TR-"XT*&(I,C0N,RAE*2TW+C,H;F4I,32!P82DQ-BXT*')T(&]F('1H92DQ-BXT*"`I+3(T+C0H07=A*3$V+C0H M2PI+38N,2@@92DM-RXS M*'8I,C0N,RAI9&4I,39)S*3$Q+C(H(&)O;VLI,C0N-BAS*2TQ,RXR*"!I M;B!T:"DR-"XV*&4I+32`I+3(T+C0H M2!G;W9E*3$V+C0H2`I751*"BTU,"XW,38S("TQ M+C$R,B!41`HP+C`Q,B!48PHP+C`P-C4@5'<*6RAB*3(S+CDH;V1Y+"DQ-RXY M*"!<*&DI,C$N-2AI:2DR,2XU*%PI('0I,C$N-2AH*2TP+C4H92DQ-BXW*"!O M8G0I,C$N-2AA*2TW+C2DP+C$H("DM,C0N M-"AO*3(T+C4H2DU+C8H('1H*3,P*&4@*5U42@HM-3(N-S0R,2`M,2XQ,C(@5$0*,"XP,3(S M(%1C"BTP+C`Q.#(@5'<*6RA#*3(P+C,H;RDM,"XR*&TI+3$U+C$H<"DR-"XR M*&$I+32!F;W(@=&@I,C0N,BAE*2TW+C0H('!U"`I751*"BTU,"XW M-#`W("TQ+C$T-C,@5$0*,"XP,3(X(%1C"BTP+C`Q.#<@5'<*6RAO*3(T+C2!I;B!M*2TQ M-"XV*&$I,36TI.2XX*&4I+38N.2AN*3(T+C"DP+C4H8RDQ-RXW M*&@I,"XU*&$I+38N-RAN*3`N-2AG*3(T+CDH92DM-BXW*',I,3$N-2@@;RDR M-"XY*&8I-"XS*"!S*3$Q+C4H:"DP+C4H82DQ-RXW*'(I-"XS*&4I+38N-RAS M*3$Q+C4H("DR-"XT*&$I+38N-RAN*3`N-2AD*3(T+CDH('0I,C(N-2AH*3`N M-2AE*5U42@HU,2XP-3@@,"!41`HP+C`Q,C(@5&,*,"XP,#8S(%1W"ELH("DR M-"XT*&QI*3(Q+C2`I+3(T+C0H="DR,2XY*&\I+3`N M,2@@=&AE*3$W+C$H("DM,C0N-"AA*3$W+C$H9"DM,"XQ*&IU*3(T+C,H7!E+U!A9V4^/@UE;F1O8FH-."`P(&]B:CP\+T9O;G0\/"]&,2`S,R`P(%(^ M/B]0"DP+C,H8RDQ-RXU*&4I+38N.2AP M="DR,BXS*"`I+3(T+C0H82DQ-RXU*',I,3$N,R@@*2TR-"XT*&4I,36TI.2XS*&4I+32!O9B`I+3(T+C0H:2DR,2XX*'0I+3(N-BAS*3$P+C@H(%,I M+3$W+C4H=2DR-"XR*&)S*3$P+C@H:61I*3(Q+C@H82DM-RXT*')I*3(Q+C@H M92DM-RXT*',I,3`N."@@;W(@*2TR-"XT*$%F9BDR."AI;&DI,C$N."AA*2TW M+C0H="DR,2XX*&4I+32!T:2DR,BXR*&TI+3$T+C"DM,"XR*'1E*3$W*&YT*3(Q+C@H("DM,C0N M-"AT*3(Q+C@H:"DM,"XR*&$I+32!T:&4I,38N M."@@*2TR-"XT*$$I751*"C4S+C2DR-"XV*"`I+3(T+C0H9&\I,C0N-BAC*2TW*'4I,"XR*&TI.2XW*&4I+32!B M92DQ-BXV*"`I+3(T+C0H9W)A*3$V+C8H;BDM,"XV*'0I,C$N-"AE*2TW+C@H M9"!U;F1E*3$V+C8H2DM,"XU*"`I+3(T+C0H92DQ M-BXW*&PI+3(N.2AE*3$V+C"DR+C4H=&4I,3DN-RAN="DR-"XU M*"!A*3$Y+C2`I+3(T M+C0H0V\I,C0N,2AD92DM-RXU*"!3*38N.2AE*2TW+C4H8RDQ-BXY*'0I+3(N M-RAI*3(Q+C2DP+C,H("DM,C0N-"AW:2DR,BXS*'1H($-O M9&4I,32!M*2TQ-2XQ M*&4I,32!B92DM-RXS*&YE*3$W+C$H M9FEC*3$W+C$H:2DM,BXU*&$I,32DR-"XS*"`I+3(T+C0H2`I,C0N-"AS*2TQ,RXU*&4I,3%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH-,3$@,"!O8FH\/"]&;VYT/#PO1C$@,S,@ M,"!2/CXO4')O8U-E=%LO4$1&+U1E>'1=+T5X=$=3=&%T93P\+T=3,2`S."`P M(%(^/CX^#65N9&]B:@TQ,B`P(&]B:CP\+TQE;F=T:"`U,3@U/CYS=')E86T- M"C$@,2`Q(')G"B]'4S$@9W,*,3@@,3@@-3@P+C`X(#2`I+3(T+C0H;BDR-"XV*&\I,"XR*'0@8F4I+32DR-"@@*2TR-"XT*'=I;"DR,2XV*&PI+3(N."@@;F]T M*3(Q+C8H("DM,C0N-"AC*3$V+C@H;VYS*3$P+C8H=&DI,C$N-BAT=70I,C$N M-BAE*2TW+C8H(&$I+32DU+C(H('1H*3(Y+C8H92!#;RDU+C(H;2DQ-"XW*'`I-2XR*&%N M*34N,BAY*3(Y+C8H("E=5$H*+34Q+C0R-#$@+3$N,3(Q.2!41`HP+C`Q,C(@ M5&,*+3`N,#$X,2!4=PI;*&\I,C0N,2AF*3,N-2@@*2TR-"XT*'0I,C$N-RAH M*2TP+C,H92DM-RXU*"!S*3$P+C2!O=&@I,C0H92DM-RXV*'(@<')O=FDI,C$N-BAS M*3$P+C8H:2DM,BXX*&]N(&]R(')I9V@I,C0H="XI,3@H("DM,C0N-"A4*3$R M+CDH:"DM,"XT*&4I+32DM,"XR*"`I+3(T+C0H;RDR-"XR*'(I,RXV*"`I+3(T+C0H M=2DR-"XR*&XI+3`N,BAE*2TW+C0H;BDM,"XR*&9O*3(T+C(H2DR-BXS*"!A*3$Y+C$H;F0@*5U42@HM-3`N-C8W-2`M,2XQ,C(@5$0* M,"XP,3(T(%1C"BTP+C`Q.#,@5'<*6RAC*3$W+C$H;VYS*3$P+CDH="DR,2XY M*'(I,RXW*'5C*2TW+C,H="DR,2XY*&DI+3(N-2AO;BDR-"XS*"`I+3(T+C0H M;V8@=&@I,C0N,RAI2!T:"DR-"XS M*&4I+32E=5$H*,"XT M-SD@,"`P(#`N-#@@,3@@-C,R+C0@5&T*+3`N,C4@5&,*,"!4=PI;*"`@*2TU M,#$H("E=5$H*-C,T+C(V.#4@+3`N.3DY.2!41`HP(%1C"B@@*51J"CDN,#$X M,2`P+CDY.3D@5$0**"`I5&H*150*,S,W+C8X(#8S,BXQ-B`R-38N,S(@,"XW M,3DY-R!R90IF"D)4"C`N-#%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH-,30@,"!O8FH\/"]&;VYT/#PO1C$@ M,S,@,"!2+T8R(#,T(#`@4CX^+U!R;V-3971;+U!$1B]497AT72]%>'1'4W1A M=&4\/"]'4S$@,S@@,"!2/CX^/@UE;F1O8FH-,34@,"!O8FH\/"],96YG=&@@ M.#(X-CX^'!R M92DQ-BXX*',I,3`N-BAS*3$P+C8H92DM-RXV*&0@82DM-RXV*',I,3`N-B@@ M82DM-RXV*"!P92DM-RXV*'(I,C&DI,C(N-"AM M*2TQ-"XU*'4I,"XT*&TI.2XY*"`@*2TR-"XT*"`Q,C`E*2TX+C,H("DM-S`R M.2@@*2TV,S7!E+UA-3"],96YG=&@@,S,R,"]4>7!E+TUE=&%D871A/CYS=')E86T- M"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZDY4 M8WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B M('@Z>&UP=&L](C,N,2TW,#$B/@H@("`\&UL;G,Z>&%P/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q M+C`O(CX*("`@("`@("`@/'AA<#I#&%P.DUO M9&EF>41A=&4^,C`P-RTP."TP-U0Q,#HQ.#HR-2TP-#HP,#PO>&%P.DUO9&EF M>41A=&4^"B`@("`@(#PO&UP;65T83X*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H\/WAP86-K970@96YD/2)W(C\^#0IE;F1S=')E M86T-96YD;V)J#3$X(#`@;V)J/#PO05LR-R`P(%)=+U8@,2XQ+T-N6S$Y(#`@ M4ET^/@UE;F1O8FH-,3D@,"!O8FH\/"]$6S(R(#`@4ETO5'EP92]*;V)4:6-K M971#;VYT96YT EX-31.1 10 c17407exv31w1xpdfy.pdf SECTION 302 CERTIFICATION PDF begin 644 c17407exv31w1xpdfy.pdf M)5!$1BTQ+C(-)>+CS],-"C$T(#`@;V)J(#P\+TQI;F5AF4@,S0O4')E=B`R.#$U-2]2;V]T(#$U(#`@4B]);F9O(#$S(#`@4B]) M1%L\,S!"1D8V14$Q1$1".$0V,S4P-CA&-S9&-C%$,C5#1C@^/#2DM,S,W+C2DM M,S,U+C0H2DM,C8X+C$H=&\I+3(U.2XT*&UA:V4I+3(W,2XU*'1H92DM M,C8X+CDH2DM,C(P+C4H<')E'1E2DM,S(P+C@H=&AI6EN9RDM,C`T+C@H;V8I,38N-RAF:2DQ,"XQ*&-E2DM-#`W*&QI:V5L>2DM-#$T+C8H=&\I+30P M-BXX*&%D=BDY+C@H97)S96QY*2TT,3(N,RAA9BDQ-RXT*&9E8W0I+30Q,2XT M*'1H92DM-#`T+CDH2DM,SDX+C$H9G)A=60L*2TT,3(H=VAE=&AE65E M7!E+U1Y M<&4Q+T9O;G1$97-CUL;P<[VLG.=K&KW>QN#WO:R][VL:_][.\`!SK(P0YQJ,,<[@A'.LK1 MCG&LXQSO!"ZRM6N M<:WK7.\&-[K)S6YQJ]O<[@YWNLO=[G&O^]SO`0]ZR,,>\:C'/.X)3WK*TY[Q MK.<\[P4O>LG+7O&JU[SN#6]ZR]O>\:[WO.\#'_K(QS[QJ<]\[@M?^LK7OO&M M[WSO!S_ZR<]^\:O?_.X/?_K+WW\$&`"]PG\""@T*96YD5`4=Q;N9ICNP6.BT[8K/6[/ M!/`*BJ`&):(!#"H(B.`9XC'"@"/,#/1P*KJ*P("<2G954!.AD:B`B@>7&L]X MX$$@7EF/F)0IMXSNKIJ\GCQV:WM(=LO:ZJ[WQZMZ[WO?][WW(PE7%X(D24WX M_)#(L#G>"TUFHVU"B#4EP9GUE+2D-,Q5&CEH.`:BY=?<7ZFJB/,%FLZ3FI1GWP'+W!DC#1*NA-L`N%*T,0'A)GXG&@C M[A-OR#`RC[SC,MTEW^6V8I9BK^L8USS7)\J%RG;*A]I-W:;_2&?37:I`U4FW MZ6[E;C\/V#+@^4#KP$=]:]3.G\5`QRNR'90*^,H1SBX4T(!#L(T+:,"UD(M# M^0;ZO:^6]8#(P:6NUD<7^/^60(A(MQ46V&UL^B4N*7R%C191E.C[.(FWPK0+..^:P?A1N^M?'RJ>4>F.# MP[V!K(-),!(F*:`'!#8L;UYA)I]5N"DI4;MD71=XZB"'?E0"FIN=GR]`;QX[ M<""+RU^@%PP#_1,(@+F0CX-`Y3$:-9Y8R:M+ZASCLTB(@K$**:J.'9NW_Z9. MNKF.QDHDE6GTSJ:F';NT+24K!5T?2T<6):"JE+=)`VEU";A+D4"1:M_E=+7I3X`\^2J"`++G[!0?C\9WF2'PW&L?$9/$-U.,C5[?5:E_5 MC+'B`!R,(]`?@W7ITA1:O>&T=.N!!@[#Z""@F.Y+TF=L777SY6XM\]TWC2NC M?0.$N%S=.IKIOIL&0PWHSODML<3QD>874[7)YO2U$3V6O\H$!X,:]'=6]09^ MH6.^:]W?(M[CGLTZX8T#9OI%6&3&4(4*4$BA69J]Q\$(GDRVY`M5K!0ZG9Z( M@^1Y9DQ"#Q4JH91FVF3E1M%,-GA=`P6-JX>CD8)XZ%"64>HM5Z1\8$C)[;X" MQDGM+!RD3@*CQ#O4>_BBM_!NX4VS^]GT<\NBN("P#!,?$?/];.VJ[&1KS(V4 M>Q#^&ES@#R^BKZT0=7./1F[SK52IJS+AL[:T>OCW?DT]C`<>_)A3!S>R(&^< M!RR$<$[V3G?1#^<:<>8BGGF`0>!J[-Y375I>S3.GJLMV5597+<4%Z+9T3)8* MQDCE[+D%2XO6\UNVIA:NU\Y>?Q>\=.J*$A&"6B1YUSYU!"H< MH2(;5[R^:<4O:)-J1U@I%/K:S$$;3(NVN`NP4J1-97'E1[F:FN,-O3QD4+N2 M#P6G@_H`@:E[#%/"%`.0A MB+'`;GC.'J"8C.M%/^2B)Q>U<1*Z&')JVGBIU+6VM+3^C);)?+`O.G14A@$Y M'9;VN;%PAV+,D%3Q]8O''%`>IZ?NXLMHIOG$3E#6@X(#7UQ5$MTD$_Q)7O<_0PB3LFLX=%-0606$3#B"`Q]?",%&'B]1S&Z!;K&W M%D=Q?9OIQ"Q+!,^D0+%TD]VW=:O8I86@6C3YXI;)\]`U+F_/,5V_A`?A3!,< M:NJ7T!_\ZX$2F2SF<(U#Q_Z/:&1*44P!SV0)TD/Z&"0H9>.\(T:EC=.&9^]H MU4$A_?*,&8?NT-7#CVE4+@Y9FN9=JH)<^N2>BO.@[1'0HU9FO+SO-J76RPMQ M\2W`"2+0=Q&*!4ENE%S!$+A2_!-%!G)87<^D<\% MJMM^J'@>YT&O6F^>C`L*H*P'@H[)IS"*9][\[H_N__U)05Y^099A"+AB*)3K M&.E[T#8T=>J`H1_6E5_=SJLOR\S.=CJE,G MI=`_'"S]VCG4/P6ZK=\3YHASW\U%L?D\DRI(=VCG:F9D.OQD%UNE6:U,6\UP MR!*IX*K,O;VT]5GH,&O^_'S>:9]C1"/9+'OW"X0J)'?':!;^PV+9QC1U M1G$2_9)J*)7QP(DR7-$&6S#!4%#%D-3$4:7FUAL`$"(J6O M4.3]M;P4J(516!2(4QPO:@RP"#*S!20.''+N=W M_N?X]F,8^@648`'*45X"!4O@UP]AX,OUOH?1&(B[,0T381_N(:,V`?;!'DB$ M-`R$W1C-;6#GZ(/Q/H+=6U*>P\0F5HCD)9OX6%6.>8&!2`I\3".F2:=D?KAF MMH\T+!YO"&&)T=(+:NIGK4,7Q*Q%4J?SKQ1<9:]I]8:X8@F]`@;^=VF;J:[N M!]DSYT44H_>Y--QJ_L_X;O;`78%S$$:5`N3T`GE@YU>D#HNY9DPV?S/>#W?$ M9N%.`\=Q6@0)8B\\1-+'.+;UV;/!G7"XY>0-^B6?PZ=+ M(365RM%J\S+3ONX-D=&_850*?A"I-`:"_%/NEV315,IMS1?,%:T_>K+T7TB? M`M&[;"X-C79Q8[FEN=4QK/I;!A&3L/4%N,OOJYHXW#LGHN>";N6TC3)38S?N MP>:'2!UM9@7*^/4>]W4WWT*W=3=9H1M$DQREZYJ MK1@@L8OUH!2MK8AUJ!39Q58(6+7,E$O6.J@@C3Y4(-Y%@,NYXW*WN?\#G\#3 M(0_7*5>P%#/4XC]*:U619(NB%'H\0!#YV`CL!`M+`L/3`L/+:FJ\I%,?Q.`2 MA6Z=28,7V:BIUR5#LH=++:-WN5O#]2\?,/"$FFZO&:MD-PIG_9;WMKDWNN0> MKC`A3)E:/*3K-J0P&48CJ?%!=C_L%Q4TZRKJ&+O5^*"<1'E#VE??I&Y-@3@< M\L$C>/F24J55:$A4G5MSN8C)2-?'ZH2. MME'IYEQSS#,\#DX?LGVI6[J6*R6"FHTN=PAVLO,!G)9ZX5LNB! M7Y%=*T]4W)AK:V"Z:RL>$S4OU-2(KB/>$D.]GF5> M9"""@M,P:>VQE[>4[?+*GU3,\MM[MMG`#VG8!1)@Z0MT+Y\Z*2TJ$NET.D.I M+,O84L%!/?7ZX"")ZAT1&1$^:JR]US#0S/Z86MG*-+9;G;_6)YYE0RDZ$S^, M1_K\1XS\4%8[OWD4)VP#\80\E%]'L5M/BTNWO`R1ZGZ+Q'354F\&Z0D(.X5]+"Q)/*$"/LN+]2 M_^?L>%ND@?7*:7$%-^#WM6)HO;Z654;EU_,QU7"N7H)I)EY3"=[&36SKD>]V MKGMN`FZ+R=.+UVUW?2/]5X`!`!\HA#L*#0IE;F1S=')E86T-96YD;V)J#3(U M(#`@;V)J/#PO4W1E;58@,3,Y+T9O;G1.86UE+TI/0DU)1RM4:6UE%LM,38X("TR,3@@,3`P,"`Y,S5=+T%S8V5N="`V.3DO0V%P2&5I M9VAT(#8W-B]82&5I9VAT(#0V,2]4>7!E+T9O;G1$97-C5`49Q;OINEN0!EDVD;H<;MGC;CK!8@:1(C+J*`(J04/ M/'"70X8(`H,S(S,X(H<O)QQX]4I6X%6OKJWI_O/K>[_W>[_N];AQS=L)P'&=6_7[INY$K9Z]- MRU3KYJ[69"9E.=)OB0I<]'$6IT[T0J$HZ\==/WJ14S68.Y@\H,5S<"KK*L>< M;]MY6O?*W6V8JYP4O6CC'$8->Q6!'#`Y0JE(TR6KEFER=7IVI M4T9F;=%HLS7:)+TZQ4^I5&5D*%<[$'3*U6J=6ILC95^Q4:;IE$E*O38I19V9 MI-VFU*0JH].R-/K<;+52M4*9E)7BK]$JTZ0ZW8YD75I*6I(V3:WS>WT2#)<. MYN*$N;MBWABFP+%I)#83QP)Q;"&&A6#84A!9X+G.7F4_%,F M@C$K94J93@R',H0!)A\!(:6/B6%:7HKA[$3L^.$OK]WB1F/K]-KT78E;N@O; MJ_=75E;QE?NJ*BV*ZNK2(J/ICY%)@DQG7V3`!Q\0,&A?Q")_?W\T"X5QB.]< M=GX9W[OF6OBEC-KWO=$2P,V@L7%0_6SXSL?\>!G$/R!Z43@+_M]\`[,@C`,^ M_?:FV[QZ*/)F[(E\DSXRW@<51!\<9J.AXC(M4Q8`@=\$@@#/`FGJEE.-/2>VMV=F:K7; MU%VF%D$66IUCCS#@17">@-/2A"LIE/NO"/(Z),@"H[S\)D M"]JW(K0<%:/):'(Y%-V_;H%],%EH=T;12"UH90.;11X;,YEI%EWE[CC"VD5:E MEL>6\S+S7?'H'1R>/"!$#?R*W;V?C$XQ[DU5H#T4A,)R\NRYKYZ\Y,!YWO6` M^7/CT>Q,OJ64_.C(\;M/%.#6YK\A+''>`C\!1:!8,E_D:%E>M_CD$SG<&E'? M9F[`7!AE;UC:2KN-+E?2:U5:+BPYU(^/40_]06'2%VO6/RQMA7DP\1%,`^^W M3R4U"*.]UQ&_S#X@.RI&'! M%'5%C#7(:T]#\3!C%#/`Q/J*L0D4^G0LEHR"+IKY$(5\03-&"+'1:.45%A53 M4`1/28LD>H_XUQ$A\759.["HH*MBN0FD(X*B2+ M]U:5'%``5@;AF]$"#LE4:U;QZ[+_'J788LXJ?.^<;@0"P>DE^#PNZ$B\*,3< MGML84N\BJ\L1G][!FT45(:ZSSV+'*,J4D#B]<0]YL;.IXZH",BFT:>PI>96" MK?9II"Q4,A!4`B&_#P23"%/A'V^R$=."D/,;[?7*S_!\'""_C\G^P>'JCL[: MD:LWN:]B:G,*XO>N33V^^^3_N'KKSZYF`GK%]#=:5\3-5MC8+RXTX`WV%80] MSLHF5.75;/L,6<2KW@8*I8SE&Q,RENJU/KG&G>6F"A7;J)2TVO2.6-<)`>VRTM$-!P#%S0,5(&E\U68P\,G(;: M'J-5#J0-2FV+@69.-=JGL%^6U>>KN+$8>GG^SJ!RJ?XAS72!MAGXWG^&#"YH M$BS2Q0]K'AT!@@-_M*Q^`8\Z*=B$'K//3I86=@G,CHNF\^G!'.*0>U%D;.Z^ M'EZL=VZPU#?SA^LK6Q3,F5LOC&B"XY1KA#D5#D)Y9\7GIW&)'V''Q/5L$>P@ MGFTAVK.@,5*$SZH[@C/;*`:C8LA.@'X&FI%'*;R,R,9;_I=&<]DP&KQ"MMLMIX#^5!VXB!_X]W6 MQ4$<.HLJS%'Q^=5=O`RJI1:],-`/AWJE+M_;H/%HYW^P*0488Q"_A7=8#34C M86,F\E2@F>;*?@$J:?`K'ZUHR*L-\3D*N_34\H)"G32G'VBIKEIS"P\*"HAV M4V"#T$;MA;?(L6,4TVVD+Y>VEH0ZN"W1%T5)W`Q&L8>60;SDG+_]W/S@T8'Q MYM^+.FE;)7PZK##7$*Q`OA+^\>I];3Q,_27^Z$_XX71P_JZP,NGQ.ZWT\BI# M[><<:&CP+?^\HK6P)LAGW*OGST*/%?_!!D,VPNH%)ZS4._L+K=B^:S_I;5QS?W[*R/NUC4Z`)8'?B]@&P.=J(@:3<622<(N:)J:S97U`GIJO\3:@%@LW='X!B("$;Z/00.Y0-RW":\V M"_J[X93#:S8;[):\]IW]-U8VV:)KVO$!2H8#WG\^#%ZMP''@AX);`GG403'W MC?1_B:[2J"BN+"PZW8\9$TRH5-`JIXJ))HY19Y23B4M<\Z\ MQHQS3OVI<^Y]][OO?O>[]PVG",F_9AV[2DMNK;X,?9&M*1MBP`OU&R`9#TC@ M+U+J^:2/.$[7Y1WK:0<''9Z#Y^%/TY=GO*&@^*+#IKP"0E]":,4'*T3/,GIY M5F+9#4;,[44PW1R/IU?PU=)46"N9')"FXK62:M(,E;5E,)WMG=1)U^MBEEH+ M=A993SLE/CQEDR<^FB'>`F=Z@TR^!3NP.%\J.HN_2(3)*A2'UTEJI$.FPK_! M/!:BI9.ND[](5.(`JB;3S.ZQYA)H8V%UM7W+DTT/X8]CU"MH@UETA"XQ7,5I MD\/5,C8HLJ&3R,F)@GY8=($C8N)')R>I-;%LI+ZNCH?=Z*K^1[R0HYYC6U_G M`\K"J(::LLH*/D\K"$S#J=*F^LZDC9P;HE[AY5]_%KJ`<>D.ZNWK:6MJX38: M.S)*V>*&S*X.WD[3*,Z\#BN$,W'V-RT0]X0:(^-RE+Z4/5C:R/ZC>?Z?7)58 M@M%A9]-)?KF2#GIUZ`)LO0).$Z^W`\+OKO/8%I/*I4.?5&N04),^"N\$'[6M M$F7FY.MSV#/ZV`B>9/N=**FS.7YWAO@1+*4]0X/\-[++-]TAHKO@64-+CS$^ M(I?/D>7(2J)K#'/J#<5E54RINB&B@BL^["<$LW@:MK6RS^GUEOMC?ST-TEX" MNUM?+/[._`9X[3C$6:B3\,^7=/#1@"/[6->-_;`0YM[HZN_L"MM\C*LF1#8":K8Y?G.&N!A6T$$Q_IN=6-=5[?!5(@^# M4G!(PGZ!WW/#6_%'=U:2\3K_,LQMR.?Q?5A,/RENK>UC[^6[^!PC"YU> M$![$WMH=V$6/O]K!KPQ[ M@(>D:Q7)KCI.!28!_=F043/`P!#8(3L<>0D^N;,O%A8=AX.M1K.]>3CRX>JK MX'FWUDR-.%*G'5\LH^M+*QI:./+;J:G4?Z^S'4GO2O=C/#;OQ;_EB`66!K6&#H*!V2Y M(>RZ13YXYK83>ZY$\]3M"J?5>K6"B:I)K%5SU*BC9[#O?A)C=._+"5C5#Q)S MPHBCD:/&'F$Z1Q*1Z9-5Q92WM9<;N)QF;2';_U,K3+N07*:ILBZ6(MO[IMZW M+>!FH<9$I4![Y6F,MQGP06T9,!//^M8[S"OD#1VS?J6CWU2)L]Z6>#(,;="D M[$HAEQ8N(&^CW'B7@51TOKU5J&/[*@-<>.R-ULJUWEIB$8+L5I/`LPKZXN`/ M+^W__O)S"_6*S$>-(-V4K2TA<@XH+6NWW%.^6S%'A0PFDZ&(+2[+<.>Q"JU1 MI&[5<=3L:^)_R$XC+PIKKJ^LK#/+JB)"5&%RSIK1"@$V%I&,'EBHN\<^!+4@ MC@W@)>,RNJY6` M/;!F?0\K8/\$U)%[-"GY:)(J@3\0ZKXS.#S=,%O\#*41NHL>"H\$[S=TS\LT ML:TY2C]^,A;M.IKNDL1-9?G:BN2%A6JI^!"2!.FV+$7N94;\?LK]WU9WCRGW MPO^[1Z.=\6IW,H?$E<3?P932;3]N@6^LWP=SJ:[Q1[1+1/J!#'*1AP44DGG0 MT,7`260\UWNSNR3`E<,1:$N,SL_*WQ@![<\,S[K#@!&=J#Q!VN*[3'=/'@>C MKY7I7JG$(DI`T0;)WF.9]95DB**1A)_GK7;[]D@LUY$4WK&%W;4_S,^='T4I M!.S8'H6ORE=MJT"&W/PW!9EZF1"$FC[[^Q9PME!G[T_0[BJUKS5XB(!V9R44 M-S%D7V\YU5!>SUXI#7;C<2!:%ZT-LEH$$*9D)PJ=#,0CF.55G879B/M"P>!CX?\'' M2QYC![YDTHW&[Y#'U,C/?=W7GUTD9N_A>2Z!GKP=CBB%;8VBK9!\U7[4`K)Q M:FP4.]#^:;&N6DX!VE*T45DPR,,R%-9D3FIC@;\%CD18YZQ[X+1VCW=4+)]N MD-Q&J03F@SPZ2XAJX,B#%YLOC]A7@ZYO"B4>>G`\,= M]26\$;M)O1)BOM018$E%R"\_/OL\0]J4,"@[12?9@!_2&6%ZY6ZY;4J$EW% M.@7\\(PG9[[;>WOLATSG*.LZ(\"/+UP+DZ_;W[%0`W&%"!%0)Z& MT.R;#&4"&6H\;XBI"`T/CG'WY]*=3@ZC..\XKWEM) MT:-97&6'%K57*<_<5K;B8('?8Q435P`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`G=@XXERNI`P-C!(;\)A0G;OK?/_I&4Q7Y#NJQ>DAYF34ZQJFH]8 M.TE;C\%JI"MP.T8P0+@"]DB8G)CCX[Q,4V=&8>ZI<[@=5-BM$5J63[-D=SVF M;]-J8T]+U$CIN0:'3KW0%C>L?'GQ'LA7-)R23HJRX8:]VMSOGI1$IK+V%.46 MQ9XBSZ)02N5`%3[V$17=CI8B"M,J&)=*"!'_02Z<0T15JP'?[`8%M`J/[I;( M^?80RC4+.\<%S`R!R:,",;C+\L@L2+>&H%;(Q@]XR12$/,_^R9RM`Y*K`'8* M_PLP`#$,)4D*#0IE;F1S=')E86T-96YD;V)J#3(W(#`@;V)J/#PO4W1E;58@ M.#0O1F]N=$YA;64O2D]"34E(*U1I;65S+5)O;6%N+T9O;G1&:6QE,R`R-B`P M(%(O1FQA9W,@,S0O1&5S8V5N="`M,C$W+T9O;G1"0F]X6RTQ-C@@+3(Q."`Q M,#`P(#@Y.%TO07-C96YT(#8Y.2]#87!(96EG:'0@-C8R+UA(96EG:'0@-#4P M+U1Y<&4O1F]N=$1EF5R M;R]H>7!H96XO42]:+T@O9R]S96UI8V]L;VXO='=O+T(O8B]T:')E92]F;W5R M+U0O<75O=&5R:6=H="]P87)E;FQE9G0O12]X+T$O4B]F:79E+W!AB]S;&%S:"]S979E;BD^/@UE;F1O8FH-,C@@,"!O8FH\/"]3=6)T>7!E M+U1Y<&4Q0R],96YG=&@@,C,U,B]&:6QT97(O1FQA=&5$96-O9&4^/G-T\`@80AJ?"*@(B(FIW;:W6[JJHK*O5^J#NSN@Z=L[5 M'U,W<6;_V/G-G#_.S/E]S^=[SF%A_GX8B\6:MWWWEEW;(Y?NDV2)Y[9X!G)/,R/ MQ:KR;)7FY,LDA],5PL6I2X2?A*U;L\P70S_$,%\,6R4,3Y.FB(5[\^4*<99< M&)F=*I7E2&4BA3AMA5`8GIDIC/;](!=&B^5BF=*;_="44"(7BH0*F2A-G"62 M'1%*#PEW2K*EBOP.OD>2ER29I$)).(Y2O^#PAC>1_V M.PP+P;!5+&P+AFUC8Y$L;#>&[?7'XC%LGM<,C(WA6!+V@K6>->`7ZF=B![/S MV*_]S?XO<`E^G?,9IRZ`##`$A@BY0BYRJ<%3-R'\"S4)?(#7*]L)%`[GO1U!`'%C@ M@&"Z&UGY,/\E3,#^%WT1JQ!W*?H)):'Y#EC8*O"AN>%,/YSH\J&5O":FB+L0 M\G8N_XRUTW:(U!M3+0H!^FAZ4_Z.`GN<.4@+=G=`;*76>8)L=#AJAP3C$(-; M6^IM?Z,@\6O@WJ:)*5B*-I0F"5`I![;MX=>65;B[*/#K$H6C,!3DV%)0Z'2I M:*YA-&&,X;;P&A]"W"UK(S%`J)DT\.,G'53)=)2YJ**R^SG\[*JE+2Z<&(BR MV&S&)-S.Z;!EM"=3*`@M1[O1HFS7IR]I8OC*>!=P']!..TZHM5'6/`6I<>2> M&3S1=_N*@!B8GEG-?_H4PZX[E@8B#T+[^5&.KQN?O8!, M\!]Q)"G0;Y:@Z&4T<1+&;_,31"J%BC*:*QO<,)O9/`A;:&LY3N3%&>(L<=9` M3<"EDDJK@M1;9&:I(!FMMMOQEF)+[U[OFJ+-:`=:&ML<^8`FE.&_E^T`$I]Y0WTQUE.*QM_?G^)#F4>3S.2_LIVH@6[NS9 M].;EL^?N&@%W(TIM9B9[0-W"0HON,)]-LD\R0OY3SNKI=7BJ.1=Q=U"%EJHJ MNJ;:T4BVY=;I2P2'[0ZQC3Q0,5#03<&,R[`&N!WT3;B%`XM3T8,CC#-6W041 M_Z3JCA:;:8/1D4<:*G)Z6IL\'H]V>"OBQ:.PM;F"E1RN:42C9,BQ]]@5`_8> MFV/`6E0\&)ATW2-DQ"`CAAG\!+$\4T69S96U-*%IO@_5)\EK!RKS/OD]6A&? M*;`[X2-FA\]M66SA5Z;8HD!M0'LIWEM255!(ZK31!I$`_7;:CD]P>H'7<&GX M1F"'YR'@YREWG5%#$X,%8>AT+IE3I^ZY/OCMA3ZO&X81!G.WJ8#XA3WILGKZ)YBP.7%B.LVR3BNV>T4O55F5M'0C*DTD M\QU)(Y>'+OWUE("8U\E8^+.P%DUOAERA3D]OU;3UNKL]@O]Q)[IY<'JBY#Z1 M3G0RR5[:Q$.R(RK*KG41P_L&XEHL,3O;3?@=BG&Q=CB#'& M&+VZ%X\:=,H_H8),A-,3G`$(KAL\^T,@D7:Y[^JC<]2Q"GT^372FAB.;G,QV M9IV]>/+L]^<%W)YF)4R]VGXMK98WS+");V#V_`$(JA_^\\U`HK.AZ@JPNRGB MF^.ZPX-439_CP@E9@V+GYVA&9`9M5MF=HY#@:Z+NH.7+@CB+=[^=-36N&JJ[ M7*LW%4F,A^CU:!CG]AB:F66M/&#=.GNGW4V\ZH,0O@JMQMVH'$]QVPM,FJR5(T'J07Z#9DT M\6HSS%P:269H$_:NUSX?LO@&-@KO>EC]4,N&4>:/_`V!MSE;4@1=KU5$Z,JO#Z+EP:NCNF*"@$C\B M2T]4409K5;7+X2QU>*=^8>;+I'N(BO&)%W7DGI MTG0U92BI*6^H&ZKPT)-P`0_GI`GS=NX/#R1 M_NRJ]_I=2B:LKLU[',%_AXUCQ##!-/\7)@'9_O@G%=62C7N;,0B549C[-D,: M>HM^E)J=G]+-'A.XK*[W*?=&YQJP$I)N''X6D:?<J,;HY6>G1\3E*-UEWA77$XY M5QZ`P@7C>7R+=1MK27."9YU&W5_>7L?$Y1SFWBLJI>6GIP>K;"UP;O-J?L,&%:8FGVH&Z*H MB_<&TA\.>9WY(9S[AICW?Y(&]Z"._'2/!WV9^%:5]UZ9"/MNC/ASD_<0BPG7 M"_B(%/?Y%0(,`,1>>E\*#0IE;F1S=')E86T-96YD;V)J#3(Y(#`@;V)J/#PO M4W1E;58@-S8O1F]N=$YA;64O2D]"34I)*U1I;65S+4ET86QI8R]&;VYT1FEL M93,@,C@@,"!2+T9L86=S(#DX+T1E%LM,38Y M("TR,3<@,3`Q,"`X.#-=+T%S8V5N="`V.3DO0V%P2&5I9VAT(#8U,R]82&5I M9VAT(#0T,2]4>7!E+T9O;G1$97-C"]C+W4O=B]/*3X^#65N9&]B:@TS,"`P(&]B:CP\+TQE;F=T:"`R M-S$O1G5N8W1I;VY4>7!E(#`O1FEL=&5R+T9L871E1&5C;V1E+T5N8V]D95LP M(#(U-5TO0FETF5;,C4V72]2 M86YG95LP(#%=+T1E8V]D95LP(#%=/CYS=')E86T-"DB)```!__X``0(#!`4& M!P@)"@L,#0X/$!$2$Q05%A<8&1H;'!T>'R`A(B,D)28G*"DJ*RPM+B\P,3(S M-#4V-S@Y.CL\/3X_0$%"0T1%1D=(24I+3$U.3U!14E-455976%E:6UQ=7E]@ M86)C9&5F9VAI:FML;6YO<'%R7I[?'U^?X"!@H.$A8:'B(F*BXR- MCH^0D9*3E)66EYB9FINHJ:JKK*VNK["QLK.TM;:WN+FZ MN[R]OK_`P<+#Q,7&Q\C)RLO,S<[/T-'2T]35UM?8V=K;W-W>W^#AXN/DY>;G MZ.GJZ^SM[N_P\?+S]/7V]_CY^OO\_?[_`@P`K?9_@0H-"F5N9'-T("(B(B0F)B8H*BHJ+"XN+C`R,C(T-C8V.#HZ.CP^/CY`0D)"1 M$9&1DA*2DI,3DY.4%)24E165E986EI:7%Y>7F!B8F)D9F9F:&IJ:FQN;FYP< MG)R='9V=GAZ>GI\?GY^@(*"@H2&AH:(BHJ*C(Z.CI"2DI*4EI:6F)J:FIR>G MIZ@HJ*BI*:FIJBJJJJLKJZNL+*RLK2VMK:XNKJZO+Z^OL#"PL+$QL;&R,K*R MLS.SL[0TM+2U-;6UMC:VMKX.+BXN3FYN;HZNKJ[.[N[O#R\O+T]O;V^ M/KZ^OS^_O\!`P,#!0<'!PD+"PL-#P\/$1,3$Q47%Q<9&QL;'1\?'R$C(R,E) MRWM[?7]_? MX&#@X.%AX>'B8N+BXV/CX^1DY.3E9>7EYF;FYN=GY^?H:.CHZ6GIZ>IJZNKK M:^OK[&SL[.UM[>WN;N[N[V_O[_!P\/#QOKZ^WO[^_Q\_/S]??W]_G[^_O]___\"#`#GK#\0 M"@T*96YD2](5"]$969A=6QT+T]0('1R=64O54-2(#,Q(#`@4B]4>7!E+T5X M=$=3=&%T92]302!F86QS92]332`P+C`R/CX-96YD;V)J#3$@,"!O8FH\/"]# M;W5N="`Q+U1Y<&4O4&%G97,O2VED7!E+UA-3"],96YG=&@@,S0P.2]4>7!E+TUE=&%D871A/CYS M=')E86T-"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ MDY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z M;65T82\B('@Z>&UP=&L](C,N,2TW,#$B/@H@("`\&UL;G,Z>&%P/2)H='1P.B\O;G,N861O8F4N8V]M M+WAA<"\Q+C`O(CX*("`@("`@("`@/'AA<#I#&%P.D-R96%T;W)4;V]L/D%R8F]R=&5X="!!9'9A;F-E9"!0&UL.FQA;F<](G@M9&5F875L="(^=6YT:71L M960\+W)D9CIL:3X*("`@("`@("`@("`@/"]R9&8Z06QT/@H@("`@("`@("`\ M+V1C.G1I=&QE/@H@("`@("`\+W)D9CI$97-C&UL;G,Z M>&%P34T](FAT='`Z+R]N&%P+S$N,"]M;2\B/@H@("`@ M("`@("`\>&%P34TZ1&]C=6UE;G1)1#YU=6ED.F4X8S0U9C-A+65F9&4M-&%F M-"TX8SDU+60X9C9D-&5F83)C9CPO>&%P34TZ1&]C=6UE;G1)1#X*("`@("`@ M("`@/'AA<$U-.DEN#IX;7!M971A/@H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"CP_>'!A8VME="!E;F0](G')E9@T*,"`Q-`T*,#`P M,#`P,#`P,"`V-34S-2!F#0HP,#`P,#(S.3F4@,30^/@T* EX-31.2 11 c17407exv31w2xpdfy.pdf SECTION 302 CERTIFICATION PDF begin 644 c17407exv31w2xpdfy.pdf M)5!$1BTQ+C(-)>+CS],-"C$T(#`@;V)J(#P\+TQI;F5AF4@,S0O4')E=B`R.#Z#:A)_,,B')>!H:\#4":$8C/`P08`-J-#`$-"F5N9'-T2DM,C`W+C(H:VYO*3(V+C$H M=VQE9&=E+"DM,C$R+C(H=&AI2DM,C(P+C4H<')E&-H86YG92DM,S,V+C@H06-T*2TS,C0N-BA2=6QE2DM,S,Y+C@H;V8I751*"C`@+3$N,3DV,2!41`I;*&9I;F%N8VEA;"DM-#0P M+C'1E2DM M,S(P+C@H=&AI6EN9RDM,C`T+C@H;V8I,38N-RAF:2DQ,"XQ*&-E2DM-#`W*&QI:V5L>2DM-#$T+C8H=&\I+30P-BXX M*&%D=BDY+C@H97)S96QY*2TT,3(N,RAA9BDQ-RXT*&9E8W0I+30Q,2XT*'1H M92DM-#`T+CDH&5C=71I=F4I M+3,T-RXU*%8I-C8N."AI8V4I+3,S,"XV*%!R*3,P+C8H97-I9&5N="PI+3,R M.2XU*$8I,S@N-"AI;F%N8V4I751*"C`@+3$N,C`Q."!41`I;*&%N9"DM,S$Y M+C7!E+U1Y<&4Q+T9O;G1$97-CUL;P<[VLG.=K&KW>QN#WO:R][VL:_][.\` M!SK(P0YQJ,,<[@A'.LK1CG&LXQSO!"ZRM6N<:WK7.\&-[K)S6YQJ]O<[@YWNLO=[G&O^]SO`0]Z MR,,>\:C'/.X)3WK*TY[QK.<\[P4O>LG+7O&JU[SN#6]ZR]O>\:[WO.\#'_K( MQS[QJ<]\[@M?^LK7OO&M[WSO!S_ZR<]^\:O?_.X/?_K+WW\$&`"]PG\""@T* M96YD5`4 M=Q;N9ICNP6.BT[:K/6[/!/`*BJ`&)6("*"H(B.`9XC'"@"/,#/1P"KJ*P("< M2G954!.AD:B`B@>7&L]XX$$@7EF/F)0IMXSNKIJ\GCQV:WM(=LO:ZJ[WQZMZ M[WO?][WW(PE7%X(D24W8@ME!8>%>BTQFHVUBL#4YWIGUD+2D-,Q5&C5H.`:@ MY=?<7V&^]/B@Y61_M[ M1QMM1B%#SO8/HS?9]`9]FF"(-YH-0I+>FJ`/-UFL:=DI1GW07+W!$C_)*NA- ML`N%*T,0'A)GXG&@C[A-OR%`RC[SC,L,EW^6V8I9BK^M8USS7)\I%RG;* MF]I-W:;_2&?17:H`U4FW&6[E;C\/V#+@^4#KP$=]:]7.G\4`QRNR'90*^,H1 MQBX2T(!#L(WS;\!UD(M#^0;ZO:^6]X#(P:6NUD<7^/^60+!`.5UT'!? M6JX&KT@T+PUOSVG@=U2656IW;M_\IY@/HJU9.AD%/@(5V0IV!1R#8RS:405V M2FZU$6:2QV&FXG@/.XCXY'!"9\?1PYWMQI9/8A/C5LI8X649CH\S21M\JX#S MCKFL+X6;_O6Q\BFEWMC@&-E`UL%D&`63%=`#`AN:-[\P@\\LW)28H%VZO@L\ M=)!-/RH!SB%X\=.)#%%2_0$X:!_@GXPSS(QT&@:M_E=+7I1X`?>2J"`++G[!0<3\)WF"'PW M"L=&9_(-U.,C5[?5:E_5C+7B`!R,(]`/@W1ITE1:O>&T=.N!!@[#F$"@F.Y+ MTF=L777SY6XM\]TWC:NB?/R%V%S=>IKIOIL*0PTXDO-=:HGE(\POIFF3S&GK MPGLL?Y4)#@8UZ.^L[@WX0L=\U[J_1;S'/9MUP@L'?.@;;I$90Q4J0"&%9&KV M'@#!9D@]4L5+(#'H2#I+GF3D9W56HA%*::9.5&TTS6>!Y#10TKAF.1@KB MH$-91JFW7)'R@2$EM_L*&"^ULW"0.@F,$N]0[^&+WL*[A3?-(\^FG5L>R?F' MIIOX\.COYVA79R59HV\DWX.PU^`"?W@1=6VEJ)MW-&*;3Z5*794!G[6EUL._ M]VOJ80+PX,N<.KB1!7GCW&$1A'&R=[J+OCC/B!\NYID'&`BNQNX]U:7EU3QS MJKIL5V5UU3)H(7)Y6L*PHA]^R-:4P1SLGYRYX MZM05)2($MDCRKGWJ"%`X0D0VMCBG:>4O:)-J1U@I%/K:S($;3(NWC!1@E4B; MRF++CW(U-<<;>GE(IW8E'0I*X=9E;XTHY`6X1_<5P2;V;V#_!]J5ZF4EHG`( MN@Y`_0%!U+R&J>`#_LA#(&.!W?"+?LA%#RYRXV1T,637M/%2J6MM M:6G]&2V3\6!?5,CH=`-R.BSM/.:#<3T_;Q9?13/.)G:"L M!P4'/KBZ(H;'JP+57G2B.)3KRZ(CD^PQ!;RZ(JO3X=9(GH(0R4]4.$;#!-9[ M>J!YIC8YH+K7H$OH*GA^F8.9+3`1Q@#U&-VF-O,B;$RAA,UY&2FI'Y[RU6(" M>J(/KL(%H,'IL`&&W;_VZ)M^^81FZ7633/`G>=W_#,%,\J[AT$U!9140,N%P M#KQ](!@;>;Q$,;L%NL7>6AS)]6VF$S(MX3R3#,7237;?UJUBEQ8":]'D@UNF MS$?7V+P]QW3]$AZ$,TUPJ*E?0C_PJP=*9#*9PS4.'?L_HA')1=$%/),I2`_I M8Q"OE(WS"A^=.EX;EK6C50>%],LS9ARZ0U#=%'JRUF-4"I*=*/F M"(3`E^"3(#*2P^Y$I\+5+?]4/%\SIU>G6.>@@L+H*P'`H_)IS":9][\[H_N M__U)1EY^099C,+AB")3K&.E[T#8T=>J`H1_6E5_=SJLOR\S.=#P0C&-?Y<^4F*B0.VL*9IS0<>T]5GH4&O^@GS>:9]C1"/9+'OW M"X0HI)&.,2S\A\6RC6GJC.(XA+6W*C+BM8JW\UZR3403OS@0)DN:(U!A@$61F"T@<.IP+4\.7 M$,(2HZ47U-3/6HR!NP+G((PJ!#.^%PR\D;]$L^AT^70FHJE:/5YF6F?=T;(J-_PZ@4_"!2:0P$^:?<+\FB MJ93;FB^8*UI_]&3IOY`^!:)WV5P:&NWBQG)+L+<)??5S5Q MN'=.1,\%WL][NMNOH5NZVZR0C>()CDXT^W! M5]NDGULTYN<,WT$]+EW56C%`8A?K02E:6Q'K4"FRBZT0L&J9*9>L=5!!&GVH M0+R+`)=SQ^5N<_\'/H&G0QZN4ZY@*6:HQ7^4UJHBR19%*?1X@"#RL1'8"1:6 M!(:G!8:7U=1X2:<^B,$E"MTZDP8OLE%3KTN&9`^76D;O&ZU\^8.`)-=U> M,U;);A3.^BWO;7-O=,D]7&%"F#*U>$C7;4AA,HQ&4N.#['[8+RIHUE74,7:K M\4$YB?*&M*^^2=V:`G$XY(-'\/(EI4JKTI*Y5F:CDLJ4Y7U,2TW[(GBP`R/O M$"H.K?FJ*D174>\Y2HH\+D/ M[J6"-?IC@J.\)89Z/NKUP4$2U3LB,B)\U%A[KV&@F?TQM;*5 M:6RW.G^M3SS+AE)T)GX8C_3YCQCYHY2?.F8L4U-L>D5EPHQLN+^CMYO#V`EI M;GYFADIV*<_I6'IC;[=P!-S\\:QV?O,XA'<0(?X0!!Q]A\[C'8/2*+/>WL7P M3S!90XV5MAIB&%10G1J5\X3L@'\PAI*+Z/`DSU.T7F/FJI,X-T@ M(0=QKZ2%B2>5(4;8<7^E_L_9\;9(`^N5T^(*;L#O:\70>GTMJXS*K^=CJN%< MO0333+RF$KR-F]C6(]_M7/?%LM,38X("TR,3@@,3`P,"`Y,S5=+T%S M8V5N="`V.3DO0V%P2&5I9VAT(#8W-B]82&5I9VAT(#0V,2]4>7!E+T9O;G1$ M97-CI6O[AC-6I&6K=K)6:C,1,9_IMD<-%/U=QLJ9/^;^Z$M. MUF!>8/*&)I_^R6RL''/!\7VV19JL'&WJQYOURO>2IBEGAX;,F^D\@U^=HCTZ@R==DJ96J)NRUWODJ%D`\51 M%DJD9]$Z^N]N:K<>MY?N!>Z//((]SHYS'Q?G.XU/'V_W6>#3(L?D>YD)3"5S4RE3RG1B%)0A###Y,`C)W4P,T_12C&(]L1,' MOKYV2S$26ZO7IN4F)'44ME3OJ:RLXBMW5U5:N.KJTB*CZ0_+$@69SA%BP/L? M$-#O"&%10$``FHXB%(AO6W1N$=^UZEK4Q73KP4EH(>!FT-@54/UL:/`2/U8& M\0^(+A3%0L"WW\)TB%``GW9[_6U>/;#L9FQKOFD2+$2X&6FF*E#UC`6J&%ZF M+`$L)%L.@=U,P@AZBV6:_C]1)N%UJA!W&>^&"J(;#K#14'&9EBD+@,!O`D&` M3X$T==.IAL[6K2T9&5KM%G6[J4F0A5=G.Q8;\"(X1T"/-.%2"N7\>S%YG9+E MM3CD+?C19U#[C(`J!\_"!`O:O22\'!6C"6A".13=NVZ!W3!!:'%%T8G(@#R0 M5Q_20S1$]X$>O,`C$0PH6I"9ZQW3)#%2)1$]?.%X/15AJ.D7Q'_0.RUH:2"9 M1Q\>,)NM7+MY:[8PNHY6I93'EO,R\QWQR"`.3QX0H@9^P^[80T8G&W>E<&@G M!>$029XY>__)2P6XSKX>.&=6/)J1P3>5DI\?/G'G"0<>S0%K(Q)FS_47T&(4 M2^:+"EJ6UR$^^;,<;@VK;S,W8!:,L#K.\0NS0H'4U,XNO+R&/U M?4-/N,&.N+4!$?&!F=*P8%IQ18PUR*T]4#S$&,5T,+%3Q=B-%/K;:"RY`MII MYE,4]A7-&"',3J.E5UA43$$1/"4MDNB=XI^&<1!O$K!,O,O"6JIFOWE_E=#U MN*B:S"TH*MC*(36%<%1(%N^J*MG+`58&41O07`62J58MYS_*^NL*+LF<6?CQ M6=TP!('+2_![7'`\X8(0**D+\R#&=':4HT\:$=QIV MDA?:#AV_RD$&A=://B6O4K#9,864A4L&@DH@Y/>`8!)@,OSS339BFA!R?:.] M7OD9GH\!Y':^FJJZ/;7"9^!.0CW5.X/;9E*DI%6D\$;81X_ND!8( M:#@&;N@8*8/+9INQ$_IZP-IIM,F!M$.I?3[0S*D&QT3VZ[*Z?)5B-(:.S-\> M7"[5/Z29=M`V`M_UK[#^N8<$BW3QTYI'AX%00`!:5#>71VT4K$>/V6;'.M=Y2U\@?J*MLXIC3MUX8T3AGE&N$F15. M0GEGQ.<]N,2/<&#B&K8(MI'95-K.-'/IMN5M01R*D/XI7DB/+*":`?,@^@'X M6"J%G$-D1OJB2.3-(3D:]Q`VPSMGKG1W";U]%QO/<^!].VQ*\YBNQD[Q&^>L M+^PB!3B3?M`7.BFX-`QKP0_T:`[@J%A`1RBFP4A_55)3^$J`J'S3;\MX)AU6 MBE?81K/M+,@'LA+Z^1L?'IT?K$!G4(5Y17Q^=3LO@VJI11?T]<+^+JG+]W9H M.-+V$S:Q`&,,XG>P@-50[VY.`J(%E-0O=!,[8*WR=%C%--AI"^7'BT)=W);J"]:(7$S M&,5.6@;QDG/^\G/S?4?ZQII_+^JD;97PZ8C"'$,HAZ9*^">J=S?S,/G7^"/_ MPX^B0_-S(\JDQV^ST9%5!NN7"M#0,+7\RXJCA37!?F->/7<&.FWX#W88L!,V M7VBU40OV%-JN*6`3#*`U=$39MF`G1*N-'LN+,?0M:^V=O;P-M1KIP9(Z2684 MAP8@[M=YB<)8O4QGMCE<;3C0=N*0+YRW42J+[L"0$^QN<_4755+1>2,]\III MWY<^MB?SNL2?I*)(.P&MXGEVL*YF:(]TM<=(WRNUYD4J1I/H-;EY.E[=?'\) ME[D]PYBWUW0P1\BO:=[1QWT";U5!G-,Y:+$-9AX7_].!MP,E+@2*<,2B.6R` M9>6)#9W;Z^(N%#6X`58+_B\@2P';4;"T82%2!"-WE(-2@?=_JN7/KB:#AL`W M#11<;:.YLDY`3QT763L0\Z4[FJE!_R6ZRJ.B.J^X2&<^6AM(>'FB[]GW:#2U M1DV5D\8EBE&(@HD$-V0349%]"0K,,`,#@S`,#`/#)L-C!YD90`%97!!E%_/1\_I&TCM.>^?=\Z]W_W=>W_W^]T/6V/K#Y]##"2" M]?@4.S.?T-$"S1;&3DV!0F#LRW\OK20/:8]5Q!OP(%VU M$X--8F)]=2:[)3:F\1?&%?0CF M&A/QW&JV3IP!SJ+I07$&=A;5"2-58ZB$N73?M%J\61VWRM+V\\ARVAG^\1FK M(OZ)-7\77,DM\=+MV('&Q6+>E?]9Q$W7(@G>)*H7#^M+_@J+:8@53[M/_RQ* MX@=1G:")MD^55T"5`!OJ[%N?;7T,?QPG7D,[V)%1ZI3()$:5%JF(IX.C&[N$ M2^GTB0%8?HD1KJ0`,BU5H4R@HS4F$PO[T'7-#W@90[S$-OZNA^4E,8WUE375 M;)&*XZC&,Q6G&KI271@/1+S&:[[\)&PIY=83W-??VWZJE7'1=697T&6-.=V= MK*VRB9]W$]9RYR3VM\T@>4:,"Z([2E[)&ZIHHO_>LN1C=SD687345=_,KI&3 MP:^_N00[KH'3Y)M=@/`[F[QVQF4P6=`O5FE%Q+2?S#?93V$C1SGYQ9I\^IPF M(8H5LOV6%YFL3MZWYC^`5:1W6'"@"[UFZYAP=2]]T=C:JTN,*F3SX_/CRV/K MM0L;M&65M52%HC&JFBD[&L"%T'@.MK&PS^G-]H?C?SD+XCX!=H^FC/^-<1:X M80(D9J(9_C%%AAP/.G:0=G<9@&6PZ%;W0%=WQ+8"EHB&Y=A`NJDT51T4/X0L M6"];L/K,8"U\BQ6O0J;PJ-)`&O]J!4;8`0?"8DG;2&NK01`(#W&>6D1$]U9> M*+M8;B.D=1NBFP"U6)V\;U;2G^%W M/?`._,'8.D&DEUR%18W%+'X(*\AG96V&?OI!L9M?@;`6:CA^:1,<-%K]:+:& M&[P7B>W`1MRJZ^EGNG2?=])5M7K3Z0.&W=A-@[_8S:Z+>(2'QX>X%L$&*,'IB9A_0"(C,DCCCJ&&'^"R7Q1 M5(Y?;BU5U=Y1I67R6U0E],"/;3#G4EJELM:RGO)TWVR_[YG!PTR,\W*.]"E2 MZNY1X(?:LV$>MOO:-\(G=):.N;_0,6"FQ;EO6SP=@;8HT_>F"T6+Y)"O3JJ[ M3T$&NMC1QIGH_IH@-Q;[(F>IRE:IR010`9>;NDWI+]\D6)B&M7J\MIF'4]-2F8/AWGN"8G,TB[@/T&9`MUY+YE7LN\LW8MR]'1;OCR`G4Y`>X]G MN:4R,UF^L2!Y929:J^=#*B?>F2LKO$KQW\VX_\OB[C7C7O)_]UBT)U'A*:@9 MOT[P=]"G]]A/F.$KR_?^(J)[X@GI%I5U.%LHY%$.A>:$:[LI:$:Z"WVW>\J# MW!DY9,A6,1P*%8K M.E"0TU`C2#$:2?YI\0:/KX\E,)VID9W;Z;V'(@(\V5&4+H`=WR_S3_)7V,B0 MMK!XMB$S[QL!H;+?_J$97,W$^8>3I&>2PM\2/)1#^W*3RTY1PM;?>J:QJH&^ M5A'BP>(C:%.L*MAB$20P)2^%ZZ(@$8&=JV&_YY'0_;[,@YEP]RWA`F;"Y9UX M&TYIY)V,5J9)*)VTABP^D,34.N%%8(?IR25`PHH[P/X3/ESY%#NPY=,>)/ZM M\"0;^:F_Y^:+RX+9NWBQVQ%OUA9'5<#.)MZ&2[MN/VJ&^`EB?!0[D(&9">XJ M1@:J"N0B/S'$PFH4<Q<,MJ:?@>_[.UEMCEL&N0 M?\^8*;&OFP"YF7@)T_Q&LB8H3N]-X_>6X;F8P5"KMJB$_\;2=LF M98TN@=]1FR:QOWS#0P]A=_ST1#W<@F&2*,Z$WXE2Q41#IEJ5GB:+K#I`?Q3H MOGMS?_"-4)8P7`T7-256'8N@=OG+PY9)G_:F,'(Q<02OTB/"4)2?EUM"YQC/ M2L_30^.=3Z^'>6*(!SQD2!==DF*JH^O]27+X_35UA'*=A]Q[FE!D+IIR; MG,9$-+IE\T=TFD5?F65[,?6-CL3`%,:,`K-2>P-Z^],6>MM;6GJA<&^IE+83 M*ZBL(;A)=&("V5XLBPN:R`M)]F*)DNA\]1QR2/#T'_@^YWGRG,_W^69+3^[_ M*M>/\9_F_YUNG+`\Y9#7.>1W<,;KT420_'A:<;7^4.5RN4)>'(Z%8Q'RF,V) M.Z<=CWY[,#F3)YZ4X/%UN]JDANC";3N4_D?5_GFO0;<:6_Y9AJ_X2O,8ZWQ8 M>T)5<_ABT!^X3ER.#G>']$W@3\,.2VR'&Q75"?4$ M9@FT[85S.C,;+Y7(S(QP",54P=KU8.078XZGT:1,3YF6&[2IDEXN&Y-=$0N1 ML<`5?/X8VW/A$U(/`T)8#YE#N##6EX\1DS4H:#0R&C([[AU;84K^VZJSZ5CO M@)063.RG#8QF.FI;LZH%*^C?75U"^9[37B;TAAZ^3 M[&6=7\)%02F%4AE\J]`WF>#ZWRMHNB<5G&+"'G;&U@@U)\%Z%X_GXKER]:\5 M5%!US^@9D-AKVP4CX4]*_8G4.&_Z`PC^QWS">2,6U"4]/EA*VX'`&W,J,9A- MUIF(8P**,O<9RPAMKH0GB[7QGB&O@N5`;WL99(TFNJHYM-9Y5@,-MI>P41\N M%F>T.I/M4]!()!>1L2\4.+Z?=-UJ_B.#LX58AC^H14&3VE!T^O@KMMW&1':X MK=&M.L)U"M1S/3F:4>TI(]L_0);@8X&[]_(7[^BLN<6@YZQ3]%)YY)(B3FAI M?Q<.>-K\#G*$=3($_4(X&4P/XYMWM9S&RS2[T;#Z<\]0)X@L8C/:9S]7\+46 M1KXC5H>G/>.0&M76D-TZ=3G7]O#Y_;\`/R+P&?W4Y(8['*NK_C=:I+AH6:\X MZ*M8K]CLJZBD!T&J[8X+1ZZ%VK=)C(@P1G<))GN+PFR#D!'GDO$[BQ(0D=U8 MV\7OVTVHVFVL[C:8/`C.J`BFOJ9HR&W0TX/09%2QGS3JU&%S],/Q#2]H+V-O;&]N+V]N92]V+WJ_K;6N[@\*TWK!5 M65!`"!`D%@@D(0D)@4!"2(@)!)!;@`#B. M0BE)5XBV9"3)Y)DRN5@I25XN$H6FI8EV^28H1+LD"HEPJ9CV&\Q;`&.K<2Q=1BV"-@6'-N!83LQ;+<_MA?#YGA3P7@8@2W# MBO%@O`)_[A?G=XRWDJ?S%_IG^']+Y!+/^2OY/0%D@#;@<6!"X.=!:2*!MY`0 MM/C?;_#*D%!XI>W^]=N41]XN-8K-8B9^H$1*I>Q)4>,\"][L%O@3\7 MV\";$'$2X0F((53\`G-1?H8RXLAF&N6@<)2%(E$L+`B'0%CP8KS_!*NM)6)C MPL,00:.I>Q[#.[#P.S!#+,RO1)3,S@J@W-8-9[NANEOG"N8>-I%C$X*)><+) M(CXYJ@LX7WS4G$H9C$F6`@;-F(S0[LBU["L,T7&E`==@K:Z"6!26($&1=%:" MH[.ZM.$&Z%A89[;9]E$ZBZXXEW&;[T!N3FE!=J&F4!^2G594B-98`\FQ6Z`G MW$Z[\QX-GSA4OS.R35;"9\4%UWK^9^55`SDZ$>*S8M;Q+Q2W6E.H'%-ZL?ZM MCYQM>=9H8X@.REP!4KO8WDM5.:J=SK;>/`)Y M.65QJZPVM-$2\K-X2WF5XSH-BWKRMNNM^A+]6P,\)5(L`0] M1_%HM@WFMS`_`YTZ`<<(2Y4I`L8,CG,;C3CR63]G$8^%\0AXK"SL:.3 M%A@&8\YS@N;@^B\A^KZYGNPC-5PR^`GC]ZOEN;2QR%G>^0J^=E2S)@=!]D68 M+):">,+*;[,YLF9O%BE#8O\V##14;PS-##L4UXQU.0/^/! M]S\(DP[$)NZD(]('1K^]"^$PN\%MSF6UN459E+).W]K:W-#6*3^W#BU"C%=^ M'@IY++\Y_M?AKE9&D'H@^N>P8X14QV9#>M.""-L5^J_^@;2 MP/^,+5Z)?K,8[5K*DL?AX@-AC%BM5-,%QO(Z%TSG/O3`)M9<1I#9T89H4[0Y M4!MPN:386JQ44JH*^WR0`]RL%KSS&6AN\6`IE`E?G+@S>HEN/:Q1& M?Y@H9D&Q2)BX5RR-I,51+7?<9>ZR)K:ME("U+5\_>DCUIQV)]M*^AS:B^=N[ M/AA__=4K5Q4CV(B2FKB'7:!IQM'"$>[W#WG'.9'P)7_UY'HBR9B%!-OH?%-% M!5M5::NG6K-J]"7,`:M-8J'BG'UYG30$#<$:$+2Q]^`^`3C?V44@C'^^L@/" M_T77'"XVLH8"6S9E<&9VM32XW6[=P&84O!=M6)O%K.`+"L]H51QU_B?LJ@'[ M"9MAP)K5P=#WT/$/4DYZ.`D$"6,DBC0U;3265[.DMND15!ZG;L:59Z]Z%RW? MF\98[3"%V^9+6QZ5_Z?"J*)`7<#10T1W245>/I6KVV40,VC.I)48YG=#<-WE M@3N!;>XO@3A'NVH*M"SIR=N`>K.HS!I-URW/M0L]WC0,9SC,U:H&\H?@P6'/ MO\E!D`-?^&EBACJ?+C15E%=7]Y;6LL]AV&(GR,EDTWJ=Q.H5O5QA5K&RC>A0 M+)5CBS\SU'_Y\Y,,.:N=,PFG8 M!0W,$&[?IY+)Z5Q;K;.JXL_V2I9\`TNX$1_9W:C\J%_(3MFR5.C=R485)2N5 M]E\[>7;T//-+B+&N8.@=+GE$II+M7((WNM@4^6=JVJJWU[%D:A3BF/ MQ*U?@=C06&]T-T#B@XB.-$061!9XYU\Z;,A5?8SRTA#!#O/[8&Z-Y_3=0#)Y MJ.?ZT[-THU.?PY+M2:'(HJ`R[.FG+QT_??L<(^AJ4L'8FZTWDZN#!S@>^05, MG]T'(;4#?[D72+;755P%7B=-?G$D]X"'KNJQ73@FKU-N_R,*VG*0-:JM]D&( M\9FHV6_Z)"_:Y%T6>U65HXKN+-/I"XND!2GL']``(>@R-'%+6X(!OW]ZY*B+ M?-,#"X1JM)IP\:N'&=&NRJ;&;^"U("K?T3^,RC M45*0'YL&G_&R%].VP?$_`^]PLK21IJ>UM3.GOGMX0> M#CR`O/?ZJP&P]Y<#][SX0!4[!J?RC9.)E(2)&8*-AX*'AF]H6UYJ>GJ";X2% M@HB&BX:,A0C5!D/[IP6'>WA.?!IMIX&?O[*WV+X>?I(%:W)H7'<;@(:3E(Z+ MC8R.'^/WX07?!@Z`P%BZ]_Z9G7>H=Q*UV?<]V1..$U;X8?<)%5]H;VAX&X"* MEI":F+>1GQ_:][\%009D('5,6D$($XY7:4PM8!MVB*"8CA_F]_^(C043KEE_ M68)9A0A]![2>BVX?<#_[D%\:7YY\K^75]Q'W!<\>C@833G0Y=S=Y&GR-9KB] MI:7FRAX.XHYV^#F8I'<2]QS2]SR^$[@3^*#X)Q75DHU[FS$(E5&8^S9#&GJ+ M?I2:G9_2S1X3N*RN]RGW1N<:L'.E:G=[?7P>5;669!I9._L+4E`>;&N$]QV% MW6WW&!F@AHJ*@1N&6GV`0A\.XH#"5-CWPM13PV:P$G#X;A.4^";W`Q5M<'=F M=AMWA*2;AQ^%I&GW')T:B\_W#:@>$Z2ADGJC&Z.5GIT?$Y2C=9=X5UQ..5<> M@,(%XWE\BW4;:TES@G`?$XR/?`63JYF.E!NFCWULE!^,AJW[&8(:^Q7F>=1MU?WE['Q.4@COQTCP=]F?A6E?=>F0C[;HSX'EZ>WQ]?G^`@8*# MA(6&AXB)BHN,C8Z/D)&2DY25EI>8F9J;G)V>GZ"AHJ.DI::GJ*FJJZRMKJ^P ML;*SM+6VM[BYNKN\O;Z_P,'"P\3%QL?(R+CY.7FY^CIZNOL[>[O\/'R\_3U]O?X^?K[_/W^_P(,`*WV?X$*#0IE M;F1S=')E86T-96YD;V)J#3,Q(#`@;V)J/#PO3&5N9W1H(#4R-R]&=6YC=&EO M;E1Y<&4@,"]&:6QT97(O1FQA=&5$96-O9&4O16YC;V1E6S`@,C4U72]":71S M4&5R4V%M<&QE(#$V+T1O;6%I;ELP(#%=+U-I>F5;,C4V72]286YG95LM,2`Q M72]$96-O9&5;+3$@,5T^/G-T'B`B(B(D)B8F*"HJ*BPN+BXP,C(R-#8V-C@Z. MCH\/CX^0$)"0D1&1D9(2DI*3$Y.3E!24E)45E966%I:6EQ>7EY@8F)B9&9F9 MFAJ:FIL;FYN<')RGIZ?'Y^?H""@H*$AH:&B(J*BHR.CHZ0DI*2E M):6EIB:FIJH**BHJ2FIJ:HJJJJK*ZNKK"RLK*TMK:VN+JZNKR^OK[`P ML+"Q,;&QLC*RLK,SL[.T-+2TM36UM;8VMK:W-[>WN#BXN+DYN;FZ.KJZNSN[ MN[P\O+R]/;V]OCZ^OK\_O[_`0,#`P4'!P<)"PL+#0\/#Q$3$Q,5%Q<7&1L;& MQT?'Q\A(R,C)29FYN;G9^?GZ&CH MZ.EIZ>GJ:NKJZVOKZ^QL[.SM;>WM[F[N[N]O[^_P?GY^GKZ^OM[^_O\?/S\_7W]_?Y^_O[_ M?___`@P`YZP_$`H-"F5N9'-T'1'4W1A=&4O4T$@9F%L7!E+U!A9V5S+TMI9'-;,38@,"!273X^#65N M9&]B:@TR(#`@;V)J/#PO4W5B='EP92]834PO3&5N9W1H(#,T,#DO5'EP92]- M971A9&%T83X^G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@] M(F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2(S+C$M-S`Q(CX*("`@/')D9CI2 M1$8@>&UL;G,Z&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N M8V]M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI0'0@061V86YC960@ M4')I;G0@4'5B;&ES:&5R(#DN,"XS,C4O5SPO>&%P.D-R96%T;W)4;V]L/@H@ M("`@("`@("`\>&%P.DUO9&EF>41A=&4^,C`P-RTP."TP-U0Q,#HQ.#HS-BTP M-#HP,#PO>&%P.DUO9&EF>41A=&4^"B`@("`@(#PO&UP;65T83X*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@(`H\/WAP86-K970@96YD M/2)W(C\^#0IE;F1S=')E86T-96YD;V)J#3,@,"!O8FH\/"]!6S$R(#`@4ETO M5B`Q+C$O0VY;-"`P(%)=/CX-96YD;V)J#30@,"!O8FH\/"]$6S<@,"!272]4 M>7!E+TIO8E1I8VME=$-O;G1E;G1S+TU3(#4@,"!2/CX-96YD;V)J#34@,"!O M8FH\/"]-92`V(#`@4CX^#65N9&]B:@TV(#`@;V)J/#PO1&U;-C$R+C`@-SDR M+C`@-C$R+C`@-SDR+C!=/CX-96YD;V)J#3<@,"!O8FH\/"]06S$P(#`@4ETO M1FE;."`P(%)=/CX-96YD;V)J#3@@,"!O8FH\/"]#4"A$:7-T:6QL97(I+T9I M(#D@,"!2/CX-96YD;V)J#3D@,"!O8FHO5&AI')E9@T*,3$V#0HE)45/1@T* ` end EX-32 12 c17407exv32wxpdfy.pdf SECTION 906 CERTIFICATION PDF begin 644 c17407exv32wxpdfy.pdf M)5!$1BTQ+C(-)>+CS],-"C$T(#`@;V)J(#P\+TQI;F5AF4@,S0O4')E=B`R-#0P.2]2;V]T(#$U(#`@4B]);F9O(#$S(#`@4B]) M1%L\,39&0C,V,#DV-3%",3%!0D-"-C-$0D1&1#4U,CA".#,^/$-",$)%040P M-C-$-$(Q-#`Y1#`S0D(Q0C=#,T9$,S5!/ET^/@T*7!E+T9O;G0^/@UE;F1O8FH-,3D@ M,"!O8FI;+U-E<&%R871I;VXO0FQA8VLO1&5V:6-E0TU92R`R,R`P(%)=#65N M9&]B:@TR,"`P(&]B:CP\+TQE;F=T:"`R.#4X/CYS=')E86T-"B]'4S(@9W,* M0E0*+T8Q(#$@5&8*,3`N,#`P-B`P(#`@,3`N,#`P-B`T.#`N,3,R,B`W,3`N M-#$X-R!4;0HO0W,X(&-S(#$@2DM,S(S+C$H4F5P;W)T*2TS,38N-"AO M9BDM,S$R+C$H6FEM;65R*2TS,C8N-BA(;VQD:6YG91<*2DM,S$U+CDH;VXI+3,P M.2XU*$9O2DT-RXX*"PI+3,V M-RXY*'!U&-H86YG92E=5$H*+3(N,#`Q,2`M,2XQ M.38Q(%1$"ELH06-T*2TS,C0N-BAO9BDM,S(S+C0H,3DS-#LI+3,Q."XS*&%N M9"E=5$H*,BXP,#$Q("TQ+C@P,C<@5$0*6RA<*#)<*2DM-3`P+C8H5&AE*2TT M-C@N-RAI;F9O2DM-#&5C=71I=F4I+3,T-RXU M*$]F9BDQ.2XV*&EC97(I751*"B]&,B`Q(%1F"BTR,BXX,#`U("TR+C,Y."!4 M1`HM,"XP,#`R(%1C"ELH075G=7-T*2TS,3DN-R@W+"DM,S(R+C@H,C`P-RE= M5$H*,C(N.#`P-2`M,RXU.3DX(%1$"C`@5&,*6R@O&5C=71I=F4I+3,T-RXU*%8I-C8N."AI8V4I+3,S,"XV*%!R*3,P M+C8H97-I9&5N="PI+3,R.2XU*$8I,S@N-"AI;F%N8V4I751*"C`@+3$N,3DV M,2!41`I;*&%N9"DM,S$Y+C7!E(#`O1FEL=&5R+T9L871E1&5C;V1E+T5N8V]D95LP(#(U-%TO0FET MF5;,C4U72]286YG95LP(#$@ M,"`Q(#`@,2`P(#%=+T1E8V]D95LP(#$@,"`Q(#`@,2`P(#%=/CYS=')E86T- M"DB)',,#D!`(``#`RZ[/QG^V[?ILV[:-R;9MV[9MV[9=.^W,!@3\%C&,*:QC&T]K&O_>SO``ZRYQK_O<[P$/>LC#'O&H MQSSN"4]ZRM.>\:SG/.\%+WK)RU[QJM>\[@UO>LO;WO&N][SO`Q_ZR,<^\:G/ M?.X+7_K*U[[QK>]\[P<_^LG/?O&KW_SN#W_ZR]]_!!@`O<)_`@H-"F5N9'-T M7!E+U1Y<&4Q0R],96YG=&@@ M,S,S,"]&:6QT97(O1FQA=&5$96-O9&4^/G-TL8##Q2#FKAJXIHE9319W>3KR9M*;0_9VK+>J^^/K^I]O^/] M/AQSD&$XCJLB5H8N#XGV7*/3:TUS0HQI2?:NNZC&Q>FN7RMPF0X7K=WJ3$]C]>E?)BIF94X6^,;X+_`RUX7CM<` M>PWPT00G&3_0:F+S3)E:O4D3;D@T\NE&/B%3F^2MT02GI6EB[!-,FABM203DK3Z!#Y58TS61.H,QLR\=*TF^#U-@B%IKI'7Z*1WIJP/ M3+HD70*OTYJ\7Q."X=+!7&38)#DV!<=<<&O2W'`G!L*8:% MX]A:#-N`8=,E1S`'C,3>P6(P$W99,F(M/B!SENEE(-?*SSB$.P@*N2);\0T1 M0>P@AD@/,I]\YJAU_,$IT*EE@N^$A@F_.,Y-^47 M4!A]YB`HKH&*^;OA2LC&%/WZR/Z"=K:^MJI6O?N3XH]BWXDQYG)*]!"6@"/> M"^5R.`;':%2.'*&/YP\.'#T\&"_MN?]^)3$3:RR MJ-WJVHZWP#R8!O/D#$&_DDJD6X(H/FL5FAF3P[83CXYW-'9?&E93C^]T M;E[E$\#'%W+Y)#5\-P,F)2!7QG>](9Z-TC]?J$[59VZ-O&WX1A+H`DK0C&X9 M"3S`48][VWJ$>\S8TA.>:,)BWT@#J]QQ62P!"A>=[LMAMMA/0P=Q$B@%&B7^ MC)Z/E-TMNZ%W/9-Y=D,T$Q">I6,C8[Y;KMZ2FVJ,N9YV#R)>@0S^]'S5U4T" M%W8T:I=/K:.RJ`U^[X-].7@[^`(+7G)QJW49C<[HD1M:@R(85`)0[.?5@('[O^[#I+$5MQ:< M9JE_GMO[X/!CAKIS(?$)\F*I,>1D:Z?O?-YQL(^]N>G:E@`FP^PS+T)_?815 MUF7#OKZ,5OB]3=4*7I):7^I41Q$-4O+=8`U$,%*\N`N^*$R+%J]EJ0OE*8Q3:D%D:5U'`[MB9 M7E:@7EYP%R3=7YH%".H1_Y*#?VH-E%M#!3J^LJ!KTZ_()#9/-1*(M_7I@[;I MUNYPY6&S0.JJXJN/,DU-Q]M'6,@B&E(/!:>$8?)*BL:Q5/"I$[$UTT#\D2 M\IKZ6-'BT&RQM)Y64]D/]J\*G9&5@!@.66Q.-(P2E!Y2:FX]?\0`X?;%P@:V MBJ2Z3^P&12O(&?!!6VIB672%)_HK3E2&,[9<,CJU/+:457Z9.VAUZL1/0:CH M)\BM,\"+]O8/TB]2IP4VCB1PR4.ESRXQL*@'YH`'$(^0T_QN5H"B=((OWIZ= MGK'XE*\:):/IR`=M1BM!A?QA&TR^?_7AG7'[^&[Q59H/?OW"D, MJ2&H&>E\T(ZW5R"'^.U[CW'C%G;`Z2XXU#5NH1_XM0(A4#G4X28K1_]?:%1: M14PI2^7PXC_(8Y"DD#[.,W)&QFQU1&Y]+P=EY(O3>C2IGFN%[S.(0O1F7(:G MQ1$*R9-[:\Z!^C:/W)HEQ1MM7Q'*]5(@+KP&.$<`LH5Z03VT`PY4''\=D`>; M0(96)U9=9V`;":JFD(#/.`&^YXEM[Q8N0V]6.5(O_D"1MK(MTGT_VR*!#!%* M("64LP/0(>"_2!BEX">WF@5ZW23U_JI>>_\I3YXH/UD98:>R*K5L78E$Y:E`KMN57'.9@7PH1?ED='+Y.CO% M,5*)VLR"E1!P4$A`(B'0:VH2JX?L0#<'+0-5TL"7/-E?,?`_;4GE:^UQ?DG^ MX;\5$U3_`3\JW:J"'-I`(,7&6'_DJ0[+JAODQ#3R28?EEIW4OWFR;]P?ZH@] M>_J*V!*62N?%4=(>DZQLJZ_D:*^XM)?J:YH".0(17)?]MQ%&G"[%.%=<;>M1 MM(O?$H.[FD<^E::E\N2#TOJM*QETOI)$/XE+%"B%)W8W52P_SU%]-@,9;BQ9 M6<)*5N9V6J=VXMT0"K]"J%QTM7K0H#F"EB&/^:7H([0$+2F%C[X#CR.P##1< MI\-_6:S2H*:N*`S-)#=6I0PQ!5_J>_RH:^M86RDN.(Q:I16+"P@6#<*XL(B` MB6!D+TMX(1L($I80EA`R)+2HN*6,KC*;JQ'*E:A2JQ4?J#DMCXPG-D]Y=J,#`I"R<:OW/ MA4YWPT6)="`];=$0J1JF!SSBJ-I;8VVXK'E\.GD6OI^0B\'5G!B-]]4EA9;6 M(@ZU<$H^Z'SCA?<8U3!$8%K=:@I#I[A:Y36%21B6'N"CRNDZ7[K)5_6YML<, M;#E*8`?>ED.*(B"43H_Q!O5X#H`_Y>'D#<=4+T2#F*V&O7N)P6@LW)^U[?@R MC>HA;LK$#V*TYC"(7,+=V2._E7E>_R53;)R#4R0_5VT$^=@!+@O-'D6+O::U MW7LV_0\-K+L)4Y^#?^2U=">'L^_+5??#SQ@Z!IE;EX]=@G=O(%G=RDHL$R>Z M_2?\0DO])OPTI7ZPF8X@KDLF'G:K5]3HK<\842!#56^,;;A(Z5&80"L?'U7P MJ)5[%&VPZ$W-+W;EN$#"]::5$N-]E'"&"SY_M_^?\!D\Z)?Y-OH6JS%'I_BM MRI$>P^`U$FW"^90A'YJ!O)$[<[;IQ74&[I';G0V7Z]BW>VO+$P/=_BV^2)GO"ZF-3:?HY[NJ M,YDR4[6_W_E\_Q)TTXF9T]<12F+,OR:1K-">7E+@;N9 MZ7+4#E$TSW5D@!>2:\H@&I^%X&RR6&]:(SG*:VINAW*M3QE81R`6;K9U>^PN MV_2`T*)N<>8@1`G^]X"#<)@M<_I"U;T5KJIMS/C?#O+K%7G2N1]*O!I8\C,- MA2H(7CF&9$WJKH/Y'#@PGD`\#JD[ZIM/GM.,U"*S`1>F;5D?5SS0Q06$F@4Q MZ(Y4>XC69H&3B5Y!G6CN!DQ4*I[JJ*Y(HG!\V1K/I]:1L^5$]4GF"#Z:&Q.[DX_ MUW?B>']?>D]R4D9J"DOS=LE=^*=?&H<,KHDIZOFP7*>(FI>T/3Y)F7,)'Y(\ MBST<_#2_]P[UM7.Z!GE>:7YFEF:'Y70+!X.O:-05H",/E@A!#C%S/`.60Q!$ MJ,9$@Z`NMI?;RAIQ#AA"5*-C$-3:*3BZ[-,%C*"WYQW5>4R1V;SB8[;0%?O( MR;1TV@560)N>'*VJ*W/N@VGX30@&8R1?O=VHU,-R@>1;,LQNINVG1ZY.UIOH MS*LO5#H,M0653,'^JMQJ:80DP.#R+6[&?(<"V@^-Y]I(49,8?QB2FI2891'U M=1!HGL2VKSH8/#%E$G"3+5,"1'Z:[R/UOP(,`$V'TUP*#0IE;F1S=')E86T- M96YD;V)J#3(U(#`@;V)J/#PO4W1E;58@,3,Y+T9O;G1.86UE+TI/149"3BM4 M:6UE%LM,38X("TR,3@@,3`P,"`Y,S5=+T%S8V5N="`V M.3DO0V%P2&5I9VAT(#8W-B]82&5I9VAT(#0V,2]4>7!E+T9O;G1$97-C"]H+VDO8B]T+W1H"](+T(O M:'EP:&5N+U@O3"]9*3X^#65N9&]B:@TR-B`P(&]B:CP\+U-U8G1Y<&4O5'EP M93%#+TQE;F=T:"`U-C8T+T9I;'1E879F`&$1AB$RZ\VN1KU3(B#J*8(>J"`JN0#B$SU88!$06-Q= MV"6(O%%8'HH*B+@2'D$4Y"%(%"UC$HTBX,42_,&2H'S`+'CYC6J)/3-'&[8W6* M/T3-5RSR7+[T@TF[[&?K.6D]W16^T>I(E6)3FE:G2M0JUB=%J37):HU2IXIV M52A\$Q(4(9,(6D6(2JO2I(K>G]DHXK0*I4*G44:K$I6:/0IUC"(P+DFM2TM6 M*7S7*91)T6YJC2).C-.F1&KCHN.4FCB5UO5_*\%P\6!6.&9KA\W&L#D$-M\" M<\P56)#,`(C,6],B[5C?=@+[-]X`+X?OVVQ MU$)K,40L(:*(5Y(-DD+)2_+/9`ME1Y72&+V'KJ5'+9=9GK.:;W7$ZIGU:NN\ M:7;3---NV*RWJ;)Y:?N9U%U:9.=DM]G./#UV^CG[!?8U]L@ARZ&?6<*4.2H< MZUD9^]QII].@0JJ0:LW+]7CO,P)ZS#VZA4L`!\.^/C!'8.\JF_]O>`S MF>DS8!7"C4@]ET/E+BM]@WBI(A^PY:D.X-[)1#Q!LUBFMOG8-P/WN2?!53I- M_+Z(J+;LQO)#Q<6E?'%9:7&)C(DH+R_(,:3_9;U2+M7"EIMX)Q01G7",#82B MF[14D04$?@\(`NRS6!NL]EQ-^YF]C8F)<>56MZK5SJ79YJ]M?C.7"9@/-B MA0$42ON7/WF'DF8TFAT:\?K74/6:@%(SSX)C"2I;YUV(\I`C@K M>N7"]W1N"0IP)S/H3_J,QDI9JW%OJGQB.^T;4QAXKN3O$!O@ MD8#>B^*K#Y!-U=T/1V5#;5NVN?F$N2>)Q4+ZQEM"L-ZA\CSD/60,0@*DLW.% MX'`*W9X()C="*\U\AKQ&:,8`7N,T"KC%HCP*_M2DU,SZ4-X'T#0$[ M05'IX1%S:G+)JRTG3_?+()%".R;&R'X*8LVS29&-6=KDT#?L-P3JNZ'#S!C$ M0C_+O`#:LSO1E_/;J0Q,)T7OQH10M(KMY. MO8ZXUW)FY-KIQ]VON.$/!Q"Y=-[F>2O.QSWU%0,]UD4F+.&8D7SQD).:4B'W@B!IPIM?0=[WQ(T4%LI/P#P(@5@.O%R` M1';(R0MAR-GS(K($[LKG)]M[^)+"?$VH./0%4[Y")4+_##V%HB$)JW4:YS3#QX7I198& MV&&B4W<:NRM*CQ^JDE\$*Q*JJ2X7\G!&57PZ%Q-?%,,;X`@]L5^4(:"A"2Q1 M$RF%FQD]P@_G_JOG[JB@SL!KUF-TR586@7 MOFTWF!S^.2Y0@#,))YR@G8(;CV`;.(,.+08CUF9E:\4Z74%#M58::WF044`TIGM4RQNH@_`^.=%$,6T&^F9!?;[W M)+=5NIR-(C>]06BGI1`F/M1??TU^I*Y[*OD;02M*C(A/^V2GZ3UE:*Z(WUQ> MUL##S-_B/_D%WX_VS-SG^<<+D!&=,U,I#V:8!#B*A#VVE?0ZD+)N$.&.BI_Q"$'V_LFKX,&]" M9PST4/YQL%`CQ,GG>"*Z;]45WE44V<6+Z9Y M'QUGM(?TB;[G>8]6K6W=F;:(ZZA4P2KBA@B(*,HB@J(L(22!($0P!,(F\`)A M$2$$$62IE:((N):.6\45C6@=[1F=*95ZG^?#F?D2>YR9D_=/SKGW^_WN=W_W MN_=2B_1["V_;#KM;G7<]FSB=E*/[^TN2[3GS2%9\23I$O>J8^&_BY#$H`8MX MDNXK.7C;0$Q;Y*A?6Z3R8(9#T`:E:B^WO=JZC(U61,E5N4G&1#[Y8+6ZC:V! M#[/!UZ8C0`)2X`"@)O%;1X$7JWQDB0('=B'IGDY\;=L0*'`$?8V?P MXAO?Q9))/\%ND(.D?W`0)'.P'.^>Y(HEM@/Q4A-,-?_OH:]6XS_3,_1KZ@*; M%"6^G:FECO!.,4Q_`;N9_\-X#R<2#&[ZTSU<^SJIZVT8LP,8MKAO MSM)VJ$0R,A`H.X5=D&BCP)/Z(MEJ;82CMA(@E-2D!)Z]FFRBM^KWEL75X*V0 M._94(8PY!`P#T[%[A2N'S92L7XZNI@FIORO20 MBB](X0M*]FPX0!R@S05YIUO!.0./PQ/P9YEN!TAE!)`K?-7J<&T`5+](Q+5D MCHBG4C*UL;OVK&]8QBW;*339<9,;\+P8C:1#RB@C]$I<,"Z?`%*ATOD!XBKT%E MC0E&L%W#&=2BC-B9-L5^BVRI/RZ^,CF\&(37QR6O;`T+*^74U?V'%"X,KD)S M-#O4<5Q@])K(^2Q>K`.^EX?K-AG?L/^90(#Z0B-?`@UX<)U^.G5E<2(D>XF]28;@*)>"%TL/4 MI>*BO\($%F*H8:_AWZ1*\0(Z1(:<40\U9T`;#_,..34]6GH?/NF7#4$+C*:C M,I)W*CEMZDYU'!L:;6GG]:CA8`],.(4E%NRR'3945?(%6$!C+L;(C=>TI2SAO)!O";E]_'C&9\>P,[>H^ MW7*DB5MB:#M0QAHM61UM_"A-O3CR>Y@M'$]PNF*%A$>R?C)%W:#/Y/26U;-_ M:YPXW2L)2S':XU%\E'=+HD.'=I^$E>?`]?'+-8#PGQ;ZKHY-YS*AF]+JI;+A M`(6_*D#MF(2R<@MUN>QQ77P43Z+]492:':IO2<2/8";M%Q$:O(1U6WJ3=)') M3RQ-IPV)4?E\;EQN7&G,8?VX.KW15,64J2U1%9QQ3Y`0QI(F[6@K)->7R^_V M__`-4%V$=J?.*/ZA]@WQF@%(L,J.PM-!.FS?MKU;6*\E/?`IC+_$;DL MCY=%PQ1<0WMJ=>6MC-B+;%Q/V;ANM'/-?\L5ST3F'5$EP2Q^=RI&V!D'PX2$ MYKZFIIHR7N]-Y61(9=&G32>,WY4ZDK"N0'0]H$:'ZBL2<2K,ID-C@Y>YLEYS M6N&K9!YZ*7!.\>BSH=:I M]FKT_7GGP>]63:VLST7VC)'O2EYJK&`2-F=L5I%RV;'_/3'4YVSP6NG:";%Z"D1'U^ M/#%T$4+B\L/9A5,"\,C5#9O.Q?"RZQ6N\W1J!;/K<'*-FI/=%ME_6*20&\LT!BN,Q"`6@[`2#QZE7_DQO`W`_`URPRT&TM%WKVNW.;)8W^T0*[UUQ*+<#1J M'@$>?;`[`3X<=+H]^*55-D0F$(U`+V,U,_5OP<[2=R%WT5 MOBK_-W(OR"IFFW.3@OCA>+1^7Z9G"F>/\J6-R7.KK*EB#*0(U.IL1?Y91OS9 M[OZ+S=W7[E[T7_<8M"Y1[4,ZO>A._)V+TSJ=!JRPPO9],%[6,?"`]HS*##E` M+G*/@,*S=N@[&#B*#">ZKG26;O/BCKI,R-Z<1BEX!B]-+->5EUE61,07VJ%Q/F>:_:&\^UI>QL6\ZN MWQH9Y,/?0&F$;/\F1:`R4.VH0/K\PC<)L2^LA*&FV^FN%3RLLF_O/J9]E.I` M&WBX@#9DJXQ'&++&-1VSE->QY\K"O'F\'2V,T8;:++81I>0D"^T,)"(8[5&S MR6=[^"9_[HX=[I8-+L@.EW/P+9RF5G2M=3`_AI+'$L@4@VG,N),5;S1F'T\$ M&J9>!?X?,&G:0^S,EPY[T_B/L;"B[T5WY_=/3A&S]_$$S^U^_"@<50:KZT5' M(?6\TPTKQ`W\A_(J?VKJBL)031YM+:T\TL)[XWOM3+55.U7IM.ITM$BI(],1 M-ZK()K*'1<(6`GF!)&9?2,A&%D)"PA9!ELBFC,I2%'%<<*Q.'931<5KKTFK; MF?N:&,,;!-2 MTM']3 M?2Z)+BZI.$/-,]T#.(@TPF^J8<(F07%*QJ@OQ-T*]L_1*[N5M5'^^T"XA#X% MK^AMG/:\:GLJ#E>NA6]!`JZ_E?AP;F$DT$H:83+[L*@Z7L4D)G8@6=8ZPP3& MC"G300:9BI4`[W$T)5KA(4&$K*Y>3>%Q>8]_)QG,]Z9N+C[6)9:'/HQ.\->S MI!;I?-3M)73N]A+G@%"5(F$>0.9$4O5NL\ M5278_@PA=ZW@P60C(62C^7"C'4&[+,V&IA9+!.;W!Z;)R_NIV9-,EY>D5O^`(C\F9&Y-.$&"X',D4C+; MZ*`_=$3=6`([F99&!7356M=HW@($G,*X>65`;^+D8.@X;D6*91'J_!H!'YY->J8?>$(1@D1D=96Q"]FH4*SK0..:8< M$9$F/OV3,[R-SEI&5X2,B:38'9IV:356F`@W#0>N;-L(/$)I/R[([)=>J4%-UE\73821(-?_!=,KI--H77$Q`>3?+#= M&>Y]^?4R^AJ#3R%^A4=9A37*>>)*8A.L_!84LZB@W.;&>CJ:^HP,_A$*&5;8 M9(.0M1&FQV2"Z+T`[<>Z?09?B'T7A72HS0V>=(##QS%ID9-QNL01<)"/"G<]!H]9IBG0@C$R#`9WPFO)7.60:F;W(,BI9& M"N-+E:4A(ZU:3-X6VV M$'?`^RS&O9'KARGV+TZET2`21M*)#QB&ZR$"&AFJ4PR MEQWKZM?Y=`Q-C@BQJSL5+96`#34QCM*)#10FS(7$(0+E-92Z>7BF.E].HH,5 MOI*SM\:N`.P<`;ZDOW`RAFO7QT;"S[W`Z`42+S!XHQ8F!2_6,P[]+&.F\3Q* MQR^`?DY:S[[K!PGT7S&S,"UW"8]BAXN.I:4(_#;"?M)Z$FNE_,45Y76%^^>R M[SP=GY^?J>A+FB'TS#S^'7__^-C\5>Q"SE3Z*0*N`BQ6I5=ZPH/YVLY<)-!_ MPDZW4W6DC$N58"++L:%^ES\PFQS\,6%G_N9=(T73F82::4X1;49"1-CZ43_*]E9W#V$30'2`B']`_@#`8!I3:VJC18!X@'X4" M.HSN`AN8)69%6)ED:U(BMF6VP=?1YQP]56BMD"DT&A6A4:HT:EPF,UK:7.-7 M1D@T`52UO<'YU\Q*ACDL*@#(O."C4$!34._/]`\,3,!Z]\H-[-X^>W5E,96= M.R#I-!EUNB9"9VC2Z7&322$5"+.2CI*H"L@%;W`^4N1XNZ,\0Z>0'4A1B1(!7OUBE5TC2E>'-ZHER1(5=(5-*DI6)Q:&JJ M>)=O@E*\2ZJ4*M3>TW>FQ#*E6")6*21)TC2)XC.Q/%F\398N5^DRI.+0C\62 M]*1E,MY>G^1?[K_MT0. M\9R_G-\30`9D!SP.C`_\/"A5+/`6$D$V_K<;O#(D$EUINW_]-N51M,M,$HN$ MB1LHEE')>Y(UN8P`KNL&N#<]^"WPYV(:>.-B3BHZ`=&$FI]O*2_&^D^PV;5$3'38)D30:/*>Q_`>S/\.+!`#P M`BBW=\/9;JCNUKN$W,,F\O6X8'R.:**03X[J`\X7';6D4$93HC6?0=,FPK.W MYUCW%03KN=*`:[!:7T$LV!0O11%T9GQ)9W5IPPW0L[#&8K?OH_16?5$.X[;< M@1Q=:7Y6@;;`$)R56EB`5MD"R=>WP$"XG0[G/1IVEJA_8V*;;(3/B@NN]?S7 MRJL&VJ*P&MMXR`KFZLM@5-CM:9PW^6;REO*KD.@T+>G*W M&6R&8L,[`QRNZ^;^W8U?'>-"QWCC.[@/1;`.^0^C*>ACI$7IWG1W`;7G":@@ M"LP0RTQT(HL(9KZ!8=CW34_8W4_^R1LB"M?S&VW]1>F4/#ZT0,^@_>@[PL+?PGUB&NHJO>`,=J%" M?<"0N<3B1M.>3-3/:N1S01PB#CL;.SII@7$P^CPG:!;6?PE1]RWU9!^IY9+` M3Q2W7Z/(H4V%SO+.5_!U235K+B'(OG"SU9H?1]CX;=:#1^-I%(R6H!UH?GK) M!V]8OD2,B"HO4T; MO7`A2IV3<;#A(B-X9NSAV":\XRDHGO'@^Q]$B0=B$G;0X6D#H]_>A3"8V>"V MY+#9.869E*K.T-K:W-#6J3BW!BU`C%=^#@I^K+@Y]I?AKE9&D'LQZBPWO07V MUS=HA'7/8/N(N8[,@C4G1.'V*_5??0.IX'_&'J="OUJ(=BUFR>-P\8$H6J)1 M:>A\4WF="Z9R'WE@`VLI(\BL*&.4.44J124>H*QWR0`]R, M%KSS&6AO\6`QE(E>G+@S>HEN/:Q5FRS>?Y@@84&Y0)2P5R*+H"61+7?<9>ZR M)K:ME(#5+5\_>DCUIQZ)\M)^@-:AN=NZUH^]^>J5JXH1K$.)3=S#+M`VXVC^ M"/?;A[SCG%CTDK]R8BV1:,I$@JUTGKFB@JVJM-=3K9DUAF+F@,TNM5*QSK[< M3AJ"AF`5"-K8>W"?`)SO["(0QC]?V0%A_Z1K#A>96&.^/8LR.C.Z6AK<;K=^ M8",2[D4AJS.997Q!P9EL-4>=_PF[:L1^PJ89L6:-$/H>EOR=5)`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`%("K?T3^,RC45*0'YL&G_ M&R%].VP?$_`^]PLK21IJ>UM3.GOGMX0>#CR`O/?ZJP&P]Y<#][SX0!4[!J?R MC9.)E(2)&8*-AX*'AF]H6UYJ>GJ";X2%@HB&BX:,A0C5!D/[IP6'>WA.?!IM MIX&?O[*WV+X>?I(%:W)H7'<;@(:3E(Z+C8R.'^/WX07?!@Z`P%BZ]_Z9G7>H M=Q*UV?<]V1..$U;X8?<)%5]H;VAX&X"*EI":F+>1GQ_:][\%009D('5,6D$( M$XY7:4PM8!MVB*"8CA_F]_^(C043KEE_68)9A0A]![2>BVX?<#_[D%\:7YY\ MK^75]Q'W!<\>C@833G0Y=S=Y&GR-9KB]I:7FRAX.XHYV^#F8I'<2]QS2]SR^ M$[@3^*#X)Q75DHU[FS$(E5&8^S9#&GJ+?I2:G9_2S1X3N*RN]RGW1N<:L'.E M:G=[?7P>5;669!I9._L+4E`>;&N$]QV%W6WW&!F@AHJ*@1N&6GV`0A\.XH#" M5-CWPM13PV:P$G#X;A.4^";W`Q5M<'=F=AMWA*2;AQ^%I&GW')T:B\_W#:@> M$Z2ADGJC&Z.5GIT?$Y2C=9=X5UQ..5<>@,(%XWE\BW4;:TES@G`?$XR/?`63 MJYF.E!NFCWULE!^,AJW[&8(:^Q7F>=1MU?WE['Q.4@COQT MCP=]F?A6E?=>F0C[;HSX'EZ>WQ]?G^`@8*#A(6&AXB)BHN,C8Z/D)&2DY25EI>8 MF9J;G)V>GZ"AHJ.DI::GJ*FJJZRMKJ^PL;*SM+6VM[BYNKN\O;Z_P,'"P\3% MQL?(R+CY.7FY^CIZNOL[>[O\/'R M\_3U]O?X^?K[_/W^_P(,`*WV?X$*#0IE;F1S=')E86T-96YD;V)J#3,Q(#`@ M;V)J/#PO3&5N9W1H(#4R-R]&=6YC=&EO;E1Y<&4@,"]&:6QT97(O1FQA=&5$ M96-O9&4O16YC;V1E6S`@,C4U72]":71S4&5R4V%M<&QE(#$V+T1O;6%I;ELP M(#%=+U-I>F5;,C4V72]286YG95LM,2`Q72]$96-O9&5;+3$@,5T^/G-T'B`B( MB(D)B8F*"HJ*BPN+BXP,C(R-#8V-C@Z.CH\/CX^0$)"0D1&1D9(2DI*3$Y.3 ME!24E)45E966%I:6EQ>7EY@8F)B9&9F9FAJ:FIL;FYN<')RGIZ? M'Y^?H""@H*$AH:&B(J*BHR.CHZ0DI*2E):6EIB:FIJH**BHJ2FIJ:HJ MJJJK*ZNKK"RLK*TMK:VN+JZNKR^OK[`PL+"Q,;&QLC*RLK,SL[.T-+2TM36U MM;8VMK:W-[>WN#BXN+DYN;FZ.KJZNSN[N[P\O+R]/;V]OCZ^OK\_O[_`0,#` MP4'!P<)"PL+#0\/#Q$3$Q,5%Q<7&1L;&QT?'Q\A(R,C)29FYN;G9^?GZ&CHZ.EIZ>GJ:NKJZVOKZ^QL[.SM;>WM M[F[N[N]O[^_P?GY^GKZ^OM[^_O\?/S\_7W]_?Y^_O[_?___`@P`YZP_$`H-"F5N9'-T'1'4W1A=&4O4T$@ M9F%L7!E M+U!A9V5S+TMI9'-;,38@,"!273X^#65N9&]B:@TR(#`@;V)J/#PO4W5B='EP M92]834PO3&5N9W1H(#,T,#DO5'EP92]-971A9&%T83X^G)E4WI.5&-Z:V,Y M9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM M<'1K/2(S+C$M-S`Q(CX*("`@/')D9CI21$8@>&UL;G,Z&UL M;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*("`@("`@ M("`@/'!D9CI0'0@061V86YC960@4')I;G0@4'5B;&ES:&5R(#DN,"XS M,C4O5SPO>&%P.D-R96%T;W)4;V]L/@H@("`@("`@("`\>&%P.DUO9&EF>41A M=&4^,C`P-RTP."TP-U0Q,#HQ.#HT,2TP-#HP,#PO>&%P.DUO9&EF>41A=&4^ M"B`@("`@(#PO&UP;65T83X*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H\/WAP86-K970@96YD/2)W(C\^#0IE;F1S=')E86T-96YD M;V)J#3,@,"!O8FH\/"]!6S$R(#`@4ETO5B`Q+C$O0VY;-"`P(%)=/CX-96YD M;V)J#30@,"!O8FH\/"]$6S<@,"!272]4>7!E+TIO8E1I8VME=$-O;G1E;G1S M+TU3(#4@,"!2/CX-96YD;V)J#34@,"!O8FH\/"]-92`V(#`@4CX^#65N9&]B M:@TV(#`@;V)J/#PO1&U;-C$R+C`@-SDR+C`@-C$R+C`@-SDR+C!=/CX-96YD M;V)J#3<@,"!O8FH\/"]06S$P(#`@4ETO1FE;."`P(%)=/CX-96YD;V)J#3@@ M,"!O8FH\/"]#4"A$:7-T:6QL97(I+T9I(#D@,"!2/CX-96YD;V)J#3D@,"!O M8FHO5&AI')E9@T*,3$V#0HE)45/1@T* ` end GRAPHIC 13 c17407c1740700.gif GRAPHIC begin 644 c17407c1740700.gif M1TE&.#EA<`!/`,0``$&GQX#$VO#X^^#Q]J#3XS&?PM#I\2&8O6&UT!&0N9#, MWG&]U;#:Z%&NS,#B[`&)M/___P`````````````````````````````````` M`````````````````````````"'Y!```````+`````!P`$\```7_("2.9&F> M:)H*3FNH<"S/=*T*3``<`!#\"$`!@%"\;,BDTB8@-`H+AT!E4#P7@Z5VNQ0$ M"H&LC=!S<,]HE+=`V`Z"Q[1\ZP"G'8#%=,ZW+0!B<@H%<7V&:G:&!@!MAXXD M!@4,CP)LCX\&!PPMG)V>GZ"AG):7?94&`0^JJZRMJD*NL;&,I7.5DZFRJP<+ M#'L`NL$(M[5I12*YL@!F)`[!P5D"!X'%2PP`(\FM!Q#: MJP$HSN"N">@0"PKE2O0DZ@F-)]_OK.Q(G+-G8\"!$MH2%"I!X%^K>"8(!"0X M`P$_9*PNFCC@$""*`O(HKCB(<)V*AAU5_T$\(5%D#`7U2CXH`(-CR@8H8@.WG`P0W$A#5:(*!.*41<^9[D#0;4:,J:&(M M@?3$EZA390`(B57L3ZU.;X)5$:#;6`A-?W:%,$#JS4DR",!5*B`O0A4(B!J& MX6#BV,8H`)\80/2!71@#&MP5`5GG4<4V%BOM3,-`Y:!9A"$%+)CQ( ME(0BF+;*8CN)F"%;ZOQC8`D&0-@?6=;I1D"#E*7%DHTWCA")BR,L0T)B--5!$`Y(K9H`@@&2(@F1)8`P20GRM-,?#.:IYYY\]K!`)@.ZB$"#BAP0*)W#..*`H6C",`A\9WPQ M9Z/-%#"8&WE0.H,`;N*&Q!J>:HH"4T8J$28IHMHPW`$*0*J3$ZBFFD033Q3A MP'8.Y"#$G[*F88!$>RY0UZ2]%FOLL<@FJ^RRIHK2R0`#@#(%"YZ(,8#_1$9` MH@!X\ACPR3@_^#("#@%DRU(#!R"(Q3B?H-/"5JL4\&8K65#8"C-#L3*-EZHT MP$)^^XP[)@$$`$P`IZU@-P)3JM1C[P,!U=@*`08\G`!@N2C(KRK`(:=*-^$` M>4`!#Z\22(PDN\(+D,3UM ~~-----END PRIVACY-ENHANCED MESSAGE-----~~

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents